[
  {
    "text": "At 4 hours losartan blocked 43 of the Ang II induced systolic blood pressure increase valsartan 51 and irbesartan 88 P001 between drugs",
    "triple_list": [
      [
        "Ang II",
        "CPR:4",
        "valsartan"
      ],
      [
        "Ang II",
        "CPR:4",
        "irbesartan"
      ]
    ],
    "updated": "No",
    "original": "At 4 hours losartan blocked 43 of the Ang II induced systolic blood pressure increase valsartan 51 and irbesartan 88 P001 between drugs",
    "simplified": "At 4 hours, losartan blocked 43 of the 46 systolic blood pressure changes. After 4 hours, valsartan and irbesartan stopped working."
  },
  {
    "text": "The results of this study show that the first dose of irbesartan given to healthy people causes a greater and longer lasting Ang II receptor blockade than valsartan and losartan in normal people .",
    "triple_list": [
      [
        "irbesartan",
        "CPR:4",
        "Ang II receptor"
      ],
      [
        "Ang II receptor",
        "CPR:4",
        "valsartan"
      ],
      [
        "Ang II receptor",
        "CPR:4",
        "losartan"
      ]
    ],
    "updated": "Yes",
    "original": "This study thus demonstrates that the first administration of the recommended starting dose of irbesartan induces a greater and longer lasting Ang II receptor blockade than that of valsartan and losartan in normotensive subjects",
    "simplified": "The results of this study show that the first dose of irbesartan given to healthy people causes a greater and longer lasting Ang II receptor blockade than valsartan and losartan in normal people."
  },
  {
    "text": "In humans , long-term use of the beta 2adrenoceptor agonist terbutaline can cause the beta 2adrenoceptormediated cardiovascular responses to become less intense . This can be treated with the antianaphylactic drug ketotifen .",
    "triple_list": [
      [
        "beta 2adrenoceptor",
        "CPR:5",
        "terbutaline"
      ]
    ],
    "updated": "Yes",
    "original": "In humans prolonged administration of the beta 2adrenoceptor agonist terbutaline leads to a desensitization of beta 2adrenoceptormediated cardiovascular responses which can be blunted by concomitant administration of the antianaphylactic drug ketotifen",
    "simplified": "In humans, long-term use of the beta 2adrenoceptor agonist terbutaline can cause the beta 2adrenoceptormediated cardiovascular responses to become less intense. This can be treated with the antianaphylactic drug ketotifen."
  },
  {
    "text": "beta 2Adrenoceptor cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure induced by an incremental intravenous infusion of the unselective betaadrenoceptor agonist isoprenaline beta 1adrenoceptor cardiovascular function was assessed by exerciseinduced tachycardia",
    "triple_list": [
      [
        "betaadrenoceptor",
        "CPR:5",
        "isoprenaline"
      ]
    ],
    "updated": "No",
    "original": "beta 2Adrenoceptor cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure induced by an incremental intravenous infusion of the unselective betaadrenoceptor agonist isoprenaline beta 1adrenoceptor cardiovascular function was assessed by exerciseinduced tachycardia",
    "simplified": "Beta 1adrenoceptor cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure caused by an incremental intravenous infusion of the unselective isoprenaline beta 2adrenoceptor cardiovascular function was assessed by exerciseinduced tachycardia."
  },
  {
    "text": "OBJECTIVES This study examined the effect of a smallmolecule direct thrombin inhibitor argatroban on reperfusion induced by tissue plasminogen activator TPA in patients with acute myocardial infarction AMI",
    "triple_list": [
      [
        "thrombin",
        "CPR:4",
        "argatroban"
      ]
    ],
    "updated": "No",
    "original": "OBJECTIVES This study examined the effect of a smallmolecule direct thrombin inhibitor argatroban on reperfusion induced by tissue plasminogen activator TPA in patients with acute myocardial infarction AMI",
    "simplified": "OBJECTIVES This study examined the effect of a smallmolecule direct thrombin inhibitor in patients with acute myocardial infarction (AMI) on reperfusion caused by tissue plasminogen activator."
  },
  {
    "text": "In vitro and in vivo studies have shown that argatroban has advantages over heparin for the inhibition of clotbound thrombin and for the enhancement of thrombolysis with TPA",
    "triple_list": [
      [
        "argatroban",
        "CPR:4",
        "thrombin"
      ]
    ],
    "updated": "No",
    "original": "In vitro and in vivo studies have shown that argatroban has advantages over heparin for the inhibition of clotbound thrombin and for the enhancement of thrombolysis with TPA",
    "simplified": "Studies have shown that argatroban is better than heparin at stopping blood clotting. It can also improve thrombolysis ( clotting of the blood) with TPA."
  },
  {
    "text": "At clinically relevant concentrations , candesartan is an effective and long-lasting drug against Ang II and other blood vessels .",
    "triple_list": [
      [
        "candesartan",
        "CPR:4",
        "Ang II"
      ]
    ],
    "updated": "Yes",
    "original": "At clinically relevant concentrations candesartan is an insurmountable and longlasting antagonist of the vascular contractile responses to Ang II",
    "simplified": "At clinically relevant concentrations, candesartan is an effective and long-lasting drug against Ang II and other blood vessels."
  },
  {
    "text": "In both vascular preparations candesartan caused a marked decrease in the maximal contractile response of the angiotensin II Ang II concentrationresponse curve",
    "triple_list": [
      [
        "candesartan",
        "CPR:4",
        "angiotensin II"
      ],
      [
        "candesartan",
        "CPR:4",
        "Ang II"
      ]
    ],
    "updated": "No",
    "original": "In both vascular preparations candesartan caused a marked decrease in the maximal contractile response of the angiotensin II Ang II concentrationresponse curve",
    "simplified": "In both vascular preparations candesartan caused a marked decrease in angiotensin II concentration. Angiotensin II concentrationresponse curve"
  },
  {
    "text": "The functional inhibitory characteristics of the angiotensin II type 1 receptor blockers ARB candesartan irbesartan and losartan and its active metabolite EXP 3174 EXP were studied in rabbit aortic strips and rat portal vein preparations in vitro",
    "triple_list": [
      [
        "angiotensin II type 1 receptor",
        "CPR:4",
        "irbesartan"
      ],
      [
        "angiotensin II type 1 receptor",
        "CPR:4",
        "candesartan"
      ],
      [
        "angiotensin II type 1 receptor",
        "CPR:4",
        "losartan"
      ],
      [
        "angiotensin II type 1 receptor",
        "CPR:4",
        "EXP 3174"
      ],
      [
        "angiotensin II type 1 receptor",
        "CPR:4",
        "EXP"
      ]
    ],
    "updated": "No",
    "original": "The functional inhibitory characteristics of the angiotensin II type 1 receptor blockers ARB candesartan irbesartan and losartan and its active metabolite EXP 3174 EXP were studied in rabbit aortic strips and rat portal vein preparations in vitro",
    "simplified": "The effects of ARB candesartan, irbesartan and losartan and its active metabolite EXP 3174 EXP were studied in rabbit aortic strips and rat portal vein preparations in vitro. ARB candesartan and losartan work differently."
  },
  {
    "text": "In addition when candesartan was given to conscious rats the inhibitory effect on Ang II induced blood pressure responses persisted during the 24hour period despite nondetectable plasma concentrations of candesartan at 24 hours",
    "triple_list": [
      [
        "candesartan",
        "CPR:4",
        "Ang II"
      ]
    ],
    "updated": "No",
    "original": "In addition when candesartan was given to conscious rats the inhibitory effect on Ang II induced blood pressure responses persisted during the 24hour period despite nondetectable plasma concentrations of candesartan at 24 hours",
    "simplified": "In addition, when candesartan was given to conscious rats, the blood pressure responses did not change during the 24hour period after candesartan was added. There was also no change in plasma levels after 24 hours."
  },
  {
    "text": "Dosedependent inhibition of platelet cyclooxygenase1 and monocyte cyclooxygenase2 by meloxicam in healthy subjects",
    "triple_list": [
      [
        "cyclooxygenase1",
        "CPR:4",
        "meloxicam"
      ],
      [
        "cyclooxygenase2",
        "CPR:4",
        "meloxicam"
      ]
    ],
    "updated": "No",
    "original": "Dosedependent inhibition of platelet cyclooxygenase1 and monocyte cyclooxygenase2 by meloxicam in healthy subjects",
    "simplified": "Meloxicam can inhibit platelet cyclooxygenase1 and monocyte cyclooxygenase2 in healthy people."
  },
  {
    "text": "In contrast , when 75 and 15 mg of meloxicam were given , platelet COX1 activity was reduced by 25 and 35 and monocyte COX2 activity was reduced by 51 and 70 respectively .",
    "triple_list": [
      [
        "meloxicam",
        "CPR:4",
        "COX2"
      ],
      [
        "meloxicam",
        "CPR:4",
        "COX1"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast the administration of 75 and 15 mg of meloxicam caused dosedependent reductions in monocyte COX2 activity by 51 and 70 respectively and in platelet COX1 activity by 25 and 35 respectively",
    "simplified": "In contrast, when 75 and 15 mg of meloxicam were given, platelet COX1 activity was reduced by 25 and 35 and monocyte COX2 activity was reduced by 51 and 70 respectively."
  },
  {
    "text": "Although the IC50 value of meloxicam for inhibition of COX1 was 10fold higher than the IC50 value of COX2 in vitro , this biochemical selectivity was not high enough to clearly separate the effects of meloxicam on the two isozymes after oral dosing and how much of the drug was taken each day .",
    "triple_list": [
      [
        "meloxicam",
        "CPR:4",
        "COX1"
      ],
      [
        "meloxicam",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Although the IC50 value of meloxicam for inhibition of COX1 was 10fold higher than the IC50 value of COX2 in vitro this biochemical selectivity was inadequate to clearly separate the effects of meloxicam on the two isozymes after oral dosing as a function of the daily dose and interindividual variation in steadystate plasma levels",
    "simplified": "Although the IC50 value of meloxicam for inhibition of COX1 was 10fold higher than the IC50 value of COX2 in vitro, this biochemical selectivity was not high enough to clearly separate the effects of meloxicam on the two isozymes after oral dosing and how much of the drug was taken each day."
  },
  {
    "text": "Concentrationresponse curves for the inhibition of monocyte COX2 and platelet COX1 were obtained in vitro after the incubation of meloxicam with whole blood samples",
    "triple_list": [
      [
        "COX2",
        "CPR:4",
        "meloxicam"
      ],
      [
        "COX1",
        "CPR:4",
        "meloxicam"
      ]
    ],
    "updated": "No",
    "original": "Concentrationresponse curves for the inhibition of monocyte COX2 and platelet COX1 were obtained in vitro after the incubation of meloxicam with whole blood samples",
    "simplified": "Concentrationresponse curves were obtained in vitro after the whole blood samples were incubated with meloxicam for a period of time."
  },
  {
    "text": "Before dosing and 24 h after the seventh dose of each regimen heparinized whole blood samples were incubated with lipopolysaccharide 10 microgramml for 24 h at 37 degrees C and prostaglandin E2 was measured in plasma as an index of monocyte COX2 activity",
    "triple_list": [
      [
        "prostaglandin E2",
        "CPR:9",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "Before dosing and 24 h after the seventh dose of each regimen heparinized whole blood samples were incubated with lipopolysaccharide 10 microgramml for 24 h at 37 degrees C and prostaglandin E2 was measured in plasma as an index of monocyte COX2 activity",
    "simplified": "Before dosing and 24 h after the seventh dose, whole blood samples were incubated with lipopolysaccharide 10 microgramml for 24 h at 37 degrees C/O. The level of prostaglandin E2 in the plasma was measured after each treatment."
  },
  {
    "text": "The production of thromboxane B2 in whole blood allowed to clot at 37 degrees C for 60 min was assessed as an index of platelet COX1 activity",
    "triple_list": [
      [
        "thromboxane B2",
        "CPR:9",
        "COX1"
      ]
    ],
    "updated": "No",
    "original": "The production of thromboxane B2 in whole blood allowed to clot at 37 degrees C for 60 min was assessed as an index of platelet COX1 activity",
    "simplified": "The amount of thromboxane B2 in whole blood allowed to clot at 37 degrees C for 60 minutes was measured. This was measured in whole blood."
  },
  {
    "text": "In distinction the preferential beta 1AR antagonist betaxolol and the preferential beta 2AR antagonist ICI118551 did not increase basal levels of DA NAD or 5HT",
    "triple_list": [
      [
        "beta 1AR",
        "CPR:6",
        "betaxolol"
      ],
      [
        "beta 2AR",
        "CPR:6",
        "ICI118551"
      ]
    ],
    "updated": "No",
    "original": "In distinction the preferential beta 1AR antagonist betaxolol and the preferential beta 2AR antagonist ICI118551 did not increase basal levels of DA NAD or 5HT",
    "simplified": "Betaxolol and the beta-2 antagonist ICI118551 did not increase basal levels of DA NAD or 5HT, but they did increase levels of other substances."
  },
  {
    "text": "The selective 5HT1A receptor antagonist WAY100635 reduced the increase in DA and NAD levels while the selective 5HT1B antagonist SB224289 did not have an effect .",
    "triple_list": [
      [
        "5HT1A",
        "CPR:6",
        "WAY100635"
      ],
      [
        "5HT1B",
        "CPR:6",
        "SB224289"
      ]
    ],
    "updated": "Yes",
    "original": "The selective 5HT1A receptor antagonist WAY100635 slightly attenuated the pindololinduced increase in DA and NAD levels while the selective 5HT1B antagonist SB224289 was ineffective",
    "simplified": "The selective 5HT1A receptor antagonist WAY100635 reduced the increase in DA and NAD levels while the selective 5HT1B antagonist SB224289 did not have an effect."
  },
  {
    "text": "UNLABELLED Entacapone is a potent and specific peripheral catecholOmethyltransferase COMT inhibitor",
    "triple_list": [
      [
        "Entacapone",
        "CPR:4",
        "catecholOmethyltransferase"
      ],
      [
        "Entacapone",
        "CPR:4",
        "COMT"
      ]
    ],
    "updated": "No",
    "original": "UNLABELLED Entacapone is a potent and specific peripheral catecholOmethyltransferase COMT inhibitor",
    "simplified": "Entacapone is an anti-psychotic drug. It works by inhibiting catecholOmethyltransferase."
  },
  {
    "text": "We found that 5HT helped 3HLarginine 3HLArg to be converted to 3HLCit , indicating eNOS activity .",
    "triple_list": [
      [
        "5HT",
        "CPR:3",
        "eNOS"
      ],
      [
        "3HLarginine",
        "CPR:9",
        "eNOS"
      ],
      [
        "3HLArg",
        "CPR:9",
        "eNOS"
      ],
      [
        "3HLCit",
        "CPR:9",
        "eNOS"
      ]
    ],
    "updated": "Yes",
    "original": "We found that 5HT stimulated the conversion of 3HLarginine 3HLArg to 3HLCit indicating eNOS activation",
    "simplified": "We found that 5HT helped 3HLarginine 3HLArg to be converted to 3HLCit, indicating eNOS activity."
  },
  {
    "text": "5hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures",
    "triple_list": [
      [
        "5hydroxytryptamine",
        "CPR:3",
        "endothelial nitric oxide synthase"
      ]
    ],
    "updated": "No",
    "original": "5hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures",
    "simplified": "5hydroxytryptamine makes nitric oxide synthase work again in endothelial cells. This makes them work."
  },
  {
    "text": "These findings show that a 5HT-receptoreNOS pathway is involved in the activation of eNOS by 5HT .",
    "triple_list": [
      [
        "5HT",
        "CPR:3",
        "eNOS"
      ]
    ],
    "updated": "Yes",
    "original": "These findings lend evidence of a 5HT 1B receptoreNOS pathway accounting in part for the activation of eNOS by 5HT",
    "simplified": "These findings show that a 5HT-receptoreNOS pathway is involved in the activation of eNOS by 5HT."
  },
  {
    "text": "The 5HT1B receptor agonist 5nonyloxytryptamine 5NOTstimulated 3HLCit turnover responses were very high from 0.001 to 100 microM .",
    "triple_list": [
      [
        "5HT1B",
        "CPR:5",
        "5nonyloxytryptamine"
      ]
    ],
    "updated": "Yes",
    "original": "The high affinity 5HT1B receptor agonist 5nonyloxytryptamine 5NOTstimulated 3HLCit turnover responses were concentration001 nM to 100 microM and timedependent",
    "simplified": "The 5HT1B receptor agonist 5nonyloxytryptamine 5NOTstimulated 3HLCit turnover responses were very high from 0.001 to 100 microM."
  },
  {
    "text": "These responses were effectively blocked by the 5HT1B receptor antagonist isamoltane the 5HT1B 5HT2 receptor antagonist methiothepin and the eNOS selective antagonists 00110 microM LNomega monomethylLarginine LNMMA and LN omegaiminoethylLornithine LNIO",
    "triple_list": [
      [
        "eNOS",
        "CPR:6",
        "LNomega monomethylLarginine"
      ],
      [
        "5HT1B",
        "CPR:6",
        "methiothepin"
      ],
      [
        "5HT2 receptor",
        "CPR:6",
        "methiothepin"
      ],
      [
        "eNOS",
        "CPR:6",
        "LNMMA"
      ],
      [
        "eNOS",
        "CPR:6",
        "LN omegaiminoethylLornithine"
      ],
      [
        "eNOS",
        "CPR:6",
        "LNIO"
      ]
    ],
    "updated": "No",
    "original": "These responses were effectively blocked by the 5HT1B receptor antagonist isamoltane the 5HT1B 5HT2 receptor antagonist methiothepin and the eNOS selective antagonists 00110 microM LNomega monomethylLarginine LNMMA and LN omegaiminoethylLornithine LNIO",
    "simplified": "These responses were effectively blocked by the 5HT1B receptor antagonist isamoltane, the 5HT2 receptor antagonist methiothepin, and the eNOS selective antagonists. These are called 5HT1B, 5HT2, and 5HT3 receptors."
  },
  {
    "text": "Here we tested the hypothesis that 5HT receptors mediate eNOS activation by measuring agoniststimulated 3HLcitrulline 3HLCit formation in BAEC cultures",
    "triple_list": [
      [
        "eNOS",
        "CPR:9",
        "3HLcitrulline"
      ],
      [
        "eNOS",
        "CPR:9",
        "3HLCit"
      ]
    ],
    "updated": "No",
    "original": "Here we tested the hypothesis that 5HT receptors mediate eNOS activation by measuring agoniststimulated 3HLcitrulline 3HLCit formation in BAEC cultures",
    "simplified": "Here we tested the hypothesis that 5HT receptors mediate eNOS activation by measuring the amount of 3HLcitrulline in human blood."
  },
  {
    "text": "Activation of endothelial nitric oxide synthase eNOS results in the production of nitric oxide NO that mediates the vasorelaxing properties of endothelial cells",
    "triple_list": [
      [
        "endothelial nitric oxide synthase",
        "CPR:9",
        "nitric oxide"
      ],
      [
        "nitric oxide",
        "CPR:9",
        "eNOS"
      ],
      [
        "endothelial nitric oxide synthase",
        "CPR:9",
        "NO"
      ],
      [
        "eNOS",
        "CPR:9",
        "NO"
      ]
    ],
    "updated": "No",
    "original": "Activation of endothelial nitric oxide synthase eNOS results in the production of nitric oxide NO that mediates the vasorelaxing properties of endothelial cells",
    "simplified": "When the nitric oxide synthase is activated, nitric oxide is produced. The nitric oxide is released and helps the body to relax."
  },
  {
    "text": "We have shown that caffeine causes the activation of the kinase Cds1 4 also known as Chk2 5 in the human body . ATM kinase activity is directly inhibited by caffeine in vitro .",
    "triple_list": [
      [
        "caffeine",
        "CPR:4",
        "ATM"
      ],
      [
        "kinase",
        "CPR:4",
        "caffeine"
      ],
      [
        "kinase",
        "CPR:4",
        "caffeine"
      ],
      [
        "Cds1",
        "CPR:4",
        "caffeine"
      ],
      [
        "Chk2",
        "CPR:4",
        "caffeine"
      ]
    ],
    "updated": "Yes",
    "original": "We report that the radiationinduced activation of the kinase Cds1 4 also known as Chk2 5 is inhibited by caffeine in vivo and that ATM kinase activity is directly inhibited by caffeine in vitro",
    "simplified": "We have shown that caffeine causes the activation of the kinase Cds1 4 also known as Chk2 5 in the human body. ATM kinase activity is directly inhibited by caffeine in vitro."
  },
  {
    "text": "Inhibition of ATM provides a molecular explanation for the increased radiosensitivity of caffeine treated cells and the attenuation of DNAdamage checkpoint responses .",
    "triple_list": [
      [
        "ATM",
        "CPR:4",
        "caffeine"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition of ATM provides a molecular explanation of the attenuation of DNAdamage checkpoint responses and for the increased radiosensitivity of caffeine treated cells 6 7 8",
    "simplified": "Inhibition of ATM provides a molecular explanation for the increased radiosensitivity of caffeine treated cells and the attenuation of DNAdamage checkpoint responses."
  },
  {
    "text": "Caffeine inhibits the checkpoint kinase ATM",
    "triple_list": [
      [
        "Caffeine",
        "CPR:4",
        "kinase"
      ],
      [
        "Caffeine",
        "CPR:4",
        "ATM"
      ]
    ],
    "updated": "No",
    "original": "Caffeine inhibits the checkpoint kinase ATM",
    "simplified": "Caffeine does not work in this way."
  },
  {
    "text": "The rate of recovery of binding was determined from the turnover of SERT after administration of RTI76 an irreversible inhibitor of ligand binding .",
    "triple_list": [
      [
        "SERT",
        "CPR:4",
        "RTI76"
      ]
    ],
    "updated": "Yes",
    "original": "The turnover of SERT was determined from the rate of recovery of binding after administration of RTI76 an irreversible inhibitor of ligand binding",
    "simplified": "The rate of recovery of binding was determined from the turnover of SERT after administration of RTI76 an irreversible inhibitor of ligand binding."
  },
  {
    "text": "In preliminary studies in vitro incubation of rat cerebral cortex with RTI76 produced a wash and temperature resistant inhibition of SERT binding densities Bmax",
    "triple_list": [
      [
        "RTI76",
        "CPR:4",
        "SERT"
      ]
    ],
    "updated": "No",
    "original": "In preliminary studies in vitro incubation of rat cerebral cortex with RTI76 produced a wash and temperature resistant inhibition of SERT binding densities Bmax",
    "simplified": "In preliminary studies in vitro incubation of rat cerebral cortex with RTI76 produced a wash and temperature resistant effect Bmax in vitro."
  },
  {
    "text": "Citalopram protected against the RTI76 induced inhibition of SERT binding",
    "triple_list": [
      [
        "RTI76",
        "CPR:4",
        "SERT"
      ]
    ],
    "updated": "No",
    "original": "Citalopram protected against the RTI76 induced inhibition of SERT binding",
    "simplified": "Citalopram protects against the effects of Rituximab by itself."
  },
  {
    "text": "The increase and decrease of 3H5HT uptake was highly related to the recovery of SERT binding .",
    "triple_list": [
      [
        "3H5HT",
        "CPR:9",
        "SERT"
      ]
    ],
    "updated": "Yes",
    "original": "The decrease and recovery of 3H5HT uptake correlated highly r = 093 with the recovery of SERT binding",
    "simplified": "The increase and decrease of 3H5HT uptake was highly related to the recovery of SERT binding."
  },
  {
    "text": "The mode of functional AT1 receptor antagonism has been characterized as surmountablenoncompetitive losartan tasosartan eprosartan or insurmountablenoncompetitive candesartan saprisartan zolasartan irbesartan valsartan telmisartan E3174",
    "triple_list": [
      [
        "AT1",
        "CPR:6",
        "saprisartan"
      ],
      [
        "AT1",
        "CPR:6",
        "zolasartan"
      ],
      [
        "AT1",
        "CPR:6",
        "irbesartan"
      ],
      [
        "AT1",
        "CPR:6",
        "valsartan"
      ],
      [
        "AT1",
        "CPR:6",
        "telmisartan"
      ],
      [
        "AT1",
        "CPR:6",
        "E3174"
      ],
      [
        "AT1",
        "CPR:6",
        "losartan"
      ],
      [
        "AT1",
        "CPR:6",
        "tasosartan"
      ],
      [
        "AT1",
        "CPR:6",
        "eprosartan"
      ],
      [
        "AT1",
        "CPR:6",
        "candesartan"
      ]
    ],
    "updated": "No",
    "original": "The mode of functional AT1 receptor antagonism has been characterized as surmountablenoncompetitive losartan tasosartan eprosartan or insurmountablenoncompetitive candesartan saprisartan zolasartan irbesartan valsartan telmisartan E3174",
    "simplified": "The effects of losartan have been described as: surmountablenoncompetitive candesartan saprisartan zolasartan irbesartan valsartan telmisartan E3174 The mode of functional AT1 receptor antagonism has been characterized."
  },
  {
    "text": "Among the current AT1 receptor antagonists the rank order of the relative binding affinities highest affinity = 1 is candesartan 1 telmisartan 10 E3174 the active metabolite of losartan 10 tasosartan 20 losartan 50 eprosartan 100 and the prodrug candesartan cilexetil 280",
    "triple_list": [
      [
        "AT1",
        "CPR:6",
        "losartan"
      ],
      [
        "AT1",
        "CPR:6",
        "tasosartan"
      ],
      [
        "AT1",
        "CPR:6",
        "candesartan"
      ],
      [
        "AT1",
        "CPR:6",
        "telmisartan"
      ],
      [
        "AT1",
        "CPR:6",
        "E3174"
      ],
      [
        "AT1",
        "CPR:6",
        "losartan"
      ],
      [
        "AT1",
        "CPR:6",
        "eprosartan"
      ],
      [
        "AT1",
        "CPR:6",
        "candesartan cilexetil"
      ]
    ],
    "updated": "No",
    "original": "Among the current AT1 receptor antagonists the rank order of the relative binding affinities highest affinity = 1 is candesartan 1 telmisartan 10 E3174 the active metabolite of losartan 10 tasosartan 20 losartan 50 eprosartan 100 and the prodrug candesartan cilexetil 280",
    "simplified": "Among the current AT1 receptor antagonists the rank order of the relative binding affinities highest affinity = 1 is candesartan 1 telmisartan 10, tasosartan 20, losartan 50, eprosartan 100, and the prodrug candesartan cilexetil."
  },
  {
    "text": "Losartan was the first but by no means remained the only AT1 receptor antagonist",
    "triple_list": [
      [
        "Losartan",
        "CPR:6",
        "AT1"
      ]
    ],
    "updated": "No",
    "original": "Losartan was the first but by no means remained the only AT1 receptor antagonist",
    "simplified": "Losartan was the first drug to work, but it is not the only one."
  },
  {
    "text": "The mNQO activity was insensitive to dicoumarol a potent inhibitor of cytosolic NQO1",
    "triple_list": [
      [
        "dicoumarol",
        "CPR:4",
        "NQO1"
      ]
    ],
    "updated": "No",
    "original": "The mNQO activity was insensitive to dicoumarol a potent inhibitor of cytosolic NQO1",
    "simplified": "The activity of mNQO was not changed when dicoumarol was added."
  },
  {
    "text": "A role of NQO1 in the protection of cells from oxidative stress and mutagenicity of quinones has been established .",
    "triple_list": [
      [
        "NQO1",
        "CPR:9",
        "quinones"
      ]
    ],
    "updated": "Yes",
    "original": "A role of cytosolic NQO1 in protection of cells from oxidative stress cytotoxicity and mutagenicity of quinones was established",
    "simplified": "A role of NQO1 in the protection of cells from oxidative stress and mutagenicity of quinones has been established."
  },
  {
    "text": "The mNQO activity showed significantly higher affinity for NADH than NADPH . 26dichlorophenolindophenol and menadione were reduced to mNQO .",
    "triple_list": [
      [
        "mNQO",
        "CPR:9",
        "26dichlorophenolindophenol"
      ],
      [
        "mNQO",
        "CPR:9",
        "menadione"
      ]
    ],
    "updated": "Yes",
    "original": "The mNQO activity showed significantly higher affinity for NADH than NADPH as electron donors and catalyzed reduction of 26dichlorophenolindophenol and menadione",
    "simplified": "The mNQO activity showed significantly higher affinity for NADH than NADPH. 26dichlorophenolindophenol and menadione were reduced to mNQO."
  },
  {
    "text": "Quinone oxidoreductases are important because they allow quinones to be removed from foods .",
    "triple_list": [
      [
        "Quinone oxidoreductases",
        "CPR:9",
        "quinones"
      ]
    ],
    "updated": "Yes",
    "original": "Quinone oxidoreductases are flavoproteins that catalyze twoelectron reduction and detoxification of quinones",
    "simplified": "Quinone oxidoreductases are important because they allow quinones to be removed from foods."
  },
  {
    "text": "The related piperidines ohmefentanyl and sufentanil and the nonselective opioid receptor agonist etorphine were less potent nociceptin receptor agonists",
    "triple_list": [
      [
        "sufentanil",
        "CPR:5",
        "nociceptin receptor"
      ],
      [
        "opioid receptor",
        "CPR:5",
        "etorphine"
      ],
      [
        "etorphine",
        "CPR:5",
        "nociceptin receptor"
      ],
      [
        "piperidines",
        "CPR:5",
        "nociceptin receptor"
      ],
      [
        "ohmefentanyl",
        "CPR:5",
        "nociceptin receptor"
      ]
    ],
    "updated": "No",
    "original": "The related piperidines ohmefentanyl and sufentanil and the nonselective opioid receptor agonist etorphine were less potent nociceptin receptor agonists",
    "simplified": "The related piperidines ohmefentanyl and sufentanil were less effective, but their effects were still felt by many people."
  },
  {
    "text": "The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist quadazocine exhibited pure antagonism at rat brain receptors but displayed partial agonism at human ORL1 receptors",
    "triple_list": [
      [
        "opioid receptor",
        "CPR:5",
        "buprenorphine"
      ],
      [
        "quadazocine",
        "CPR:5",
        "human ORL1"
      ],
      [
        "opioid receptor",
        "CPR:6",
        "quadazocine"
      ]
    ],
    "updated": "No",
    "original": "The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist quadazocine exhibited pure antagonism at rat brain receptors but displayed partial agonism at human ORL1 receptors",
    "simplified": "The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist quadazocine work differently in the brain. Quadazocine works differently in the brain from buprenorphine."
  },
  {
    "text": "The muopioid receptor selective agonist lofentanil has completely taken over 3Hnociceptin at rat brain receptors .",
    "triple_list": [
      [
        "muopioid receptor",
        "CPR:5",
        "lofentanil"
      ]
    ],
    "updated": "Yes",
    "original": "The muopioid receptor selective agonist lofentanil potently and competitively displaced 3Hnociceptin at rat brain receptors IC50 62 nM",
    "simplified": "The muopioid receptor selective agonist lofentanil has completely taken over 3Hnociceptin at rat brain receptors."
  },
  {
    "text": "Lofentanil was found to improve the binding of 35SGTPgammaS to human recombinant ORL1 receptors EC50 50 nM .",
    "triple_list": [
      [
        "Lofentanil",
        "CPR:5",
        "ORL1"
      ]
    ],
    "updated": "Yes",
    "original": "Lofentanil exhibited full agonism for enhancement of 35SGTPgammaS binding to human recombinant ORL1 receptors EC50 50 nM",
    "simplified": "Lofentanil was found to improve the binding of 35SGTPgammaS to human recombinant ORL1 receptors EC50 50 nM."
  },
  {
    "text": "The kappa1kappa3opioid receptor agonist muopioid receptor antagonist naloxone benzoylhydrazone was a pure antagonist at both rat brain and human ORL1 receptors",
    "triple_list": [
      [
        "naloxone benzoylhydrazone",
        "CPR:6",
        "ORL1"
      ],
      [
        "muopioid receptor",
        "CPR:6",
        "naloxone benzoylhydrazone"
      ]
    ],
    "updated": "No",
    "original": "The kappa1kappa3opioid receptor agonist muopioid receptor antagonist naloxone benzoylhydrazone was a pure antagonist at both rat brain and human ORL1 receptors",
    "simplified": "The muopioid receptor antagonist naloxone benzoylhydrazone was a pure antagonist at both the human and rat brain receptors."
  },
  {
    "text": "Thirtyweek administration of UFT with or without leucovorin markedly suppressed both colorectal carcinogenesis and tumor growth resulted in the increase of thymidylate synthase inhibition and the decrease of thymidine kinase activity in the tumor cells",
    "triple_list": [
      [
        "UFT",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "UFT",
        "CPR:4",
        "thymidine kinase"
      ],
      [
        "leucovorin",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "leucovorin",
        "CPR:4",
        "thymidine kinase"
      ]
    ],
    "updated": "No",
    "original": "Thirtyweek administration of UFT with or without leucovorin markedly suppressed both colorectal carcinogenesis and tumor growth resulted in the increase of thymidylate synthase inhibition and the decrease of thymidine kinase activity in the tumor cells",
    "simplified": "Thirtyweek administration of UFT with or without leucovorin markedly suppressed both colorectal carcinogenesis and tumor growth. Thymidine kinase activity in the tumor cells was reduced and thymidylate synthase was increased."
  },
  {
    "text": "Thymidylate synthase is inhibited by 5fluorodeoxyuridine monophosphate forming an inactive ternary complex with intracellular folate",
    "triple_list": [
      [
        "Thymidylate synthase",
        "CPR:4",
        "5fluorodeoxyuridine monophosphate"
      ]
    ],
    "updated": "No",
    "original": "Thymidylate synthase is inhibited by 5fluorodeoxyuridine monophosphate forming an inactive ternary complex with intracellular folate",
    "simplified": "5fluorodeoxyuridine monophosphate inhibits thymidylate synthase. This makes an inactive ternary complex with folate."
  },
  {
    "text": "Thymidylate synthase and thymidine kinase are key enzymes involved in the de novo and salvage pathways for pyrimidine nucleotide synthesis respectively",
    "triple_list": [
      [
        "Thymidylate synthase",
        "CPR:9",
        "pyrimidine nucleotide"
      ],
      [
        "thymidine kinase",
        "CPR:9",
        "pyrimidine nucleotide"
      ]
    ],
    "updated": "No",
    "original": "Thymidylate synthase and thymidine kinase are key enzymes involved in the de novo and salvage pathways for pyrimidine nucleotide synthesis respectively",
    "simplified": "Thymidylate synthase, also known as thymidine kinase, is an enzyme. It is found in the thymus and in the nucleosome."
  },
  {
    "text": "Ornithine decarboxylase ( ODC ) is a enzyme in the body . It breaks down putrescine to make spermidine and spermine .",
    "triple_list": [
      [
        "ODC",
        "CPR:9",
        "spermidine"
      ],
      [
        "Ornithine decarboxylase",
        "CPR:9",
        "spermidine"
      ],
      [
        "ODC",
        "CPR:9",
        "spermine"
      ],
      [
        "Ornithine decarboxylase",
        "CPR:9",
        "spermine"
      ],
      [
        "ODC",
        "CPR:9",
        "putrescine"
      ],
      [
        "Ornithine decarboxylase",
        "CPR:9",
        "putrescine"
      ]
    ],
    "updated": "Yes",
    "original": "Ornithine decarboxylase ODC catalyses the first step in the synthesis of the polyamines putrescine spermidine and spermine",
    "simplified": "Ornithine decarboxylase (ODC) is a enzyme in the body. It breaks down putrescine to make spermidine and spermine."
  },
  {
    "text": "In alpha2Aadrenoceptor transfected cells the rank order of agonist potency was A54741 mean pEC50=896 dexmedetomidine 888 UK14304 842 BHT 920 705 noradrenaline 692",
    "triple_list": [
      [
        "alpha2Aadrenoceptor",
        "CPR:5",
        "A54741"
      ],
      [
        "alpha2Aadrenoceptor",
        "CPR:5",
        "dexmedetomidine"
      ],
      [
        "alpha2Aadrenoceptor",
        "CPR:5",
        "UK14304"
      ],
      [
        "alpha2Aadrenoceptor",
        "CPR:5",
        "BHT 920"
      ],
      [
        "alpha2Aadrenoceptor",
        "CPR:5",
        "noradrenaline"
      ]
    ],
    "updated": "No",
    "original": "In alpha2Aadrenoceptor transfected cells the rank order of agonist potency was A54741 mean pEC50=896 dexmedetomidine 888 UK14304 842 BHT 920 705 noradrenaline 692",
    "simplified": "In alpha2Aadrenoceptor transfected cells, dexmedetomidine was the most effective agonist, followed by BHT and noradrenaline."
  },
  {
    "text": "Glucocorticoid receptors were activated by dexamethasone . Glucocorticoid responsiveness was assessed using a plasmid .",
    "triple_list": [
      [
        "Glucocorticoid receptors",
        "CPR:3",
        "dexamethasone"
      ]
    ],
    "updated": "Yes",
    "original": "Glucocorticoid receptors were activated by dexamethasone as assessed using a glucocorticoidresponsive reporter plasmid pTAT3CAT",
    "simplified": "Glucocorticoid receptors were activated by dexamethasone. Glucocorticoid responsiveness was assessed using a plasmid."
  },
  {
    "text": "The glucocorticoid receptor antagonist RU486 mifepristone significantly counteracted the effect of dexamethasone on the glucocorticoid receptor . This means that dexamethasone does not work as well as it used to .",
    "triple_list": [
      [
        "glucocorticoid receptor",
        "CPR:6",
        "RU486"
      ],
      [
        "glucocorticoid receptor",
        "CPR:6",
        "mifepristone"
      ]
    ],
    "updated": "Yes",
    "original": "The glucocorticoid receptor antagonist RU486 mifepristone significantly counteracted the effect of dexamethasone on glucocorticoid receptor activation indicating that the dexamethasone effect is specific and is mediated through the glucocorticoid receptor",
    "simplified": "The glucocorticoid receptor antagonist RU486 mifepristone significantly counteracted the effect of dexamethasone on the glucocorticoid receptor. This means that dexamethasone does not work as well as it used to."
  },
  {
    "text": "RESULTS Quetiapine was an effective antipsychotic and improved the extrapyramidal symptoms and prolactin level elevation noted at baseline",
    "triple_list": [
      [
        "Quetiapine",
        "CPR:3",
        "prolactin"
      ]
    ],
    "updated": "No",
    "original": "RESULTS Quetiapine was an effective antipsychotic and improved the extrapyramidal symptoms and prolactin level elevation noted at baseline",
    "simplified": "Results Quetiapine was an effective anti-psychotic and improved the symptoms of extrapyramidal psychosis at baseline."
  },
  {
    "text": "In a physiological K gradient TWIK2 is half inhibited by 01 mm Ba2 quinine and quinidine",
    "triple_list": [
      [
        "TWIK2",
        "CPR:4",
        "Ba2"
      ],
      [
        "TWIK2",
        "CPR:4",
        "quinine"
      ],
      [
        "TWIK2",
        "CPR:4",
        "quinidine"
      ]
    ],
    "updated": "No",
    "original": "In a physiological K gradient TWIK2 is half inhibited by 01 mm Ba2 quinine and quinidine",
    "simplified": "In a physiological K gradient TWIK2 does not work at all. It is inhibited by quinine."
  },
  {
    "text": "Initial in vitro studies utilizing HEPG2 liver cells revealed that addition of eicosapentaenoic acid EPA blocked Delta5desaturase activity the terminal enzymatic step in AA synthesis",
    "triple_list": [
      [
        "eicosapentaenoic acid",
        "CPR:4",
        "Delta5desaturase"
      ],
      [
        "EPA",
        "CPR:4",
        "Delta5desaturase"
      ]
    ],
    "updated": "No",
    "original": "Initial in vitro studies utilizing HEPG2 liver cells revealed that addition of eicosapentaenoic acid EPA blocked Delta5desaturase activity the terminal enzymatic step in AA synthesis",
    "simplified": "Initial in vitro studies using HEPG2 liver cells showed that when eicosapentaenoic acid was added to the cells, Delta5desaturase activity was stopped."
  },
  {
    "text": "BACKGROUND This study examines the effects of nicorandil a K channel opener on torsade de pointes TdP under conditions mimicking the congenital longQT syndrome LQTS and the effects of nicorandil a K channel opener on repolarization TDR .",
    "triple_list": [
      [
        "nicorandil",
        "CPR:3",
        "K channel"
      ]
    ],
    "updated": "Yes",
    "original": "BACKGROUND This study examines the effects of nicorandil a K channel opener on transmural dispersion of repolarization TDR and induction of torsade de pointes TdP under conditions mimicking the LQT1 LQT2 and LQT3 forms of the congenital longQT syndrome LQTS",
    "simplified": "BACKGROUND This study examines the effects of nicorandil a K channel opener on torsade de pointes TdP under conditions mimicking the congenital longQT syndrome LQTS and the effects of nicorandil a K channel opener on repolarization TDR."
  },
  {
    "text": "Isoproterenol 50 to 100 nmolL was used to mimic an increase in betaadrenergic tone dsotalol 100 micromolL to block IKr LQT2 model and ATXII 20 nmolL to augment late INa LQT3 model",
    "triple_list": [
      [
        "dsotalol",
        "CPR:4",
        "IKr"
      ],
      [
        "dsotalol",
        "CPR:4",
        "ATXII"
      ],
      [
        "Isoproterenol",
        "CPR:4",
        "IKr"
      ],
      [
        "Isoproterenol",
        "CPR:4",
        "ATXII"
      ]
    ],
    "updated": "No",
    "original": "Isoproterenol 50 to 100 nmolL was used to mimic an increase in betaadrenergic tone dsotalol 100 micromolL to block IKr LQT2 model and ATXII 20 nmolL to augment late INa LQT3 model",
    "simplified": "Isoproterenol 50 to 100 nmolL was used to mimic an increase in betaadrenergic tone. Dsotalol 100 micromolL was used to mimic the increase in tone."
  },
  {
    "text": "Peroxisome proliferatoractivated receptor alpha PPARalpha activators bezafibrate and Wy14643 increase uncoupling protein3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes",
    "triple_list": [
      [
        "Peroxisome proliferatoractivated receptor alpha",
        "CPR:3",
        "bezafibrate"
      ],
      [
        "bezafibrate",
        "CPR:3",
        "uncoupling protein3"
      ],
      [
        "PPARalpha",
        "CPR:3",
        "bezafibrate"
      ],
      [
        "Peroxisome proliferatoractivated receptor alpha",
        "CPR:3",
        "Wy14643"
      ],
      [
        "Wy14643",
        "CPR:3",
        "uncoupling protein3"
      ],
      [
        "PPARalpha",
        "CPR:3",
        "Wy14643"
      ]
    ],
    "updated": "No",
    "original": "Peroxisome proliferatoractivated receptor alpha PPARalpha activators bezafibrate and Wy14643 increase uncoupling protein3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes",
    "simplified": "Peroxisome proliferator-activated receptor alpha PPARalpha activators bezafibrate and Wy14643 increase uncoupling protein3 mRNA levels in primary culture of rat preadipocytes without affecting mitochondrial function"
  },
  {
    "text": "The changes in UCP3 expression were not accompanied by changes in the mitochondrial membrane potential of the rat primary preadipocytes after bezafibrate or Wy14643 .",
    "triple_list": [
      [
        "UCP3",
        "CPR:3",
        "bezafibrate"
      ],
      [
        "UCP3",
        "CPR:3",
        "Wy14643"
      ]
    ],
    "updated": "Yes",
    "original": "The induction in UCP3 expression was not accompanied by changes in the mitochondrial membrane potential of rat primary preadipocytes after bezafibrate or Wy14643 treatment",
    "simplified": "The changes in UCP3 expression were not accompanied by changes in the mitochondrial membrane potential of the rat primary preadipocytes after bezafibrate or Wy14643."
  },
  {
    "text": "Since it has been proposed that UCP3 could be involved in the regulation of the use of fatty acids as fuel substrates , it is important to ensure that UCP3 is not changed too much during treatment with bezafibrate and Wy14 643 to reduce the amount of UCP3 needed .",
    "triple_list": [
      [
        "UCP3",
        "CPR:3",
        "bezafibrate"
      ],
      [
        "UCP3",
        "CPR:3",
        "Wy14 643"
      ]
    ],
    "updated": "Yes",
    "original": "Since it has been proposed that UCP3 could be involved in the regulation of the use of fatty acids as fuel substrates the UCP3 induction achieved after bezafibrate and Wy14 643 treatment may indicate a higher oxidation of fatty acids limiting their availability to be stored as triglycerides",
    "simplified": "Since it has been proposed that UCP3 could be involved in the regulation of the use of fatty acids as fuel substrates, it is important to ensure that UCP3 is not changed too much during treatment with bezafibrate and Wy14 643 to reduce the amount of UCP3 needed."
  },
  {
    "text": "Thus bezafibrate treatment resulted in an 8fold increase in UCP3 mRNA levels in preadipocytes and a 35fold increase in adipocytes .",
    "triple_list": [
      [
        "bezafibrate",
        "CPR:3",
        "UCP3"
      ]
    ],
    "updated": "Yes",
    "original": "Thus bezafibrate treatment resulted in an 8fold induction in UCP3 mRNA levels in preadipocytes compared with the 35fold induction observed in adipocytes",
    "simplified": "Thus bezafibrate treatment resulted in an 8fold increase in UCP3 mRNA levels in preadipocytes and a 35fold increase in adipocytes."
  },
  {
    "text": "Uncoupling proteins UCPs are inner mitochondrial membrane transporters . They act as pores for H ions to pass through the inner mitochondrial membrane to reach the outside mitochondrial membrane .",
    "triple_list": [
      [
        "Uncoupling proteins",
        "CPR:9",
        "H"
      ],
      [
        "UCPs",
        "CPR:9",
        "H"
      ]
    ],
    "updated": "Yes",
    "original": "Uncoupling proteins UCPs are inner mitochondrial membrane transporters which act as pores for H ions dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis",
    "simplified": "Uncoupling proteins UCPs are inner mitochondrial membrane transporters. They act as pores for H ions to pass through the inner mitochondrial membrane to reach the outside mitochondrial membrane."
  },
  {
    "text": "The ensemble of results suggests that the ability of Sch B pretreatment to protect against menadione hepatotoxicity may at least in part be attributed to the protection of DTD activity .",
    "triple_list": [
      [
        "Sch B",
        "CPR:3",
        "DTD"
      ]
    ],
    "updated": "Yes",
    "original": "The ensemble of results suggests that the ability of Sch B pretreatment to enhance hepatocellular DTD activity may at least in part be attributed to the protection against menadione hepatotoxicity",
    "simplified": "The ensemble of results suggests that the ability of Sch B pretreatment to protect against menadione hepatotoxicity may at least in part be attributed to the protection of DTD activity."
  },
  {
    "text": "Schisandrin B protects against hepatotoxicity by increasing the activity of DTdiaphorase .",
    "triple_list": [
      [
        "Schisandrin B",
        "CPR:3",
        "DTdiaphorase"
      ]
    ],
    "updated": "Yes",
    "original": "Schisandrin B protects against menadioneinduced hepatotoxicity by enhancing DTdiaphorase activity",
    "simplified": "Schisandrin B protects against hepatotoxicity by increasing the activity of DTdiaphorase."
  },
  {
    "text": "Hepatocytes isolated from Sch B pretreated a daily dose of 1 mmolkg for 3 days rats showed a significant increase 25 in DTD activity",
    "triple_list": [
      [
        "Sch B",
        "CPR:3",
        "DTD"
      ]
    ],
    "updated": "No",
    "original": "Hepatocytes isolated from Sch B pretreated a daily dose of 1 mmolkg for 3 days rats showed a significant increase 25 in DTD activity",
    "simplified": "Hepatocytes isolated from Sch B pretreated a daily dose of 1 mmolkg for 3 days showed a 25% increase in cell division."
  },
  {
    "text": "Pretreating mice with schisandrin B Sch B a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis at a daily dose of 1 mmolkg for 3 days protected against menadione-induced hepatic oxidative damage in mice . When menadione and schisandrin B were placed in the mice 's blood for 3 days , alanine aminotransferase activity and hepatic malondialdehyde level were measured .",
    "triple_list": [
      [
        "menadione",
        "CPR:4",
        "alanine aminotransferase"
      ]
    ],
    "updated": "Yes",
    "original": "Pretreating mice with schisandrin B Sch B a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis at a daily dose of 1 mmolkg for 3 days protected against menadione induced hepatic oxidative damage in mice as evidenced by decreases in plasma alanine aminotransferase activity 78 and hepatic malondialdehyde level 70 when compared with the menadione intoxicated control",
    "simplified": "Pretreating mice with schisandrin B Sch B a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis at a daily dose of 1 mmolkg for 3 days protected against menadione-induced hepatic oxidative damage in mice. When menadione and schisandrin B were placed in the mice's blood for 3 days, alanine aminotransferase activity and hepatic malondialdehyde level were measured."
  },
  {
    "text": "Creatine phosphokinase activity in plasma increased slightly compared to control pyridostigmine or exercise group in mice treated with pyridostigmine plus exercise . This may be due to the combination of pyridostigmine and exercise .",
    "triple_list": [
      [
        "Creatine phosphokinase",
        "CPR:3",
        "pyridostigmine"
      ],
      [
        "Creatine phosphokinase",
        "CPR:3",
        "pyridostigmine"
      ]
    ],
    "updated": "Yes",
    "original": "Creatine phosphokinase activity in plasma increased slightly compared to control pyridostigmine or exercise group in mice treated with pyridostigmine plus exercise which may be indicative of perturbation in the integrity of the skeletal muscle due to combination",
    "simplified": "Creatine phosphokinase activity in plasma increased slightly compared to control pyridostigmine or exercise group in mice treated with pyridostigmine plus exercise. This may be due to the combination of pyridostigmine and exercise."
  },
  {
    "text": "The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase BChE activity 87 of control and the group treated with pyridostigmine plus exercise showed significantly decreased BChE activity 79 of control .",
    "triple_list": [
      [
        "pyridostigmine",
        "CPR:4",
        "butyrylcholinesterase"
      ],
      [
        "pyridostigmine",
        "CPR:4",
        "BChE"
      ],
      [
        "pyridostigmine",
        "CPR:4",
        "BChE"
      ]
    ],
    "updated": "Yes",
    "original": "The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase BChE activity 87 of control whereas pyridostigmine plus exercise significantly decreased the BChE activity 79 of control indicating an interactive effect of the combination",
    "simplified": "The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase BChE activity 87 of control and the group treated with pyridostigmine plus exercise showed significantly decreased BChE activity 79 of control."
  },
  {
    "text": "However AChE activity in triceps muscle decreased significantly in the group treated with pyridostigmine plus exercise .",
    "triple_list": [
      [
        "AChE",
        "CPR:4",
        "pyridostigmine"
      ]
    ],
    "updated": "Yes",
    "original": "However AChE activity in triceps muscle decreased significantly 78 of control in the group treated with pyridostigmine plus exercise",
    "simplified": "However AChE activity in triceps muscle decreased significantly in the group treated with pyridostigmine plus exercise."
  },
  {
    "text": "RESULTS Buserelin acetate a GnRH agonist 0110 ngmL had no significant effect on MCP1 expression whereas danazol 107105 M a testosterone analog and dexamethasone an antiinflammatory glucocorticoid hormone 1012106M showed a direct and a dosedependent inhibitory effect on MCP1 expression",
    "triple_list": [
      [
        "MCP1",
        "CPR:4",
        "danazol"
      ],
      [
        "MCP1",
        "CPR:4",
        "testosterone"
      ],
      [
        "MCP1",
        "CPR:4",
        "dexamethasone"
      ],
      [
        "Buserelin acetate",
        "CPR:5",
        "GnRH"
      ]
    ],
    "updated": "No",
    "original": "RESULTS Buserelin acetate a GnRH agonist 0110 ngmL had no significant effect on MCP1 expression whereas danazol 107105 M a testosterone analog and dexamethasone an antiinflammatory glucocorticoid hormone 1012106M showed a direct and a dosedependent inhibitory effect on MCP1 expression",
    "simplified": " RESULTS Buserelin acetate a GnRH agonist 0110 ngmL had no significant effect on MCP1 expression. Danazol 107105 M showed a direct and a dosedependent inhibitory effect on MCP1 expression while dexamethasone showed a direct and a dosedependent inhibitory effect."
  },
  {
    "text": "Mobility shift assays on whole cell extracts showed that clenbuterol increased AP1 binding in 3T3 cells prior to increasing NGF synthesis",
    "triple_list": [
      [
        "clenbuterol",
        "CPR:3",
        "NGF"
      ]
    ],
    "updated": "No",
    "original": "Mobility shift assays on whole cell extracts showed that clenbuterol increased AP1 binding in 3T3 cells prior to increasing NGF synthesis",
    "simplified": "Movement shift studies on whole cell extracts showed that clenbuterol increased the ability of 3T3 cells to move around."
  },
  {
    "text": "Clenbuterol had no effect on the levels of NGF in L929 cells , but CB1093 increased the levels of both NGF and protein in both 3T3 and L929 cells .",
    "triple_list": [
      [
        "NGF",
        "CPR:3",
        "CB1093"
      ]
    ],
    "updated": "Yes",
    "original": "Clenbuterol was without effect on NGF mRNA levels in L929 cells whereas CB1093 caused significant increases in both NGF mRNA and protein levels in both 3T3 and L929 cells",
    "simplified": "Clenbuterol had no effect on the levels of NGF in L929 cells, but CB1093 increased the levels of both NGF and protein in both 3T3 and L929 cells."
  },
  {
    "text": "This study shows that CB1093 and clenbuterol can increase the level of NGF in vitro , and that AP1 binding could be a common mechanism between these two compounds .",
    "triple_list": [
      [
        "CB1093",
        "CPR:3",
        "NGF"
      ],
      [
        "CB1093",
        "CPR:3",
        "NGF"
      ],
      [
        "clenbuterol",
        "CPR:3",
        "NGF"
      ],
      [
        "clenbuterol",
        "CPR:3",
        "NGF"
      ]
    ],
    "updated": "Yes",
    "original": "This study demonstrates that CB1093 and clenbuterol stimulate NGF levels in vitro and that AP1 binding could be a commonality between the mechanism of NGF induction of these two compounds",
    "simplified": "This study shows that CB1093 and clenbuterol can increase the level of NGF in vitro, and that AP1 binding could be a common mechanism between these two compounds."
  },
  {
    "text": "The present studies were undertaken to compare two compounds a vitamin D3 analogue CB1093 with minimal calcaemic effects and clenbuterol a longacting beta2adrenoceptor agonist both of which induce NGF synthesis in vivo",
    "triple_list": [
      [
        "CB1093",
        "CPR:3",
        "NGF"
      ],
      [
        "clenbuterol",
        "CPR:3",
        "NGF"
      ],
      [
        "vitamin D3",
        "CPR:4",
        "NGF"
      ],
      [
        "clenbuterol",
        "CPR:5",
        "beta2adrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "The present studies were undertaken to compare two compounds a vitamin D3 analogue CB1093 with minimal calcaemic effects and clenbuterol a longacting beta2adrenoceptor agonist both of which induce NGF synthesis in vivo",
    "simplified": "The present studies were undertaken to compare two compounds clenbuterol a longacting beta2adrenoceptor agonist and a vitamin D3 analogue CB1093 with minimal calcaemic effects."
  },
  {
    "text": "Clenbuterol caused significant increases in both NGF mRNA and protein in 3T3 cells when they were exposed to it for 812 hours .",
    "triple_list": [
      [
        "Clenbuterol",
        "CPR:3",
        "NGF"
      ]
    ],
    "updated": "Yes",
    "original": "Clenbuterol caused significant increases in both NGF mRNA and protein in 3T3 cells with maxima at 10 nM and at 812 h exposure",
    "simplified": "Clenbuterol caused significant increases in both NGF mRNA and protein in 3T3 cells when they were exposed to it for 812 hours."
  },
  {
    "text": "After the bleach halothane slowed down the absorption of light by rhodopsin . It also stopped the metabolism of rhodopsin .",
    "triple_list": [
      [
        "halothane",
        "CPR:4",
        "rhodopsin"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS After the initial bleach halothane impeded photon absorption by rhodopsin by inhibiting metabolic rhodopsin regeneration",
    "simplified": "After the bleach halothane slowed down the absorption of light by rhodopsin. It also stopped the metabolism of rhodopsin."
  },
  {
    "text": "RESULTS Halothane anesthesia changed the metabolism of rhodopsin and prevented rhodopsin from absorbing high numbers of light during light exposure .",
    "triple_list": [
      [
        "Halothane",
        "CPR:4",
        "rhodopsin"
      ],
      [
        "Halothane",
        "CPR:4",
        "rhodopsin"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS Halothane anesthesia reversibly inhibited metabolic rhodopsin regeneration and thus prevented rhodopsin from absorbing high numbers of photons during light exposure",
    "simplified": " RESULTS Halothane anesthesia changed the metabolism of rhodopsin and prevented rhodopsin from absorbing high numbers of light during light exposure."
  },
  {
    "text": "The protective effect of halothane anesthesia on metabolic rhodopsin regeneration in healthy people .",
    "triple_list": [
      [
        "halothane",
        "CPR:4",
        "rhodopsin"
      ]
    ],
    "updated": "Yes",
    "original": "Protective effect of halothane anesthesia on retinal light damage inhibition of metabolic rhodopsin regeneration",
    "simplified": "The protective effect of halothane anesthesia on metabolic rhodopsin regeneration in healthy people."
  },
  {
    "text": "METHODS Different classes of antidepressants fluvoxamine and sertraline selective serotonin reuptake inhibitor were tested in the same randomised experimental session alone and in combination with 5HT1A and 5HT1B receptor agonists buspirone partial 5HT1A agonist anpirtoline 5HT1B agonist in the mouse forced swimming test .",
    "triple_list": [
      [
        "5HT1A",
        "CPR:5",
        "buspirone"
      ],
      [
        "5HT1B",
        "CPR:5",
        "anpirtoline"
      ]
    ],
    "updated": "Yes",
    "original": "METHODS Different classes of antidepressants imipramine tricyclic maprotiline noradrenline reuptake inhibitor venlafaxine mixed serotonin and noradrenaline reuptake inhibitors fluvoxamine and sertraline selective serotonin reuptake inhibitor were tested in the same randomised experimental session alone and in combination with 5HT1A and 5HT1B receptor agonists buspirone partial 5HT1A agonist anpirtoline 5HT1B agonist in the mouse forced swimming test",
    "simplified": "METHODS Different classes of antidepressants fluvoxamine and sertraline selective serotonin reuptake inhibitor were tested in the same randomised experimental session alone and in combination with 5HT1A and 5HT1B receptor agonists buspirone partial 5HT1A agonist anpirtoline 5HT1B agonist in the mouse forced swimming test."
  },
  {
    "text": "Pemetrexed disodium Alimta LY231514 is a novel multitargeted antifolate that inhibits thymidylate synthase dihydrofolate reductase and glycinamide ribonucleotide formyl transferase",
    "triple_list": [
      [
        "Pemetrexed disodium",
        "CPR:4",
        "dihydrofolate reductase"
      ],
      [
        "Pemetrexed disodium",
        "CPR:4",
        "glycinamide ribonucleotide formyl transferase"
      ],
      [
        "Pemetrexed disodium",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "Alimta",
        "CPR:4",
        "dihydrofolate reductase"
      ],
      [
        "Alimta",
        "CPR:4",
        "glycinamide ribonucleotide formyl transferase"
      ],
      [
        "Alimta",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "LY231514",
        "CPR:4",
        "dihydrofolate reductase"
      ],
      [
        "LY231514",
        "CPR:4",
        "glycinamide ribonucleotide formyl transferase"
      ],
      [
        "LY231514",
        "CPR:4",
        "thymidylate synthase"
      ]
    ],
    "updated": "No",
    "original": "Pemetrexed disodium Alimta LY231514 is a novel multitargeted antifolate that inhibits thymidylate synthase dihydrofolate reductase and glycinamide ribonucleotide formyl transferase",
    "simplified": "Pemetrexed disodium Alimta LY231514 is a novel antifolate that works by inhibiting two enzymes. They are thymidylate synthase and dihydrofolate reductase."
  },
  {
    "text": "To mechanistically evaluate this regional selectivity we assessed cyclooxygenase2 COX2 expression in the uninvolved mucosa and in both MIN mice and AOM treated rats showed a 3 to 4fold excess relative to the proximal bowel .",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:3",
        "AOM"
      ],
      [
        "COX2",
        "CPR:3",
        "AOM"
      ]
    ],
    "updated": "Yes",
    "original": "To mechanistically evaluate this regional selectivity we assessed cyclooxygenase2 COX2 expression in the uninvolved mucosa and demonstrated a 3 to 4fold excess in the distal relative to the proximal bowel in both MIN mice and AOM treated rats",
    "simplified": "To mechanistically evaluate this regional selectivity we assessed cyclooxygenase2 COX2 expression in the uninvolved mucosa and in both MIN mice and AOM treated rats showed a 3 to 4fold excess relative to the proximal bowel."
  },
  {
    "text": "The previous observation that phosphatidylserine inhibits DGKdelta has been taken into account . Sakane F Imai S Kai M Wada I and Kanoh H 1996",
    "triple_list": [
      [
        "phosphatidylserine",
        "CPR:4",
        "DGKdelta"
      ]
    ],
    "updated": "Yes",
    "original": "We took advantage of the previous observations that phosphatidylserine inhibits DGKdelta reviewed by Sakane F Imai S Kai M Wada I and Kanoh H 1996 J Biol",
    "simplified": "The previous observation that phosphatidylserine inhibits DGKdelta has been taken into account. Sakane F Imai S Kai M Wada I and Kanoh H 1996"
  },
  {
    "text": "Diacylglycerol kinase , also known as DGK , is an enzyme . It converts diacylglycerol to phosphatidic acid , which it then turns into phosphatidic acid .",
    "triple_list": [
      [
        "Diacylglycerol kinase",
        "CPR:9",
        "diacylglycerol"
      ],
      [
        "DGK",
        "CPR:9",
        "diacylglycerol"
      ],
      [
        "Diacylglycerol kinase",
        "CPR:9",
        "phosphatidic acid"
      ],
      [
        "DGK",
        "CPR:9",
        "phosphatidic acid"
      ]
    ],
    "updated": "Yes",
    "original": "Diacylglycerol kinase DGK catalyzes the conversion of diacylglycerol to phosphatidic acid making it an attractive candidate for a signal transduction component",
    "simplified": "Diacylglycerol kinase, also known as DGK, is an enzyme. It converts diacylglycerol to phosphatidic acid, which it then turns into phosphatidic acid."
  },
  {
    "text": "Nordihydroguaiaretic acid NDGA has been shown to inhibit both 5lipoxygenase and ornithine decarboxylase and is active against several cancer cell lines and at least one mouse tumor model",
    "triple_list": [
      [
        "Nordihydroguaiaretic acid",
        "CPR:4",
        "ornithine decarboxylase"
      ],
      [
        "Nordihydroguaiaretic acid",
        "CPR:4",
        "5lipoxygenase"
      ],
      [
        "NDGA",
        "CPR:4",
        "ornithine decarboxylase"
      ],
      [
        "NDGA",
        "CPR:4",
        "5lipoxygenase"
      ]
    ],
    "updated": "No",
    "original": "Nordihydroguaiaretic acid NDGA has been shown to inhibit both 5lipoxygenase and ornithine decarboxylase and is active against several cancer cell lines and at least one mouse tumor model",
    "simplified": "Nordihydroguaiaretic acid has been shown to inhibit the enzyme 5lipoxygenase. It has also been shown to inhibit the enzyme ornithine decarboxylase."
  },
  {
    "text": "Carbonic anhydrase CA is a zinc enzyme that catalyses the reversible hydration reaction of CO2 and plays a major role in the acidbase balance",
    "triple_list": [
      [
        "Carbonic anhydrase",
        "CPR:9",
        "CO2"
      ],
      [
        "CA",
        "CPR:9",
        "CO2"
      ]
    ],
    "updated": "No",
    "original": "Carbonic anhydrase CA is a zinc enzyme that catalyses the reversible hydration reaction of CO2 and plays a major role in the acidbase balance",
    "simplified": "Carbonic anhydrase CA is an enzyme in the body. It helps in the hydration reaction of carbon dioxide with water."
  },
  {
    "text": "In a cohort of 25 organophosphatepoisoned patients , butyrylcholinesterase BuChE and in vitro pralidoxime reactivated BuChE were studied . Their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of oxime treatment was also studied .",
    "triple_list": [
      [
        "BuChE",
        "CPR:3",
        "pralidoxime"
      ]
    ],
    "updated": "Yes",
    "original": "The temporal profile of butyrylcholinesterase BuChE and in vitro pralidoxime reactivated BuChE was studied in a cohort of 25 organophosphatepoisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of oxime treatment",
    "simplified": "In a cohort of 25 organophosphatepoisoned patients, butyrylcholinesterase BuChE and in vitro pralidoxime reactivated BuChE were studied. Their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of oxime treatment was also studied."
  },
  {
    "text": "Reactivation potentials of BuChE After organophosphate was added , the difference between oxime reactivated and unreactivated enzyme activity went down .",
    "triple_list": [
      [
        "BuChE",
        "CPR:3",
        "oxime"
      ],
      [
        "BuChE",
        "CPR:4",
        "organophosphate"
      ]
    ],
    "updated": "Yes",
    "original": "Reactivation potentials of BuChE the difference between oxime reactivated and unreactivated enzyme activity declined significantly with time after organophosphate ingestion",
    "simplified": "Reactivation potentials of BuChE After organophosphate was added, the difference between oxime reactivated and unreactivated enzyme activity went down."
  },
  {
    "text": "Patients who received oxime before going to the hospital had a lower BuChE level at admission and a higher rate of intermediate syndrome .",
    "triple_list": [
      [
        "oxime",
        "CPR:4",
        "BuChE"
      ]
    ],
    "updated": "Yes",
    "original": "Patients who received oxime prior to hospitalization had a higher rate of intermediate syndrome and lower levels of BuChE at admission than those who had not",
    "simplified": "Patients who received oxime before going to the hospital had a lower BuChE level at admission and a higher rate of intermediate syndrome."
  },
  {
    "text": "CONCLUSIONS The alpha2adrenoceptor agonists brimonidine apraclonidine and oxymetazoline are potent vasoconstrictors in the porcine ciliary artery",
    "triple_list": [
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "brimonidine"
      ],
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "apraclonidine"
      ],
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "oxymetazoline"
      ]
    ],
    "updated": "No",
    "original": "CONCLUSIONS The alpha2adrenoceptor agonists brimonidine apraclonidine and oxymetazoline are potent vasoconstrictors in the porcine ciliary artery",
    "simplified": "The alpha2adrenoceptor agonists brimonidine and oxymetazoline are very powerful vasoconstrictors in the ciliary artery."
  },
  {
    "text": "The segments were contracted with the alpha2adrenoceptor agonists brimonidine apraclonidine and oxymetazoline",
    "triple_list": [
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "brimonidine"
      ],
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "apraclonidine"
      ],
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "oxymetazoline"
      ]
    ],
    "updated": "No",
    "original": "The segments were contracted with the alpha2adrenoceptor agonists brimonidine apraclonidine and oxymetazoline",
    "simplified": "The alpha2adrenoceptor agonists brimonidine and oxymetazoline were used to contract the segments."
  },
  {
    "text": "Results The alpha2adrenoceptor agonists caused vasoconstriction in the porcine ciliary artery . The potency order EC50 was found in brimonidine 211 oxymetazoline 526 and apraclonidine 130 .",
    "triple_list": [
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "brimonidine"
      ],
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "oxymetazoline"
      ],
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "apraclonidine"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS The alpha2adrenoceptor agonists induced vasoconstriction in the porcine ciliary artery with the following potency order EC50 expressed in nanomolar brimonidine 211 oxymetazoline 526 and apraclonidine 130",
    "simplified": "Results The alpha2adrenoceptor agonists caused vasoconstriction in the porcine ciliary artery. The potency order EC50 was found in brimonidine 211 oxymetazoline 526 and apraclonidine 130."
  },
  {
    "text": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies pKB for BRL44408 78 ARC 239 58 and for prazosin 60/O . This means that alpha2Aadrenoceptors may be involved .",
    "triple_list": [
      [
        "BRL44408",
        "CPR:6",
        "alpha2Aadrenoceptors"
      ],
      [
        "ARC 239",
        "CPR:6",
        "alpha2Aadrenoceptors"
      ],
      [
        "prazosin",
        "CPR:6",
        "alpha2Aadrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies pKB for BRL44408 78 ARC 239 58 and for prazosin 60 suggesting the presence of functional alpha2Aadrenoceptors",
    "simplified": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies pKB for BRL44408 78 ARC 239 58 and for prazosin 60/O. This means that alpha2Aadrenoceptors may be involved."
  },
  {
    "text": "The following alpha2adrenoceptor antagonists were applied BRL44408 alpha2A selective ARC239 alpha2B and alpha2Cselective and prazosin alpha2B and alpha2C selective",
    "triple_list": [
      [
        "BRL44408",
        "CPR:6",
        "alpha2A"
      ],
      [
        "ARC239",
        "CPR:6",
        "alpha2B"
      ],
      [
        "ARC239",
        "CPR:6",
        "alpha2C"
      ],
      [
        "alpha2B",
        "CPR:6",
        "prazosin"
      ],
      [
        "alpha2C",
        "CPR:6",
        "prazosin"
      ]
    ],
    "updated": "No",
    "original": "The following alpha2adrenoceptor antagonists were applied BRL44408 alpha2A selective ARC239 alpha2B and alpha2Cselective and prazosin alpha2B and alpha2C selective",
    "simplified": "The following drugs were used: BRL44408 alpha2A selective ARC239 alpha2B selective prazosin selective The following drugs were used:"
  },
  {
    "text": "Pemetrexed disodium ALIMTA is a novel antimetabolite . It works by inhibiting the enzymes thymidylate synthase , dihydrofolate reductase and glycinamide ribonucleotide formyltransferase .",
    "triple_list": [
      [
        "Pemetrexed disodium",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "Pemetrexed disodium",
        "CPR:4",
        "dihydrofolate reductase"
      ],
      [
        "Pemetrexed disodium",
        "CPR:4",
        "glycinamide ribonucleotide formyltransferase"
      ],
      [
        "ALIMTA",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "ALIMTA",
        "CPR:4",
        "dihydrofolate reductase"
      ],
      [
        "ALIMTA",
        "CPR:4",
        "glycinamide ribonucleotide formyltransferase"
      ]
    ],
    "updated": "Yes",
    "original": "Pemetrexed disodium ALIMTA is a novel antimetabolite that inhibits at least three folatedependent enzymes thymidylate synthase dihydrofolate reductase and glycinamide ribonucleotide formyltransferase",
    "simplified": "Pemetrexed disodium ALIMTA is a novel antimetabolite. It works by inhibiting the enzymes thymidylate synthase, dihydrofolate reductase and glycinamide ribonucleotide formyltransferase."
  },
  {
    "text": "DHFS is only found in the mitochondria . Because of this , it is the only place where dihydrofolate is made .",
    "triple_list": [
      [
        "DHFS",
        "CPR:9",
        "dihydrofolate"
      ]
    ],
    "updated": "Yes",
    "original": "DHFS is present exclusively in the mitochondria making this compartment the sole site of synthesis of dihydrofolate in the plant cell",
    "simplified": "DHFS is only found in the mitochondria. Because of this, it is the only place where dihydrofolate is made."
  },
  {
    "text": "Rabeprazole is a proton pump inhibitor that works well .",
    "triple_list": [
      [
        "Rabeprazole",
        "CPR:4",
        "proton pump"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSION Rabeprazole is a well tolerated proton pump inhibitor",
    "simplified": "Rabeprazole is a proton pump inhibitor that works well."
  },
  {
    "text": "UNLABELLED Rabeprazole is an inhibitor of the gastric proton pump",
    "triple_list": [
      [
        "Rabeprazole",
        "CPR:4",
        "gastric proton pump"
      ]
    ],
    "updated": "No",
    "original": "UNLABELLED Rabeprazole is an inhibitor of the gastric proton pump",
    "simplified": "Rabeprazole is a drug that is used to treat cancer."
  },
  {
    "text": "At the same time , the mean plasma active renin was increased 16 and 34fold when Aliskiren was used .",
    "triple_list": [
      [
        "renin",
        "CPR:3",
        "Aliskiren"
      ]
    ],
    "updated": "Yes",
    "original": "At the same time mean plasma active renin was increased 16 and 34fold at the highest dose of Aliskiren",
    "simplified": "At the same time, the mean plasma active renin was increased 16 and 34fold when Aliskiren was used."
  },
  {
    "text": "The renin inhibitor Aliskiren dosedependently decreases Ang II levels in humans following oral treatment .",
    "triple_list": [
      [
        "renin",
        "CPR:4",
        "Aliskiren"
      ],
      [
        "Aliskiren",
        "CPR:4",
        "Ang II"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion the renin inhibitor Aliskiren dosedependently decreases Ang II levels in humans following oral administration",
    "simplified": "The renin inhibitor Aliskiren dosedependently decreases Ang II levels in humans following oral treatment."
  },
  {
    "text": "Aliskiren has the potential to become the first orally active renin inhibitor that provides a true alternative to ACE inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases",
    "triple_list": [
      [
        "Aliskiren",
        "CPR:4",
        "renin"
      ],
      [
        "Aliskiren",
        "CPR:4",
        "ACE"
      ],
      [
        "Aliskiren",
        "CPR:6",
        "Ang II receptor"
      ]
    ],
    "updated": "No",
    "original": "Aliskiren has the potential to become the first orally active renin inhibitor that provides a true alternative to ACE inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases",
    "simplified": "Aliskiren has the potential to become the first orally active renin inhibitor that can be used as a therapy for hypertension and other cardiovascular and renal diseases."
  },
  {
    "text": "We tested the new orally active nonpeptidic renin inhibitor SPP100 Aliskiren an octanamide in 18 healthy volunteers on a constant 100 mmold sodium diet using a doubleblind 3way crossover protocol in the low nanomolar range .",
    "triple_list": [
      [
        "renin",
        "CPR:4",
        "SPP100"
      ],
      [
        "renin",
        "CPR:4",
        "Aliskiren"
      ],
      [
        "renin",
        "CPR:4",
        "octanamide"
      ]
    ],
    "updated": "Yes",
    "original": "We tested the new orally active nonpeptidic renin inhibitor SPP100 Aliskiren an octanamide with a 50 inhibitory concentration IC50 in the low nanomolar range in 18 healthy volunteers on a constant 100 mmold sodium diet using a doubleblind 3way crossover protocol",
    "simplified": "We tested the new orally active nonpeptidic renin inhibitor SPP100 Aliskiren an octanamide in 18 healthy volunteers on a constant 100 mmold sodium diet using a doubleblind 3way crossover protocol in the low nanomolar range."
  },
  {
    "text": "There was a dosedependent decrease in plasma renin activity Ang I and Ang II following single doses of Aliskiren starting with 40 mg Inhibition was still marked and significant when the highest dose of Aliskiren was compared with placebo , with maximal decreases in Ang II levels by 89 and 75 on Days 1 and 8 .",
    "triple_list": [
      [
        "renin",
        "CPR:4",
        "Aliskiren"
      ],
      [
        "Ang I",
        "CPR:4",
        "Aliskiren"
      ],
      [
        "Ang II",
        "CPR:4",
        "Aliskiren"
      ],
      [
        "Ang II",
        "CPR:4",
        "Aliskiren"
      ]
    ],
    "updated": "Yes",
    "original": "There was a dosedependent decrease in plasma renin activity Ang I and Ang II following single doses of Aliskiren starting with 40 mg Inhibition was still marked and significant after repeated dosing with maximal decreases in Ang II levels by 89 and 75 on Days 1 and 8 respectively when the highest dose of Aliskiren was compared with placebo",
    "simplified": "There was a dosedependent decrease in plasma renin activity Ang I and Ang II following single doses of Aliskiren starting with 40 mg Inhibition was still marked and significant when the highest dose of Aliskiren was compared with placebo, with maximal decreases in Ang II levels by 89 and 75 on Days 1 and 8."
  },
  {
    "text": "The orally active renin inhibitor Aliskiren SPP100 can reduce Angiotensin II in humans , but not in animals .",
    "triple_list": [
      [
        "Angiotensin II",
        "CPR:4",
        "Aliskiren"
      ],
      [
        "renin",
        "CPR:4",
        "Aliskiren"
      ],
      [
        "Angiotensin II",
        "CPR:4",
        "SPP100"
      ],
      [
        "renin",
        "CPR:4",
        "SPP100"
      ]
    ],
    "updated": "Yes",
    "original": "Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren SPP100 comparison with enalapril",
    "simplified": "The orally active renin inhibitor Aliskiren SPP100 can reduce Angiotensin II in humans, but not in animals."
  },
  {
    "text": "The first AChE inhibitors , physostigmine and tacrine , did not work very well in clinical trials . They did not work at all in brain penetration .",
    "triple_list": [
      [
        "AChE",
        "CPR:4",
        "physostigmine"
      ],
      [
        "AChE",
        "CPR:4",
        "tacrine"
      ]
    ],
    "updated": "Yes",
    "original": "The earliest known AChE inhibitors namely physostigmine and tacrine performed poorly in clinical trials eg poor oral activity brain penetration and hepatotoxic liability",
    "simplified": "The first AChE inhibitors, physostigmine and tacrine, did not work very well in clinical trials. They did not work at all in brain penetration."
  },
  {
    "text": "Donepezil hydrochloride inaugurates a new class of AChE inhibitors with longer and more selective action and with manageable adverse effects",
    "triple_list": [
      [
        "Donepezil hydrochloride",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "No",
    "original": "Donepezil hydrochloride inaugurates a new class of AChE inhibitors with longer and more selective action and with manageable adverse effects",
    "simplified": "Donepezil hydrochloride started a new class of drugs that could work for a longer period of time. They had better action."
  },
  {
    "text": "Thalidomide removed from widespread clinical use by 1962 because of severe teratogenicityhas antiangiogenic and immunomodulatory effects including the inhibition of TNF alpha",
    "triple_list": [
      [
        "Thalidomide",
        "CPR:4",
        "TNF alpha"
      ]
    ],
    "updated": "No",
    "original": "Thalidomide removed from widespread clinical use by 1962 because of severe teratogenicityhas antiangiogenic and immunomodulatory effects including the inhibition of TNF alpha",
    "simplified": "Thalidomide was removed from widespread clinical use by 1962 because of its bad health effects. It has antiangiogenic and immunomodulatory effects."
  },
  {
    "text": "As a prodrug leflunomide is completely converted to its active metabolite A 77 1726 M1 which blocks the dihydroorotate dehydrogenase a key enzyme of the pyrimidine de novo synthesis",
    "triple_list": [
      [
        "leflunomide",
        "CPR:4",
        "dihydroorotate dehydrogenase"
      ],
      [
        "A 77 1726",
        "CPR:4",
        "dihydroorotate dehydrogenase"
      ]
    ],
    "updated": "No",
    "original": "As a prodrug leflunomide is completely converted to its active metabolite A 77 1726 M1 which blocks the dihydroorotate dehydrogenase a key enzyme of the pyrimidine de novo synthesis",
    "simplified": "As a prodrug leflunomide is completely changed into its active metabolite A 77 1726 M1. This metabolite blocks a key enzyme of the pyrimidine synthesis."
  },
  {
    "text": "A recent study showed that anastrozole ( an aromatase inhibitor ) is better than tamoxifen when used firstly in patients with breast cancer .",
    "triple_list": [
      [
        "anastrozole",
        "CPR:4",
        "aromatase"
      ]
    ],
    "updated": "Yes",
    "original": "A recent study showed that anastrozole an aromatase inhibitor is as effective or even superior to tamoxifen when used as a firstline therapy",
    "simplified": "A recent study showed that anastrozole (an aromatase inhibitor) is better than tamoxifen when used firstly in patients with breast cancer."
  },
  {
    "text": "Fulvestrant , the first drug in this new class , not only acts on the estrogen receptor , but also acts on other cells in the body as well . This gives a better safety profile .",
    "triple_list": [
      [
        "Fulvestrant",
        "CPR:4",
        "estrogen receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Fulvestrant the first agent in this new class not only induces the degradation of the estrogen receptor but also is an estrogen antagonist further its lack of agonist activity provides a better safety profile",
    "simplified": "Fulvestrant, the first drug in this new class, not only acts on the estrogen receptor, but also acts on other cells in the body as well. This gives a better safety profile."
  },
  {
    "text": "Lovastatin , a specific inhibitor of HMGCoA reductase , has been shown to reduce cell death in certain types of bone cancer .",
    "triple_list": [
      [
        "Lovastatin",
        "CPR:4",
        "HMGCoA reductase"
      ]
    ],
    "updated": "Yes",
    "original": "Lovastatin a specific inhibitor of HMGCoA reductase induces a pronounced apoptotic response in a specific subset of tumor types including HNSCC and CC",
    "simplified": "Lovastatin, a specific inhibitor of HMGCoA reductase, has been shown to reduce cell death in certain types of bone cancer."
  },
  {
    "text": "The NET inhibitor desipramine DMI was shown to reduce NET levels in both control and Dbh mice . This showed that NE is not necessary for antidepressant drugs to work .",
    "triple_list": [
      [
        "NET",
        "CPR:4",
        "desipramine"
      ],
      [
        "NET",
        "CPR:4",
        "desipramine"
      ]
    ],
    "updated": "Yes",
    "original": "Chronic treatment with the NET inhibitor desipramine DMI reduced NET levels in both control and Dbh mice demonstrating that NE is not required for the regulation of NET by antidepressant drugs",
    "simplified": "The NET inhibitor desipramine DMI was shown to reduce NET levels in both control and Dbh mice. This showed that NE is not necessary for antidepressant drugs to work."
  },
  {
    "text": "Probes were perfused with artificial cerebrospinal fluid containing nicotine the specific alpha4beta2 nAChR agonist metanicotine or nicotine plus nAChR antagonists and norepinephrine measured in the microdialysates",
    "triple_list": [
      [
        "alpha4beta2 nAChR",
        "CPR:5",
        "metanicotine"
      ],
      [
        "nicotine",
        "CPR:5",
        "alpha4beta2 nAChR"
      ]
    ],
    "updated": "No",
    "original": "Probes were perfused with artificial cerebrospinal fluid containing nicotine the specific alpha4beta2 nAChR agonist metanicotine or nicotine plus nAChR antagonists and norepinephrine measured in the microdialysates",
    "simplified": "Probes were perfused with artificial cerebrospinal fluid containing nicotine. Metanicotine or nicotine plus nAChR antagonists and norepinephrine were measured in the microdialysates."
  },
  {
    "text": "Cilostazol causes some increase in HDL cholesterol levels and decreases serum triglycerides .",
    "triple_list": [
      [
        "Cilostazol",
        "CPR:3",
        "HDL"
      ]
    ],
    "updated": "Yes",
    "original": "Cilostazol decreases levels of serum triglycerides and causes some increase in HDL cholesterol levels",
    "simplified": "Cilostazol causes some increase in HDL cholesterol levels and decreases serum triglycerides."
  },
  {
    "text": "Cilostazol goes through a very hard hepatic metabolism . This is done by the cytochrome P450 systems .",
    "triple_list": [
      [
        "Cilostazol",
        "CPR:9",
        "cytochrome P450"
      ]
    ],
    "updated": "Yes",
    "original": "Cilostazol undergoes intensive and finally complete hepatic metabolism via the cytochrome P450 systems",
    "simplified": "Cilostazol goes through a very hard hepatic metabolism. This is done by the cytochrome P450 systems."
  },
  {
    "text": "In contrast the mutants T844A F972A and Q975A showed increased Ki for cilostazol but no difference for milrinone from the recombinant PDE3A",
    "triple_list": [
      [
        "cilostazol",
        "CPR:4",
        "PDE3A"
      ],
      [
        "T844A",
        "CPR:4",
        "cilostazol"
      ],
      [
        "F972A",
        "CPR:4",
        "cilostazol"
      ],
      [
        "Q975A",
        "CPR:4",
        "cilostazol"
      ],
      [
        "milrinone",
        "CPR:4",
        "PDE3A"
      ],
      [
        "T844A",
        "CPR:4",
        "milrinone"
      ],
      [
        "F972A",
        "CPR:4",
        "milrinone"
      ],
      [
        "Q975A",
        "CPR:4",
        "milrinone"
      ]
    ],
    "updated": "No",
    "original": "In contrast the mutants T844A F972A and Q975A showed increased Ki for cilostazol but no difference for milrinone from the recombinant PDE3A",
    "simplified": "In contrast the mutants T844A F972A and Q975A showed no difference in Ki for milrinone but increased Ki for cilostazol."
  },
  {
    "text": "Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site . Because of this , it is possible to design inhibitors with different sizes .",
    "triple_list": [
      [
        "PDE3",
        "CPR:4",
        "cilostazol"
      ],
      [
        "PDE3",
        "CPR:4",
        "milrinone"
      ]
    ],
    "updated": "Yes",
    "original": "Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site suggesting that selective inhibitors can be designed with flexible size against PDE3 active site",
    "simplified": "Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site. Because of this, it is possible to design inhibitors with different sizes."
  },
  {
    "text": "The highly conserved residues Y751 D950 and F1004 in the PDE families are key residues for binding both substrate and inhibitors . These residues may be responsible for the cilostazol selectivity of PDE3A .",
    "triple_list": [
      [
        "PDE",
        "CPR:4",
        "cilostazol"
      ],
      [
        "cilostazol",
        "CPR:4",
        "PDE3A"
      ]
    ],
    "updated": "Yes",
    "original": "Our study implies that highly conserved residuals Y751 D950 and F1004 in the PDE families are key residues for binding of both substrate and inhibitors and nonconserved T844 may be responsible for the cilostazol selectivity of PDE3A",
    "simplified": "The highly conserved residues Y751 D950 and F1004 in the PDE families are key residues for binding both substrate and inhibitors. These residues may be responsible for the cilostazol selectivity of PDE3A."
  },
  {
    "text": "We changed the residues to alanine and expressed the mutants in a baculovirusSf9 cell system . We then analyzed the kinetic characteristics of inhibition of the mutant enzymes by milrinone and cilostazol specific inhibitors of PDE3 .",
    "triple_list": [
      [
        "milrinone",
        "CPR:4",
        "PDE3"
      ],
      [
        "cilostazol",
        "CPR:4",
        "PDE3"
      ]
    ],
    "updated": "Yes",
    "original": "We changed the residues to alanine using sitedirected mutagenesis technique expressed the mutants in a baculovirusSf9 cell system and analyzed the kinetic characteristics of inhibition of the mutant enzymes by milrinone and cilostazol specific inhibitors of PDE3",
    "simplified": "We changed the residues to alanine and expressed the mutants in a baculovirusSf9 cell system. We then analyzed the kinetic characteristics of inhibition of the mutant enzymes by milrinone and cilostazol specific inhibitors of PDE3."
  },
  {
    "text": "Mutants Y751A D950A and F1004A had reduced sensitivity to milrinone Ki changed from 066 microM for the recombinant PDE3A to 75 to 156 microM for the mutants and diminished sensitivity to cilostazol Ki of the mutants were 18 to 371fold higher than that of the recombinant PDE3A",
    "triple_list": [
      [
        "Y751A",
        "CPR:4",
        "milrinone"
      ],
      [
        "D950A",
        "CPR:4",
        "milrinone"
      ],
      [
        "F1004A",
        "CPR:4",
        "milrinone"
      ],
      [
        "milrinone",
        "CPR:4",
        "PDE3A"
      ],
      [
        "PDE3A",
        "CPR:4",
        "cilostazol"
      ]
    ],
    "updated": "No",
    "original": "Mutants Y751A D950A and F1004A had reduced sensitivity to milrinone Ki changed from 066 microM for the recombinant PDE3A to 75 to 156 microM for the mutants and diminished sensitivity to cilostazol Ki of the mutants were 18 to 371fold higher than that of the recombinant PDE3A",
    "simplified": "The sensitivity to milrinone Ki changed from 066 microM for the recombinant PDE3A to 75 to 156 microM for the mutants. The sensitivity to cilostazol Ki of the mutants was 18 to 371fold higher than that of the recombinant PDE3A."
  },
  {
    "text": "The enzyme maltodextrin phosphorylase MalP removes the nonreducing glucosyl residues of linear oligosaccharides as glucose1phosphate Glc1P in maltodextrins . This is done by phosphorolysis of an alpha14glycosidic bond .",
    "triple_list": [
      [
        "maltodextrin phosphorylase",
        "CPR:9",
        "glucose1phosphate"
      ],
      [
        "MalP",
        "CPR:9",
        "glucose1phosphate"
      ],
      [
        "maltodextrin phosphorylase",
        "CPR:9",
        "Glc1P"
      ],
      [
        "MalP",
        "CPR:9",
        "Glc1P"
      ]
    ],
    "updated": "Yes",
    "original": "The bacterial enzyme maltodextrin phosphorylase MalP catalyses the phosphorolysis of an alpha14glycosidic bond in maltodextrins removing the nonreducing glucosyl residues of linear oligosaccharides as glucose1phosphate Glc1P",
    "simplified": "The enzyme maltodextrin phosphorylase MalP removes the nonreducing glucosyl residues of linear oligosaccharides as glucose1phosphate Glc1P in maltodextrins. This is done by phosphorolysis of an alpha14glycosidic bond."
  },
  {
    "text": "Objective Fondaparinux sodium is the first in a new class of synthetic factor Xa inhibitors . It binds to antithrombin III very well .",
    "triple_list": [
      [
        "Fondaparinux sodium",
        "CPR:4",
        "factor Xa"
      ]
    ],
    "updated": "Yes",
    "original": "OBJECTIVE Fondaparinux sodium is the first in a new class of synthetic factor Xa inhibitors that binds reversibly with high affinity to antithrombin III",
    "simplified": "Objective Fondaparinux sodium is the first in a new class of synthetic factor Xa inhibitors. It binds to antithrombin III very well."
  },
  {
    "text": "It is caused by a deficiency of propionylCoA carboxylase PCC EC 6413 a biotindependent enzyme that catalyzes the carboxylation of propionylCoA to DmethylmalonylCoA",
    "triple_list": [
      [
        "propionylCoA",
        "CPR:9",
        "propionylCoA carboxylase"
      ],
      [
        "propionylCoA",
        "CPR:9",
        "PCC"
      ],
      [
        "propionylCoA",
        "CPR:9",
        "EC 6413"
      ],
      [
        "propionylCoA carboxylase",
        "CPR:9",
        "DmethylmalonylCoA"
      ],
      [
        "PCC",
        "CPR:9",
        "DmethylmalonylCoA"
      ],
      [
        "EC 6413",
        "CPR:9",
        "DmethylmalonylCoA"
      ]
    ],
    "updated": "No",
    "original": "It is caused by a deficiency of propionylCoA carboxylase PCC EC 6413 a biotindependent enzyme that catalyzes the carboxylation of propionylCoA to DmethylmalonylCoA",
    "simplified": "It is caused by a lack of an enzyme called propionylCoA carboxylase. This enzyme catalyzes the carboxylation of propionylCoA into DmethylmalonylCoA."
  },
  {
    "text": "Only clozapine and ziprasidone are directly acting 5HT1A agonists . A selective 5HT1A antagonist , WAY100635 , is used in certain studies to reduce the effects of 5HT2A and/or D2 blockade on the central nervous system .",
    "triple_list": [
      [
        "clozapine",
        "CPR:4",
        "5HT2A"
      ],
      [
        "clozapine",
        "CPR:4",
        "D2"
      ],
      [
        "ziprasidone",
        "CPR:4",
        "5HT2A"
      ],
      [
        "ziprasidone",
        "CPR:4",
        "D2"
      ],
      [
        "WAY100635",
        "CPR:4",
        "5HT2A"
      ],
      [
        "WAY100635",
        "CPR:4",
        "D2"
      ],
      [
        "clozapine",
        "CPR:5",
        "5HT1A"
      ],
      [
        "ziprasidone",
        "CPR:5",
        "5HT1A"
      ],
      [
        "5HT1A",
        "CPR:6",
        "WAY100635"
      ]
    ],
    "updated": "Yes",
    "original": "Although only clozapine and ziprasidone are directly acting 5HT1A agonists WAY100635 a selective 5HT1A antagonist partially attenuates these atypical APDinduced increases in cortical DA release that may be due to combined 5HT2A and D2 blockade",
    "simplified": "Only clozapine and ziprasidone are directly acting 5HT1A agonists. A selective 5HT1A antagonist, WAY100635, is used in certain studies to reduce the effects of 5HT2A and/or D2 blockade on the central nervous system."
  },
  {
    "text": "However , the 5HT1A agonism may only be important when quetiapine is used .",
    "triple_list": [
      [
        "5HT1A",
        "CPR:5",
        "quetiapine"
      ]
    ],
    "updated": "Yes",
    "original": "However 5HT1A agonism may be important only for quetiapine induced ACh release",
    "simplified": "However, the 5HT1A agonism may only be important when quetiapine is used."
  },
  {
    "text": "The drug retigabine is the first selective Mcurrent potassium channel opener . It can open KCNQ23 and KCNQ35 channels .",
    "triple_list": [
      [
        "retigabine",
        "CPR:3",
        "KCNQ23"
      ],
      [
        "retigabine",
        "CPR:3",
        "KCNQ35"
      ],
      [
        "retigabine",
        "CPR:3",
        "Mcurrent potassium channel"
      ]
    ],
    "updated": "Yes",
    "original": "BACKGROUND The novel antiepileptic drug retigabine is the first selective Mcurrent potassium channel opener for KCNQ23 and KCNQ35 channels",
    "simplified": "The drug retigabine is the first selective Mcurrent potassium channel opener. It can open KCNQ23 and KCNQ35 channels."
  },
  {
    "text": "OBJECTIVE We wanted to determine if inhibition of COX2 would affect incisional skin wound healing , given the widespread use of the selective COX2 inhibitor celecoxib .",
    "triple_list": [
      [
        "COX2",
        "CPR:4",
        "celecoxib"
      ]
    ],
    "updated": "Yes",
    "original": "OBJECTIVE Because of these physiological effects and the widespread use of the selective COX2 inhibitor celecoxib we wanted to determine if inhibition of COX2 would affect incisional skin wound healing",
    "simplified": "OBJECTIVE We wanted to determine if inhibition of COX2 would affect incisional skin wound healing, given the widespread use of the selective COX2 inhibitor celecoxib."
  },
  {
    "text": "METHODS Using a hairless SKH1 mice model , we evaluated the role of COX2 in the wound healing process by comparing the effects of a nonselective COX inhibitor diclofenac with a selective COX2 inhibitor SC791 .",
    "triple_list": [
      [
        "COX",
        "CPR:4",
        "diclofenac"
      ]
    ],
    "updated": "Yes",
    "original": "METHODS Using a cutaneous fullthickness sutured incisional wound model in hairless SKH1 mice we evaluated the role of COX2 in the wound healing process by comparing the effects of a nonselective COX inhibitor diclofenac with a selective COX2 inhibitor SC791",
    "simplified": "METHODS Using a hairless SKH1 mice model, we evaluated the role of COX2 in the wound healing process by comparing the effects of a nonselective COX inhibitor diclofenac with a selective COX2 inhibitor SC791."
  },
  {
    "text": "The effects of histamine H1receptor antagonists promethazine and homochlorcyclizine both of which are inhibitors of CYP2D6 on the steadystate plasma concentrations Css of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol 12 to 36 mgd for 2 to 29 weeks",
    "triple_list": [
      [
        "promethazine",
        "CPR:4",
        "CYP2D6"
      ],
      [
        "homochlorcyclizine",
        "CPR:4",
        "CYP2D6"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "promethazine"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "homochlorcyclizine"
      ]
    ],
    "updated": "No",
    "original": "The effects of histamine H1receptor antagonists promethazine and homochlorcyclizine both of which are inhibitors of CYP2D6 on the steadystate plasma concentrations Css of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol 12 to 36 mgd for 2 to 29 weeks",
    "simplified": "The effects of histamine H1receptor antagonists promethazine and homochlorcyclizine on the steadystate plasma concentrations of haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol 12 to 36 mgd for 2 to 29 weeks."
  },
  {
    "text": "The current study suggests that when promethazine and homochlorcyclizine are co-administered , it increases the Css of haloperidol and reduced haloperidol . The inhibitory effects on the CYP2D6 catalyzed metabolism of haloperidol are also noted .",
    "triple_list": [
      [
        "promethazine",
        "CPR:4",
        "CYP2D6"
      ],
      [
        "homochlorcyclizine",
        "CPR:4",
        "CYP2D6"
      ],
      [
        "haloperidol",
        "CPR:9",
        "CYP2D6"
      ],
      [
        "haloperidol",
        "CPR:9",
        "CYP2D6"
      ]
    ],
    "updated": "Yes",
    "original": "Thus the current study suggests that coadministration of clinical doses of promethazine and homochlorcyclizine increases the Css of haloperidol and reduced haloperidol via the inhibitory effects on the CYP2D6 catalyzed metabolism of haloperidol and reduced haloperidol",
    "simplified": "The current study suggests that when promethazine and homochlorcyclizine are co-administered, it increases the Css of haloperidol and reduced haloperidol. The inhibitory effects on the CYP2D6 catalyzed metabolism of haloperidol are also noted."
  },
  {
    "text": "Histamine H1receptor antagonists promethazine and homochlorcyclizine increase the steadystate plasma concentrations of haloperidol and reduced haloperidol",
    "triple_list": [
      [
        "Histamine H1receptor",
        "CPR:6",
        "promethazine"
      ],
      [
        "Histamine H1receptor",
        "CPR:6",
        "homochlorcyclizine"
      ]
    ],
    "updated": "No",
    "original": "Histamine H1receptor antagonists promethazine and homochlorcyclizine increase the steadystate plasma concentrations of haloperidol and reduced haloperidol",
    "simplified": "Promethazine and homochlorcyclizine increase the plasma concentrations of haloperidol, but reduced the plasma concentrations of haloperidol."
  },
  {
    "text": "The four lysine residues located in the SMG loop also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase . These residues are Lys260 Lys263 Lys265 and Lys268 , which are located in the SMG loop .",
    "triple_list": [
      [
        "OTCase",
        "CPR:4",
        "ornithine"
      ]
    ],
    "updated": "Yes",
    "original": "The four lysine residues located in the SMG loop Lys260 Lys263 Lys265 and Lys268 also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain",
    "simplified": "The four lysine residues located in the SMG loop also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase. These residues are Lys260 Lys263 Lys265 and Lys268, which are located in the SMG loop."
  },
  {
    "text": "The binding of both plasminogen and plasmin to gp330 by benzamidine was similar , although the binding of plasmin to gp330 was slightly more inhibited by EACA .",
    "triple_list": [
      [
        "plasminogen",
        "CPR:4",
        "benzamidine"
      ],
      [
        "plasmin",
        "CPR:4",
        "benzamidine"
      ],
      [
        "plasmin",
        "CPR:4",
        "EACA"
      ],
      [
        "plasminogen",
        "CPR:4",
        "EACA"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330",
    "simplified": "The binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although the binding of plasmin to gp330 was slightly more inhibited by EACA."
  },
  {
    "text": "Involvement of alpha1adrenoceptors was established as mydriatic responses were inhibited by systemic administration of nonselective alphaadrenoceptor antagonists phentolamine 033 mgkg and phenoxybenzamine 00303 mgkg as well as by the selective alpha1adrenoceptor antagonist prazosin 03 mgkg",
    "triple_list": [
      [
        "alphaadrenoceptor",
        "CPR:6",
        "phentolamine"
      ],
      [
        "alphaadrenoceptor",
        "CPR:6",
        "phenoxybenzamine"
      ],
      [
        "alpha1adrenoceptor",
        "CPR:6",
        "prazosin"
      ]
    ],
    "updated": "No",
    "original": "Involvement of alpha1adrenoceptors was established as mydriatic responses were inhibited by systemic administration of nonselective alphaadrenoceptor antagonists phentolamine 033 mgkg and phenoxybenzamine 00303 mgkg as well as by the selective alpha1adrenoceptor antagonist prazosin 03 mgkg",
    "simplified": "The involvement of alpha1adrenoceptors was established as systemic administration of phentolamine 033 mgkg and phenoxybenzamine 00303 mgkg as well as the selective alpha1adrenoceptor antagonist prazosin 03 mgkg inhibited mydriatic responses."
  },
  {
    "text": "The alpha2adrenoceptor blocker rauwolscine did not work at all .",
    "triple_list": [
      [
        "alpha2adrenoceptor",
        "CPR:6",
        "rauwolscine"
      ]
    ],
    "updated": "Yes",
    "original": "The alpha2adrenoceptor antagonist rauwolscine 05 mgkg was without antagonistic effects",
    "simplified": "The alpha2adrenoceptor blocker rauwolscine did not work at all."
  },
  {
    "text": "alpha1AAdrenoceptor selective antagonists 226dimethoxyphenoxyethylaminomethyl14benzodioxane WB4101 011 mgkg and 5methylurapidil 011 mgkg the alpha1Badrenoceptor selective antagonist 4amino241benzyloxycarbonyl2S 11dimethylethylaminocarbonylpiperazinyl67dimethoxyquinazoline L765314 031 mgkg as well as the alpha1Dadrenoceptor selective antagonist 8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione BMY7378 1 mgkg were used to delineate the adrenoceptor subtypes involved",
    "triple_list": [
      [
        "alpha1AAdrenoceptor",
        "CPR:6",
        "226dimethoxyphenoxyethylaminomethyl14benzodioxane"
      ],
      [
        "alpha1AAdrenoceptor",
        "CPR:6",
        "WB4101"
      ],
      [
        "alpha1AAdrenoceptor",
        "CPR:6",
        "5methylurapidil"
      ],
      [
        "alpha1Badrenoceptor",
        "CPR:6",
        "4amino241benzyloxycarbonyl2S 11dimethylethylaminocarbonylpiperazinyl67dimethoxyquinazoline"
      ],
      [
        "alpha1Badrenoceptor",
        "CPR:6",
        "L765314"
      ],
      [
        "alpha1Dadrenoceptor",
        "CPR:6",
        "8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione"
      ],
      [
        "alpha1Dadrenoceptor",
        "CPR:6",
        "BMY7378"
      ]
    ],
    "updated": "No",
    "original": "alpha1AAdrenoceptor selective antagonists 226dimethoxyphenoxyethylaminomethyl14benzodioxane WB4101 011 mgkg and 5methylurapidil 011 mgkg the alpha1Badrenoceptor selective antagonist 4amino241benzyloxycarbonyl2S 11dimethylethylaminocarbonylpiperazinyl67dimethoxyquinazoline L765314 031 mgkg as well as the alpha1Dadrenoceptor selective antagonist 8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione BMY7378 1 mgkg were used to delineate the adrenoceptor subtypes involved",
    "simplified": "alpha1AAdrenoceptor selective antagonists 226dimethoxyphenoxyethylaminomethyl14benzodioxane WB4101 011 mgkg and 5methylurapidil 011 mgkg were used to show the difference between different types of adrenal insufficiency and the disease-free adrenal insufficiency."
  },
  {
    "text": "To further investigate this positive correlation a selective COX2 inhibitor etodolac was tested on three variants of HT29 colon cancer cell lines HT29Inv1 HT29Inv2 and HT29Inv3 . Matrigel invasive potential and COX2 expression levels were increased in all three cell lines .",
    "triple_list": [
      [
        "COX2",
        "CPR:4",
        "etodolac"
      ]
    ],
    "updated": "Yes",
    "original": "To further investigate this positive correlation and its possible therapeutic implications a selective COX2 inhibitor etodolac was tested on three variants of HT29 colon cancer cell lines HT29Inv1 HT29Inv2 and HT29Inv3 with graded increases of in vitro Matrigel invasive potential and COX2 expression levels",
    "simplified": "To further investigate this positive correlation a selective COX2 inhibitor etodolac was tested on three variants of HT29 colon cancer cell lines HT29Inv1 HT29Inv2 and HT29Inv3. Matrigel invasive potential and COX2 expression levels were increased in all three cell lines."
  },
  {
    "text": "Other alpha1adrenoceptor antagonists , such as tamsulosin WB4101 and corynanthine did not inhibit the binding . However , noradrenaline rauwolscine and propranolol were without effect on the 3Hprazosin binding , so it is possible that these other drugs also affect the binding .",
    "triple_list": [
      [
        "alpha1adrenoceptor",
        "CPR:6",
        "tamsulosin"
      ],
      [
        "alpha1adrenoceptor",
        "CPR:6",
        "WB4101"
      ],
      [
        "alpha1adrenoceptor",
        "CPR:6",
        "corynanthine"
      ]
    ],
    "updated": "Yes",
    "original": "However other alpha1adrenoceptor antagonists tamsulosin WB4101 and corynanthine did not inhibit the binding at a range of concentrations that generally exhibit alpha1adrenoceptor antagonism and noradrenaline rauwolscine and propranolol were without effect on the 3Hprazosin binding",
    "simplified": "Other alpha1adrenoceptor antagonists, such as tamsulosin WB4101 and corynanthine did not inhibit the binding. However, noradrenaline rauwolscine and propranolol were without effect on the 3Hprazosin binding, so it is possible that these other drugs also affect the binding."
  },
  {
    "text": "A comparison of the results with previous data for desipramine and cocaine inhibition of norepinephrine uptake by the mutant hNETs shows that the binding sites for tricyclic antidepressants and cocaine are located at the same site as the MrIA binding site .",
    "triple_list": [
      [
        "norepinephrine",
        "CPR:9",
        "hNETs"
      ]
    ],
    "updated": "Yes",
    "original": "A comparison of the results with previous data for desipramine and cocaine inhibition of norepinephrine uptake by the mutant hNETs reveals that MrIA binding to hNET occurs at a site that is distinct from but overlaps with the binding sites for tricyclic antidepressants and cocaine",
    "simplified": "A comparison of the results with previous data for desipramine and cocaine inhibition of norepinephrine uptake by the mutant hNETs shows that the binding sites for tricyclic antidepressants and cocaine are located at the same site as the MrIA binding site."
  },
  {
    "text": "MrIA has been shown to inhibit the uptake of 3Hnorepinephrine and 3Hdopamine by the human human dopamine transporter and the human serotonin transporter . MrIA was also able to inhibit hNET by 7 microM .",
    "triple_list": [
      [
        "hNET",
        "CPR:9",
        "3Hnorepinephrine"
      ],
      [
        "hNET",
        "CPR:9",
        "3Hdopamine"
      ]
    ],
    "updated": "Yes",
    "original": "The potency of MrIA was greater for inhibition of uptake by hNET of 3Hnorepinephrine Ki 189 microM than 3Hdopamine Ki 433 microM and the human dopamine transporter and serotonin transporter were not inhibited by MrIA to 7 microM",
    "simplified": "MrIA has been shown to inhibit the uptake of 3Hnorepinephrine and 3Hdopamine by the human human dopamine transporter and the human serotonin transporter. MrIA was also able to inhibit hNET by 7 microM."
  },
  {
    "text": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 Nacylamino acid aminohydrolase ACY1 EC 35114 a dimeric metalloprotein having two Zn2 in the molecule which catalyzes the deacylation of Nacylated Lamino acids except Laspartic acid has been isolated from porcine kidney lambda gt10 cDNA library and sequenced",
    "triple_list": [
      [
        "ACY1",
        "CPR:9",
        "Nacylated Lamino acids"
      ],
      [
        "EC 35114",
        "CPR:9",
        "Nacylated Lamino acids"
      ],
      [
        "metalloprotein",
        "CPR:9",
        "Nacylated Lamino acids"
      ],
      [
        "aminoacylase 1",
        "CPR:9",
        "Nacylated Lamino acids"
      ],
      [
        "Nacylamino acid aminohydrolase",
        "CPR:9",
        "Nacylated Lamino acids"
      ]
    ],
    "updated": "No",
    "original": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 Nacylamino acid aminohydrolase ACY1 EC 35114 a dimeric metalloprotein having two Zn2 in the molecule which catalyzes the deacylation of Nacylated Lamino acids except Laspartic acid has been isolated from porcine kidney lambda gt10 cDNA library and sequenced",
    "simplified": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 Nacylamino acid aminohydrolase ACY1 EC 35114 A cDNA encoding the complete amino acid sequence of aminoacylase 1 Nacylamino acid aminohydrolase ACY1 EC 35114 has been isolated from porcine kidney lambda gt10 cDNA library and sequenced"
  },
  {
    "text": "Patients stable on warfarin therapy and taking a cyclooxygenase2 COX2 inhibitor comparator salsalate or acetaminophen randomly received rofecoxib 25 mgday for three weeks or celecoxib 200 mgday for three weeks .",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:4",
        "salsalate"
      ],
      [
        "COX2",
        "CPR:4",
        "salsalate"
      ],
      [
        "cyclooxygenase2",
        "CPR:4",
        "acetaminophen"
      ],
      [
        "COX2",
        "CPR:4",
        "acetaminophen"
      ],
      [
        "cyclooxygenase2",
        "CPR:4",
        "celecoxib"
      ],
      [
        "COX2",
        "CPR:4",
        "celecoxib"
      ],
      [
        "cyclooxygenase2",
        "CPR:4",
        "rofecoxib"
      ],
      [
        "COX2",
        "CPR:4",
        "rofecoxib"
      ]
    ],
    "updated": "Yes",
    "original": "Patients stable on warfarin therapy and concurrently taking a cyclooxygenase2 COX2 inhibitor comparator traditional nonsteroidal antiinflammatory medications salsalate or acetaminophen randomly received celecoxib 200 mgday or rofecoxib 25 mgday for three weeks",
    "simplified": "Patients stable on warfarin therapy and taking a cyclooxygenase2 COX2 inhibitor comparator salsalate or acetaminophen randomly received rofecoxib 25 mgday for three weeks or celecoxib 200 mgday for three weeks."
  },
  {
    "text": "Results Eprosartan tended to lower mean AP . It slightly increased heart rate p005 It markedly increased circulating AngII levels p001",
    "triple_list": [
      [
        "Eprosartan",
        "CPR:3",
        "AngII"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS Eprosartan tended to lower mean AP it slightly increased heart rate HR p005 and markedly increased circulating AngII levels p001",
    "simplified": "Results Eprosartan tended to lower mean AP. It slightly increased heart rate p005 It markedly increased circulating AngII levels p001"
  },
  {
    "text": "We sought to assess the effects of the angiotensin type 1 AT1 receptor blocker eprosartan on HRV and BRG",
    "triple_list": [
      [
        "angiotensin type 1 AT1 receptor",
        "CPR:4",
        "eprosartan"
      ]
    ],
    "updated": "No",
    "original": "We sought to assess the effects of the angiotensin type 1 AT1 receptor blocker eprosartan on HRV and BRG",
    "simplified": "The angiotensin type 1 receptor blocker, eprosartan, was tested against HRV and BRG."
  },
  {
    "text": "AT1 antagonism by eprosartan decreases heart rate and blood pressure",
    "triple_list": [
      [
        "AT1",
        "CPR:6",
        "eprosartan"
      ]
    ],
    "updated": "Yes",
    "original": "AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain",
    "simplified": "AT1 antagonism by eprosartan decreases heart rate and blood pressure"
  },
  {
    "text": "CONCLUSIONS AT1 antagonism by eprosartan lowers baroreflex gain and heart rate variability",
    "triple_list": [
      [
        "AT1",
        "CPR:6",
        "eprosartan"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain",
    "simplified": "CONCLUSIONS AT1 antagonism by eprosartan lowers baroreflex gain and heart rate variability"
  },
  {
    "text": "The antinociceptive activity of the alpha 2adrenoceptor agonist clonidine was also increased in mice treated with alpha Nacetyl betaendorphin131",
    "triple_list": [
      [
        "alpha 2adrenoceptor",
        "CPR:5",
        "clonidine"
      ]
    ],
    "updated": "No",
    "original": "The antinociceptive activity of the alpha 2adrenoceptor agonist clonidine was also increased in mice treated with alpha Nacetyl betaendorphin131",
    "simplified": "The antinociceptive activity of clonidine was also increased in mice treated with alpha Nacetyl betaendorphin when compared with untreated mice."
  },
  {
    "text": "In seven normal subjects , after 16 mg loperamide , plasma ACTH levels were significantly reduced 3 h after administration .",
    "triple_list": [
      [
        "ACTH",
        "CPR:4",
        "loperamide"
      ]
    ],
    "updated": "Yes",
    "original": "In seven normal subjects basal ACTH plasma levels were significantly suppressed 3 h after loperamide administration 16 mg orally from 5 1 to 2 0 pmolL P less than 00001",
    "simplified": "In seven normal subjects, after 16 mg loperamide, plasma ACTH levels were significantly reduced 3 h after administration."
  },
  {
    "text": "After the combined pituitary stimulation test 100 micrograms human CRH 100 micrograms GnRH 100 micrograms GHreleasing hormone and 200 micrograms TRH the ACTH peak maximum increase at 30 min was significantly blunted by loperamide from 9 1 to 4 1 pmolL P less than 0001 and the area under the curve of ACTH from 0120 min was reduced from 35 5 to 23 4 pmolL2 h P less than 005",
    "triple_list": [
      [
        "human CRH",
        "CPR:4",
        "loperamide"
      ],
      [
        "GnRH",
        "CPR:4",
        "loperamide"
      ],
      [
        "GHreleasing hormone",
        "CPR:4",
        "loperamide"
      ],
      [
        "TRH",
        "CPR:4",
        "loperamide"
      ],
      [
        "ACTH",
        "CPR:4",
        "loperamide"
      ],
      [
        "ACTH",
        "CPR:4",
        "loperamide"
      ]
    ],
    "updated": "No",
    "original": "After the combined pituitary stimulation test 100 micrograms human CRH 100 micrograms GnRH 100 micrograms GHreleasing hormone and 200 micrograms TRH the ACTH peak maximum increase at 30 min was significantly blunted by loperamide from 9 1 to 4 1 pmolL P less than 0001 and the area under the curve of ACTH from 0120 min was reduced from 35 5 to 23 4 pmolL2 h P less than 005",
    "simplified": "After the combined pituitary stimulation test 100 micrograms human CRH 100 micrograms GnRH 100 micrograms GHreleasing hormone and 200 micrograms TRH the area under the curve of ACTH from 0120 min was reduced from 35 5 to 23 4 pmolL2 h P less than 0001 and the ACTH peak maximum increase at 30 min was significantly reduced from 9 1 to 4 1 pmolL P less than 0001."
  },
  {
    "text": "Loperamide , an opiate that works best with mureceptors , has been shown to reduce ACTH and cortisol levels in normal people . However , it does not do this in people with Cushings disease .",
    "triple_list": [
      [
        "Loperamide",
        "CPR:4",
        "ACTH"
      ]
    ],
    "updated": "Yes",
    "original": "Loperamide an opiate agonist of high specificity for mureceptors was recently reported to suppress ACTH and cortisol levels in normal subjects but not in patients with proven ACTHdependent Cushings disease",
    "simplified": "Loperamide, an opiate that works best with mureceptors, has been shown to reduce ACTH and cortisol levels in normal people. However, it does not do this in people with Cushings disease."
  },
  {
    "text": "In summary loperamide is able to reduce basal and CRH induced ACTH and cortisol levels in normal subjects but not in patients with Cushings disease or secondary adrenal failure of hypothalamic origin",
    "triple_list": [
      [
        "loperamide",
        "CPR:4",
        "CRH"
      ],
      [
        "loperamide",
        "CPR:4",
        "ACTH"
      ]
    ],
    "updated": "No",
    "original": "In summary loperamide is able to reduce basal and CRH induced ACTH and cortisol levels in normal subjects but not in patients with Cushings disease or secondary adrenal failure of hypothalamic origin",
    "simplified": "Loperamide can reduce the levels of ACTH and cortisol in normal people, but not in people with Cushings disease. This is because it may cause a secondary adrenal failure."
  },
  {
    "text": "We also examined the effects of WEB 2086 a plateletactivating factor PAF receptor antagonist in parallel",
    "triple_list": [
      [
        "WEB 2086",
        "CPR:6",
        "plateletactivating factor PAF receptor"
      ]
    ],
    "updated": "No",
    "original": "We also examined the effects of WEB 2086 a plateletactivating factor PAF receptor antagonist in parallel",
    "simplified": "We also tested the effects of a PAF receptor antagonist plateletactivating factor in parallel."
  },
  {
    "text": "The compounds identified as 5LO inhibitors can be divided into a large group of inhibitors where hydroxamic acids are more selective , and a large group of inhibitors where 5LO is not as selective .",
    "triple_list": [
      [
        "5LO",
        "CPR:4",
        "hydroxamic acids"
      ]
    ],
    "updated": "Yes",
    "original": "The compounds identified as 5LO inhibitors can be divided into antioxidants substrateanalogous and a large miscellaneous group of inhibitors where hydroxamic acids are potent and more selective inhibitors of 5LO",
    "simplified": "The compounds identified as 5LO inhibitors can be divided into a large group of inhibitors where hydroxamic acids are more selective, and a large group of inhibitors where 5LO is not as selective."
  },
  {
    "text": "The first selective 5LO inhibitor , benzothiophene hydroxyurea zileuton , is currently under development .",
    "triple_list": [
      [
        "benzothiophene hydroxyurea",
        "CPR:4",
        "5LO"
      ],
      [
        "zileuton",
        "CPR:4",
        "5LO"
      ]
    ],
    "updated": "Yes",
    "original": "The benzothiophene hydroxyurea zileuton is the first selective 5LO inhibitor evaluated for the treatment of patients with IBD",
    "simplified": "The first selective 5LO inhibitor, benzothiophene hydroxyurea zileuton, is currently under development."
  },
  {
    "text": "The unique role of the enzyme 5lipoxygenase 5LO in producing leukotrienes LTs makes it a possible target for chemical control .",
    "triple_list": [
      [
        "5lipoxygenase",
        "CPR:9",
        "leukotrienes"
      ],
      [
        "5LO",
        "CPR:9",
        "leukotrienes"
      ],
      [
        "5lipoxygenase",
        "CPR:9",
        "LTs"
      ],
      [
        "5LO",
        "CPR:9",
        "LTs"
      ]
    ],
    "updated": "Yes",
    "original": "The unique role of the enzyme 5lipoxygenase 5LO in the production of leukotrienes LTs makes it a likely target for biochemical manipulation",
    "simplified": "The unique role of the enzyme 5lipoxygenase 5LO in producing leukotrienes LTs makes it a possible target for chemical control."
  },
  {
    "text": "In PC3 cells , hydroxyurea stopped hRRM2 from working . This made them more sensitive to UV .",
    "triple_list": [
      [
        "hydroxyurea",
        "CPR:4",
        "hRRM2"
      ]
    ],
    "updated": "Yes",
    "original": "In PC3 cells hydroxyurea inhibited hRRM2 and resulted in increased sensitivity to UV irradiation",
    "simplified": "In PC3 cells, hydroxyurea stopped hRRM2 from working. This made them more sensitive to UV."
  },
  {
    "text": "Ribonucleotide reductase ( RR ) is a enzyme in the body . It changes ribonucleoside diphosphates into deoxyribonucleoside diphosphates , which are needed for DNA to be made .",
    "triple_list": [
      [
        "RR",
        "CPR:9",
        "deoxyribonucleoside diphosphates"
      ],
      [
        "Ribonucleotide reductase",
        "CPR:9",
        "deoxyribonucleoside diphosphates"
      ],
      [
        "RR",
        "CPR:9",
        "ribonucleoside diphosphates"
      ],
      [
        "Ribonucleotide reductase",
        "CPR:9",
        "ribonucleoside diphosphates"
      ]
    ],
    "updated": "Yes",
    "original": "Ribonucleotide reductase RR is responsible for the de novo conversion of the ribonucleoside diphosphates to deoxyribonucleoside diphosphates which are essential for DNA synthesis and repair",
    "simplified": "Ribonucleotide reductase (RR) is a enzyme in the body. It changes ribonucleoside diphosphates into deoxyribonucleoside diphosphates, which are needed for DNA to be made."
  },
  {
    "text": "In addition , RTPCR analysis showed that minocycline treatment increased interleukin10 mRNA expression , but decreased tumor necrosis factoralpha .",
    "triple_list": [
      [
        "minocycline",
        "CPR:3",
        "interleukin10"
      ],
      [
        "minocycline",
        "CPR:4",
        "tumor necrosis factoralpha"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore RTPCR analyses revealed that minocycline treatment increased expression of interleukin10 mRNA but decreased tumor necrosis factoralpha expression",
    "simplified": "In addition, RTPCR analysis showed that minocycline treatment increased interleukin10 mRNA expression, but decreased tumor necrosis factoralpha."
  },
  {
    "text": "In addition , minocycline treatment significantly reduced specific caspase3 activity after vehicle control treatment .",
    "triple_list": [
      [
        "minocycline",
        "CPR:4",
        "caspase3"
      ]
    ],
    "updated": "Yes",
    "original": "In addition minocycline treatment significantly reduced the specific caspase3 activity after SCI as compared to that of vehicle control",
    "simplified": "In addition, minocycline treatment significantly reduced specific caspase3 activity after vehicle control treatment."
  },
  {
    "text": "Conclusion Nandrolone phenylpropionate increased the density of AR in the liver , but there was no effect on the density of AR in the testis or ovary .",
    "triple_list": [
      [
        "Nandrolone phenylpropionate",
        "CPR:3",
        "AR"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSION Nandrolone phenylpropionate upregulated the density of AR in liver tissue whereas it had no significant effects on the density of AR in testis and ovary tissues",
    "simplified": "Conclusion Nandrolone phenylpropionate increased the density of AR in the liver, but there was no effect on the density of AR in the testis or ovary."
  },
  {
    "text": "The amount of AR in the liver tissue in the NP group was higher than in the control group .",
    "triple_list": [
      [
        "AR",
        "CPR:3",
        "NP"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS The density of AR in liver tissue in NP group was higher than that in control group P 005",
    "simplified": "The amount of AR in the liver tissue in the NP group was higher than in the control group."
  },
  {
    "text": "The pretreatment with salbutamol caused left ventricular beta2adrenoceptors to decrease by 59 % .",
    "triple_list": [
      [
        "salbutamol",
        "CPR:4",
        "beta2adrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "The pretreatment with salbutamol induced a 59 downregulation of left ventricular beta2adrenoceptors compared to control",
    "simplified": "The pretreatment with salbutamol caused left ventricular beta2adrenoceptors to decrease by 59%."
  },
  {
    "text": "Beta2adrenoceptor agonist salbutamol 40 microgkgh for 1 week to induce beta2adrenoceptor desensitization in humans or animals",
    "triple_list": [
      [
        "beta2adrenoceptor",
        "CPR:5",
        "salbutamol"
      ]
    ],
    "updated": "Yes",
    "original": "or were chronically pretreated with the selective beta2adrenoceptor agonist salbutamol 40 microgkgh for 1 week to induce beta2adrenoceptor desensitization",
    "simplified": "Beta2adrenoceptor agonist salbutamol 40 microgkgh for 1 week to induce beta2adrenoceptor desensitization in humans or animals"
  },
  {
    "text": "Rats were then given the drug bisoprolol , a highly selective beta1adrenoceptor antagonist .",
    "triple_list": [
      [
        "beta1adrenoceptor",
        "CPR:6",
        "bisoprolol"
      ]
    ],
    "updated": "Yes",
    "original": "Rats received a concomitant treatment with the selective beta1adrenoceptor antagonist bisoprolol 50 mgkgday po",
    "simplified": "Rats were then given the drug bisoprolol, a highly selective beta1adrenoceptor antagonist."
  },
  {
    "text": "Known VR1 antagonists BCTC thioBCTC and capsazepine were also able to block the response of TRPM8 to menthol IC50 0810 3511 and 1811 microM respectively",
    "triple_list": [
      [
        "TRPM8",
        "CPR:3",
        "menthol"
      ],
      [
        "BCTC",
        "CPR:4",
        "TRPM8"
      ],
      [
        "thioBCTC",
        "CPR:4",
        "TRPM8"
      ],
      [
        "capsazepine",
        "CPR:4",
        "TRPM8"
      ],
      [
        "VR1",
        "CPR:6",
        "BCTC"
      ],
      [
        "VR1",
        "CPR:6",
        "thioBCTC"
      ],
      [
        "VR1",
        "CPR:6",
        "capsazepine"
      ]
    ],
    "updated": "No",
    "original": "Known VR1 antagonists BCTC thioBCTC and capsazepine were also able to block the response of TRPM8 to menthol IC50 0810 3511 and 1811 microM respectively",
    "simplified": "BCTC thioBCTC and capsazepine block the TRPM8 response. Capazepine and BCTC thioBCTC block the response to menthol."
  },
  {
    "text": "The Ca2 response of hVR1 transfected HEK293 cells to the endogenous VR1 agonist Narachidonoyldopamine was potentiated by low pH",
    "triple_list": [
      [
        "hVR1",
        "CPR:3",
        "Narachidonoyldopamine"
      ],
      [
        "VR1",
        "CPR:5",
        "Narachidonoyldopamine"
      ]
    ],
    "updated": "No",
    "original": "The Ca2 response of hVR1 transfected HEK293 cells to the endogenous VR1 agonist Narachidonoyldopamine was potentiated by low pH",
    "simplified": "The Ca2 response of hVR1 transfected HEK293 cells to Narachidonoyldopamine was increased by low pH."
  },
  {
    "text": "In contrast menthol and icilin activated TRPM8 currents were suppressed by low pH",
    "triple_list": [
      [
        "menthol",
        "CPR:3",
        "TRPM8"
      ],
      [
        "icilin",
        "CPR:3",
        "TRPM8"
      ]
    ],
    "updated": "No",
    "original": "In contrast menthol and icilin activated TRPM8 currents were suppressed by low pH",
    "simplified": "In contrast, when icilin was added, the TRPM8 currents were reduced."
  },
  {
    "text": "TRPM8 CMR1 is a Ca2permeable channel which can be activated by low temperatures menthol eucalyptol and icilin",
    "triple_list": [
      [
        "CMR1",
        "CPR:3",
        "eucalyptol"
      ],
      [
        "Ca2permeable channel",
        "CPR:3",
        "eucalyptol"
      ],
      [
        "TRPM8",
        "CPR:3",
        "eucalyptol"
      ],
      [
        "CMR1",
        "CPR:3",
        "menthol"
      ],
      [
        "Ca2permeable channel",
        "CPR:3",
        "menthol"
      ],
      [
        "TRPM8",
        "CPR:3",
        "menthol"
      ],
      [
        "CMR1",
        "CPR:3",
        "icilin"
      ],
      [
        "Ca2permeable channel",
        "CPR:3",
        "icilin"
      ],
      [
        "TRPM8",
        "CPR:3",
        "icilin"
      ]
    ],
    "updated": "No",
    "original": "TRPM8 CMR1 is a Ca2permeable channel which can be activated by low temperatures menthol eucalyptol and icilin",
    "simplified": "The TRPM8 CMR1 is a Ca2permeable channel. It can be activated by menthol when it is very cold."
  },
  {
    "text": "The inhibitory effects of tranylcypromine a nonselective irreversible inhibitor of monoamine oxidase MAO on three cytochrome P450 CYP enzymes namely CYP2C9 CYP2C19 and CYP2D6 have been evaluated in vitro",
    "triple_list": [
      [
        "tranylcypromine",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "tranylcypromine",
        "CPR:4",
        "MAO"
      ]
    ],
    "updated": "No",
    "original": "The inhibitory effects of tranylcypromine a nonselective irreversible inhibitor of monoamine oxidase MAO on three cytochrome P450 CYP enzymes namely CYP2C9 CYP2C19 and CYP2D6 have been evaluated in vitro",
    "simplified": "The inhibitory effects of tranylcypromine on three cytochrome P450 CYP enzymes have been evaluated in vitro. These enzymes are CYP2C9, CYP2C19 and CYP2D6."
  },
  {
    "text": "The results demonstrated that tranylcypromine is a competitive inhibitor of CYP2C19 Ki = 32 microM and CYP2D6 Ki = 367 microM and a noncompetitive inhibitor of CYP2C9 Ki = 56 microM",
    "triple_list": [
      [
        "tranylcypromine",
        "CPR:4",
        "CYP2C19"
      ],
      [
        "tranylcypromine",
        "CPR:4",
        "CYP2D6"
      ],
      [
        "tranylcypromine",
        "CPR:4",
        "CYP2C9"
      ]
    ],
    "updated": "No",
    "original": "The results demonstrated that tranylcypromine is a competitive inhibitor of CYP2C19 Ki = 32 microM and CYP2D6 Ki = 367 microM and a noncompetitive inhibitor of CYP2C9 Ki = 56 microM",
    "simplified": "The results showed that tranylcypromine is a noncompetitive inhibitor of CYP2C9 Ki = 56 microM and a competitive inhibitor of CYP2C19 Ki = 32 microM."
  },
  {
    "text": "The drug tranylcypromine inhibits the enzyme cytochrome P450 . The enzyme is a monoamine oxidase .",
    "triple_list": [
      [
        "monoamine oxidase",
        "CPR:4",
        "tranylcypromine"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19 CYP2C9 and CYP2D6",
    "simplified": "The drug tranylcypromine inhibits the enzyme cytochrome P450. The enzyme is a monoamine oxidase."
  },
  {
    "text": "Studies in rats mice and monkeys show that GC1 lowers cholesterol with 600 to 1400fold more potency than atorvastatin . Atorvastatin is a drug that works by stopping HMGCoA reductase .",
    "triple_list": [
      [
        "atorvastatin",
        "CPR:4",
        "HMGCoA reductase"
      ]
    ],
    "updated": "Yes",
    "original": "Studies in rats mice and monkeys show that GC1 lowers cholesterol with 600 to 1400fold more potency and approximately two to threefold more efficacy than atorvastatin a compound that blocks HMGCoA reductase",
    "simplified": "Studies in rats mice and monkeys show that GC1 lowers cholesterol with 600 to 1400fold more potency than atorvastatin. Atorvastatin is a drug that works by stopping HMGCoA reductase."
  },
  {
    "text": "Compounds of several other structural families including the quinoxaline AG1296 the bis1H2indolyl1methanone D65476 the indolinones SU5416 and SU11248 the indolocarbazoles PKC412 and CEP701 and the piperazonyl quinazoline CT53518 are potent inhibitors of Flt3 kinase",
    "triple_list": [
      [
        "quinoxaline",
        "CPR:4",
        "Flt3"
      ],
      [
        "quinoxaline",
        "CPR:4",
        "kinase"
      ],
      [
        "AG1296",
        "CPR:4",
        "Flt3"
      ],
      [
        "AG1296",
        "CPR:4",
        "kinase"
      ],
      [
        "bis1H2indolyl1methanone",
        "CPR:4",
        "Flt3"
      ],
      [
        "bis1H2indolyl1methanone",
        "CPR:4",
        "kinase"
      ],
      [
        "D65476",
        "CPR:4",
        "Flt3"
      ],
      [
        "D65476",
        "CPR:4",
        "kinase"
      ],
      [
        "indolinones",
        "CPR:4",
        "Flt3"
      ],
      [
        "indolinones",
        "CPR:4",
        "kinase"
      ],
      [
        "SU5416",
        "CPR:4",
        "Flt3"
      ],
      [
        "SU5416",
        "CPR:4",
        "kinase"
      ],
      [
        "SU11248",
        "CPR:4",
        "Flt3"
      ],
      [
        "SU11248",
        "CPR:4",
        "kinase"
      ],
      [
        "indolocarbazoles",
        "CPR:4",
        "Flt3"
      ],
      [
        "indolocarbazoles",
        "CPR:4",
        "kinase"
      ],
      [
        "PKC412",
        "CPR:4",
        "Flt3"
      ],
      [
        "PKC412",
        "CPR:4",
        "kinase"
      ],
      [
        "CEP701",
        "CPR:4",
        "Flt3"
      ],
      [
        "CEP701",
        "CPR:4",
        "kinase"
      ],
      [
        "piperazonyl quinazoline",
        "CPR:4",
        "Flt3"
      ],
      [
        "piperazonyl quinazoline",
        "CPR:4",
        "kinase"
      ],
      [
        "CT53518",
        "CPR:4",
        "Flt3"
      ],
      [
        "CT53518",
        "CPR:4",
        "kinase"
      ]
    ],
    "updated": "No",
    "original": "Compounds of several other structural families including the quinoxaline AG1296 the bis1H2indolyl1methanone D65476 the indolinones SU5416 and SU11248 the indolocarbazoles PKC412 and CEP701 and the piperazonyl quinazoline CT53518 are potent inhibitors of Flt3 kinase",
    "simplified": "Quinoxaline, indolinones, bis1H2indolyl1methanone, the indolocarbazoles PKC412 and CEP701, and the piperazonyl quinazoline CT53518 are strong inhibitors of Flt3 kinase, but other compounds may also work this way."
  },
  {
    "text": "Although highly homologous to other class III RTKs Flt3 is resistant to the phenylaminopyrimidine STI571 Gleevec Imatinib a potent inhibitor of other RTKs in the family such as the PDGFbetareceptor or cKit",
    "triple_list": [
      [
        "RTKs",
        "CPR:4",
        "phenylaminopyrimidine"
      ],
      [
        "phenylaminopyrimidine",
        "CPR:4",
        "PDGFbetareceptor"
      ],
      [
        "phenylaminopyrimidine",
        "CPR:4",
        "cKit"
      ],
      [
        "RTKs",
        "CPR:4",
        "STI571"
      ],
      [
        "STI571",
        "CPR:4",
        "PDGFbetareceptor"
      ],
      [
        "STI571",
        "CPR:4",
        "cKit"
      ],
      [
        "RTKs",
        "CPR:4",
        "Gleevec"
      ],
      [
        "Gleevec",
        "CPR:4",
        "PDGFbetareceptor"
      ],
      [
        "Gleevec",
        "CPR:4",
        "cKit"
      ],
      [
        "RTKs",
        "CPR:4",
        "Imatinib"
      ],
      [
        "Imatinib",
        "CPR:4",
        "PDGFbetareceptor"
      ],
      [
        "Imatinib",
        "CPR:4",
        "cKit"
      ]
    ],
    "updated": "No",
    "original": "Although highly homologous to other class III RTKs Flt3 is resistant to the phenylaminopyrimidine STI571 Gleevec Imatinib a potent inhibitor of other RTKs in the family such as the PDGFbetareceptor or cKit",
    "simplified": "Although highly homologous to other class III RTKs Flt3 is resistant to Gleevec's Gleevec Imatinib. It is a potent inhibitor of other RTKs in the family such as cKit and PDGFbetareceptor."
  },
  {
    "text": "STI571 binding to Flt3 is prevented by the phenylalanine 691 sidechain in the ATP binding center . If this sidechain is changed to threonine , STI571 can not bind to Flt3 .",
    "triple_list": [
      [
        "STI571",
        "CPR:4",
        "Flt3"
      ]
    ],
    "updated": "Yes",
    "original": "STI571 binding to Flt3 is prevented by the phenylalanine 691 sidechain in the ATP binding center and mutating this site to threonine renders the corresponding Flt3 mutant sensitive to STI571",
    "simplified": "STI571 binding to Flt3 is prevented by the phenylalanine 691 sidechain in the ATP binding center. If this sidechain is changed to threonine, STI571 can not bind to Flt3."
  },
  {
    "text": "Hydralazine induced rapid and transient expression of HIF1alpha and downstream targets of HIF endothelin1 adrenomedullin haem oxygenase 1 and vascular endothelial growth factor VEGF in endothelial and smooth muscle cells and induced endothelial cellspecific proliferation",
    "triple_list": [
      [
        "Hydralazine",
        "CPR:3",
        "HIF1alpha"
      ],
      [
        "Hydralazine",
        "CPR:3",
        "HIF"
      ],
      [
        "Hydralazine",
        "CPR:3",
        "endothelin1"
      ],
      [
        "Hydralazine",
        "CPR:3",
        "adrenomedullin"
      ],
      [
        "Hydralazine",
        "CPR:3",
        "haem oxygenase 1"
      ],
      [
        "Hydralazine",
        "CPR:3",
        "vascular endothelial growth factor"
      ],
      [
        "Hydralazine",
        "CPR:3",
        "VEGF"
      ]
    ],
    "updated": "No",
    "original": "Hydralazine induced rapid and transient expression of HIF1alpha and downstream targets of HIF endothelin1 adrenomedullin haem oxygenase 1 and vascular endothelial growth factor VEGF in endothelial and smooth muscle cells and induced endothelial cellspecific proliferation",
    "simplified": "Hydralazine caused the expression of HIF1alpha and downstream targets of HIF endothelin1 and vascular endothelial growth factor VEGF to be very fast and short-lived in endothelial and smooth muscle cells."
  },
  {
    "text": "Hydralazine inhibited the activity of the PHD enzyme and nonhydroxylated HIF1alpha was produced . This showed that HIF stabilization was possible .",
    "triple_list": [
      [
        "Hydralazine",
        "CPR:3",
        "HIF1alpha"
      ],
      [
        "Hydralazine",
        "CPR:4",
        "PHD"
      ],
      [
        "Hydralazine",
        "CPR:4",
        "PHD"
      ]
    ],
    "updated": "Yes",
    "original": "Hydralazine dosedependently inhibited PHD activity and induced nonhydroxylated HIF1alpha evidence for HIF stabilization specifically by inhibition of PHD enzyme activity",
    "simplified": "Hydralazine inhibited the activity of the PHD enzyme and nonhydroxylated HIF1alpha was produced. This showed that HIF stabilization was possible."
  },
  {
    "text": "In humans , in-vitro hydralazine increases HIF1alpha and VEGF protein in tissue extracts and plasma",
    "triple_list": [
      [
        "hydralazine",
        "CPR:3",
        "VEGF"
      ],
      [
        "hydralazine",
        "CPR:3",
        "HIF1alpha"
      ],
      [
        "hydralazine",
        "CPR:3",
        "VEGF"
      ]
    ],
    "updated": "Yes",
    "original": "In vivo hydralazine induced HIF1alpha and VEGF protein in tissue extracts and elevated plasma VEGF levels",
    "simplified": "In humans, in-vitro hydralazine increases HIF1alpha and VEGF protein in tissue extracts and plasma"
  },
  {
    "text": "Novel mechanism of action for hydralazine induction of hypoxiainducible factor1alpha vascular endothelial growth factor and angiogenesis by inhibition of prolyl hydroxylases",
    "triple_list": [
      [
        "hydralazine",
        "CPR:3",
        "hypoxiainducible factor1alpha"
      ],
      [
        "hydralazine",
        "CPR:3",
        "vascular endothelial growth factor"
      ],
      [
        "hydralazine",
        "CPR:4",
        "prolyl hydroxylases"
      ]
    ],
    "updated": "No",
    "original": "Novel mechanism of action for hydralazine induction of hypoxiainducible factor1alpha vascular endothelial growth factor and angiogenesis by inhibition of prolyl hydroxylases",
    "simplified": "Novel mechanism of action for hydralazine induction of vascular endothelial growth factor and angiogenesis by inhibition of prolyl hydroxylases"
  },
  {
    "text": "Thus , hydralazine activates the HIF pathway . It also inhibits PHD activity , so that proangiogenic effects occur .",
    "triple_list": [
      [
        "hydralazine",
        "CPR:3",
        "HIF"
      ],
      [
        "hydralazine",
        "CPR:4",
        "PHD"
      ]
    ],
    "updated": "Yes",
    "original": "Thus hydralazine activates the HIF pathway through inhibition of PHD activity and initiates a proangiogenic phenotype",
    "simplified": "Thus, hydralazine activates the HIF pathway. It also inhibits PHD activity, so that proangiogenic effects occur."
  },
  {
    "text": "RESULTS Aspirin diclofenac indomethacin ketoprofen meclofenamic acid and piroxicam had little selectivity toward COX isozymes whereas NS398 carprofen tolfenamic acid nimesulide and etodolac had more than 5 times greater preference for inhibiting COX2 than COX1",
    "triple_list": [
      [
        "NS398",
        "CPR:4",
        "COX2"
      ],
      [
        "NS398",
        "CPR:4",
        "COX1"
      ],
      [
        "carprofen",
        "CPR:4",
        "COX2"
      ],
      [
        "carprofen",
        "CPR:4",
        "COX1"
      ],
      [
        "tolfenamic acid",
        "CPR:4",
        "COX2"
      ],
      [
        "tolfenamic acid",
        "CPR:4",
        "COX1"
      ],
      [
        "nimesulide",
        "CPR:4",
        "COX2"
      ],
      [
        "nimesulide",
        "CPR:4",
        "COX1"
      ],
      [
        "etodolac",
        "CPR:4",
        "COX2"
      ],
      [
        "etodolac",
        "CPR:4",
        "COX1"
      ]
    ],
    "updated": "No",
    "original": "RESULTS Aspirin diclofenac indomethacin ketoprofen meclofenamic acid and piroxicam had little selectivity toward COX isozymes whereas NS398 carprofen tolfenamic acid nimesulide and etodolac had more than 5 times greater preference for inhibiting COX2 than COX1",
    "simplified": "Results Aspirin diclofenac indomethacin ketoprofen meclofenamic acid and piroxicam had little selectivity toward COX isozymes. NS398 carprofen tolfenamic acid nimesulide and etodolac had more than 5 times greater preference for inhibiting COX2 than other drugs."
  },
  {
    "text": "CONCLUSIONS AND CLINICAL RELEVANCE Canine COX2 was inhibited by etodolac nimesulide and carprofen in dogs , but not by NS398 tolfenamic acid in humans .",
    "triple_list": [
      [
        "Canine COX2",
        "CPR:4",
        "etodolac"
      ],
      [
        "Canine COX2",
        "CPR:4",
        "nimesulide"
      ],
      [
        "Canine COX2",
        "CPR:4",
        "NS398"
      ],
      [
        "COX2",
        "CPR:4",
        "tolfenamic acid"
      ],
      [
        "COX2",
        "CPR:4",
        "carprofen"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS AND CLINICAL RELEVANCE Canine COX2 was selectively inhibited by etodolac nimesulide and NS398 tolfenamic acid and carprofen also appeared to be preferential COX2 inhibitors in dogs",
    "simplified": "CONCLUSIONS AND CLINICAL RELEVANCE Canine COX2 was inhibited by etodolac nimesulide and carprofen in dogs, but not by NS398 tolfenamic acid in humans."
  },
  {
    "text": "Acarbose stopped an enzyme called an acid alphaglucosidase from working properly . This enzyme is important in a disease called Pompe disease .",
    "triple_list": [
      [
        "Acarbose",
        "CPR:4",
        "acid alphaglucosidase"
      ]
    ],
    "updated": "Yes",
    "original": "Acarbose served as inhibitor of an interfering acid alphaglucosidase present in neutrophils which allowed the lysosomal enzyme implicated in Pompe disease to be selectively analyzed",
    "simplified": "Acarbose stopped an enzyme called an acid alphaglucosidase from working properly. This enzyme is important in a disease called Pompe disease."
  },
  {
    "text": "Univariate regression analyses showed that only the use of carvedilol was related to plasma BNP levels . p 003 The results were surprising .",
    "triple_list": [
      [
        "carvedilol",
        "CPR:4",
        "plasma BNP"
      ]
    ],
    "updated": "Yes",
    "original": "Univariate regression analyses showed that only the use of carvedilol was correlated with the decrease in plasma BNP concentration p 003",
    "simplified": "Univariate regression analyses showed that only the use of carvedilol was related to plasma BNP levels. p 003 The results were surprising."
  },
  {
    "text": "Terbinafine is a chemical compound . It is an inhibitor of squalene epoxidase .",
    "triple_list": [
      [
        "Terbinafine",
        "CPR:4",
        "squalene epoxidase"
      ]
    ],
    "updated": "Yes",
    "original": "Terbinafine is a potent noncompetitive inhibitor of squalene epoxidase from Candida Ki = 30 nM",
    "simplified": "Terbinafine is a chemical compound. It is an inhibitor of squalene epoxidase."
  },
  {
    "text": "Terbinafine mode of action and properties of the squalene epoxidase inhibition",
    "triple_list": [
      [
        "Terbinafine",
        "CPR:4",
        "squalene epoxidase"
      ]
    ],
    "updated": "No",
    "original": "Terbinafine mode of action and properties of the squalene epoxidase inhibition",
    "simplified": "The squalene epoxidase mechanism of action and its properties."
  },
  {
    "text": "Terbinafine Lamisil works by inhibiting the squalene epoxidase in fungi . This action works against many fungi .",
    "triple_list": [
      [
        "Terbinafine",
        "CPR:4",
        "squalene epoxidase"
      ],
      [
        "Lamisil",
        "CPR:4",
        "squalene epoxidase"
      ]
    ],
    "updated": "Yes",
    "original": "Terbinafine Lamisil has primarily fungicidal action against many fungi as a result of its specific mechanism of squalene epoxidase inhibition",
    "simplified": "Terbinafine Lamisil works by inhibiting the squalene epoxidase in fungi. This action works against many fungi."
  },
  {
    "text": "In contrast inhibition of rat liver squalene epoxidase is competitive with squalene and only occurs at higher drug concentrations .",
    "triple_list": [
      [
        "rat liver squalene epoxidase",
        "CPR:4",
        "squalene"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast inhibition of rat liver squalene epoxidase only occurs at higher drug concentrations Ki = 77 microM and is competitive with squalene",
    "simplified": "In contrast inhibition of rat liver squalene epoxidase is competitive with squalene and only occurs at higher drug concentrations."
  },
  {
    "text": "Based on HMGCoA reductase inhibition pitavastatin induced apoAI more efficiently than simvastatin and atorvastatin",
    "triple_list": [
      [
        "apoAI",
        "CPR:3",
        "simvastatin"
      ],
      [
        "apoAI",
        "CPR:3",
        "atorvastatin"
      ],
      [
        "pitavastatin",
        "CPR:3",
        "apoAI"
      ]
    ],
    "updated": "No",
    "original": "Based on HMGCoA reductase inhibition pitavastatin induced apoAI more efficiently than simvastatin and atorvastatin",
    "simplified": "Pavastatin is an anti-angiogenic drug. It works more efficiently than simvastatin and atorvastatin."
  },
  {
    "text": "Further study revealed that pitavastatin increased ABCA1 mRNA in HMGCoA reductasedependent manner and that Rho and Rho kinase inhibitor C3T and Y27632 increased apoAI production in the HepG2 cells",
    "triple_list": [
      [
        "pitavastatin",
        "CPR:3",
        "ABCA1"
      ],
      [
        "Y27632",
        "CPR:3",
        "apoAI"
      ],
      [
        "Rho",
        "CPR:4",
        "Y27632"
      ],
      [
        "Rho kinase",
        "CPR:4",
        "Y27632"
      ]
    ],
    "updated": "No",
    "original": "Further study revealed that pitavastatin increased ABCA1 mRNA in HMGCoA reductasedependent manner and that Rho and Rho kinase inhibitor C3T and Y27632 increased apoAI production in the HepG2 cells",
    "simplified": "Further study revealed that pitavastatin increased ABCA1 mRNA in HMGCoA-deficient cells. It also showed that C3T and Y27632 increased the production of Rho-Rho kinase."
  },
  {
    "text": "These results suggest that pitavastatin efficiently increases apoAI in the culture medium of HepG2 cells by promoting apoAI production through inhibition of HMGCoA reductase and suppression of Rho activity and by protecting apoAI from catabolism through ABCA1 induction and lipidation of apoAI",
    "triple_list": [
      [
        "pitavastatin",
        "CPR:3",
        "apoAI"
      ],
      [
        "pitavastatin",
        "CPR:3",
        "apoAI"
      ],
      [
        "pitavastatin",
        "CPR:3",
        "ABCA1"
      ],
      [
        "pitavastatin",
        "CPR:3",
        "apoAI"
      ],
      [
        "pitavastatin",
        "CPR:4",
        "HMGCoA reductase"
      ],
      [
        "pitavastatin",
        "CPR:4",
        "Rho"
      ]
    ],
    "updated": "No",
    "original": "These results suggest that pitavastatin efficiently increases apoAI in the culture medium of HepG2 cells by promoting apoAI production through inhibition of HMGCoA reductase and suppression of Rho activity and by protecting apoAI from catabolism through ABCA1 induction and lipidation of apoAI",
    "simplified": "These results suggest that pitavastatin efficiently increases apoAI in the culture medium of HepG2 cells by protecting apoAI from catabolism through ABCA1 induction and lipidation and by promoting apoAI production through inhibition of HMGCoA reductase."
  },
  {
    "text": "Each statin induced apoAI expression mRNA and protein dosedependently the rank order of the apoAI induction pitavastatin 3 microM simvastatin 10 microM atorvastatin 30 microM",
    "triple_list": [
      [
        "apoAI",
        "CPR:3",
        "pitavastatin"
      ],
      [
        "apoAI",
        "CPR:3",
        "simvastatin"
      ],
      [
        "apoAI",
        "CPR:3",
        "atorvastatin"
      ]
    ],
    "updated": "No",
    "original": "Each statin induced apoAI expression mRNA and protein dosedependently the rank order of the apoAI induction pitavastatin 3 microM simvastatin 10 microM atorvastatin 30 microM",
    "simplified": "Each statin induced apoAI expression mRNA and protein dosedependently the rank order of the statins atorvastatin 3 microM simvastatin 10 microM atorvastatin 30 microM"
  },
  {
    "text": "The effect of statins on apoAI did not exist when mevalonate was added . This suggests that the effect is HMGCoA inhibition .",
    "triple_list": [
      [
        "apoAI",
        "CPR:4",
        "mevalonate"
      ]
    ],
    "updated": "Yes",
    "original": "The induction of apoAI by statins disappeared with addition of mevalonate which indicates that the effect is HMGCoA reductase inhibitiondependent",
    "simplified": "The effect of statins on apoAI did not exist when mevalonate was added. This suggests that the effect is HMGCoA inhibition."
  },
  {
    "text": "MATERIALS AND METHODS Seeking to improve efficacy against otherwise intractable endstage pancreatic islet tumors two receptor tyrosine kinase inhibitors imatinib and SU11248 were used to disrupt PDGFR mediated pericyte support of tumor endothelial cells in concert with maximumtolerated dose MTD or metronomic chemotherapy andor VEGFR inhibition",
    "triple_list": [
      [
        "receptor tyrosine kinase",
        "CPR:4",
        "imatinib"
      ],
      [
        "imatinib",
        "CPR:4",
        "PDGFR"
      ],
      [
        "imatinib",
        "CPR:4",
        "VEGFR"
      ],
      [
        "receptor tyrosine kinase",
        "CPR:4",
        "SU11248"
      ],
      [
        "SU11248",
        "CPR:4",
        "PDGFR"
      ],
      [
        "SU11248",
        "CPR:4",
        "VEGFR"
      ]
    ],
    "updated": "No",
    "original": "MATERIALS AND METHODS Seeking to improve efficacy against otherwise intractable endstage pancreatic islet tumors two receptor tyrosine kinase inhibitors imatinib and SU11248 were used to disrupt PDGFR mediated pericyte support of tumor endothelial cells in concert with maximumtolerated dose MTD or metronomic chemotherapy andor VEGFR inhibition",
    "simplified": "MATERIALS AND METHODS Seeking to improve efficacy against otherwise intractable endstage pancreatic islet tumors, imatinib and SU11248 were used to disrupt PDGFR mediated pericyte support of tumor endothelial cells in concert with maximumtolerated dose MTD or metronomic chemotherapy and/or VEGFR inhibition."
  },
  {
    "text": "Results Imatinib as a monotherapy reduced pericyte coverage of tumor vessels and in combination with metronomic chemotherapy or VEGFR inhibition was more effective .",
    "triple_list": [
      [
        "Imatinib",
        "CPR:4",
        "VEGFR"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS Imatinib despite equivocal efficacy as monotherapy reduced pericyte coverage of tumor vessels and enhanced efficacy in combination with metronomic chemotherapy or VEGFR inhibition",
    "simplified": "Results Imatinib as a monotherapy reduced pericyte coverage of tumor vessels and in combination with metronomic chemotherapy or VEGFR inhibition was more effective."
  },
  {
    "text": "In addition , phenylbutazone significantly reduced PGE2 levels 6h after LPS injection . The possible COX1 prostanoid TXB2 was also significantly reduced by phenylbutazone but not etodolac .",
    "triple_list": [
      [
        "COX1",
        "CPR:4",
        "phenylbutazone"
      ]
    ],
    "updated": "Yes",
    "original": "In addition both drugs significantly reduced PGE2 levels P005 6h following LPS injection whereas the probable COX1 prostanoid TXB2 was significantly reduced by phenylbutazone P005 but not etodolac",
    "simplified": "In addition, phenylbutazone significantly reduced PGE2 levels 6h after LPS injection. The possible COX1 prostanoid TXB2 was also significantly reduced by phenylbutazone but not etodolac."
  },
  {
    "text": "The present study was to compare the antiinflammatory effects of the nonselective COX inhibitor phenylbutazone with the preferential COX2 inhibitor etodolac in horses with lipopolysaccharide LPSinduced synovitis .",
    "triple_list": [
      [
        "COX",
        "CPR:4",
        "phenylbutazone"
      ]
    ],
    "updated": "Yes",
    "original": "The objective of the present study was to compare the antiinflammatory effects of the preferential COX2 inhibitor etodolac with the nonselective COX inhibitor phenylbutazone in horses with lipopolysaccharide LPSinduced synovitis",
    "simplified": "The present study was to compare the antiinflammatory effects of the nonselective COX inhibitor phenylbutazone with the preferential COX2 inhibitor etodolac in horses with lipopolysaccharide LPSinduced synovitis."
  },
  {
    "text": "Effect of bosentan ETA ETB receptor antagonist on metabolic changes during stress and diabetes",
    "triple_list": [
      [
        "bosentan",
        "CPR:6",
        "ETA"
      ],
      [
        "bosentan",
        "CPR:6",
        "ETB"
      ]
    ],
    "updated": "No",
    "original": "Effect of bosentan ETA ETB receptor antagonist on metabolic changes during stress and diabetes",
    "simplified": "The effects of bosentan on metabolism during stress and diabetes The."
  },
  {
    "text": "To test this we studied the possible effect of the endothelin receptor antagonist bosentan 50 and 100 mg kg1 on serum glucose and insulin levels in normal and stressed animals .",
    "triple_list": [
      [
        "endothelin receptor",
        "CPR:6",
        "bosentan"
      ]
    ],
    "updated": "Yes",
    "original": "To test this we studied the possible effect of the endothelin receptor antagonist bosentan 50 and 100 mg kg1 on serum glucose and insulin levels as well as on liver glycogen contents in normoglycemic stressed animals",
    "simplified": "To test this we studied the possible effect of the endothelin receptor antagonist bosentan 50 and 100 mg kg1 on serum glucose and insulin levels in normal and stressed animals."
  },
  {
    "text": "Preirradiation administration of RP1 enhanced levels of GSH induced increase in complex I upto 16 h complex IIII 4 h complex IIIII activity upto 24 h p 001 and inhibited the radiationinduced decrease in MMP significantly 24 h p 001",
    "triple_list": [
      [
        "GSH",
        "CPR:3",
        "complex I"
      ],
      [
        "GSH",
        "CPR:3",
        "complex IIII"
      ],
      [
        "GSH",
        "CPR:3",
        "complex IIIII"
      ]
    ],
    "updated": "No",
    "original": "Preirradiation administration of RP1 enhanced levels of GSH induced increase in complex I upto 16 h complex IIII 4 h complex IIIII activity upto 24 h p 001 and inhibited the radiationinduced decrease in MMP significantly 24 h p 001",
    "simplified": "Preirradiation administration of RP1 increased complex IIIII activity upto 24 h p 001 and inhibited the radiationinduced decrease in MMP significantly 24 h p 001. Preirradiation administration of RP1 enhanced levels of GSH induced increase in complex I."
  },
  {
    "text": "In addition , minocycline reduced the release of cytochrome c from the liver tissues in Jo2challenged mice .",
    "triple_list": [
      [
        "minocycline",
        "CPR:4",
        "cytochrome c"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover minocycline efficiently suppressed the release of cytochrome c from mitochondria of the liver tissues from Jo2challenged mice",
    "simplified": "In addition, minocycline reduced the release of cytochrome c from the liver tissues in Jo2challenged mice."
  },
  {
    "text": "Our results suggest that easing of Fastriggered fulminant hepatitis by minocycline may involve a mitochondrial apoptotic pathway probably through preventing cytochrome c release and thereby blocking downstream caspase activation",
    "triple_list": [
      [
        "minocycline",
        "CPR:4",
        "cytochrome c"
      ],
      [
        "minocycline",
        "CPR:4",
        "caspase"
      ]
    ],
    "updated": "No",
    "original": "Our results suggest that easing of Fastriggered fulminant hepatitis by minocycline may involve a mitochondrial apoptotic pathway probably through preventing cytochrome c release and thereby blocking downstream caspase activation",
    "simplified": "Our results suggest that minocycline can reduce fastriggered fulminant hepatitis by blocking a mitochondrial apoptotic pathway. This is probably done by preventing cytochrome c release."
  },
  {
    "text": "placebo n=24 animals in each group 2 neutrophil sequestration in the pancreas pancreatic myeloperoxidase oxidase MPO activity fold increase over control prophylactic treatment placebo 578063 PAG 297039 therapeutic treatment placebo 548052 PAG 303047 P005 PAG cf",
    "triple_list": [
      [
        "myeloperoxidase oxidase",
        "CPR:3",
        "PAG"
      ],
      [
        "MPO",
        "CPR:3",
        "PAG"
      ]
    ],
    "updated": "No",
    "original": "placebo n=24 animals in each group 2 neutrophil sequestration in the pancreas pancreatic myeloperoxidase oxidase MPO activity fold increase over control prophylactic treatment placebo 578063 PAG 297039 therapeutic treatment placebo 548052 PAG 303047 P005 PAG cf",
    "simplified": "pancreatic myeloperoxidase oxidase MPO activity fold increase over control placebo n=24 animals in each group 2 neutrophil sequestration in the pancreas placebo n=24 animals in each group 2 neutrophil sequestration in the pancreas n=24 animals in each group."
  },
  {
    "text": "Also prophylactic as well as therapeutic treatment with the CSE inhibitor DLpropargylglycine PAG significantly reduced the severity of caeruleininduced pancreatitis and associated lung injury as determined by 1 hyperamylasemia plasma amylase UL control The long-term results of this study are not yet available , however .",
    "triple_list": [
      [
        "CSE",
        "CPR:4",
        "DLpropargylglycine"
      ],
      [
        "CSE",
        "CPR:4",
        "PAG"
      ]
    ],
    "updated": "Yes",
    "original": "Also prophylactic as well as therapeutic treatment with the CSE inhibitor DLpropargylglycine PAG significantly reduced the severity of caeruleininduced pancreatitis and associated lung injury as determined by 1 hyperamylasemia plasma amylase UL control 120459 prophylactic treatment placebo 10635305 PAG 7904495 therapeutic treatment placebo 10427470 PAG 7811428 P005 PAG cf",
    "simplified": "Also prophylactic as well as therapeutic treatment with the CSE inhibitor DLpropargylglycine PAG significantly reduced the severity of caeruleininduced pancreatitis and associated lung injury as determined by 1 hyperamylasemia plasma amylase UL control The long-term results of this study are not yet available, however."
  },
  {
    "text": "Cystathioninegammalyase CSE and cystathioninebetasynthase CBS utilize Lcysteine as substrate to form H2S",
    "triple_list": [
      [
        "CSE",
        "CPR:9",
        "Lcysteine"
      ],
      [
        "cystathioninebetasynthase",
        "CPR:9",
        "Lcysteine"
      ],
      [
        "CBS",
        "CPR:9",
        "Lcysteine"
      ],
      [
        "Cystathioninegammalyase",
        "CPR:9",
        "Lcysteine"
      ],
      [
        "CSE",
        "CPR:9",
        "H2S"
      ],
      [
        "cystathioninebetasynthase",
        "CPR:9",
        "H2S"
      ],
      [
        "CBS",
        "CPR:9",
        "H2S"
      ],
      [
        "Cystathioninegammalyase",
        "CPR:9",
        "H2S"
      ]
    ],
    "updated": "No",
    "original": "Cystathioninegammalyase CSE and cystathioninebetasynthase CBS utilize Lcysteine as substrate to form H2S",
    "simplified": "Cystathioninebetasynthase CBS and Cystathioninegammalyase CSE use Lcysteine as a base to make H2S."
  },
  {
    "text": "Of these two enzymes cystathioninegammalyase CSE is believed to be the key enzyme that forms H2S in the cardiovascular system",
    "triple_list": [
      [
        "cystathioninegammalyase",
        "CPR:9",
        "H2S"
      ],
      [
        "CSE",
        "CPR:9",
        "H2S"
      ]
    ],
    "updated": "No",
    "original": "Of these two enzymes cystathioninegammalyase CSE is believed to be the key enzyme that forms H2S in the cardiovascular system",
    "simplified": "Cystathioninegammalyase (CSE) is an enzyme. It is an important enzyme in the cardiovascular system."
  },
  {
    "text": "ABCG5 and ABCG8 themselves are regulated by cholesterol via liver X receptors LXRs which are also activated by oxy sterols and some derivatives of plant sterols",
    "triple_list": [
      [
        "LXRs",
        "CPR:3",
        "sterols"
      ]
    ],
    "updated": "No",
    "original": "ABCG5 and ABCG8 themselves are regulated by cholesterol via liver X receptors LXRs which are also activated by oxy sterols and some derivatives of plant sterols",
    "simplified": "The levels of ABCG5 and ABCG8 are controlled by cholesterol in the liver. They are controlled by liver X receptors called LXRs."
  },
  {
    "text": "NPC1L1 has recently been found to be a major sterol transporter . It helps cholesterol and plant sterols get into the body .",
    "triple_list": [
      [
        "NPC1L1",
        "CPR:9",
        "cholesterol"
      ],
      [
        "sterol transporter",
        "CPR:9",
        "cholesterol"
      ],
      [
        "NPC1L1",
        "CPR:9",
        "sterols"
      ],
      [
        "sterol transporter",
        "CPR:9",
        "sterols"
      ]
    ],
    "updated": "Yes",
    "original": "NPC1L1 could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant sterols",
    "simplified": "NPC1L1 has recently been found to be a major sterol transporter. It helps cholesterol and plant sterols get into the body."
  },
  {
    "text": "Bupropion has an antidepressant effect through blocking the dopamine transporter",
    "triple_list": [
      [
        "Bupropion",
        "CPR:4",
        "dopamine transporter"
      ]
    ],
    "updated": "No",
    "original": "Bupropion has an antidepressant effect through blocking the dopamine transporter",
    "simplified": "Bupropion has an antidepressant effect. It blocks the transport of dopamine."
  },
  {
    "text": "Our results demonstrate that the combination of denileukin diftitox and bexarotene is well tolerated and that even low doses of bexarotene are able to increase CD25 expression in circulating leukemia cells .",
    "triple_list": [
      [
        "bexarotene",
        "CPR:3",
        "CD25"
      ]
    ],
    "updated": "Yes",
    "original": "Our results demonstrate that the combination of denileukin diftitox and bexarotene is well tolerated and that even low doses 150 mgday of bexarotene are capable of in vivo upregulation of CD25 expression on circulating leukemia cells",
    "simplified": "Our results demonstrate that the combination of denileukin diftitox and bexarotene is well tolerated and that even low doses of bexarotene are able to increase CD25 expression in circulating leukemia cells."
  },
  {
    "text": "In vitro studies demonstrated that the retinoid X receptor RXR retinoid bexarotene at biologically relevant concentrations of 106 M to 108 M upregulated both the p55 and p75 subunits of the IL2R and enhanced 5 to 10fold the susceptibility of Tcell leukemia cells to denileukin diftitox",
    "triple_list": [
      [
        "bexarotene",
        "CPR:3",
        "p55"
      ],
      [
        "bexarotene",
        "CPR:3",
        "p75"
      ],
      [
        "bexarotene",
        "CPR:3",
        "IL2R"
      ]
    ],
    "updated": "No",
    "original": "In vitro studies demonstrated that the retinoid X receptor RXR retinoid bexarotene at biologically relevant concentrations of 106 M to 108 M upregulated both the p55 and p75 subunits of the IL2R and enhanced 5 to 10fold the susceptibility of Tcell leukemia cells to denileukin diftitox",
    "simplified": "In vitro studies demonstrated that the retinoid X receptor RXR retinoid bexarotene increased the susceptibility of Tcell leukemia cells to denileukin diftitox by 5 to 10fold when concentrations of 106 M to 108 M were used."
  },
  {
    "text": "PSMA acts as a glutamate carboxypeptidase GCPII on small molecule substrates including folate the anticancer drug methotrexate and the neuropeptide Nacetyllaspartyllglutamate",
    "triple_list": [
      [
        "PSMA",
        "CPR:9",
        "folate"
      ],
      [
        "glutamate carboxypeptidase",
        "CPR:9",
        "folate"
      ],
      [
        "GCPII",
        "CPR:9",
        "folate"
      ],
      [
        "PSMA",
        "CPR:9",
        "methotrexate"
      ],
      [
        "glutamate carboxypeptidase",
        "CPR:9",
        "methotrexate"
      ],
      [
        "GCPII",
        "CPR:9",
        "methotrexate"
      ],
      [
        "PSMA",
        "CPR:9",
        "Nacetyllaspartyllglutamate"
      ],
      [
        "glutamate carboxypeptidase",
        "CPR:9",
        "Nacetyllaspartyllglutamate"
      ]
    ],
    "updated": "No",
    "original": "PSMA acts as a glutamate carboxypeptidase GCPII on small molecule substrates including folate the anticancer drug methotrexate and the neuropeptide Nacetyllaspartyllglutamate",
    "simplified": "PSMA acts as a glutamate carboxypeptidase GCPII on small molecules. These small molecules include the drug methotrexate and the neuropeptide Nacetyllaspartyllglutamate"
  },
  {
    "text": "The structure of the PSMA has been determined , and docking studies and a proposed catalytic mechanism have been carried out . The natural substrate Nacetyllaspartyllglutamate has been identified .",
    "triple_list": [
      [
        "PSMA",
        "CPR:9",
        "Nacetyllaspartyllglutamate"
      ]
    ],
    "updated": "Yes",
    "original": "Elucidation of the PSMA structure combined with docking studies and a proposed catalytic mechanism provides insight into the recognition of inhibitors and the natural substrate Nacetyllaspartyllglutamate",
    "simplified": "The structure of the PSMA has been determined, and docking studies and a proposed catalytic mechanism have been carried out. The natural substrate Nacetyllaspartyllglutamate has been identified."
  },
  {
    "text": "While the substituted benzamide prokinetics for example metoclopramide cisapride also block 5HT3 receptors in high concentrations , the prokinetic effect of metoclopramide on the 5HT4 receptor is not known .",
    "triple_list": [
      [
        "benzamide",
        "CPR:4",
        "5HT3"
      ],
      [
        "metoclopramide",
        "CPR:4",
        "5HT3"
      ],
      [
        "cisapride",
        "CPR:4",
        "5HT3"
      ],
      [
        "benzamide",
        "CPR:5",
        "5HT4"
      ],
      [
        "metoclopramide",
        "CPR:5",
        "5HT4"
      ],
      [
        "cisapride",
        "CPR:5",
        "5HT4"
      ]
    ],
    "updated": "Yes",
    "original": "While the substituted benzamide prokinetics for example metoclopramide cisapride also block 5HT3 receptors in high concentrations their prokinetic action is believed to be on the basis of their agonist effects on the putative 5HT4 receptor",
    "simplified": "While the substituted benzamide prokinetics for example metoclopramide cisapride also block 5HT3 receptors in high concentrations, the prokinetic effect of metoclopramide on the 5HT4 receptor is not known."
  },
  {
    "text": "Some 5HT3 antagonists have 5HT4 agonist activity for example renzapride zacopride and others do not for example ondansetron granisetron while tropisetron in high concentrations is a 5HT4 antagonist",
    "triple_list": [
      [
        "5HT4",
        "CPR:5",
        "renzapride"
      ],
      [
        "5HT4",
        "CPR:5",
        "zacopride"
      ],
      [
        "5HT3",
        "CPR:6",
        "renzapride"
      ],
      [
        "5HT3",
        "CPR:6",
        "zacopride"
      ],
      [
        "5HT4",
        "CPR:6",
        "tropisetron"
      ]
    ],
    "updated": "No",
    "original": "Some 5HT3 antagonists have 5HT4 agonist activity for example renzapride zacopride and others do not for example ondansetron granisetron while tropisetron in high concentrations is a 5HT4 antagonist",
    "simplified": "Some 5HT3 antagonists have 5HT4 agonist activity, for example ondansetron granisetron and renzapride zacopride. Other 5HT3 antagonists have no 5HT4 activity at all."
  },
  {
    "text": "A number of selective 5HT3 antagonists have been developed including ondansetron granisetron tropisetron renzapride and zacopride",
    "triple_list": [
      [
        "5HT3",
        "CPR:6",
        "zacopride"
      ],
      [
        "5HT3",
        "CPR:6",
        "ondansetron"
      ],
      [
        "5HT3",
        "CPR:6",
        "granisetron"
      ],
      [
        "5HT3",
        "CPR:6",
        "tropisetron"
      ],
      [
        "5HT3",
        "CPR:6",
        "renzapride"
      ]
    ],
    "updated": "No",
    "original": "A number of selective 5HT3 antagonists have been developed including ondansetron granisetron tropisetron renzapride and zacopride",
    "simplified": "A number of selective 5HT3 antagonists have been developed. These include ondansetron, granisetron and tropisetron."
  },
  {
    "text": "We present our studies to demonstrate that HM74A but not HM74 binds niacin at high affinities and effectively mediates Gi signaling in 3T3L1 adipocytes as well as in human embryonic kidney HEK293 cells .",
    "triple_list": [
      [
        "niacin",
        "CPR:3",
        "Gi"
      ]
    ],
    "updated": "Yes",
    "original": "We present our studies to demonstrate that HM74A but not HM74 binds niacin at high affinities and effectively mediates Gi signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing HM74A",
    "simplified": "We present our studies to demonstrate that HM74A but not HM74 binds niacin at high affinities and effectively mediates Gi signaling in 3T3L1 adipocytes as well as in human embryonic kidney HEK293 cells."
  },
  {
    "text": "When cultured in YPD medium containing 15 glucose under aerobic conditions the KGD1 alphaketoglutarate dehydrogenase gene was disrupted , the wildtype strain had a lower level of succinate , and the SDH1 succinate dehydrogenase genedisrupted mutant had a higher level of succinate .",
    "triple_list": [
      [
        "KGD1",
        "CPR:9",
        "succinate"
      ],
      [
        "alphaketoglutarate dehydrogenase",
        "CPR:9",
        "succinate"
      ],
      [
        "succinate",
        "CPR:9",
        "SDH1"
      ],
      [
        "succinate",
        "CPR:9",
        "succinate dehydrogenase"
      ]
    ],
    "updated": "Yes",
    "original": "When cultured in YPD medium containing 15 glucose under aerobic conditions the KGD1 alphaketoglutarate dehydrogenase gene disrupted mutant produced a lower level of succinate than the wildtype strain while the SDH1 succinate dehydrogenase genedisrupted mutant produced an increased level of succinate",
    "simplified": "When cultured in YPD medium containing 15 glucose under aerobic conditions the KGD1 alphaketoglutarate dehydrogenase gene was disrupted, the wildtype strain had a lower level of succinate, and the SDH1 succinate dehydrogenase genedisrupted mutant had a higher level of succinate."
  },
  {
    "text": "On the other hand the FUM1 fumarase gene disrupted mutant produced significantly higher levels of fumarate but did not form malate at all",
    "triple_list": [
      [
        "FUM1",
        "CPR:9",
        "fumarate"
      ],
      [
        "fumarase",
        "CPR:9",
        "fumarate"
      ]
    ],
    "updated": "No",
    "original": "On the other hand the FUM1 fumarase gene disrupted mutant produced significantly higher levels of fumarate but did not form malate at all",
    "simplified": "On the other hand, when the FUM1 gene was disrupted, fumarate was made much more. However, it did not form malate."
  },
  {
    "text": "When the growth condition was changed from aerobic to anaerobic , the level of succinate in the KGD1 diruptant decreased , but the level of succinate in the SDH1 disruptants remained the same .",
    "triple_list": [
      [
        "succinate",
        "CPR:9",
        "SDH1"
      ],
      [
        "succinate",
        "CPR:9",
        "KGD1"
      ]
    ],
    "updated": "Yes",
    "original": "When the growth condition was shifted from aerobic to anaerobic the increased level of succinate in SDH1 disruptants was no longer observed whereas the decreased level of succinate in the KGD1 diruptant was still observed",
    "simplified": "When the growth condition was changed from aerobic to anaerobic, the level of succinate in the KGD1 diruptant decreased, but the level of succinate in the SDH1 disruptants remained the same."
  },
  {
    "text": "A double mutant of the two fumarate reductase isozyme genes OSM1 and FRDS showed a succinate productivity of 50 as compared to the parent when cells were incubated in glucosebuffered solution",
    "triple_list": [
      [
        "fumarate reductase",
        "CPR:9",
        "succinate"
      ],
      [
        "OSM1",
        "CPR:9",
        "succinate"
      ],
      [
        "FRDS",
        "CPR:9",
        "succinate"
      ]
    ],
    "updated": "No",
    "original": "A double mutant of the two fumarate reductase isozyme genes OSM1 and FRDS showed a succinate productivity of 50 as compared to the parent when cells were incubated in glucosebuffered solution",
    "simplified": "A double mutant of the two fumarate reductase isozyme genes OSM1 and FRDS showed that when cells were put in glucosebuffered solution, they grew better by 50%."
  },
  {
    "text": "However plasma highdensity lipoprotein cholesterol HDL C and HDL CtotalC ratio levels and plasma paraoxonase activity were only significantly higher in vitamin E group after 8 weeks",
    "triple_list": [
      [
        "highdensity lipoprotein",
        "CPR:3",
        "vitamin E"
      ],
      [
        "HDL",
        "CPR:3",
        "vitamin E"
      ],
      [
        "HDL",
        "CPR:3",
        "vitamin E"
      ],
      [
        "paraoxonase",
        "CPR:3",
        "vitamin E"
      ]
    ],
    "updated": "No",
    "original": "However plasma highdensity lipoprotein cholesterol HDL C and HDL CtotalC ratio levels and plasma paraoxonase activity were only significantly higher in vitamin E group after 8 weeks",
    "simplified": "However, plasma high density lipoprotein cholesterol and plasma paraoxonase activity were only significantly higher in the vitamin E group after 8 weeks."
  },
  {
    "text": "Hepatic ACAT activity was significantly lower in both vitamin E and probucol groups than in HCcontrol group while HMGCoA reductase activity was the highest only in the probucol group",
    "triple_list": [
      [
        "probucol",
        "CPR:3",
        "HMGCoA reductase"
      ],
      [
        "ACAT",
        "CPR:4",
        "vitamin E"
      ],
      [
        "ACAT",
        "CPR:4",
        "probucol"
      ]
    ],
    "updated": "No",
    "original": "Hepatic ACAT activity was significantly lower in both vitamin E and probucol groups than in HCcontrol group while HMGCoA reductase activity was the highest only in the probucol group",
    "simplified": "Hepatic ACAT activity was lower in both vitamin E and probucol groups than in HCcontrol group. The highest activity was only in the probucol group."
  },
  {
    "text": "Vitamin E and probucol significantly reduced the total cholesterol and lowdensity lipoprotein levels in the plasma compared to the control group .",
    "triple_list": [
      [
        "Vitamin E",
        "CPR:4",
        "lowdensity lipoprotein"
      ],
      [
        "probucol",
        "CPR:4",
        "lowdensity lipoprotein"
      ]
    ],
    "updated": "Yes",
    "original": "Vitamin E and probucol significantly suppressed an increase in plasma totalcholesterol totalC and lowdensity lipoprotein cholesterol compared to HCcontrol group",
    "simplified": "Vitamin E and probucol significantly reduced the total cholesterol and lowdensity lipoprotein levels in the plasma compared to the control group."
  },
  {
    "text": "The levels of apo B100 and apo CIII were significantly lower in the probucol group than in the control group .",
    "triple_list": [
      [
        "apo B100",
        "CPR:4",
        "probucol"
      ],
      [
        "apo CIII",
        "CPR:4",
        "probucol"
      ]
    ],
    "updated": "Yes",
    "original": "Hepatic mRNA expressions of apo B100 and apo CIII were significantly lower in probucol group than in other groups",
    "simplified": "The levels of apo B100 and apo CIII were significantly lower in the probucol group than in the control group."
  },
  {
    "text": "Vitamin E supplementation was found to alter the plasma HDLCrelated factors while probucol supplementation had a negative effect on the plasma HDL C concentration but was very effective in enhancing cholesterol metabolism .",
    "triple_list": [
      [
        "HDL",
        "CPR:4",
        "probucol"
      ]
    ],
    "updated": "Yes",
    "original": "Vitamin E supplementation was found to alter the plasma HDLCrelated factors meanwhile probucol supplementation was very effective in enhancing cholesterol metabolism except for a negative effect that reduced plasma HDL C concentration",
    "simplified": "Vitamin E supplementation was found to alter the plasma HDLCrelated factors while probucol supplementation had a negative effect on the plasma HDL C concentration but was very effective in enhancing cholesterol metabolism."
  },
  {
    "text": "However as with the human receptor maraviroc was shown to be a high affinity potent functional antagonist of macaque CCR5 thus indicating that novel CCR5 antagonists may be able to be developed and be given to humans without serious side effects .",
    "triple_list": [
      [
        "maraviroc",
        "CPR:6",
        "macaque CCR5"
      ],
      [
        "maraviroc",
        "CPR:6",
        "CCR5"
      ]
    ],
    "updated": "Yes",
    "original": "However as with the human receptor maraviroc was shown to be a high affinity potent functional antagonist of macaque CCR5 thereby indicating that the macaque should be a suitable species in which to evaluate the pharmacology safety and potential mechanismrelated toxicology of novel CCR5 antagonists",
    "simplified": "However as with the human receptor maraviroc was shown to be a high affinity potent functional antagonist of macaque CCR5 thus indicating that novel CCR5 antagonists may be able to be developed and be given to humans without serious side effects."
  },
  {
    "text": "The aim of this study was to determine if macaque represents a suitable species for the preclinical evaluation of novel CCR5 antagonists such as maraviroc UK427857",
    "triple_list": [
      [
        "CCR5",
        "CPR:6",
        "maraviroc"
      ],
      [
        "CCR5",
        "CPR:6",
        "UK427857"
      ]
    ],
    "updated": "No",
    "original": "The aim of this study was to determine if macaque represents a suitable species for the preclinical evaluation of novel CCR5 antagonists such as maraviroc UK427857",
    "simplified": "The aim of this study was to determine if macaque represents a suitable species for the preclinical evaluation of novel anti-CCR5 drugs, such as maraviroc."
  },
  {
    "text": "Maraviroc inhibited binding of 125IMIP1beta to CCR5 from macaque and human with similar potency IC50 = 1750 124 nM and 718 093 nM respectively and antagonised MIP1beta induced intracellular calcium release from macaque and human with similar potency IC50 = 1750 330 nM and 1207 189 nM respectively",
    "triple_list": [
      [
        "Maraviroc",
        "CPR:6",
        "CCR5"
      ]
    ],
    "updated": "Yes",
    "original": "Maraviroc inhibited binding of 125IMIP1beta to CCR5 from macaque and human with similar potency IC50 = 1750 124 nM and 718 093 nM respectively and antagonised MIP1beta induced intracellular calcium release mediated through CCR5 from macaque and human with similar potency IC50 = 1750 330 nM and 1207 189 respectively",
    "simplified": "Maraviroc inhibited binding of 125IMIP1beta to CCR5 from macaque and human with similar potency IC50 = 1750 124 nM and 718 093 nM respectively and antagonised MIP1beta induced intracellular calcium release from macaque and human with similar potency IC50 = 1750 330 nM and 1207 189 nM respectively"
  },
  {
    "text": "The reexpression of the p75NTR appears to partially reverse dedifferentiation of prostate cancer cells . This may be because the expression of CRABPI is increased , allowing the retinoids to be sequestered more effectively .",
    "triple_list": [
      [
        "CRABPI",
        "CPR:3",
        "retinoids"
      ]
    ],
    "updated": "Yes",
    "original": "Hence reexpression of the p75NTR appears to partially reverse dedifferentiation of prostate cancer cells by upregulating the expression of CRABPI for localized sequestration of retinoids that are available to newly upregulated RARbeta RXRalpha and RXRbeta",
    "simplified": "The reexpression of the p75NTR appears to partially reverse dedifferentiation of prostate cancer cells. This may be because the expression of CRABPI is increased, allowing the retinoids to be sequestered more effectively."
  },
  {
    "text": "Its special action profile , especially the increase in HDL cholesterol levels caused by nicotinic acid , is unique among the drugs currently available to treat lipid disorders .",
    "triple_list": [
      [
        "HDL",
        "CPR:3",
        "nicotinic acid"
      ]
    ],
    "updated": "Yes",
    "original": "Its special profile of actions especially the rise in HDL cholesterol levels induced by nicotinic acid is unique among the currently available pharmacological tools to treat lipid disorders",
    "simplified": "Its special action profile, especially the increase in HDL cholesterol levels caused by nicotinic acid, is unique among the drugs currently available to treat lipid disorders."
  },
  {
    "text": "RATIONALE Several drugs used to treat bipolar disorder lithium and carbamazepine when administered chronically to rats reduce the turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids by decreasing the activity of an arachidonic acidselective phospholipase A2",
    "triple_list": [
      [
        "lithium",
        "CPR:4",
        "phospholipase A2"
      ],
      [
        "carbamazepine",
        "CPR:4",
        "phospholipase A2"
      ]
    ],
    "updated": "No",
    "original": "RATIONALE Several drugs used to treat bipolar disorder lithium and carbamazepine when administered chronically to rats reduce the turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids by decreasing the activity of an arachidonic acidselective phospholipase A2",
    "simplified": "Several drugs used to treat bipolar disorder reduce the turnover of arachidonic acid in brain phospholipids by decreasing the activity of an arachidonic acidselective phospholipase A2, but not docosahexaenoic acid in brain phospholipids when administered chronically to rats."
  },
  {
    "text": "MATERIALS AND METHODS By isolating rat brain microsomal longchain fatty acylCoA synthetases Acsl we show in vitro that valproic acid reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme by which it works .",
    "triple_list": [
      [
        "Acsl",
        "CPR:4",
        "valproic acid"
      ]
    ],
    "updated": "Yes",
    "original": "MATERIALS AND METHODSRESULTS By isolating rat brain microsomal longchain fatty acylCoA synthetases Acsl we show in vitro that valproic acid is a noncompetitive inhibitor of Acsl as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme",
    "simplified": "MATERIALS AND METHODS By isolating rat brain microsomal longchain fatty acylCoA synthetases Acsl we show in vitro that valproic acid reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme by which it works."
  },
  {
    "text": "Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoylCoA by brain microsomal longchain fatty acylCoA synthetases relevance to bipolar disorder",
    "triple_list": [
      [
        "Valproic acid",
        "CPR:4",
        "brain microsomal longchain fatty acylCoA synthetases"
      ],
      [
        "arachidonic acid",
        "CPR:9",
        "brain microsomal longchain fatty acylCoA synthetases"
      ],
      [
        "arachidonoylCoA",
        "CPR:9",
        "brain microsomal longchain fatty acylCoA synthetases"
      ]
    ],
    "updated": "No",
    "original": "Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoylCoA by brain microsomal longchain fatty acylCoA synthetases relevance to bipolar disorder",
    "simplified": "Valproic acid stops the conversion of arachidonic acid to arachidonoylCoA in the brain. Brain microsomal longchain fatty acylCoA synthetases do this."
  },
  {
    "text": "CONCLUSIONS This study shows that valproic acid acts as a noncompetitive inhibitor of brain microsomal Acsl and that inhibition is substrateselective",
    "triple_list": [
      [
        "valproic acid",
        "CPR:4",
        "brain microsomal Acsl"
      ]
    ],
    "updated": "No",
    "original": "CONCLUSIONS This study shows that valproic acid acts as a noncompetitive inhibitor of brain microsomal Acsl and that inhibition is substrateselective",
    "simplified": "The results of this study show that valproic acid acts as a noncompetitive inhibitor of microsomal activity in the brain."
  },
  {
    "text": "On the other hand holocarboxylase synthetase HCS mRNA levels were very low in the animals that did not get the biotin .",
    "triple_list": [
      [
        "HCS",
        "CPR:3",
        "biotin"
      ],
      [
        "holocarboxylase synthetase",
        "CPR:3",
        "biotin"
      ]
    ],
    "updated": "Yes",
    "original": "On the other hand holocarboxylase synthetase HCS mRNA levels were markedly low in the deficient animals and increased upon biotin injection",
    "simplified": "On the other hand holocarboxylase synthetase HCS mRNA levels were very low in the animals that did not get the biotin."
  },
  {
    "text": "Furthermore PS liposomeinduced PGE2 production was significantly suppressed by indomethacin a preferential COX1 inhibitor but not by NS398 a selective COX2 inhibitor",
    "triple_list": [
      [
        "indomethacin",
        "CPR:4",
        "COX1"
      ],
      [
        "NS398",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "Furthermore PS liposomeinduced PGE2 production was significantly suppressed by indomethacin a preferential COX1 inhibitor but not by NS398 a selective COX2 inhibitor",
    "simplified": "In addition, the PS liposome produced less PGE2 when indomethacin was used, but this was because indomethacin is a COX1 inhibitor."
  },
  {
    "text": "Involvement of COX1 and upregulated prostaglandin E synthases in phosphatidylserine liposomeinduced prostaglandin E2 production by microglia",
    "triple_list": [
      [
        "COX1",
        "CPR:9",
        "prostaglandin E2"
      ],
      [
        "prostaglandin E synthases",
        "CPR:9",
        "prostaglandin E2"
      ]
    ],
    "updated": "No",
    "original": "Involvement of COX1 and upregulated prostaglandin E synthases in phosphatidylserine liposomeinduced prostaglandin E2 production by microglia",
    "simplified": "The involvement of COX1 and liposome in phosphatidylserine liposome induced prostaglandin E2 production by microglia"
  },
  {
    "text": "These observations strongly suggest that mPGES2 plays the pivotal role in PS liposomeinduced PGE2 production by microglia and that terminal PGESs are preferentially coupled with COX1 .",
    "triple_list": [
      [
        "PGESs",
        "CPR:9",
        "PGE2"
      ],
      [
        "COX1",
        "CPR:9",
        "PGE2"
      ],
      [
        "mPGES2",
        "CPR:9",
        "PGE2"
      ]
    ],
    "updated": "Yes",
    "original": "These observations strongly suggest that the upregulation of terminal PGESs that are preferentially coupled with COX1 especially mPGES2 plays the pivotal role in PS liposomeinduced PGE2 production by microglia",
    "simplified": "These observations strongly suggest that mPGES2 plays the pivotal role in PS liposomeinduced PGE2 production by microglia and that terminal PGESs are preferentially coupled with COX1."
  },
  {
    "text": "The multiple kinase inhibitors MKIs sorafenib sunitinib and AG013736 which target multiple VEGFRs as well as PDGFRbeta have been successful in the treatment of patients with clearcell RCC .",
    "triple_list": [
      [
        "kinase",
        "CPR:4",
        "sorafenib"
      ],
      [
        "sorafenib",
        "CPR:4",
        "VEGFRs"
      ],
      [
        "sorafenib",
        "CPR:4",
        "PDGFRbeta"
      ],
      [
        "kinase",
        "CPR:4",
        "sunitinib"
      ],
      [
        "sunitinib",
        "CPR:4",
        "VEGFRs"
      ],
      [
        "sunitinib",
        "CPR:4",
        "PDGFRbeta"
      ],
      [
        "kinase",
        "CPR:4",
        "AG013736"
      ],
      [
        "AG013736",
        "CPR:4",
        "VEGFRs"
      ],
      [
        "AG013736",
        "CPR:4",
        "PDGFRbeta"
      ]
    ],
    "updated": "Yes",
    "original": "Significant advances in the treatment of clearcell RCC have been derived from agents that target these pathways including the multiple kinase inhibitors MKIs sorafenib sunitinib and AG013736 which target multiple VEGFRs as well as PDGFRbeta",
    "simplified": "The multiple kinase inhibitors MKIs sorafenib sunitinib and AG013736 which target multiple VEGFRs as well as PDGFRbeta have been successful in the treatment of patients with clearcell RCC."
  },
  {
    "text": "Sorafenib has the added advantage of inhibiting multiple different Raf isoforms which enables it to target TGFalpha EGFR signaling and may also enhance its inhibition of VEGFR and PDGFRbeta",
    "triple_list": [
      [
        "Sorafenib",
        "CPR:4",
        "Raf"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "TGFalpha"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "EGFR"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "VEGFR"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "PDGFRbeta"
      ]
    ],
    "updated": "No",
    "original": "Sorafenib has the added advantage of inhibiting multiple different Raf isoforms which enables it to target TGFalpha EGFR signaling and may also enhance its inhibition of VEGFR and PDGFRbeta",
    "simplified": "Sorafenib has the added advantage of inhibiting multiple different Raf isoforms. This allows Sorafenib to target TGFalpha and EGFR signaling more effectively."
  },
  {
    "text": "Low TS expression levels cytoplasmic expression pattern and C SNP in patients treated with 5FU have been associated with longer survival .",
    "triple_list": [
      [
        "TS",
        "CPR:4",
        "5FU"
      ]
    ],
    "updated": "Yes",
    "original": "Low TS expression levels cytoplasmic expression pattern and C SNP arose as variables associated to longer progressionfree survival PFS in patients treated with 5FU",
    "simplified": "Low TS expression levels cytoplasmic expression pattern and C SNP in patients treated with 5FU have been associated with longer survival."
  },
  {
    "text": "Our results suggest that long-term DPDPE treatment reduces deltaopioid receptor binding activity .",
    "triple_list": [
      [
        "DPDPE",
        "CPR:4",
        "deltaopioid receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Our conclusion is that chronic DPDPE treatment preferentially reduces deltaopioid receptor binding activity",
    "simplified": "Our results suggest that long-term DPDPE treatment reduces deltaopioid receptor binding activity."
  },
  {
    "text": "Therefore in the present studies animals were rendered tolerant to the deltaopioid receptor selective agonist DPen2DPen5enkephalin DPDPE and receptor binding activities were measured",
    "triple_list": [
      [
        "deltaopioid receptor",
        "CPR:5",
        "DPDPE"
      ],
      [
        "deltaopioid receptor",
        "CPR:5",
        "DPen2DPen5enkephalin"
      ]
    ],
    "updated": "No",
    "original": "Therefore in the present studies animals were rendered tolerant to the deltaopioid receptor selective agonist DPen2DPen5enkephalin DPDPE and receptor binding activities were measured",
    "simplified": "Accordingly, in the present study, animals were tolerant to the deltaopioid receptor selective agonist DPen2DPen5enkephalin and receptor activity was measured."
  },
  {
    "text": "Amoxapine really acts in vivo as a 5HT3 antagonist . experiments using the BezoldJarisch reflex confirmed that amoxapine works this way .",
    "triple_list": [
      [
        "5HT3",
        "CPR:6",
        "amoxapine"
      ]
    ],
    "updated": "Yes",
    "original": "Complementary experiments using the 5HT3dependent BezoldJarisch reflex confirmed that amoxapine really acts in vivo as a 5HT3 antagonist IC50 = 50 microgramskg iv",
    "simplified": "Amoxapine really acts in vivo as a 5HT3 antagonist. experiments using the BezoldJarisch reflex confirmed that amoxapine works this way."
  },
  {
    "text": "Competitive radioligand binding assays were performed using cells expressing either the human serotonin 5HT transporter hSERT or norepinephrine NE transporter hNET with Ki values for DVS of 402 16 and 5584 1216 nM respectively",
    "triple_list": [
      [
        "human serotonin 5HT transporter",
        "CPR:4",
        "DVS"
      ],
      [
        "hSERT",
        "CPR:4",
        "DVS"
      ],
      [
        "norepinephrine NE transporter",
        "CPR:4",
        "DVS"
      ],
      [
        "hNET",
        "CPR:4",
        "DVS"
      ]
    ],
    "updated": "No",
    "original": "Competitive radioligand binding assays were performed using cells expressing either the human serotonin 5HT transporter hSERT or norepinephrine NE transporter hNET with Ki values for DVS of 402 16 and 5584 1216 nM respectively",
    "simplified": "Competitive radioligand binding assays were performed using cells expressing either the human serotonin transporter hSERT or the norepinephrine transporter hNET. Ki values for DVS were 402 16 and 5584 1216 nM."
  },
  {
    "text": "To mimic chronic selective serotonin reuptake inhibitor treatment and to block the inhibitory 5HT1A autoreceptors a 5HT1A antagonist N242methoxyphenyl1piperazinylethylN2pyridinylcyclo hexanecarboxamide maleate salt WAY100635 03 mgkg sc was administered with DVS 30 mgkg orally",
    "triple_list": [
      [
        "5HT1A",
        "CPR:6",
        "N242methoxyphenyl1piperazinylethylN2pyridinylcyclo hexanecarboxamide maleate salt"
      ],
      [
        "5HT1A",
        "CPR:6",
        "WAY100635"
      ]
    ],
    "updated": "No",
    "original": "To mimic chronic selective serotonin reuptake inhibitor treatment and to block the inhibitory 5HT1A autoreceptors a 5HT1A antagonist N242methoxyphenyl1piperazinylethylN2pyridinylcyclo hexanecarboxamide maleate salt WAY100635 03 mgkg sc was administered with DVS 30 mgkg orally",
    "simplified": "To mimic chronic selective serotonin reuptake inhibitor treatment and to block the inhibitory 5HT1A autoreceptors a 5HT1A antagonist was administered with DVS 30 mgkg orally and a 5HT1A antagonist was administered with DVS 30 mgkg orally."
  },
  {
    "text": "Inhibition of 3H5HT or 3HNE uptake by DVS for the hSERT or hNET produced IC50 values of 473 194 and 5313 1130 nM respectively",
    "triple_list": [
      [
        "3H5HT",
        "CPR:9",
        "hSERT"
      ],
      [
        "3HNE",
        "CPR:9",
        "hNET"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of 3H5HT or 3HNE uptake by DVS for the hSERT or hNET produced IC50 values of 473 194 and 5313 1130 nM respectively",
    "simplified": "Inhibition of the uptake of 3H5HT by DVS produced IC50 values of 473 194 and 5313 1130 nM for the hSERT or hNET."
  },
  {
    "text": "Further cholesterol metabolites predominantly the oxysterols the natural ligands for liver X receptor LXR induced these genes via upregulation of sterol regulatory element binding protein1c SREBP1c that bound to the regulatory regions of these genes",
    "triple_list": [
      [
        "cholesterol",
        "CPR:3",
        "sterol regulatory element binding protein1c"
      ],
      [
        "cholesterol",
        "CPR:3",
        "SREBP1c"
      ],
      [
        "oxysterols",
        "CPR:3",
        "sterol regulatory element binding protein1c"
      ],
      [
        "oxysterols",
        "CPR:3",
        "SREBP1c"
      ]
    ],
    "updated": "No",
    "original": "Further cholesterol metabolites predominantly the oxysterols the natural ligands for liver X receptor LXR induced these genes via upregulation of sterol regulatory element binding protein1c SREBP1c that bound to the regulatory regions of these genes",
    "simplified": "Further cholesterol metabolites mainly the oxysterols the natural ligands for liver X receptor LXR that bound to the regulatory regions of these genes caused these genes to upregulation."
  },
  {
    "text": "The tissue RA level is maintained through a cascade of metabolic reactions where retinal dehydrogenases RALDHs catalyze the terminal reaction of RA biosynthesis from retinal a ratelimiting step",
    "triple_list": [
      [
        "RA",
        "CPR:9",
        "retinal dehydrogenases"
      ],
      [
        "RA",
        "CPR:9",
        "RALDHs"
      ],
      [
        "retinal",
        "CPR:9",
        "retinal dehydrogenases"
      ],
      [
        "retinal",
        "CPR:9",
        "RALDHs"
      ]
    ],
    "updated": "No",
    "original": "The tissue RA level is maintained through a cascade of metabolic reactions where retinal dehydrogenases RALDHs catalyze the terminal reaction of RA biosynthesis from retinal a ratelimiting step",
    "simplified": "The tissue RA level is maintained through a cascade of metabolic reactions. Retinal dehydrogenases RALDHs are important because they catalyze the final step in the production of RA."
  },
  {
    "text": "Hypermethlyation of RELN and GAD67 promoters can be induced by treating mice with methionine and these mice display brain and behavioral abnormalities similar to rl",
    "triple_list": [
      [
        "RELN and GAD67 promoters",
        "CPR:3",
        "methionine"
      ]
    ],
    "updated": "No",
    "original": "Hypermethlyation of RELN and GAD67 promoters can be induced by treating mice with methionine and these mice display brain and behavioral abnormalities similar to rl",
    "simplified": "Hypermethlyation of RELN and GAD67 can be caused by methionine in mice. These mice have brain and behavioral problems that are similar to rl"
  },
  {
    "text": "Because of this , severe left ventricular dysfunction was prevented by the AT1 antagonist olmesartan medoxomil .",
    "triple_list": [
      [
        "AT1",
        "CPR:6",
        "olmesartan medoxomil"
      ]
    ],
    "updated": "Yes",
    "original": "Thus severe LV dysfunction and accompanying abnormal myocardial bioenergetic phenotype were prevented by the AT1 antagonist olmesartan medoxomil",
    "simplified": "Because of this, severe left ventricular dysfunction was prevented by the AT1 antagonist olmesartan medoxomil."
  },
  {
    "text": "Functional and bioenergetic consequences of AT1 antagonist olmesartan medoxomil in hearts with postinfarction LV remodeling",
    "triple_list": [
      [
        "AT1",
        "CPR:6",
        "olmesartan medoxomil"
      ]
    ],
    "updated": "No",
    "original": "Functional and bioenergetic consequences of AT1 antagonist olmesartan medoxomil in hearts with postinfarction LV remodeling",
    "simplified": "The biological and functional effects of AT1 antagonist medoxomil in heart function in postinfarction patients"
  },
  {
    "text": "Results Imatinib did not affect the phosphorylation of RET Y1062 after 15 hours after exposure .",
    "triple_list": [
      [
        "Imatinib",
        "CPR:4",
        "RET"
      ],
      [
        "Imatinib",
        "CPR:4",
        "Y1062"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS Imatinib inhibited RET Y1062 phosphorylation in a dosedependent manner after 15 hours of exposure",
    "simplified": "Results Imatinib did not affect the phosphorylation of RET Y1062 after 15 hours after exposure."
  },
  {
    "text": "CONCLUSION Imatinib inhibits MTC cell growth in vitro and affects RET protein levels in a dosedependent manner .",
    "triple_list": [
      [
        "Imatinib",
        "CPR:4",
        "RET"
      ],
      [
        "Imatinib",
        "CPR:4",
        "RET"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS Imatinib inhibits RETmediated MTC cell growth affecting RET protein levels in vitro in a dosedependent manner",
    "simplified": "CONCLUSION Imatinib inhibits MTC cell growth in vitro and affects RET protein levels in a dosedependent manner."
  },
  {
    "text": "The concentration of imatinib necessary to inhibit RET in vitro however makes it impossible to use it for systemic treatment of MTC in humans .",
    "triple_list": [
      [
        "imatinib",
        "CPR:4",
        "RET"
      ]
    ],
    "updated": "Yes",
    "original": "The concentration of imatinib necessary to inhibit RET in vitro however makes it impossible to conclude that imatinib monotherapy will be a good option for systemic therapy of MTC",
    "simplified": "The concentration of imatinib necessary to inhibit RET in vitro however makes it impossible to use it for systemic treatment of MTC in humans."
  },
  {
    "text": "We evaluated imatinib , a tyrosine kinase inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors in 2 MTC cell lines expressing multiple endocrine neoplasiaassociated mutant RET receptors .",
    "triple_list": [
      [
        "imatinib",
        "CPR:4",
        "tyrosine kinase"
      ]
    ],
    "updated": "Yes",
    "original": "We evaluated imatinib a tyrosine kinase inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors as a potential drug for systemic treatment of MTC in 2 MTCderived cell lines expressing multiple endocrine neoplasiaassociated mutant RET receptors",
    "simplified": "We evaluated imatinib, a tyrosine kinase inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors in 2 MTC cell lines expressing multiple endocrine neoplasiaassociated mutant RET receptors."
  },
  {
    "text": "Retinoid is a collective term for compounds which bind to and activate retinoic acid receptors RARalpha beta gamma and RXRalpha beta gamma members of nuclear hormone receptor superfamily",
    "triple_list": [
      [
        "Retinoid",
        "CPR:3",
        "nuclear hormone receptor"
      ],
      [
        "Retinoid",
        "CPR:3",
        "retinoic acid receptors"
      ]
    ],
    "updated": "No",
    "original": "Retinoid is a collective term for compounds which bind to and activate retinoic acid receptors RARalpha beta gamma and RXRalpha beta gamma members of nuclear hormone receptor superfamily",
    "simplified": "Retinoid is a collective term for compounds which bind to and activate retinoic acid receptors. The two main types of retinoid receptors are RAR and RX."
  },
  {
    "text": "Simvastatin removed these anti CD11a mAbinduced increases in lymphocytic cholinergic activity in a way that did not affect the activity of CD12 .",
    "triple_list": [
      [
        "Simvastatin",
        "CPR:4",
        "CD11a"
      ]
    ],
    "updated": "Yes",
    "original": "Simvastatin abolished these anti CD11a mAbinduced increases in lymphocytic cholinergic activity in a manner independent of its cholesterollowering activity",
    "simplified": "Simvastatin removed these anti CD11a mAbinduced increases in lymphocytic cholinergic activity in a way that did not affect the activity of CD12."
  },
  {
    "text": "The drug simvastatin inhibits LFA1 by binding to an allosteric site on CD11 . When this happens , LFA1 starts to signal to the immune system .",
    "triple_list": [
      [
        "simvastatin",
        "CPR:4",
        "LFA1"
      ]
    ],
    "updated": "Yes",
    "original": "The cholesterollowering drug simvastatin inhibits LFA1 signaling by binding to an allosteric site on CD11a LFA1 alpha chain which leads to immunomodulation",
    "simplified": "The drug simvastatin inhibits LFA1 by binding to an allosteric site on CD11. When this happens, LFA1 starts to signal to the immune system."
  },
  {
    "text": "Menthol popularly known for its cooling effect activates TRPM8 a coldactivated thermoTRP ion channel",
    "triple_list": [
      [
        "Menthol",
        "CPR:3",
        "TRPM8"
      ],
      [
        "Menthol",
        "CPR:3",
        "thermoTRP ion channel"
      ]
    ],
    "updated": "No",
    "original": "Menthol popularly known for its cooling effect activates TRPM8 a coldactivated thermoTRP ion channel",
    "simplified": "Menthol is popular because it helps to cool things down. It also has a cooling effect."
  },
  {
    "text": "However , human studies show that menthol can also make people feel warm . In these studies , we show that menthol makes people feel warm because of TRPV3 .",
    "triple_list": [
      [
        "menthol",
        "CPR:3",
        "TRPV3"
      ]
    ],
    "updated": "Yes",
    "original": "However human physiological studies demonstrate a paradoxical role of menthol in modulation of warm sensation and here we show that menthol also activates heatactivated TRPV3",
    "simplified": "However, human studies show that menthol can also make people feel warm. In these studies, we show that menthol makes people feel warm because of TRPV3."
  },
  {
    "text": "Similar to menthol , both camphor and cinnamaldehyde are thought to be specific activators of TRPV3 and TRPA1 , but this is not always the case .",
    "triple_list": [
      [
        "menthol",
        "CPR:3",
        "TRPV3"
      ],
      [
        "menthol",
        "CPR:3",
        "TRPA1"
      ],
      [
        "camphor",
        "CPR:3",
        "TRPV3"
      ],
      [
        "camphor",
        "CPR:3",
        "TRPA1"
      ],
      [
        "cinnamaldehyde",
        "CPR:3",
        "TRPV3"
      ],
      [
        "cinnamaldehyde",
        "CPR:3",
        "TRPA1"
      ]
    ],
    "updated": "Yes",
    "original": "Similar to menthol both camphor and cinnamaldehyde initially reported to be specific activators of TRPV3 and TRPA1 respectively also modulate other thermoTRPs",
    "simplified": "Similar to menthol, both camphor and cinnamaldehyde are thought to be specific activators of TRPV3 and TRPA1, but this is not always the case."
  },
  {
    "text": "We have also shown that menthol inhibits TRPA1 . This means that menthol can be used as an analgesic .",
    "triple_list": [
      [
        "menthol",
        "CPR:4",
        "TRPA1"
      ]
    ],
    "updated": "Yes",
    "original": "We further show that menthol inhibits TRPA1 potentially explaining the use of menthol as an analgesic",
    "simplified": "We have also shown that menthol inhibits TRPA1. This means that menthol can be used as an analgesic."
  },
  {
    "text": "These currents were produced by glutamateaspartate transporters GLAST excitatory amino acid transporter 1 because they were weakly inhibited by dihydrokainate an antagonist of glutamate transporter1 excitatory amino acid transporter 2 and were absent from IPCs in GLAST cochleas",
    "triple_list": [
      [
        "glutamateaspartate transporters",
        "CPR:4",
        "dihydrokainate"
      ],
      [
        "GLAST",
        "CPR:4",
        "dihydrokainate"
      ],
      [
        "excitatory amino acid transporter 1",
        "CPR:4",
        "dihydrokainate"
      ],
      [
        "dihydrokainate",
        "CPR:6",
        "glutamate transporter1"
      ],
      [
        "dihydrokainate",
        "CPR:6",
        "excitatory amino acid transporter 2"
      ]
    ],
    "updated": "No",
    "original": "These currents were produced by glutamateaspartate transporters GLAST excitatory amino acid transporter 1 because they were weakly inhibited by dihydrokainate an antagonist of glutamate transporter1 excitatory amino acid transporter 2 and were absent from IPCs in GLAST cochleas",
    "simplified": "These currents were produced by glutamateaspartate transporters GLAST excitatory amino acid transporter 1 and were absent from IPCs in GLAST cochleas because these transporters were weakly inhibited by dihydrokainate an antagonist of glutamate transporter1."
  },
  {
    "text": "Focal application of the transporter substrate Daspartate caused inward currents in IPCs which were larger in the presence of anion channel blocked by the transporter antagonist DLthreobetabenzyloxyaspartate .",
    "triple_list": [
      [
        "anion channel",
        "CPR:6",
        "DLthreobetabenzyloxyaspartate"
      ]
    ],
    "updated": "Yes",
    "original": "Focal application of the transporter substrate Daspartate elicited inward currents in IPCs which were larger in the presence of anions that permeate the transporterassociated anion channel and blocked by the transporter antagonist DLthreobetabenzyloxyaspartate",
    "simplified": "Focal application of the transporter substrate Daspartate caused inward currents in IPCs which were larger in the presence of anion channel blocked by the transporter antagonist DLthreobetabenzyloxyaspartate."
  },
  {
    "text": "The glutamateaspartate transporter GLAST transports glutamate from the outside to the inside of hair cells .",
    "triple_list": [
      [
        "glutamate",
        "CPR:9",
        "GLAST"
      ],
      [
        "glutamate",
        "CPR:9",
        "glutamateaspartate transporter"
      ]
    ],
    "updated": "Yes",
    "original": "The glutamateaspartate transporter GLAST mediates glutamate uptake at inner hair cell afferent synapses in the mammalian cochlea",
    "simplified": "The glutamateaspartate transporter GLAST transports glutamate from the outside to the inside of hair cells."
  },
  {
    "text": "Daspartateinduced currents in outsideout patches from IPCs exhibited larger steadystate currents than responses elicited by Lglutamate and examination of cochlea from GLAST showed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs and was not found in other parts of the body .",
    "triple_list": [
      [
        "Lglutamate",
        "CPR:9",
        "GLAST"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore Daspartateinduced currents in outsideout patches from IPCs exhibited larger steadystate currents than responses elicited by Lglutamate a prominent feature of GLAST and examination of cochlea from GLASTDiscosoma red DsRed promoter reporter mice revealed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs",
    "simplified": "Daspartateinduced currents in outsideout patches from IPCs exhibited larger steadystate currents than responses elicited by Lglutamate and examination of cochlea from GLAST showed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs and was not found in other parts of the body."
  },
  {
    "text": "Overexpression of proline oxidase induces proline dependent and mitochondriamediated apoptosis",
    "triple_list": [
      [
        "proline",
        "CPR:9",
        "proline oxidase"
      ]
    ],
    "updated": "No",
    "original": "Overexpression of proline oxidase induces proline dependent and mitochondriamediated apoptosis",
    "simplified": "When there is too much proline in the blood, it causes proline dependent apoptosis."
  },
  {
    "text": "We conclude that in the presence of proline , high POX activity is sufficient to cause cell death .",
    "triple_list": [
      [
        "proline",
        "CPR:9",
        "POX"
      ]
    ],
    "updated": "Yes",
    "original": "We conclude that in the presence of proline high POX activity is sufficient to induce mitochondriamediated apoptosis",
    "simplified": "We conclude that in the presence of proline, high POX activity is sufficient to cause cell death."
  },
  {
    "text": "Proline oxidase POX a mitochondrial innermembrane protein catalyzes the ratelimiting oxidation of proline to pyrroline 5carboxylate P5C",
    "triple_list": [
      [
        "Proline oxidase",
        "CPR:9",
        "proline"
      ],
      [
        "POX",
        "CPR:9",
        "proline"
      ],
      [
        "Proline oxidase",
        "CPR:9",
        "pyrroline 5carboxylate"
      ],
      [
        "POX",
        "CPR:9",
        "pyrroline 5carboxylate"
      ],
      [
        "Proline oxidase",
        "CPR:9",
        "P5C"
      ],
      [
        "POX",
        "CPR:9",
        "P5C"
      ]
    ],
    "updated": "No",
    "original": "Proline oxidase POX a mitochondrial innermembrane protein catalyzes the ratelimiting oxidation of proline to pyrroline 5carboxylate P5C",
    "simplified": "Proline oxidase is a protein in the mitochondria. It changes proline into pyrroline, which is very toxic."
  },
  {
    "text": "To further investigate the molecular basis of POX induced apoptosis , we used DLD1POX cells to show that an Lproline dependent response is present in cells overproducing POX .",
    "triple_list": [
      [
        "POX",
        "CPR:9",
        "Lproline"
      ]
    ],
    "updated": "Yes",
    "original": "To further investigate the molecular basis of POXinduced apoptosis we utilized the DLD1POX cells to show that cells overproducing POX exhibit an Lproline dependent apoptotic response",
    "simplified": "To further investigate the molecular basis of POX induced apoptosis, we used DLD1POX cells to show that an Lproline dependent response is present in cells overproducing POX."
  },
  {
    "text": "The apoptotic effect is specific for Lproline and occurs during 4872 h following the addition of Lproline to cells with no POX . It is only detectable at 02 mM .",
    "triple_list": [
      [
        "Lproline",
        "CPR:9",
        "POX"
      ]
    ],
    "updated": "Yes",
    "original": "The apoptotic effect is specific for Lproline detectable at 02 mM maximal at 1 mM and occurs during 4872 h following the addition of Lproline to cells with maximally induced POX",
    "simplified": "The apoptotic effect is specific for Lproline and occurs during 4872 h following the addition of Lproline to cells with no POX. It is only detectable at 02 mM."
  },
  {
    "text": "The exception was bupropion a dual norepinephrine transporter dopamine transporter blocker which tended to increase spontaneous locomotor activity",
    "triple_list": [
      [
        "bupropion",
        "CPR:4",
        "norepinephrine transporter"
      ],
      [
        "bupropion",
        "CPR:4",
        "dopamine transporter"
      ]
    ],
    "updated": "No",
    "original": "The exception was bupropion a dual norepinephrine transporter dopamine transporter blocker which tended to increase spontaneous locomotor activity",
    "simplified": "The exception was bupropion, a drug which increased spontaneous locomotor activity, but not blood pressure."
  },
  {
    "text": "Coadministration of reboxetine and the dopamine transporter blocker GBR 12909 also increased spontaneous locomotor activity",
    "triple_list": [
      [
        "dopamine transporter",
        "CPR:4",
        "GBR 12909"
      ]
    ],
    "updated": "No",
    "original": "Coadministration of reboxetine and the dopamine transporter blocker GBR 12909 also increased spontaneous locomotor activity",
    "simplified": "Coadministration of reboxetine with GBR 12909 also increased spontaneous locomotor activity."
  },
  {
    "text": "Fulvestrant is a novel ER antagonist . It does not cause the tamoxifenlike effects , but instead destroys the ER and its signaling pathway .",
    "triple_list": [
      [
        "Fulvestrant",
        "CPR:4",
        "ER"
      ],
      [
        "Fulvestrant",
        "CPR:6",
        "ER"
      ]
    ],
    "updated": "Yes",
    "original": "Fulvestrant is a novel ER antagonist that destroys the ER and its signaling pathway and is not associated with tamoxifenlike agonist effects",
    "simplified": "Fulvestrant is a novel ER antagonist. It does not cause the tamoxifenlike effects, but instead destroys the ER and its signaling pathway."
  },
  {
    "text": "Tamoxifen blocks the action of estrogen by binding to the ER and possesses both ER agonist and antagonist properties",
    "triple_list": [
      [
        "Tamoxifen",
        "CPR:5",
        "ER"
      ],
      [
        "Tamoxifen",
        "CPR:6",
        "ER"
      ]
    ],
    "updated": "No",
    "original": "Tamoxifen blocks the action of estrogen by binding to the ER and possesses both ER agonist and antagonist properties",
    "simplified": "Tamoxifen blocks the action of estrogen by binding to the nucleus accumbens of the nucleus accumbens."
  },
  {
    "text": "Binding of cGMP to GAFA increases cNPK phosphorylation of PDE5 and improves the efficiency of the enzyme .",
    "triple_list": [
      [
        "cGMP",
        "CPR:3",
        "cNPK"
      ],
      [
        "cGMP",
        "CPR:3",
        "PDE5"
      ]
    ],
    "updated": "Yes",
    "original": "Binding of cGMP to GAFA increases cNPK phosphorylation of PDE5 and improves catalytic site affinity for cGMP or inhibitors",
    "simplified": "Binding of cGMP to GAFA increases cNPK phosphorylation of PDE5 and improves the efficiency of the enzyme."
  },
  {
    "text": "Phosphodiesterase5 PDE5 contains a catalytic domain C domain that hydrolyzes cGMP and a regulatory domain R domain that contains two mammalian cGMPbinding phosphodiesterase Anabaena adenylyl cyclases Escherichia coli FhlAs GAFs A and B and a phosphorylation site for cyclic nucleotidedependent protein kinases cNPKs",
    "triple_list": [
      [
        "Phosphodiesterase5",
        "CPR:9",
        "cGMP"
      ],
      [
        "PDE5",
        "CPR:9",
        "cGMP"
      ]
    ],
    "updated": "No",
    "original": "Phosphodiesterase5 PDE5 contains a catalytic domain C domain that hydrolyzes cGMP and a regulatory domain R domain that contains two mammalian cGMPbinding phosphodiesterase Anabaena adenylyl cyclases Escherichia coli FhlAs GAFs A and B and a phosphorylation site for cyclic nucleotidedependent protein kinases cNPKs",
    "simplified": "It contains a catalytic domain that hydrolyzes cGMP and a regulatory domain that contains two mammalian cGMPbinding phosphodiesterase Anabaena adenylyl cyclases GAFs A and B and a phosphorylation site for cyclic nucleotidedependent protein kinases (cNPKs)."
  },
  {
    "text": "Km values of the mutants for cGMP were similar to that of fulllength PDE5",
    "triple_list": [
      [
        "cGMP",
        "CPR:9",
        "PDE5"
      ]
    ],
    "updated": "No",
    "original": "Km values of the mutants for cGMP were similar to that of fulllength PDE5",
    "simplified": "Km values of the mutants were similar to PDE5 but not as good."
  },
  {
    "text": "Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferatoractivated receptor gamma",
    "triple_list": [
      [
        "Telmisartan",
        "CPR:3",
        "peroxisome proliferatoractivated receptor gamma"
      ],
      [
        "Telmisartan",
        "CPR:4",
        "angiotensin II type 1 receptor"
      ]
    ],
    "updated": "No",
    "original": "Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferatoractivated receptor gamma",
    "simplified": "Telmisartan lowers the levels of angiotensin II type 1 receptor. This causes peroxisome proliferator-activated receptor gamma"
  },
  {
    "text": "Because pretreatment with GW9662 prevented the expression of AT1R , a PPARgamma antagonist should have participated in the process",
    "triple_list": [
      [
        "AT1R",
        "CPR:3",
        "GW9662"
      ],
      [
        "GW9662",
        "CPR:6",
        "PPARgamma"
      ]
    ],
    "updated": "Yes",
    "original": "Since the suppression of AT1R expression was prevented by pretreatment with GW9662 a PPARgamma antagonist PPARgamma should have participated in the process",
    "simplified": "Because pretreatment with GW9662 prevented the expression of AT1R, a PPARgamma antagonist should have participated in the process"
  },
  {
    "text": "Our data provide a novel insight into an effect of telmisartan through PPARgamma activation on AT1R gene expression .",
    "triple_list": [
      [
        "telmisartan",
        "CPR:3",
        "PPARgamma"
      ],
      [
        "telmisartan",
        "CPR:4",
        "AT1R"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSION Our data provides a novel insight into an effect of telmisartan telmisartan inhibits AT1R gene expression through PPARgamma activation",
    "simplified": "Our data provide a novel insight into an effect of telmisartan through PPARgamma activation on AT1R gene expression."
  },
  {
    "text": "The reduced AT1R promoter activity with no changes in mRNA showed that telmisartan may have reduced gene expression .",
    "triple_list": [
      [
        "AT1R",
        "CPR:4",
        "telmisartan"
      ]
    ],
    "updated": "Yes",
    "original": "Decreased AT1R promoter activity with unchanged mRNA stability suggested that telmisartan suppressed AT1R gene expression at the transcriptional level",
    "simplified": "The reduced AT1R promoter activity with no changes in mRNA showed that telmisartan may have reduced gene expression."
  },
  {
    "text": "The deletion and mutation analysis of the AT1R gene promoter indicated that a GC box located in the proximal promoter region is responsible for the telmisartan induced downregulation",
    "triple_list": [
      [
        "AT1R",
        "CPR:4",
        "telmisartan"
      ],
      [
        "GC box",
        "CPR:4",
        "telmisartan"
      ]
    ],
    "updated": "No",
    "original": "The deletion and mutation analysis of the AT1R gene promoter indicated that a GC box located in the proximal promoter region is responsible for the telmisartan induced downregulation",
    "simplified": "The deletion and mutation analysis of the AT1R gene promoter showed that a GC box in the proximal region of the gene is responsible for the downregulation."
  },
  {
    "text": "Results Telmisartan reduced the expression of AT1R at the protein and mRNA levels in a dose-dependent manner .",
    "triple_list": [
      [
        "Telmisartan",
        "CPR:4",
        "AT1R"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS Telmisartan decreased the expression of AT1R at the mRNA and protein levels in a dose and timedependent manner",
    "simplified": "Results Telmisartan reduced the expression of AT1R at the protein and mRNA levels in a dose-dependent manner."
  },
  {
    "text": "OBJECTIVE Telmisartan an angiotensin II type 1 receptor AT1R antagonist was found to have a unique property it is a partial agonist of peroxisome proliferatoractivated receptor gamma PPARgamma",
    "triple_list": [
      [
        "Telmisartan",
        "CPR:5",
        "peroxisome proliferatoractivated receptor gamma"
      ],
      [
        "Telmisartan",
        "CPR:5",
        "PPARgamma"
      ],
      [
        "Telmisartan",
        "CPR:6",
        "angiotensin II type 1 receptor"
      ],
      [
        "Telmisartan",
        "CPR:6",
        "AT1R"
      ]
    ],
    "updated": "No",
    "original": "OBJECTIVE Telmisartan an angiotensin II type 1 receptor AT1R antagonist was found to have a unique property it is a partial agonist of peroxisome proliferatoractivated receptor gamma PPARgamma",
    "simplified": "OBJECTIVE Telmisartan an angiotensin II type 1 receptor AT1R antagonist was found to be a partial agonist of the peroxisome proliferator-activated receptor gamma (PPARgamma)."
  },
  {
    "text": "AT1R can not be treated with other drugs , for example candesartan or olmesartan does not work .",
    "triple_list": [
      [
        "AT1R",
        "CPR:6",
        "candesartan"
      ],
      [
        "AT1R",
        "CPR:6",
        "olmesartan"
      ]
    ],
    "updated": "Yes",
    "original": "However the expression of AT1R was not suppressed by other AT1R antagonists such as candesartan or olmesartan",
    "simplified": "AT1R can not be treated with other drugs, for example candesartan or olmesartan does not work."
  },
  {
    "text": "Osteoclasts express the vesicular glutamate transporter 1 ( VGLUT1 ) . This transporter is necessary for the storage and exocytosis of glutamate in neurons .",
    "triple_list": [
      [
        "vesicular glutamate transporter 1",
        "CPR:9",
        "glutamate"
      ],
      [
        "glutamate",
        "CPR:9",
        "VGLUT1"
      ]
    ],
    "updated": "Yes",
    "original": "Upon differentiation osteoclasts express vesicular glutamate transporter 1 VGLUT1 which is essential for vesicular storage and subsequent exocytosis of glutamate in neurons",
    "simplified": "Osteoclasts express the vesicular glutamate transporter 1 (VGLUT1). This transporter is necessary for the storage and exocytosis of glutamate in neurons."
  },
  {
    "text": "VGLUT1 is found in transcytotic vesicles . Lglutamate is made there .",
    "triple_list": [
      [
        "VGLUT1",
        "CPR:9",
        "Lglutamate"
      ]
    ],
    "updated": "Yes",
    "original": "VGLUT1 is localized in transcytotic vesicles and accumulates Lglutamate",
    "simplified": "VGLUT1 is found in transcytotic vesicles. Lglutamate is made there."
  },
  {
    "text": "In order to produce potent new leads for anticancer drugs a new series of quinazoline analogs was designed to resemble methotrexate MTX 1 structure features and fitted with functional groups believed to enhance inhibition of mammalian DHFR activity",
    "triple_list": [
      [
        "methotrexate",
        "CPR:4",
        "mammalian DHFR"
      ],
      [
        "MTX",
        "CPR:4",
        "mammalian DHFR"
      ],
      [
        "quinazoline",
        "CPR:4",
        "mammalian DHFR"
      ]
    ],
    "updated": "No",
    "original": "In order to produce potent new leads for anticancer drugs a new series of quinazoline analogs was designed to resemble methotrexate MTX 1 structure features and fitted with functional groups believed to enhance inhibition of mammalian DHFR activity",
    "simplified": "In order to produce potent new leads for anticancer drugs a new series of quinazoline analogs was designed to look like methotrexate. The new analogs were given a structure similar to methotrexate's MTX 1 structure."
  },
  {
    "text": "Synthesis dihydrofolate reductase inhibition antitumor testing and molecular modeling study of some new 43Hquinazolinone analogs",
    "triple_list": [
      [
        "dihydrofolate reductase",
        "CPR:4",
        "43Hquinazolinone"
      ]
    ],
    "updated": "No",
    "original": "Synthesis dihydrofolate reductase inhibition antitumor testing and molecular modeling study of some new 43Hquinazolinone analogs",
    "simplified": "Dihydrofolate reductase inhibition antitumor testing and new 43Hquinazolinone analogs are being developed."
  },
  {
    "text": "Conclusions High intake of MUFAs and SFAs appears to increase the expression of D5D and D6D genes while high intake of EFAs appears to decrease the expression of D5D and D6D .",
    "triple_list": [
      [
        "SFAs",
        "CPR:3",
        "D6D"
      ],
      [
        "SFAs",
        "CPR:3",
        "D5D"
      ],
      [
        "MUFAs",
        "CPR:3",
        "D6D"
      ],
      [
        "MUFAs",
        "CPR:3",
        "D5D"
      ],
      [
        "D6D",
        "CPR:4",
        "EFAs"
      ],
      [
        "D5D",
        "CPR:4",
        "EFAs"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSION Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes",
    "simplified": "Conclusions High intake of MUFAs and SFAs appears to increase the expression of D5D and D6D genes while high intake of EFAs appears to decrease the expression of D5D and D6D."
  },
  {
    "text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes but a significant negative correlation between dietary intake of linoleic acid LA and alphalinolenic acid LNA and the expression of PBMC D6D and D5D genes",
    "triple_list": [
      [
        "D6D",
        "CPR:4",
        "linoleic acid"
      ],
      [
        "D5D",
        "CPR:4",
        "linoleic acid"
      ],
      [
        "D6D",
        "CPR:4",
        "LA"
      ],
      [
        "D5D",
        "CPR:4",
        "LA"
      ],
      [
        "D6D",
        "CPR:4",
        "alphalinolenic acid"
      ],
      [
        "D5D",
        "CPR:4",
        "alphalinolenic acid"
      ],
      [
        "D6D",
        "CPR:4",
        "LNA"
      ],
      [
        "D5D",
        "CPR:4",
        "LNA"
      ]
    ],
    "updated": "No",
    "original": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes but a significant negative correlation between dietary intake of linoleic acid LA and alphalinolenic acid LNA and the expression of PBMC D6D and D5D genes",
    "simplified": "A significant positive correlation was found between total SFAs and total MUFAs and the expression of PBMC D6D and D5D genes. A significant negative correlation was found between total SFAs and the expression of PBMC D6D and D5D genes."
  },
  {
    "text": "Decitabine can stop DNA methyltransferase . This has been shown to help some patients with cancer .",
    "triple_list": [
      [
        "Decitabine",
        "CPR:4",
        "DNA methyltransferase"
      ]
    ],
    "updated": "Yes",
    "original": "Decitabine inhibits DNA methyltransferase and has shown therapeutic effects in patients with hematologic malignancies",
    "simplified": "Decitabine can stop DNA methyltransferase. This has been shown to help some patients with cancer."
  },
  {
    "text": "Our data suggest that larginine is taken up by Sertoli cells and peritubular cells principally via system yL SLC3A2 SLC7A6 and system y SLC7A1 and SLC7A2 with system B0 making a minor contribution",
    "triple_list": [
      [
        "larginine",
        "CPR:9",
        "SLC3A2"
      ]
    ],
    "updated": "No",
    "original": "Our data suggest that larginine is taken up by Sertoli cells and peritubular cells principally via system yL SLC3A2 SLC7A6 and system y SLC7A1 and SLC7A2 with system B0 making a minor contribution",
    "simplified": "Our data suggest that larginine is taken up by Sertoli cells and peritubular cells principally via system y SLC7A1 and SLC7A2 with system B0 making a small amount of larginine."
  },
  {
    "text": "KIEs were measured on the arsenolysis of 5methylthioadenosine MTA catalyzed by MTAP and were corrected for the forward commitment to catalysis",
    "triple_list": [
      [
        "5methylthioadenosine",
        "CPR:9",
        "MTAP"
      ],
      [
        "MTA",
        "CPR:9",
        "MTAP"
      ]
    ],
    "updated": "No",
    "original": "KIEs were measured on the arsenolysis of 5methylthioadenosine MTA catalyzed by MTAP and were corrected for the forward commitment to catalysis",
    "simplified": "KIEs were measured on the arsenolysis of 5methylthioadenosine MTA and were corrected for the forward commitment of the enzyme."
  },
  {
    "text": "Blocking retinyl ester formation by a targeted knock down of Lratb results in high levels of retinoic acid . This can cause problems during development .",
    "triple_list": [
      [
        "retinyl ester",
        "CPR:9",
        "Lratb"
      ]
    ],
    "updated": "Yes",
    "original": "Blocking retinyl ester formation by a targeted knock down of Lratb results in significantly increased retinoic acid levels which lead to severe embryonic patterning defects",
    "simplified": "Blocking retinyl ester formation by a targeted knock down of Lratb results in high levels of retinoic acid. This can cause problems during development."
  },
  {
    "text": "During development lratb is expressed in the opposite direction to retinal dehydrogenase 2 raldh2 . This enzyme is important for making retinoic acid .",
    "triple_list": [
      [
        "retinal dehydrogenase 2",
        "CPR:9",
        "retinoic acid"
      ],
      [
        "raldh2",
        "CPR:9",
        "retinoic acid"
      ]
    ],
    "updated": "Yes",
    "original": "During embryogenesis lratb is expressed in mostly nonoverlapping domains opposite to retinal dehydrogenase 2 raldh2 the key enzyme for retinoic acid synthesis",
    "simplified": "During development lratb is expressed in the opposite direction to retinal dehydrogenase 2 raldh2. This enzyme is important for making retinoic acid."
  },
  {
    "text": "ADP initiates platelet aggregation by simultaneous activation of two G proteincoupled receptors P2Y1 and P2Y12",
    "triple_list": [
      [
        "ADP",
        "CPR:3",
        "G proteincoupled receptors"
      ],
      [
        "ADP",
        "CPR:3",
        "P2Y1"
      ],
      [
        "ADP",
        "CPR:3",
        "P2Y12"
      ]
    ],
    "updated": "No",
    "original": "ADP initiates platelet aggregation by simultaneous activation of two G proteincoupled receptors P2Y1 and P2Y12",
    "simplified": "ADP causes platelet aggregation when two G-receptors, P2Y1 and P2Y12 are activated at the same time."
  },
  {
    "text": "Our results suggest that ADP ATP analogs may be able to inhibit P2Y12 and that P2Y12 may be a target of new drugs that inhibit platelet aggregation .",
    "triple_list": [
      [
        "P2Y12",
        "CPR:4",
        "ADP"
      ],
      [
        "P2Y12",
        "CPR:4",
        "ATP"
      ]
    ],
    "updated": "Yes",
    "original": "Our results imply that P2Y12 has the potential to be inhibited by ADP ATP analogs and it suggests that P2Y12 acts as a target of new drugs that inhibit platelet aggregation",
    "simplified": "Our results suggest that ADP ATP analogs may be able to inhibit P2Y12 and that P2Y12 may be a target of new drugs that inhibit platelet aggregation."
  },
  {
    "text": "Cd rapidly increased cjun cfos and PDGFA expression",
    "triple_list": [
      [
        "Cd",
        "CPR:3",
        "cjun"
      ],
      [
        "Cd",
        "CPR:3",
        "cfos"
      ],
      [
        "Cd",
        "CPR:3",
        "PDGFA"
      ]
    ],
    "updated": "No",
    "original": "Cd rapidly increased cjun cfos and PDGFA expression",
    "simplified": "The speed of light and PDGFA expression"
  },
  {
    "text": "In conclusion our results indicate that Cd increases BC cell proliferation in vitro by stimulating Akt ERK12 and PDGFRalpha kinases activity likely by activating cfos cjun and PDGFA by an ERalphadependent mechanism",
    "triple_list": [
      [
        "Cd",
        "CPR:3",
        "Akt"
      ],
      [
        "Cd",
        "CPR:3",
        "PDGFRalpha"
      ],
      [
        "Cd",
        "CPR:3",
        "kinases"
      ],
      [
        "Cd",
        "CPR:3",
        "cfos"
      ],
      [
        "Cd",
        "CPR:3",
        "cjun"
      ],
      [
        "Cd",
        "CPR:3",
        "PDGFA"
      ]
    ],
    "updated": "No",
    "original": "In conclusion our results indicate that Cd increases BC cell proliferation in vitro by stimulating Akt ERK12 and PDGFRalpha kinases activity likely by activating cfos cjun and PDGFA by an ERalphadependent mechanism",
    "simplified": "In conclusion our results indicate that Cd increases BC cell proliferation in vitro by an ERalphadependent mechanism likely by activating cfos cjun and PDGFA by an Akt-ERK-dependent mechanism."
  },
  {
    "text": "Cd also increased ERK12 Akt and PDGFRalpha phosphorylation while ICI blocked it",
    "triple_list": [
      [
        "Cd",
        "CPR:3",
        "Akt"
      ],
      [
        "Cd",
        "CPR:3",
        "PDGFRalpha"
      ]
    ],
    "updated": "No",
    "original": "Cd also increased ERK12 Akt and PDGFRalpha phosphorylation while ICI blocked it",
    "simplified": "It also increased ERK12 Akt and PDGFRalpha production, but not at ICI."
  },
  {
    "text": "Cd increases ERalpha but does not increase ERbeta",
    "triple_list": [
      [
        "Cd",
        "CPR:4",
        "ERalpha"
      ]
    ],
    "updated": "Yes",
    "original": "Cd decreased ERalpha expression but not ERbeta",
    "simplified": "Cd increases ERalpha but does not increase ERbeta"
  },
  {
    "text": "Gonadotropinreleasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic5",
    "triple_list": [
      [
        "testosterone",
        "CPR:3",
        "human androgen receptor"
      ],
      [
        "Gonadotropinreleasing hormone",
        "CPR:6",
        "human androgen receptor"
      ]
    ],
    "updated": "No",
    "original": "Gonadotropinreleasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic5",
    "simplified": "Gonadotropin-releasing hormone (GnRH) blocks the action of the human androgen receptor in prostate cells. prostate cells are special cells in the body."
  },
  {
    "text": "GnRH induced Pyk2 activation opposed the association of Hic5 with the androgen receptor . When Pyk2 was overexpressed , a green fluorescent protein was produced and the androgen receptor was activated .",
    "triple_list": [
      [
        "GnRH",
        "CPR:3",
        "Pyk2"
      ],
      [
        "GnRH",
        "CPR:4",
        "Hic5"
      ],
      [
        "GnRH",
        "CPR:4",
        "androgen receptor"
      ]
    ],
    "updated": "Yes",
    "original": "GnRH induced Pyk2 activation opposed the association of Hic5 with androgen receptor as overexpression of a dominant negative Pyk2 enhanced the GnRH induced nuclear translocation of a green fluorescent proteintagged human androgen receptor",
    "simplified": "GnRH induced Pyk2 activation opposed the association of Hic5 with the androgen receptor. When Pyk2 was overexpressed, a green fluorescent protein was produced and the androgen receptor was activated."
  },
  {
    "text": "GnRH activation of the cSrc resulted in the phosphorylation of the Hic5 gene . This made the Hic5 receptor stronger .",
    "triple_list": [
      [
        "GnRH",
        "CPR:3",
        "cSrc"
      ]
    ],
    "updated": "Yes",
    "original": "GnRH induced cSrc activation resulted in the phosphorylation of expressed Hic5 and promoted its association with the human androgen receptor",
    "simplified": "GnRH activation of the cSrc resulted in the phosphorylation of the Hic5 gene. This made the Hic5 receptor stronger."
  },
  {
    "text": "Unlike testosterone , nuclear translocation of GnRH did not activate the androgen receptor .",
    "triple_list": [
      [
        "testosterone",
        "CPR:3",
        "androgen receptor"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast to testosterone GnRHinduced nuclear translocation did not transcriptionally activate the androgen receptor",
    "simplified": "Unlike testosterone, nuclear translocation of GnRH did not activate the androgen receptor."
  },
  {
    "text": "EC50 values for SMETH were 089 092 and 444 microM/O . For rTAAR1 , mTAAR1 and hrChTAAR1 are used .",
    "triple_list": [
      [
        "SMETH",
        "CPR:3",
        "rTAAR1"
      ],
      [
        "SMETH",
        "CPR:3",
        "mTAAR1"
      ],
      [
        "SMETH",
        "CPR:3",
        "hrChTAAR1"
      ]
    ],
    "updated": "Yes",
    "original": "EC50 values for SMETH were 089 092 and 444 microM for rTAAR1 mTAAR1 and hrChTAAR1 respectively",
    "simplified": "EC50 values for SMETH were 089 092 and 444 microM/O. For rTAAR1, mTAAR1 and hrChTAAR1 are used."
  },
  {
    "text": "The discovery that METH and AMPH activate the rTAAR1 motivated us to study the effect of these drugs on a human rat called hrChTAAR1 .",
    "triple_list": [
      [
        "METH",
        "CPR:3",
        "rTAAR1"
      ],
      [
        "AMPH",
        "CPR:3",
        "rTAAR1"
      ]
    ],
    "updated": "Yes",
    "original": "The discovery that METH and AMPH activate the rTAAR1 motivated us to study the effect of these drugs on the mouse TAAR1 mTAAR1 and a humanrat chimera hrChTAAR1",
    "simplified": "The discovery that METH and AMPH activate the rTAAR1 motivated us to study the effect of these drugs on a human rat called hrChTAAR1."
  },
  {
    "text": "In addition , the sisomers of METH and AMPH are reported to be more potent and effective in vivo than R. We determined the selectivity of all three species of TAAR1 .",
    "triple_list": [
      [
        "METH",
        "CPR:3",
        "TAAR1"
      ],
      [
        "AMPH",
        "CPR:3",
        "TAAR1"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore because Sisomers of METH and AMPH are reported to be more potent and efficacious in vivo than R we determined the enantiomeric selectivity of all three species of TAAR1",
    "simplified": "In addition, the sisomers of METH and AMPH are reported to be more potent and effective in vivo than R. We determined the selectivity of all three species of TAAR1."
  },
  {
    "text": "PEA was a potent and full agonist at each species of TAAR1 whereas TYR was a full agonist for the rodent TAAR1s but was a partial agonist at hrChTAAR1",
    "triple_list": [
      [
        "PEA",
        "CPR:5",
        "TAAR1"
      ],
      [
        "TYR",
        "CPR:5",
        "rodent TAAR1s"
      ],
      [
        "TYR",
        "CPR:5",
        "hrChTAAR1"
      ]
    ],
    "updated": "No",
    "original": "PEA was a potent and full agonist at each species of TAAR1 whereas TYR was a full agonist for the rodent TAAR1s but was a partial agonist at hrChTAAR1",
    "simplified": "The drug PEA is a potent and full agonist at each species of TAAR1. The drug TYR is a partial agonist at all species of TAAR1."
  },
  {
    "text": "Interestingly both isomers of METH were partial agonists at rTAAR1 but full agonists at mTAAR1 and hrChTAAR1 .",
    "triple_list": [
      [
        "METH",
        "CPR:5",
        "mTAAR1"
      ],
      [
        "METH",
        "CPR:5",
        "hrChTAAR1"
      ],
      [
        "METH",
        "CPR:5",
        "rTAAR1"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly both isomers of METH were full agonists at mTAAR1 and hrChTAAR1 whereas both were partial agonists at rTAAR1",
    "simplified": "Interestingly both isomers of METH were partial agonists at rTAAR1 but full agonists at mTAAR1 and hrChTAAR1."
  },
  {
    "text": "Finally we showed that chlorate activated endocrine cell development by inducing neurogenin 3 Neurog3 expression in early endocrine progenitor cells",
    "triple_list": [
      [
        "chlorate",
        "CPR:3",
        "neurogenin 3"
      ],
      [
        "chlorate",
        "CPR:3",
        "Neurog3"
      ]
    ],
    "updated": "No",
    "original": "Finally we showed that chlorate activated endocrine cell development by inducing neurogenin 3 Neurog3 expression in early endocrine progenitor cells",
    "simplified": "Finally, we showed that chlorate activated endocrine cell development in early endocrine progenitor cells by inducing neurogenin 3."
  },
  {
    "text": "The metallic taste reported as a side effect after the treatment with systemic sulfonamides may be due to the inhibition of the salivary CA VI",
    "triple_list": [
      [
        "sulfonamides",
        "CPR:4",
        "salivary CA VI"
      ]
    ],
    "updated": "No",
    "original": "The metallic taste reported as a side effect after the treatment with systemic sulfonamides may be due to the inhibition of the salivary CA VI",
    "simplified": "The metallic taste reported as a side effect after the treatment with sulfonamides may be because the salivary glands are not working properly."
  },
  {
    "text": "Some clinically used compounds such as acetazolamide methazolamide ethoxzolamide dichlorophenamide dorzolamide brinzolamide topiramate sulpiride and indisulam or the orphan drug benzolamide showed effective hCA VI inhibitory activity with inhibition constants of 0879 nM",
    "triple_list": [
      [
        "dichlorophenamide",
        "CPR:4",
        "hCA VI"
      ],
      [
        "acetazolamide",
        "CPR:4",
        "hCA VI"
      ],
      [
        "methazolamide",
        "CPR:4",
        "hCA VI"
      ],
      [
        "ethoxzolamide",
        "CPR:4",
        "hCA VI"
      ],
      [
        "dorzolamide",
        "CPR:4",
        "hCA VI"
      ],
      [
        "brinzolamide",
        "CPR:4",
        "hCA VI"
      ],
      [
        "topiramate",
        "CPR:4",
        "hCA VI"
      ],
      [
        "sulpiride",
        "CPR:4",
        "hCA VI"
      ],
      [
        "indisulam",
        "CPR:4",
        "hCA VI"
      ],
      [
        "benzolamide",
        "CPR:4",
        "hCA VI"
      ]
    ],
    "updated": "No",
    "original": "Some clinically used compounds such as acetazolamide methazolamide ethoxzolamide dichlorophenamide dorzolamide brinzolamide topiramate sulpiride and indisulam or the orphan drug benzolamide showed effective hCA VI inhibitory activity with inhibition constants of 0879 nM",
    "simplified": "For example, acetazolamide, methazolamide, ethoxzolamide, dorzolamide, brinzolamide, topiramate, indisulam, and benzolamide have been shown to inhibit the growth of bacteria. Benzolamide had an inhibition constant of 0879 nM."
  },
  {
    "text": "DNA cloning characterization and inhibition studies of the human secretory isoform VI a new target for sulfonamide and sulfamate inhibitors",
    "triple_list": [
      [
        "human secretory isoform VI",
        "CPR:4",
        "sulfonamide"
      ],
      [
        "human secretory isoform VI",
        "CPR:4",
        "sulfamate"
      ]
    ],
    "updated": "No",
    "original": "DNA cloning characterization and inhibition studies of the human secretory isoform VI a new target for sulfonamide and sulfamate inhibitors",
    "simplified": "Human secretory DNA cloning and inhibition studies: a new target for sulfonamide and sulfamate inhibitors."
  },
  {
    "text": "The best inhibitors were brinzolamide and sulpiride KI values of 0809 nM the latter compound being also a CA VI selective inhibitor",
    "triple_list": [
      [
        "brinzolamide",
        "CPR:4",
        "CA VI"
      ],
      [
        "sulpiride",
        "CPR:4",
        "CA VI"
      ]
    ],
    "updated": "No",
    "original": "The best inhibitors were brinzolamide and sulpiride KI values of 0809 nM the latter compound being also a CA VI selective inhibitor",
    "simplified": "The best inhibitors were brinzolamide and sulpiride. Brinzolamide had a KI of 0809, while sulpiride had a KI of 0809."
  },
  {
    "text": "Some of the compounds investigated in this study might be used as additives in toothpastes for reducing the acidification produced by the relevant CO2 hydrase activity of enamel CA VI which leads to the formation of protons and bicarbonate and may have a role in cariogenesis",
    "triple_list": [
      [
        "CO2",
        "CPR:9",
        "CA VI"
      ],
      [
        "CA VI",
        "CPR:9",
        "bicarbonate"
      ]
    ],
    "updated": "No",
    "original": "Some of the compounds investigated in this study might be used as additives in toothpastes for reducing the acidification produced by the relevant CO2 hydrase activity of enamel CA VI which leads to the formation of protons and bicarbonate and may have a role in cariogenesis",
    "simplified": "Some of the compounds investigated in this study might be used as additives in toothpastes for reducing the acidification produced by the relevant CO2 hydrase activity of enamel and may have a role in cariogenesis, the process by which life forms."
  },
  {
    "text": "The kinetic parameters for the CO2 hydration reaction proved hCA VI to be 49 x 107 M1 s1 at pH 75 and 20 degrees C/O . This is very high .",
    "triple_list": [
      [
        "CO2",
        "CPR:9",
        "hCA VI"
      ]
    ],
    "updated": "Yes",
    "original": "The kinetic parameters for the CO2 hydration reaction proved hCA VI to possess a kcat of 34 x 105 s1 and kcatKM of 49 x 107 M1 s1 at pH 75 and 20 degrees C",
    "simplified": "The kinetic parameters for the CO2 hydration reaction proved hCA VI to be 49 x 107 M1 s1 at pH 75 and 20 degrees C/O. This is very high."
  },
  {
    "text": "Transmembrane isoforms of adenylate cyclases AC integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate cAMP production in response to calcium entry",
    "triple_list": [
      [
        "adenylate cyclases",
        "CPR:9",
        "cAMP"
      ],
      [
        "AC",
        "CPR:9",
        "cAMP"
      ]
    ],
    "updated": "No",
    "original": "Transmembrane isoforms of adenylate cyclases AC integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate cAMP production in response to calcium entry",
    "simplified": "Transmembrane adenylate cyclases (ACs) are important for many things in life. They integrate many different signals from neurotransmitters to morphogens and can also make cAMP."
  },
  {
    "text": "Here we report that the antifibrotic drug 5methyl1phenyl21Hpyridone pirfenidone PFD reduces TGFbeta2 protein levels in human glioma cell lines and inhibits growth .",
    "triple_list": [
      [
        "5methyl1phenyl21Hpyridone",
        "CPR:4",
        "TGFbeta2"
      ],
      [
        "pirfenidone",
        "CPR:4",
        "TGFbeta2"
      ],
      [
        "PFD",
        "CPR:4",
        "TGFbeta2"
      ]
    ],
    "updated": "Yes",
    "original": "Here we report that the antifibrotic drug 5methyl1phenyl21Hpyridone pirfenidone PFD elicits growthinhibitory effects and reduces TGFbeta2 protein levels in human glioma cell lines",
    "simplified": "Here we report that the antifibrotic drug 5methyl1phenyl21Hpyridone pirfenidone PFD reduces TGFbeta2 protein levels in human glioma cell lines and inhibits growth."
  },
  {
    "text": "This reduction in TGFbeta 2 is biologically relevant since PFD treatment reduces the growth inhibition of TGFbeta sensitive CCL64 cells mediated by conditioned media of glioma cells",
    "triple_list": [
      [
        "TGFbeta",
        "CPR:4",
        "PFD"
      ]
    ],
    "updated": "No",
    "original": "This reduction in TGFbeta 2 is biologically relevant since PFD treatment reduces the growth inhibition of TGFbeta sensitive CCL64 cells mediated by conditioned media of glioma cells",
    "simplified": "This reduction in TGFbeta 2 is biologically relevant since the growth inhibition of TGFbeta sensitive CCL64 cells by conditioned media of glioma cells is reduced."
  },
  {
    "text": "PFD leads to a reduction of TGFbeta2 mRNA levels and of the mature TGFbeta2 protein due to decreased expression and direct inhibition of the TGFbeta proprotein convertase furin",
    "triple_list": [
      [
        "PFD",
        "CPR:4",
        "TGFbeta2"
      ],
      [
        "PFD",
        "CPR:4",
        "TGFbeta2"
      ],
      [
        "PFD",
        "CPR:4",
        "TGFbeta"
      ],
      [
        "PFD",
        "CPR:4",
        "proprotein convertase"
      ],
      [
        "PFD",
        "CPR:4",
        "furin"
      ]
    ],
    "updated": "No",
    "original": "PFD leads to a reduction of TGFbeta2 mRNA levels and of the mature TGFbeta2 protein due to decreased expression and direct inhibition of the TGFbeta proprotein convertase furin",
    "simplified": "PFD leads to a reduction of TGFbeta2 mRNA levels and of the mature TGFbeta2 protein. The mature TGFbeta2 protein is called furin and is a protein."
  },
  {
    "text": "In addition PFD reduces the protein levels of the matrix metalloproteinase MMP11 a TGFbeta target gene and furin substrate involved in carcinogenesis",
    "triple_list": [
      [
        "PFD",
        "CPR:4",
        "matrix metalloproteinase MMP11"
      ],
      [
        "PFD",
        "CPR:4",
        "TGFbeta"
      ]
    ],
    "updated": "No",
    "original": "In addition PFD reduces the protein levels of the matrix metalloproteinase MMP11 a TGFbeta target gene and furin substrate involved in carcinogenesis",
    "simplified": "In addition, PFD reduces the levels of the matrix metalloproteinase (MMP11) and furin, two proteins that are important for cancer."
  },
  {
    "text": "Pirfenidone inhibits TGFbeta expression in malignant glioma cells",
    "triple_list": [
      [
        "Pirfenidone",
        "CPR:4",
        "TGFbeta"
      ]
    ],
    "updated": "No",
    "original": "Pirfenidone inhibits TGFbeta expression in malignant glioma cells",
    "simplified": "Pirfenidone reduces TGF-beta production in breast cancer cells"
  },
  {
    "text": "UNLABELLED Bile acidcoenzyme Aamino acid Nacyltransferase BAAT is an enzyme in the body that helps to change bile acids into taurine and glycine .",
    "triple_list": [
      [
        "Bile acidcoenzyme Aamino acid Nacyltransferase",
        "CPR:9",
        "bile acids"
      ],
      [
        "BAAT",
        "CPR:9",
        "bile acids"
      ],
      [
        "Bile acidcoenzyme Aamino acid Nacyltransferase",
        "CPR:9",
        "taurine"
      ],
      [
        "BAAT",
        "CPR:9",
        "taurine"
      ],
      [
        "Bile acidcoenzyme Aamino acid Nacyltransferase",
        "CPR:9",
        "glycine"
      ],
      [
        "BAAT",
        "CPR:9",
        "glycine"
      ]
    ],
    "updated": "Yes",
    "original": "UNLABELLED Bile acidcoenzyme Aamino acid Nacyltransferase BAAT is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine",
    "simplified": "UNLABELLED Bile acidcoenzyme Aamino acid Nacyltransferase BAAT is an enzyme in the body that helps to change bile acids into taurine and glycine."
  },
  {
    "text": "The presence or absence of a BAAT pool in the cytosol has important implications for the intracellular transport of bile salts .",
    "triple_list": [
      [
        "BAAT",
        "CPR:9",
        "bile salts"
      ]
    ],
    "updated": "Yes",
    "original": "The absence or presence of a cytosolic pool of BAAT has important implications for the intracellular transport of unconjugateddeconjugated bile salts",
    "simplified": "The presence or absence of a BAAT pool in the cytosol has important implications for the intracellular transport of bile salts."
  },
  {
    "text": "The recombinant strains of the flavinogenic yeast Candida famata which contain the DNA fragment consisting of the FMN1 gene encoding the riboflavin kinase enzyme that converts riboflavin to flavinmononucleotide driven by the strong promoters the regulated RIB1 or constitutive TEF1 promoter were isolated",
    "triple_list": [
      [
        "riboflavin",
        "CPR:9",
        "riboflavin kinase"
      ],
      [
        "riboflavin kinase",
        "CPR:9",
        "flavinmononucleotide"
      ]
    ],
    "updated": "No",
    "original": "The recombinant strains of the flavinogenic yeast Candida famata which contain the DNA fragment consisting of the FMN1 gene encoding the riboflavin kinase enzyme that converts riboflavin to flavinmononucleotide driven by the strong promoters the regulated RIB1 or constitutive TEF1 promoter were isolated",
    "simplified": "The DNA of the flavinogenic yeast Candida famata contains a small part of the FMN1 gene. This gene is used to make riboflavin. When people put riboflavin into the yeast, it turns into a flavinmononucleotide, which the yeast then turns into a vitamin."
  },
  {
    "text": "Mouse ornithine decarboxylase ODC was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5phosphate and of the residues modified in the inactivation of the enzyme by the enzymeactivated irreversible inhibitor alphadifluoromethylornithine DFMO",
    "triple_list": [
      [
        "Mouse ornithine decarboxylase",
        "CPR:4",
        "alphadifluoromethylornithine"
      ],
      [
        "ODC",
        "CPR:4",
        "alphadifluoromethylornithine"
      ],
      [
        "Mouse ornithine decarboxylase",
        "CPR:4",
        "DFMO"
      ],
      [
        "ODC",
        "CPR:4",
        "DFMO"
      ]
    ],
    "updated": "No",
    "original": "Mouse ornithine decarboxylase ODC was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5phosphate and of the residues modified in the inactivation of the enzyme by the enzymeactivated irreversible inhibitor alphadifluoromethylornithine DFMO",
    "simplified": "Mouse ornithine decarboxylase ODC was expressed in Escherichia coli and the purified recombinant enzyme was used to determine the binding site for pyridoxal 5phosphate. Alphadifluoromethylornithine DFMO was used as an irreversible inhibitor to prevent the enzyme from working properly."
  },
  {
    "text": "Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alphadifluoromethylornithine",
    "triple_list": [
      [
        "mouse ornithine decarboxylase",
        "CPR:4",
        "alphadifluoromethylornithine"
      ]
    ],
    "updated": "No",
    "original": "Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alphadifluoromethylornithine",
    "simplified": "The irreversible inactivation of ornithine decarboxylase by alphadifluoromethylornithine in the mouse."
  },
  {
    "text": "Here we describe a new photolabile alanine derivative based on protection of alanine with the 4methoxy7nitroindolinyl MNI caging group which we use for presteadystate kinetic analysis of alanine transport by ASCT2 SNAT1 and SNAT2",
    "triple_list": [
      [
        "alanine",
        "CPR:9",
        "ASCT2"
      ],
      [
        "alanine",
        "CPR:9",
        "SNAT1"
      ],
      [
        "alanine",
        "CPR:9",
        "SNAT2"
      ],
      [
        "alanine",
        "CPR:9",
        "ASCT2"
      ],
      [
        "alanine",
        "CPR:9",
        "SNAT1"
      ],
      [
        "alanine",
        "CPR:9",
        "SNAT2"
      ],
      [
        "4methoxy7nitroindolinyl",
        "CPR:9",
        "ASCT2"
      ],
      [
        "4methoxy7nitroindolinyl",
        "CPR:9",
        "SNAT1"
      ],
      [
        "4methoxy7nitroindolinyl",
        "CPR:9",
        "SNAT2"
      ],
      [
        "MNI",
        "CPR:9",
        "ASCT2"
      ],
      [
        "MNI",
        "CPR:9",
        "SNAT1"
      ],
      [
        "MNI",
        "CPR:9",
        "SNAT2"
      ]
    ],
    "updated": "No",
    "original": "Here we describe a new photolabile alanine derivative based on protection of alanine with the 4methoxy7nitroindolinyl MNI caging group which we use for presteadystate kinetic analysis of alanine transport by ASCT2 SNAT1 and SNAT2",
    "simplified": "Here we describe a new photolabile alanine derivative based on protection of alanine with the 4methoxy7nitroindolinyl MNI caging group which we use to transport alanine to and from other parts of the body."
  },
  {
    "text": "NaDependent transmembrane transport of small neutral amino acids such as glutamine and alanine is mediated among others by the neutral amino acid transporters of the solute carrier 1 SLC1 alanine serine cysteine transporter 1 ASCT1 and ASCT2 and SLC38 families sodiumcoupled neutral amino acid transporter 1 SNAT1 SNAT2 and SNAT4",
    "triple_list": [
      [
        "amino acids",
        "CPR:9",
        "neutral amino acid transporters"
      ],
      [
        "amino acids",
        "CPR:9",
        "solute carrier 1"
      ],
      [
        "amino acids",
        "CPR:9",
        "SLC1"
      ],
      [
        "amino acids",
        "CPR:9",
        "alanine serine cysteine transporter 1"
      ],
      [
        "amino acids",
        "CPR:9",
        "ASCT1"
      ],
      [
        "amino acids",
        "CPR:9",
        "ASCT2"
      ],
      [
        "amino acids",
        "CPR:9",
        "SLC38"
      ],
      [
        "amino acids",
        "CPR:9",
        "sodiumcoupled neutral amino acid transporter 1"
      ],
      [
        "amino acids",
        "CPR:9",
        "SNAT1"
      ],
      [
        "amino acids",
        "CPR:9",
        "SNAT2"
      ],
      [
        "amino acids",
        "CPR:9",
        "SNAT4"
      ],
      [
        "glutamine",
        "CPR:9",
        "neutral amino acid transporters"
      ],
      [
        "glutamine",
        "CPR:9",
        "solute carrier 1"
      ],
      [
        "glutamine",
        "CPR:9",
        "SLC1"
      ],
      [
        "glutamine",
        "CPR:9",
        "alanine serine cysteine transporter 1"
      ],
      [
        "glutamine",
        "CPR:9",
        "ASCT1"
      ],
      [
        "glutamine",
        "CPR:9",
        "ASCT2"
      ],
      [
        "glutamine",
        "CPR:9",
        "SLC38"
      ],
      [
        "glutamine",
        "CPR:9",
        "sodiumcoupled neutral amino acid transporter 1"
      ],
      [
        "glutamine",
        "CPR:9",
        "SNAT1"
      ],
      [
        "glutamine",
        "CPR:9",
        "SNAT2"
      ],
      [
        "glutamine",
        "CPR:9",
        "SNAT4"
      ],
      [
        "alanine",
        "CPR:9",
        "neutral amino acid transporters"
      ],
      [
        "alanine",
        "CPR:9",
        "solute carrier 1"
      ],
      [
        "alanine",
        "CPR:9",
        "SLC1"
      ],
      [
        "alanine",
        "CPR:9",
        "alanine serine cysteine transporter 1"
      ],
      [
        "alanine",
        "CPR:9",
        "ASCT1"
      ],
      [
        "alanine",
        "CPR:9",
        "ASCT2"
      ],
      [
        "alanine",
        "CPR:9",
        "sodiumcoupled neutral amino acid transporter 1"
      ],
      [
        "alanine",
        "CPR:9",
        "SNAT1"
      ],
      [
        "alanine",
        "CPR:9",
        "SNAT2"
      ],
      [
        "alanine",
        "CPR:9",
        "SNAT4"
      ]
    ],
    "updated": "No",
    "original": "NaDependent transmembrane transport of small neutral amino acids such as glutamine and alanine is mediated among others by the neutral amino acid transporters of the solute carrier 1 SLC1 alanine serine cysteine transporter 1 ASCT1 and ASCT2 and SLC38 families sodiumcoupled neutral amino acid transporter 1 SNAT1 SNAT2 and SNAT4",
    "simplified": "NaDependent transmembrane transport of small neutral amino acids such as glutamine and alanine is done by the solute carrier 1 SLC1 alanine and the neutral amino acid transporters 1 ASCT1 and ASCT2 and SLC38 families sodiumcoupled neutral amino acid transporter 1 SNAT1 SNAT2 and SNAT4."
  },
  {
    "text": "Stimulated Pselectin and integrin alphaIIbbeta3 expression were also higher in the upper tertile both before and after aspirin",
    "triple_list": [
      [
        "Pselectin",
        "CPR:3",
        "aspirin"
      ],
      [
        "integrin alphaIIbbeta3",
        "CPR:3",
        "aspirin"
      ]
    ],
    "updated": "No",
    "original": "Stimulated Pselectin and integrin alphaIIbbeta3 expression were also higher in the upper tertile both before and after aspirin",
    "simplified": "Stimulated Pselectin expression was also higher in the upper tertile both before and after aspirin."
  },
  {
    "text": "ERalpha also protected the body from the effects of estrogen . Only the ERalpha agonist HPTE and not the ERbeta agonist DPN could stop dopamine cell loss .",
    "triple_list": [
      [
        "ERbeta",
        "CPR:5",
        "DPN"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover ERalpha mediated the protection afforded by estrogen since only the ERalpha agonist HPTE but not the ERbeta agonist DPN protected against dopamine cell loss",
    "simplified": "ERalpha also protected the body from the effects of estrogen. Only the ERalpha agonist HPTE and not the ERbeta agonist DPN could stop dopamine cell loss."
  },
  {
    "text": "At least 4 h of estrogen pretreatment was required to elicit protection an effect that was blocked by the ER antagonist ICI 182780",
    "triple_list": [
      [
        "ER",
        "CPR:6",
        "ICI 182780"
      ]
    ],
    "updated": "No",
    "original": "At least 4 h of estrogen pretreatment was required to elicit protection an effect that was blocked by the ER antagonist ICI 182780",
    "simplified": "At least 4 h of estrogen treatment was required to protect the cells, but this effect was blocked by the ER antagonist."
  },
  {
    "text": "Differential activation of cAMP response element binding protein in discrete nucleus accumbens subregions during early and late cocaine sensitization",
    "triple_list": [
      [
        "cAMP response element binding protein",
        "CPR:3",
        "cocaine"
      ]
    ],
    "updated": "No",
    "original": "Differential activation of cAMP response element binding protein in discrete nucleus accumbens subregions during early and late cocaine sensitization",
    "simplified": "CAMP response element binding protein in discrete nucleus accumbens subregions during early and late cocaine sensitization is activated."
  },
  {
    "text": "The time of day and location of CREB activity may indicate functional differences among NAc shell subregions . It may also show that CREB is involved in early and late cocaine effects .",
    "triple_list": [
      [
        "cocaine",
        "CPR:3",
        "CREB"
      ]
    ],
    "updated": "Yes",
    "original": "The temporal and anatomical determinants of cocaine induced CREB activity may indicate functional differences among NAc shell subregions and suggest the involvement of CREB in early and late cocaine effects",
    "simplified": "The time of day and location of CREB activity may indicate functional differences among NAc shell subregions. It may also show that CREB is involved in early and late cocaine effects."
  },
  {
    "text": "The present study examined the differential activation caused by cocaine to the cyclic adenosine monophosphate cAMP response element binding protein CREB in the nucleus accumbens NAc in rats .",
    "triple_list": [
      [
        "cocaine",
        "CPR:3",
        "CREB"
      ],
      [
        "cocaine",
        "CPR:3",
        "cyclic adenosine monophosphate cAMP response element binding protein"
      ]
    ],
    "updated": "Yes",
    "original": "The present study examined the differential cocaine induced activation of the cyclic adenosine monophosphate cAMP response element binding protein CREB throughout discrete zones of analysis of the nucleus accumbens NAc in rats",
    "simplified": "The present study examined the differential activation caused by cocaine to the cyclic adenosine monophosphate cAMP response element binding protein CREB in the nucleus accumbens NAc in rats."
  },
  {
    "text": "Using immunohistochemistry the authors analyzed changes in CREB phosphorylation in the NAc after 5 days of cocaine a short or long drugfree period and a subsequent challenge injection",
    "triple_list": [
      [
        "CREB",
        "CPR:3",
        "cocaine"
      ]
    ],
    "updated": "No",
    "original": "Using immunohistochemistry the authors analyzed changes in CREB phosphorylation in the NAc after 5 days of cocaine a short or long drugfree period and a subsequent challenge injection",
    "simplified": "The authors used immunohistochemistry to find out what happened to the NAc after 5 days of cocaine. They also gave people a short or long drugfree period."
  },
  {
    "text": "Repeated cocaine caused CREB to increase in all subregions of the NAc except the most ventrolateral region of the shell 2 weeks after it was stopped . After 2 drugfree days , repeated cocaine did not cause CREB to increase , but it did cause it to increase in the 3 most dorsomedial zones of the shell .",
    "triple_list": [
      [
        "cocaine",
        "CPR:3",
        "CREB"
      ],
      [
        "cocaine",
        "CPR:3",
        "CREB"
      ]
    ],
    "updated": "Yes",
    "original": "Repeated cocaine resulted in CREB phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated cocaine but rats challenged after 2 drugfree days yielded a more localized activation of CREB in the 3 most dorsomedial zones of the shell",
    "simplified": "Repeated cocaine caused CREB to increase in all subregions of the NAc except the most ventrolateral region of the shell 2 weeks after it was stopped. After 2 drugfree days, repeated cocaine did not cause CREB to increase, but it did cause it to increase in the 3 most dorsomedial zones of the shell."
  },
  {
    "text": "The carboxylation of glutamic acid residues to gammacarboxyglutamic acid Gla by the vitamin Kdependent gammaglutamyl carboxylase gammacarboxylase is an essential posttranslational modification that is required for the biological activity of a number of proteins . The function of gammaglutamyl carboxylase is to convert glutamic acid to gammacarboxyglutamic acid .",
    "triple_list": [
      [
        "glutamic acid",
        "CPR:9",
        "vitamin Kdependent gammaglutamyl carboxylase"
      ],
      [
        "glutamic acid",
        "CPR:9",
        "gammacarboxylase"
      ],
      [
        "gammacarboxyglutamic acid",
        "CPR:9",
        "vitamin Kdependent gammaglutamyl carboxylase"
      ],
      [
        "gammacarboxyglutamic acid",
        "CPR:9",
        "gammacarboxylase"
      ],
      [
        "Gla",
        "CPR:9",
        "vitamin Kdependent gammaglutamyl carboxylase"
      ],
      [
        "Gla",
        "CPR:9",
        "gammacarboxylase"
      ]
    ],
    "updated": "Yes",
    "original": "The carboxylation of glutamic acid residues to gammacarboxyglutamic acid Gla by the vitamin Kdependent gammaglutamyl carboxylase gammacarboxylase is an essential posttranslational modification required for the biological activity of a number of proteins including proteins involved in blood coagulation and its regulation",
    "simplified": "The carboxylation of glutamic acid residues to gammacarboxyglutamic acid Gla by the vitamin Kdependent gammaglutamyl carboxylase gammacarboxylase is an essential posttranslational modification that is required for the biological activity of a number of proteins. The function of gammaglutamyl carboxylase is to convert glutamic acid to gammacarboxyglutamic acid."
  },
  {
    "text": "RAMH inhibition of cholangiocyte growth was associated with decreased cAMP levels and PKA ERK12 Elk1 phosphorylation",
    "triple_list": [
      [
        "RAMH",
        "CPR:4",
        "PKA"
      ],
      [
        "RAMH",
        "CPR:4",
        "ERK12"
      ],
      [
        "RAMH",
        "CPR:4",
        "Elk1"
      ]
    ],
    "updated": "No",
    "original": "RAMH inhibition of cholangiocyte growth was associated with decreased cAMP levels and PKA ERK12 Elk1 phosphorylation",
    "simplified": "RAMH inhibition of cholangiocyte growth was associated with increased levels of the transcription factor ERK."
  },
  {
    "text": "2 Does in vivo administration of Ralphamethylhistamine dihydrobromide RAMH H3R agonist thioperamide maleate H3R antagonist or histamine in the absencepresence of thioperamide maleate to bile duct ligated BDL rats regulate cholangiocyte proliferation",
    "triple_list": [
      [
        "Ralphamethylhistamine dihydrobromide",
        "CPR:5",
        "H3R"
      ],
      [
        "RAMH",
        "CPR:5",
        "H3R"
      ],
      [
        "H3R",
        "CPR:6",
        "thioperamide maleate"
      ]
    ],
    "updated": "No",
    "original": "2 Does in vivo administration of Ralphamethylhistamine dihydrobromide RAMH H3R agonist thioperamide maleate H3R antagonist or histamine in the absencepresence of thioperamide maleate to bile duct ligated BDL rats regulate cholangiocyte proliferation",
    "simplified": "2 Does in vivo administration of Ralphamethylhistamine dihydrobromide to BDL rats in the absence of thioperamide maleate H3R antagonist or histamine to bile duct ligated BDL rats regulate cholangiocyte proliferation"
  },
  {
    "text": "Proline dehydrogenase PRODH and Delta1pyrroline5carboxylate dehydrogenase P5CDH catalyze the twostep oxidation of proline to glutamate",
    "triple_list": [
      [
        "Proline dehydrogenase",
        "CPR:9",
        "proline"
      ],
      [
        "PRODH",
        "CPR:9",
        "proline"
      ],
      [
        "Delta1pyrroline5carboxylate dehydrogenase",
        "CPR:9",
        "proline"
      ],
      [
        "P5CDH",
        "CPR:9",
        "proline"
      ],
      [
        "Proline dehydrogenase",
        "CPR:9",
        "glutamate"
      ],
      [
        "PRODH",
        "CPR:9",
        "glutamate"
      ],
      [
        "Delta1pyrroline5carboxylate dehydrogenase",
        "CPR:9",
        "glutamate"
      ],
      [
        "P5CDH",
        "CPR:9",
        "glutamate"
      ]
    ],
    "updated": "No",
    "original": "Proline dehydrogenase PRODH and Delta1pyrroline5carboxylate dehydrogenase P5CDH catalyze the twostep oxidation of proline to glutamate",
    "simplified": "Proline dehydrogenase (PRODH) and Delta1pyrroline5carboxylate dehydrogenase (P5CDH) are enzymes that make proline."
  },
  {
    "text": "T thermophilus PRODH has been shown to react with O2 to make superoxide .",
    "triple_list": [
      [
        "T thermophilus PRODH",
        "CPR:9",
        "O2"
      ],
      [
        "T thermophilus PRODH",
        "CPR:9",
        "superoxide"
      ]
    ],
    "updated": "Yes",
    "original": "Finally we demonstrate that T thermophilus PRODH reacts with O2 producing superoxide",
    "simplified": "T thermophilus PRODH has been shown to react with O2 to make superoxide."
  },
  {
    "text": "This is important because superoxide production underlies the role of human PRODH in p53mediated apoptosis . This means that eukaryotic and bacterial PRODHs are similar .",
    "triple_list": [
      [
        "superoxide",
        "CPR:9",
        "human PRODH"
      ]
    ],
    "updated": "Yes",
    "original": "This is significant because superoxide production underlies the role of human PRODH in p53mediated apoptosis implying commonalities between eukaryotic and bacterial monofunctional PRODHs",
    "simplified": "This is important because superoxide production underlies the role of human PRODH in p53mediated apoptosis. This means that eukaryotic and bacterial PRODHs are similar."
  },
  {
    "text": "Results of early clinical trials with both topically cipamfylline CP80633 and systemically CC10004 active PDE4 inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC10004 also in psoriasis",
    "triple_list": [
      [
        "cipamfylline",
        "CPR:4",
        "PDE4"
      ],
      [
        "CP80633",
        "CPR:4",
        "PDE4"
      ]
    ],
    "updated": "No",
    "original": "Results of early clinical trials with both topically cipamfylline CP80633 and systemically CC10004 active PDE4 inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC10004 also in psoriasis",
    "simplified": "Early clinical trials with both topically-taken cipamfylline and systemically-taken CC10004 have shown good results. CC10004 has shown good results in atopic dermatitis and psoriasis."
  },
  {
    "text": "Consequently PDE4 inhibitors including cilomilast and AWD 12281 have been tested in several models of allergic and irritant skin inflammation",
    "triple_list": [
      [
        "PDE4",
        "CPR:4",
        "cilomilast"
      ],
      [
        "PDE4",
        "CPR:4",
        "AWD 12281"
      ]
    ],
    "updated": "No",
    "original": "Consequently PDE4 inhibitors including cilomilast and AWD 12281 have been tested in several models of allergic and irritant skin inflammation",
    "simplified": "Cilomilast and AWD 12281 have been tested in several models of allergic and irritant skin inflammation and did not work."
  },
  {
    "text": "The phosphodiesterase PDE 4 is the predominant cyclic AMP degrading enzyme in a variety of inflammatory cells including eosinophils neutrophils macrophages T cells and monocytes",
    "triple_list": [
      [
        "phosphodiesterase PDE 4",
        "CPR:9",
        "cyclic AMP"
      ]
    ],
    "updated": "No",
    "original": "The phosphodiesterase PDE 4 is the predominant cyclic AMP degrading enzyme in a variety of inflammatory cells including eosinophils neutrophils macrophages T cells and monocytes",
    "simplified": "Phosphodiesterase PDE 4 is an enzyme. It is a cyclic AMP degrading enzyme. It is found in many types of cells including T cells, monocytes and eosinophils."
  },
  {
    "text": "Although there are many different types , most C2 domains are activated by Ca2 and then dock to a specific cell membrane .",
    "triple_list": [
      [
        "C2 domains",
        "CPR:3",
        "Ca2"
      ]
    ],
    "updated": "Yes",
    "original": "Although considerable functional diversity exists most C2 domains are activated by Ca2 binding and then dock to a specific cellular membrane",
    "simplified": "Although there are many different types, most C2 domains are activated by Ca2 and then dock to a specific cell membrane."
  },
  {
    "text": "Bile acid coenzyme Aamino acid Nacyltransferase BAT is responsible for the amidation of bile acids with the amino acids glycine and taurine",
    "triple_list": [
      [
        "Bile acid coenzyme Aamino acid Nacyltransferase",
        "CPR:9",
        "bile acids"
      ],
      [
        "BAT",
        "CPR:9",
        "bile acids"
      ]
    ],
    "updated": "No",
    "original": "Bile acid coenzyme Aamino acid Nacyltransferase BAT is responsible for the amidation of bile acids with the amino acids glycine and taurine",
    "simplified": "Bile acid coenzyme Aamino acid Nacyltransferase BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT BAT"
  },
  {
    "text": "Asparagine secretion by MSCs was directly related to their ASNS expression levels . This suggests that the protective effects of asparagine in the leukemic cell microenvironment are directly related to ASNS levels .",
    "triple_list": [
      [
        "Asparagine",
        "CPR:9",
        "ASNS"
      ]
    ],
    "updated": "Yes",
    "original": "Asparagine secretion by MSCs was directly related to their ASNS expression levels suggesting a mechanism increased concentrations of asparagine in the leukemic cell microenvironment for the protective effects we observed",
    "simplified": "Asparagine secretion by MSCs was directly related to their ASNS expression levels. This suggests that the protective effects of asparagine in the leukemic cell microenvironment are directly related to ASNS levels."
  },
  {
    "text": "Because of their low asparagine synthetase ASNS expression and asparagine biosynthesis , acute lymphoblastic leukemia cells are very sensitive to lack of asparagine .",
    "triple_list": [
      [
        "asparagine",
        "CPR:9",
        "ASNS"
      ],
      [
        "asparagine",
        "CPR:9",
        "asparagine synthetase"
      ]
    ],
    "updated": "Yes",
    "original": "Because of their low asparagine synthetase ASNS expression and asparagine biosynthesis acute lymphoblastic leukemia ALL cells are exquisitely sensitive to asparagine depletion",
    "simplified": "Because of their low asparagine synthetase ASNS expression and asparagine biosynthesis, acute lymphoblastic leukemia cells are very sensitive to lack of asparagine."
  },
  {
    "text": "MK801 5methyl1011dihydro5Hdibenzoadcyclohepten510imine maleate a non-competitive NMDA receptor antagonist was used in the study of male pattern baldness .",
    "triple_list": [
      [
        "MK801",
        "CPR:6",
        "NMDA receptor"
      ],
      [
        "5methyl1011dihydro5Hdibenzoadcyclohepten510imine maleate",
        "CPR:6",
        "NMDA receptor"
      ]
    ],
    "updated": "Yes",
    "original": "MK801 5methyl1011dihydro5Hdibenzoadcyclohepten510imine maleate a noncompetitive NMDA receptor antagonist partially prevented the decrease in cell viability and the energy impairment",
    "simplified": "MK801 5methyl1011dihydro5Hdibenzoadcyclohepten510imine maleate a non-competitive NMDA receptor antagonist was used in the study of male pattern baldness."
  },
  {
    "text": "The parallel pattern of accumulation of 246n3 and DHA in response to increasing concentrations of ALA suggests that 245n3 and ALA are competing to get the same amount of D6D in the cell .",
    "triple_list": [
      [
        "DHA",
        "CPR:9",
        "D6D"
      ],
      [
        "ALA",
        "CPR:9",
        "D6D"
      ]
    ],
    "updated": "Yes",
    "original": "The parallel pattern of accumulation of 246n3 and DHA in response to increasing concentrations of ALA suggests that the competition between 245n3 and ALA for D6D may contribute to the limited accumulation of DHA in cell membranes",
    "simplified": "The parallel pattern of accumulation of 246n3 and DHA in response to increasing concentrations of ALA suggests that 245n3 and ALA are competing to get the same amount of D6D in the cell."
  },
  {
    "text": "The use of Delta 6 desaturase D6D twice in the conversion of alphalinolenic acid ALA 183n3 to docosahexaenoic acid DHA 226n3 suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA The amount of DHA and ALA in the blood and the amount of DHA and ALA in the blood are very important for human health .",
    "triple_list": [
      [
        "Delta 6 desaturase",
        "CPR:9",
        "DHA"
      ],
      [
        "D6D",
        "CPR:9",
        "DHA"
      ],
      [
        "Delta 6 desaturase",
        "CPR:9",
        "ALA"
      ],
      [
        "D6D",
        "CPR:9",
        "ALA"
      ],
      [
        "Delta 6 desaturase",
        "CPR:9",
        "alphalinolenic acid"
      ],
      [
        "D6D",
        "CPR:9",
        "alphalinolenic acid"
      ],
      [
        "Delta 6 desaturase",
        "CPR:9",
        "ALA"
      ],
      [
        "D6D",
        "CPR:9",
        "ALA"
      ],
      [
        "Delta 6 desaturase",
        "CPR:9",
        "docosahexaenoic acid"
      ],
      [
        "D6D",
        "CPR:9",
        "docosahexaenoic acid"
      ],
      [
        "Delta 6 desaturase",
        "CPR:9",
        "DHA"
      ],
      [
        "D6D",
        "CPR:9",
        "DHA"
      ]
    ],
    "updated": "Yes",
    "original": "The use of Delta 6 desaturase D6D twice in the conversion of alphalinolenic acid ALA 183n3 to docosahexaenoic acid DHA 226n3 suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA We examined this using an in vitro model of fatty acid metabolism to measure the accumulation of the longchain metabolites of ALA in HepG2 cell phospholipids",
    "simplified": "The use of Delta 6 desaturase D6D twice in the conversion of alphalinolenic acid ALA 183n3 to docosahexaenoic acid DHA 226n3 suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA The amount of DHA and ALA in the blood and the amount of DHA and ALA in the blood are very important for human health."
  },
  {
    "text": "The accumulation of the post D6D products of 225n3 246n3 and DHA in cell phospholipids was saturated at concentrations of 18 microM ALA The level of DHA in cell phospholipids was significantly greater compared with the accumulation of DHA from ALA , indicating that the accumulation of DHA from ALA was not limited by incorporation .",
    "triple_list": [
      [
        "D6D",
        "CPR:9",
        "DHA"
      ]
    ],
    "updated": "Yes",
    "original": "The accumulation of the post D6D products of 225n3 246n3 and DHA in cell phospholipids was saturated at concentrations of 18 microM ALA Supplementation of HepG2 cells with preformed DHA revealed that although the accumulation of DHA in cell phospholipids approached saturation the level of DHA in cell phospholipids was significantly greater compared with the accumulation of DHA from ALA indicating that the accumulation of DHA from ALA was not limited by incorporation",
    "simplified": "The accumulation of the post D6D products of 225n3 246n3 and DHA in cell phospholipids was saturated at concentrations of 18 microM ALA The level of DHA in cell phospholipids was significantly greater compared with the accumulation of DHA from ALA, indicating that the accumulation of DHA from ALA was not limited by incorporation."
  },
  {
    "text": "Dopamine D1 receptor agonist and D2 receptor antagonist effects of stepholidine Stepholidine is a natural drug .",
    "triple_list": [
      [
        "Dopamine D1 receptor",
        "CPR:5",
        "stepholidine"
      ],
      [
        "D2 receptor",
        "CPR:6",
        "stepholidine"
      ]
    ],
    "updated": "Yes",
    "original": "Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product stepholidine molecular modeling and dynamics simulations",
    "simplified": "Dopamine D1 receptor agonist and D2 receptor antagonist effects of stepholidine Stepholidine is a natural drug."
  },
  {
    "text": "Stepholidine SPD an active ingredient of the Chinese herb Stephania is the first compound found to have dual function as a dopamine receptor D1 agonist and D2 antagonist",
    "triple_list": [
      [
        "Stepholidine",
        "CPR:5",
        "dopamine receptor D1"
      ],
      [
        "SPD",
        "CPR:5",
        "dopamine receptor D1"
      ],
      [
        "Stepholidine",
        "CPR:6",
        "D2"
      ],
      [
        "SPD",
        "CPR:6",
        "D2"
      ]
    ],
    "updated": "No",
    "original": "Stepholidine SPD an active ingredient of the Chinese herb Stephania is the first compound found to have dual function as a dopamine receptor D1 agonist and D2 antagonist",
    "simplified": "Stepholidine SPD an active ingredient of the Chinese herb Stephania is the first drug to both work as a D1 agonist and an antagonist at the D2 receptor."
  },
  {
    "text": "The Ki for inosine 5monophosphate and nicotinamide adenine dinucleotide did not change significantly . The Ki for mycophenolic acid inhibition of the L263F variant was comparable with the wildtype .",
    "triple_list": [
      [
        "mycophenolic acid",
        "CPR:4",
        "L263F"
      ]
    ],
    "updated": "Yes",
    "original": "The Ki for mycophenolic acid inhibition of the L263F variant was comparable with the wildtype and the variant Km for inosine 5monophosphate and nicotinamide adenine dinucleotide did not change significantly",
    "simplified": "The Ki for inosine 5monophosphate and nicotinamide adenine dinucleotide did not change significantly. The Ki for mycophenolic acid inhibition of the L263F variant was comparable with the wildtype."
  },
  {
    "text": "Ovariectomy downregulates glutaredoxin and renders female mice vulnerable to LBOAA toxicity as evidenced by activation of AP1 loss of GSH and complex I activity indicating the important role of glutaredoxin in neuroprotection",
    "triple_list": [
      [
        "LBOAA",
        "CPR:3",
        "AP1"
      ],
      [
        "LBOAA",
        "CPR:3",
        "complex I"
      ]
    ],
    "updated": "No",
    "original": "Ovariectomy downregulates glutaredoxin and renders female mice vulnerable to LBOAA toxicity as evidenced by activation of AP1 loss of GSH and complex I activity indicating the important role of glutaredoxin in neuroprotection",
    "simplified": "Ovariectomy downregulates glutaredoxin and makes female mice vulnerable to LBOAA toxicity. Complex I activity is activated by the loss of GSH and this shows the important role of glutaredoxin in neuroprotection."
  },
  {
    "text": "Estrogen protects against excitotoxicity by maintaining cellular redox status through higher expression of glutaredoxin in the central nervous system .",
    "triple_list": [
      [
        "Estrogen",
        "CPR:3",
        "glutaredoxin"
      ]
    ],
    "updated": "Yes",
    "original": "Estrogen protects against mitochondrial dysfunction caused by excitotoxicity by maintaining cellular redox status through higher constitutive expression of glutaredoxin in the CNS",
    "simplified": "Estrogen protects against excitotoxicity by maintaining cellular redox status through higher expression of glutaredoxin in the central nervous system."
  },
  {
    "text": "LBOAA causes loss of GSH and inhibition of mitochondrial complex I in lumbosacral cord of male mice through oxidation of thiol groups while female mice are resistant",
    "triple_list": [
      [
        "LBOAA",
        "CPR:4",
        "mitochondrial complex I"
      ]
    ],
    "updated": "No",
    "original": "LBOAA causes loss of GSH and inhibition of mitochondrial complex I in lumbosacral cord of male mice through oxidation of thiol groups while female mice are resistant",
    "simplified": "LBOAA causes loss of GSH and inhibition of mitochondrial function in male mice. It does this by oxidation of thiol groups in male mice."
  },
  {
    "text": "Female mice express higher levels of glutaredoxin in certain CNS regions and downregulation of glutaredoxin using antisense oligonucleotides sensitizes them to LBOAA toxicity seen as mitochondrial complex I loss",
    "triple_list": [
      [
        "LBOAA",
        "CPR:4",
        "mitochondrial complex I"
      ]
    ],
    "updated": "No",
    "original": "Female mice express higher levels of glutaredoxin in certain CNS regions and downregulation of glutaredoxin using antisense oligonucleotides sensitizes them to LBOAA toxicity seen as mitochondrial complex I loss",
    "simplified": "Female mice have higher levels of glutaredoxin in certain areas of the brain. When antisense oligonucleotides are used, they reduce the level of glutaredoxin in the brain."
  },
  {
    "text": "We have expressed VIAAT and the plasmalemmal transporters for glycine and GABA in a neuroendocrine cell line and measured the quantal release of glycine and GABA using a novel doublesniffer patchclamp technique",
    "triple_list": [
      [
        "VIAAT",
        "CPR:9",
        "GABA"
      ],
      [
        "plasmalemmal transporters",
        "CPR:9",
        "GABA"
      ],
      [
        "VIAAT",
        "CPR:9",
        "glycine"
      ],
      [
        "plasmalemmal transporters",
        "CPR:9",
        "glycine"
      ]
    ],
    "updated": "No",
    "original": "We have expressed VIAAT and the plasmalemmal transporters for glycine and GABA in a neuroendocrine cell line and measured the quantal release of glycine and GABA using a novel doublesniffer patchclamp technique",
    "simplified": "We have expressed VIAAT in a neuroendocrine cell line and measured the quantal release of glycine and GABA using a novel doublesniffer patchclamp technique in a cell line."
  },
  {
    "text": "We found that glycine is released from vesicles when VIAAT is co-expressed with GlyT2 or when GlyT1 is present in the vesicles .",
    "triple_list": [
      [
        "glycine",
        "CPR:9",
        "VIAAT"
      ]
    ],
    "updated": "Yes",
    "original": "We found that glycine is released from vesicles when VIAAT is coexpressed with either the neuronal transporter GlyT2 or the glial transporter GlyT1",
    "simplified": "We found that glycine is released from vesicles when VIAAT is co-expressed with GlyT2 or when GlyT1 is present in the vesicles."
  },
  {
    "text": "However GlyT2 was more effective than GlyT1 probably because GlyT2 is unable to operate in the reverse mode which gives it an advantage in maintaining the high cytosolic glycine concentration required for efficient vesicular loading by VIAAT",
    "triple_list": [
      [
        "glycine",
        "CPR:9",
        "VIAAT"
      ]
    ],
    "updated": "No",
    "original": "However GlyT2 was more effective than GlyT1 probably because GlyT2 is unable to operate in the reverse mode which gives it an advantage in maintaining the high cytosolic glycine concentration required for efficient vesicular loading by VIAAT",
    "simplified": "However GlyT2 was more effective than GlyT1 probably because GlyT2 can not work in the reverse mode, GlyT2 can not make as much glycine in the blood but it can make more in the outside of the body."
  },
  {
    "text": "The vesicular inhibitory phenotype was gradually changed from glycinergic to GABAergic . At some point , GABA was introduced into the secretory cell by a chemical called VIAAT .",
    "triple_list": [
      [
        "GABA",
        "CPR:9",
        "VIAAT"
      ]
    ],
    "updated": "Yes",
    "original": "The vesicular inhibitory phenotype was gradually altered from glycinergic to GABAergic through mixed events when GABA is introduced into the secretory cell and competes for uptake by VIAAT",
    "simplified": "The vesicular inhibitory phenotype was gradually changed from glycinergic to GABAergic. At some point, GABA was introduced into the secretory cell by a chemical called VIAAT."
  },
  {
    "text": "Interestingly the VIAAT ortholog from Caenorhabditis elegans UNC47 a species lacking glycine transmission also supports glycine exocytosis in the presence of GlyT2 and a point mutation in UNC47 does not allow glycine to move from one place to another .",
    "triple_list": [
      [
        "glycine",
        "CPR:9",
        "GlyT2"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly the VIAAT ortholog from Caenorhabditis elegans UNC47 a species lacking glycine transmission also supports glycine exocytosis in the presence of GlyT2 and a point mutation of UNC47 that abolishes GABA transmission in the worm confers glycine specificity",
    "simplified": "Interestingly the VIAAT ortholog from Caenorhabditis elegans UNC47 a species lacking glycine transmission also supports glycine exocytosis in the presence of GlyT2 and a point mutation in UNC47 does not allow glycine to move from one place to another."
  },
  {
    "text": "Together these results suggest that an increased availability of glycine in VIAAT containing terminals was necessary for vertebrates to be able to carry out glycinergic function .",
    "triple_list": [
      [
        "glycine",
        "CPR:9",
        "VIAAT"
      ]
    ],
    "updated": "Yes",
    "original": "Together these results suggest that an increased cytosolic availability of glycine in VIAAT containing terminals was crucial for the emergence of glycinergic transmission in vertebrates",
    "simplified": "Together these results suggest that an increased availability of glycine in VIAAT containing terminals was necessary for vertebrates to be able to carry out glycinergic function."
  },
  {
    "text": "The reason is that the two main inhibitory transmitters glycine and GABA share the same vesicular inhibitory amino acid transporter VIAAT and are both present in neurons during postnatal development , so it is possible that they influence the vesicular phenotype .",
    "triple_list": [
      [
        "glycine",
        "CPR:9",
        "vesicular inhibitory amino acid transporter"
      ],
      [
        "glycine",
        "CPR:9",
        "VIAAT"
      ],
      [
        "GABA",
        "CPR:9",
        "vesicular inhibitory amino acid transporter"
      ],
      [
        "GABA",
        "CPR:9",
        "VIAAT"
      ]
    ],
    "updated": "Yes",
    "original": "The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters glycine and GABA share the same vesicular inhibitory amino acid transporter VIAAT and are both present in neurons during postnatal development",
    "simplified": "The reason is that the two main inhibitory transmitters glycine and GABA share the same vesicular inhibitory amino acid transporter VIAAT and are both present in neurons during postnatal development, so it is possible that they influence the vesicular phenotype."
  },
  {
    "text": "Na Cl dipole couples agonist binding to kainate receptor activation",
    "triple_list": [
      [
        "Na",
        "CPR:3",
        "kainate receptor"
      ],
      [
        "Cl",
        "CPR:3",
        "kainate receptor"
      ]
    ],
    "updated": "No",
    "original": "Na Cl dipole couples agonist binding to kainate receptor activation",
    "simplified": "Na Cl + binds to kainate receptors, making them work."
  },
  {
    "text": "Kainateselective ionotropic glutamate receptors GluRs require external Na and Cl as well as the neurotransmitter Lglutamate for activation",
    "triple_list": [
      [
        "Kainateselective ionotropic glutamate receptors",
        "CPR:3",
        "Lglutamate"
      ],
      [
        "GluRs",
        "CPR:3",
        "Lglutamate"
      ],
      [
        "Kainateselective ionotropic glutamate receptors",
        "CPR:3",
        "Na"
      ],
      [
        "GluRs",
        "CPR:3",
        "Na"
      ],
      [
        "Kainateselective ionotropic glutamate receptors",
        "CPR:3",
        "Cl"
      ],
      [
        "GluRs",
        "CPR:3",
        "Cl"
      ]
    ],
    "updated": "No",
    "original": "Kainateselective ionotropic glutamate receptors GluRs require external Na and Cl as well as the neurotransmitter Lglutamate for activation",
    "simplified": "GluRs need external Na and Cl to work. They also need the neurotransmitter Lglutamate to work properly."
  },
  {
    "text": "Na and Cl ions coactivate GluR6 receptors . This is because they have the same effect on KARs and GluR6 .",
    "triple_list": [
      [
        "Na",
        "CPR:3",
        "GluR6"
      ],
      [
        "Cl",
        "CPR:3",
        "GluR6"
      ]
    ],
    "updated": "Yes",
    "original": "Additionally Na and Cl ions coactivate GluR6 receptors by establishing a dipole accounting for their common effect on KARs",
    "simplified": "Na and Cl ions coactivate GluR6 receptors. This is because they have the same effect on KARs and GluR6."
  },
  {
    "text": "Phenserine seems to reduce the ability of APP mRNA to be translated into protein . This process may be affected by iron and/or iron-responsive elements .",
    "triple_list": [
      [
        "Phenserine",
        "CPR:4",
        "APP"
      ]
    ],
    "updated": "Yes",
    "original": "Phenserine apparently reduces translational efficiency of APP mRNA into protein a process that may involve an interaction with iron andor an ironresponsive element",
    "simplified": "Phenserine seems to reduce the ability of APP mRNA to be translated into protein. This process may be affected by iron and/or iron-responsive elements."
  },
  {
    "text": "As a consequence phenserine reduces betaamyloid peptide Abeta formation in vitro and in vivo",
    "triple_list": [
      [
        "phenserine",
        "CPR:4",
        "betaamyloid"
      ],
      [
        "phenserine",
        "CPR:4",
        "Abeta"
      ]
    ],
    "updated": "No",
    "original": "As a consequence phenserine reduces betaamyloid peptide Abeta formation in vitro and in vivo",
    "simplified": "As a consequence phenserine reduces the build-up of beta-amyloid in the body."
  },
  {
    "text": "Phenserine , a derivative of physostigmine , was first described as an inhibitor of acetylcholinesterase AChE . It was shown to improve cognitive function in animals .",
    "triple_list": [
      [
        "Phenserine",
        "CPR:4",
        "AChE"
      ],
      [
        "Phenserine",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "physostigmine",
        "CPR:4",
        "AChE"
      ],
      [
        "physostigmine",
        "CPR:4",
        "acetylcholinesterase"
      ]
    ],
    "updated": "Yes",
    "original": "Phenserine a derivative of physostigmine was first described as an inhibitor of acetylcholinesterase AChE and was shown to improve cognition in various experimental paradigms in rodents and dogs",
    "simplified": "Phenserine, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase AChE. It was shown to improve cognitive function in animals."
  },
  {
    "text": "Phenserine is also unique because of the different actions of its two different enantiomers . phenserine is the active enantiomer for AChE , but phenserine posiphen can be used as an AChE inhibitor as well .",
    "triple_list": [
      [
        "phenserine",
        "CPR:4",
        "AChE"
      ],
      [
        "phenserine",
        "CPR:4",
        "AChE"
      ],
      [
        "AChE",
        "CPR:4",
        "posiphen"
      ]
    ],
    "updated": "Yes",
    "original": "Phenserine is also unique because of differing actions of its enantiomers phenserine is the active enantiomer for inhibition of AChE whereas phenserine posiphen has weak activity as an AChE inhibitor and can be dosed much higher",
    "simplified": "Phenserine is also unique because of the different actions of its two different enantiomers. phenserine is the active enantiomer for AChE, but phenserine posiphen can be used as an AChE inhibitor as well."
  },
  {
    "text": "Phenserine has an additional quality of action in addition to inhibiting AChE . In neuronal cell culture , it reduces the amount of betaamyloid precursor protein APP by reducing APP translation .",
    "triple_list": [
      [
        "Phenserine",
        "CPR:4",
        "AChE"
      ],
      [
        "Phenserine",
        "CPR:4",
        "APP"
      ]
    ],
    "updated": "Yes",
    "original": "Phenserine deserves attention for an additional quality of action in addition to inhibiting AChE it modulates the amount of betaamyloid precursor protein APP in neuronal cell culture by reducing APP translation",
    "simplified": "Phenserine has an additional quality of action in addition to inhibiting AChE. In neuronal cell culture, it reduces the amount of betaamyloid precursor protein APP by reducing APP translation."
  },
  {
    "text": "Additional pharmacological effects evoked by AICAR and phenformin on I ouabain have important consequences for their use as pharmacological activators of AMPK in cell systems where NaKATPase is an important component . The effects of AICAR and phenformin on I ouabain include :",
    "triple_list": [
      [
        "AICAR",
        "CPR:3",
        "AMPK"
      ],
      [
        "phenformin",
        "CPR:3",
        "AMPK"
      ],
      [
        "ouabain",
        "CPR:3",
        "AMPK"
      ]
    ],
    "updated": "Yes",
    "original": "Additional pharmacological effects evoked by AICAR and phenformin on I ouabain with potential secondary effects on apical Na conductance ENaC activity and monolayer resistance have important consequences for their use as pharmacological activators of AMPK in cell systems where NaKATPase is an important component",
    "simplified": "Additional pharmacological effects evoked by AICAR and phenformin on I ouabain have important consequences for their use as pharmacological activators of AMPK in cell systems where NaKATPase is an important component. The effects of AICAR and phenformin on I ouabain include:"
  },
  {
    "text": "BACKGROUND AND PURPOSE AMPactivated protein kinase AMPK is activated by metformin phenformin and the AMP mimetic 5aminoimidazole4carboxamide1betaDribofuranoside AICAR",
    "triple_list": [
      [
        "AMPactivated protein kinase",
        "CPR:3",
        "AICAR"
      ],
      [
        "AMPK",
        "CPR:3",
        "AICAR"
      ],
      [
        "AMPactivated protein kinase",
        "CPR:3",
        "metformin"
      ],
      [
        "AMPK",
        "CPR:3",
        "metformin"
      ],
      [
        "AMPactivated protein kinase",
        "CPR:3",
        "phenformin"
      ],
      [
        "AMPK",
        "CPR:3",
        "phenformin"
      ],
      [
        "AMPactivated protein kinase",
        "CPR:3",
        "5aminoimidazole4carboxamide1betaDribofuranoside"
      ],
      [
        "AMPK",
        "CPR:3",
        "5aminoimidazole4carboxamide1betaDribofuranoside"
      ]
    ],
    "updated": "No",
    "original": "BACKGROUND AND PURPOSE AMPactivated protein kinase AMPK is activated by metformin phenformin and the AMP mimetic 5aminoimidazole4carboxamide1betaDribofuranoside AICAR",
    "simplified": "AMPactivated protein kinase AMPK is activated by metformin phenformin. The AMP mimetic 5aminoimidazole4carboxamide1beta is released by the body."
  },
  {
    "text": "KEY RESULTS Phenformin AICAR and metformin increased AMPK alpha1 activity and decreased Iamiloride",
    "triple_list": [
      [
        "Phenformin",
        "CPR:3",
        "AMPK alpha1"
      ],
      [
        "AICAR",
        "CPR:3",
        "AMPK alpha1"
      ],
      [
        "metformin",
        "CPR:3",
        "AMPK alpha1"
      ]
    ],
    "updated": "No",
    "original": "KEY RESULTS Phenformin AICAR and metformin increased AMPK alpha1 activity and decreased Iamiloride",
    "simplified": "Phenformin and metformin increased the activity of AMPK alpha1 but decreased Iamiloride."
  },
  {
    "text": "The AMPK inhibitor Compound C stopped phenformin and other drugs from working .",
    "triple_list": [
      [
        "AMPK",
        "CPR:3",
        "phenformin"
      ]
    ],
    "updated": "Yes",
    "original": "The AMPK inhibitor Compound C prevented the action of metformin and AICAR but not phenformin",
    "simplified": "The AMPK inhibitor Compound C stopped phenformin and other drugs from working."
  },
  {
    "text": "Compared with a normal control group , PTZ kindled mice had higher levels of glutathione in the whole brain homogenate but lower levels of malondialdehyde nitrite myeloperoxidase .",
    "triple_list": [
      [
        "PTZ",
        "CPR:3",
        "myeloperoxidase"
      ]
    ],
    "updated": "Yes",
    "original": "Compared with normal control group PTZ kindled mice had significantly higher levels of malondialdehyde nitrite myeloperoxidase but had lower levels of reduced glutathione in the whole brain homogenate",
    "simplified": "Compared with a normal control group, PTZ kindled mice had higher levels of glutathione in the whole brain homogenate but lower levels of malondialdehyde nitrite myeloperoxidase."
  },
  {
    "text": "Previous studies have explored the protective effect of naproxen nonselective COX inhibitor or rofecoxib selective COX 2 inhibitor against chemical kindling in mice",
    "triple_list": [
      [
        "naproxen",
        "CPR:4",
        "COX"
      ]
    ],
    "updated": "No",
    "original": "Previous studies have explored the protective effect of naproxen nonselective COX inhibitor or rofecoxib selective COX 2 inhibitor against chemical kindling in mice",
    "simplified": "Previous studies have shown that rofecoxib (a nonselective COX 2 inhibitor) protects against certain types of fire in mice."
  },
  {
    "text": "The present study was designed to explore the possible effect of nimesulide a preferential COX2 inhibitor against pentylenetetrazol-induced kindling epilepsy in mice .",
    "triple_list": [
      [
        "nimesulide",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "With this background the present study was designed to explore the possible effect of nimesulide a preferential COX2 inhibitor against pentylenetetrazol PTZinduced kindling epilepsy in mice",
    "simplified": "The present study was designed to explore the possible effect of nimesulide a preferential COX2 inhibitor against pentylenetetrazol-induced kindling epilepsy in mice."
  },
  {
    "text": "Neuroprotective effect of nimesulide a preferential COX2 inhibitor against pentylenetetrazol PTZinduced chemical kindling and associated biochemical parameters in mice",
    "triple_list": [
      [
        "nimesulide",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "Neuroprotective effect of nimesulide a preferential COX2 inhibitor against pentylenetetrazol PTZinduced chemical kindling and associated biochemical parameters in mice",
    "simplified": "Nimesulide a preferential COX2 inhibitor against pentylenetetrazol PTZinduced chemical kindling and associated biochemical parameters in human and animal models"
  },
  {
    "text": "These results suggested that nimesulide a preferential COX2 inhibitor offered neuroprotection against PTZinduced kindling in mice",
    "triple_list": [
      [
        "nimesulide",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "These results suggested that nimesulide a preferential COX2 inhibitor offered neuroprotection against PTZinduced kindling in mice",
    "simplified": "These results suggested that nimesulide could protect the brain against this damage in mice."
  },
  {
    "text": "Brain cyclooxygenases COX the ratelimiting enzyme in prostaglandin synthesis is turned off when the brain is in a seizure .",
    "triple_list": [
      [
        "COX",
        "CPR:9",
        "prostaglandin"
      ],
      [
        "cyclooxygenases",
        "CPR:9",
        "prostaglandin"
      ]
    ],
    "updated": "Yes",
    "original": "Brain cyclooxygenases COX the ratelimiting enzyme in prostaglandin synthesis is rapidly and transiently induced by convulsions in hippocampal and cortical neurons",
    "simplified": "Brain cyclooxygenases COX the ratelimiting enzyme in prostaglandin synthesis is turned off when the brain is in a seizure."
  },
  {
    "text": "While vitamin C is essential for PHD activity in vitro NacetylLcysteine had no effect and gallic acid or npropyl gallate efficiently inhibited the activity of all three PHDs demonstrating different functions of these antioxidants",
    "triple_list": [
      [
        "gallic acid",
        "CPR:4",
        "PHDs"
      ],
      [
        "npropyl gallate",
        "CPR:4",
        "PHDs"
      ]
    ],
    "updated": "No",
    "original": "While vitamin C is essential for PHD activity in vitro NacetylLcysteine had no effect and gallic acid or npropyl gallate efficiently inhibited the activity of all three PHDs demonstrating different functions of these antioxidants",
    "simplified": "While vitamin C is essential for PHD activity in vitro NacetylLcysteine had no effect and gallic acid or npropyl gallate did not work at all. Different types of gallate work in different ways."
  },
  {
    "text": "LTC4 synthase LTC4S is an enzyme in the liver . It makes LTC4 .",
    "triple_list": [
      [
        "LTC4",
        "CPR:9",
        "LTC4 synthase"
      ],
      [
        "LTC4",
        "CPR:9",
        "LTC4S"
      ]
    ],
    "updated": "Yes",
    "original": "LTC4 synthase LTC4S the pivotal enzyme for the biosynthesis of LTC4 ref",
    "simplified": "LTC4 synthase LTC4S is an enzyme in the liver. It makes LTC4."
  },
  {
    "text": "10 is an 18kDa integral nuclear membrane protein that belongs to a superfamily of membraneassociated proteins in eicosanoid and glutathione metabolism that includes 5lipoxygenaseactivating protein microsomal glutathione Stransferases MGSTs and microsomal prostaglandin E synthase 1 ref",
    "triple_list": [
      [
        "eicosanoid",
        "CPR:9",
        "microsomal glutathione Stransferases"
      ],
      [
        "eicosanoid",
        "CPR:9",
        "MGSTs"
      ],
      [
        "eicosanoid",
        "CPR:9",
        "microsomal prostaglandin E synthase 1"
      ],
      [
        "glutathione",
        "CPR:9",
        "microsomal glutathione Stransferases"
      ],
      [
        "glutathione",
        "CPR:9",
        "MGSTs"
      ],
      [
        "glutathione",
        "CPR:9",
        "microsomal prostaglandin E synthase 1"
      ]
    ],
    "updated": "No",
    "original": "10 is an 18kDa integral nuclear membrane protein that belongs to a superfamily of membraneassociated proteins in eicosanoid and glutathione metabolism that includes 5lipoxygenaseactivating protein microsomal glutathione Stransferases MGSTs and microsomal prostaglandin E synthase 1 ref",
    "simplified": "10 is an 18kDa integral nuclear membrane protein that belongs to a superfamily of proteins that are involved in eicosanoid and glutathione metabolism. This superfamily includes microsomal glutathione Stransferases and microsomal prostaglandin E synthase 1 ref."
  },
  {
    "text": "Phenelzine PLZ a nonselective irreversible inhibitor of monoamine oxidase MAO also inhibits GABAtransaminase GABAT markedly increasing brain GABA levels",
    "triple_list": [
      [
        "Phenelzine",
        "CPR:4",
        "GABAT"
      ],
      [
        "Phenelzine",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "Phenelzine",
        "CPR:4",
        "MAO"
      ],
      [
        "Phenelzine",
        "CPR:4",
        "GABAtransaminase"
      ],
      [
        "PLZ",
        "CPR:4",
        "GABAT"
      ],
      [
        "PLZ",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "PLZ",
        "CPR:4",
        "MAO"
      ],
      [
        "PLZ",
        "CPR:4",
        "GABAtransaminase"
      ]
    ],
    "updated": "No",
    "original": "Phenelzine PLZ a nonselective irreversible inhibitor of monoamine oxidase MAO also inhibits GABAtransaminase GABAT markedly increasing brain GABA levels",
    "simplified": "Phenelzine PLZ a nonselective irreversible inhibitor of monoamine oxidase MAO also inhibits GABAT in the human brain."
  },
  {
    "text": "To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the increase in brain ORN , animals were pretreated with vehicle or PLZ 15 mgkg and brains collected 3 h later . The MAO inhibitor tranylcypromine TCP was used .",
    "triple_list": [
      [
        "MAO",
        "CPR:4",
        "tranylcypromine"
      ],
      [
        "MAO",
        "CPR:4",
        "TCP"
      ]
    ],
    "updated": "Yes",
    "original": "To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the elevation in brain ORN observed animals were pretreated with vehicle or the MAO inhibitor tranylcypromine TCP before vehicle or PLZ 15 mgkg and brains collected 3 h later",
    "simplified": "To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the increase in brain ORN, animals were pretreated with vehicle or PLZ 15 mgkg and brains collected 3 h later. The MAO inhibitor tranylcypromine TCP was used."
  },
  {
    "text": "Phenelzine causes an increase in ornithine in the brain . Before , monoamine oxidase could not do this .",
    "triple_list": [
      [
        "Phenelzine",
        "CPR:4",
        "monoamine oxidase"
      ]
    ],
    "updated": "Yes",
    "original": "Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition",
    "simplified": "Phenelzine causes an increase in ornithine in the brain. Before, monoamine oxidase could not do this."
  },
  {
    "text": "ORN levels measured by an HPLC procedure were dose and timedependently increased in PLZtreated animals with levels reaching approximately 650 of control at 6 and 12 h Pretreatment with TCP completely abolished the PLZinduced increase in brain ORN suggesting as with GABA that a metabolite of PLZ formed by the action of MAO is responsible for the elevation of brain ORN observed",
    "triple_list": [
      [
        "PLZ",
        "CPR:9",
        "MAO"
      ]
    ],
    "updated": "No",
    "original": "ORN levels measured by an HPLC procedure were dose and timedependently increased in PLZtreated animals with levels reaching approximately 650 of control at 6 and 12 h Pretreatment with TCP completely abolished the PLZinduced increase in brain ORN suggesting as with GABA that a metabolite of PLZ formed by the action of MAO is responsible for the elevation of brain ORN observed",
    "simplified": "ORN levels measured by an HPLC procedure were dose and timedependently increased in PLZtreated animals with levels reaching approximately 650 of control at 6 and 12 h Pretreatment with TCP completely abolished the PLZinduced increase in brain ORN suggesting that MAO is responsible for the increase in brain ORN seen in PLZtreated animals."
  },
  {
    "text": "PLZ is also a substrate for MAO and studies suggest that the action of this enzyme on PLZ may increase the amount of GABA in the blood .",
    "triple_list": [
      [
        "PLZ",
        "CPR:9",
        "MAO"
      ]
    ],
    "updated": "Yes",
    "original": "PLZ is also a substrate for MAO and studies suggest that a metabolite formed by the action of this enzyme on PLZ may be responsible for the increase in GABA observed",
    "simplified": "PLZ is also a substrate for MAO and studies suggest that the action of this enzyme on PLZ may increase the amount of GABA in the blood."
  },
  {
    "text": "AlphamethylDLaspartate an inhibitor of argininosuccinate synthase AS a component of the citrullineNO cycle As further support alphamethylDLaspartate inhibited NO production .",
    "triple_list": [
      [
        "alphamethylDLaspartate",
        "CPR:4",
        "argininosuccinate synthase"
      ],
      [
        "alphamethylDLaspartate",
        "CPR:4",
        "AS"
      ]
    ],
    "updated": "Yes",
    "original": "As further support alphamethylDLaspartate an inhibitor of argininosuccinate synthase AS a component of the citrullineNO cycle inhibited NO production in a dosedependent manner",
    "simplified": "AlphamethylDLaspartate an inhibitor of argininosuccinate synthase AS a component of the citrullineNO cycle As further support alphamethylDLaspartate inhibited NO production."
  },
  {
    "text": "Nitric oxide NO is an important vasorelaxant produced along with Lcitrulline from Larginine in a reaction catalyzed by endothelial nitric oxide synthase eNOS",
    "triple_list": [
      [
        "NO",
        "CPR:9",
        "endothelial nitric oxide synthase"
      ],
      [
        "NO",
        "CPR:9",
        "eNOS"
      ],
      [
        "Nitric oxide",
        "CPR:9",
        "endothelial nitric oxide synthase"
      ],
      [
        "Nitric oxide",
        "CPR:9",
        "eNOS"
      ],
      [
        "Lcitrulline",
        "CPR:9",
        "endothelial nitric oxide synthase"
      ],
      [
        "Lcitrulline",
        "CPR:9",
        "eNOS"
      ],
      [
        "Larginine",
        "CPR:9",
        "endothelial nitric oxide synthase"
      ],
      [
        "Larginine",
        "CPR:9",
        "eNOS"
      ]
    ],
    "updated": "No",
    "original": "Nitric oxide NO is an important vasorelaxant produced along with Lcitrulline from Larginine in a reaction catalyzed by endothelial nitric oxide synthase eNOS",
    "simplified": "Nitric oxide is an important vasorelaxant. It is made when nitric oxide is taken from the blood by an enzyme called nitric oxide synthase."
  },
  {
    "text": "Caution is necessary only when it is coadministered with drugs that have CYP2D6 in them , such as metoprolol , or when the patient is very old or has renal problems .",
    "triple_list": [
      [
        "CYP2D6",
        "CPR:9",
        "metoprolol"
      ]
    ],
    "updated": "Yes",
    "original": "Caution is necessary only when it is coadministered with drugs metabolised by CYP2D6 such as metoprolol or administered to the elderly or patients with severe hepatic or renal impairment",
    "simplified": "Caution is necessary only when it is coadministered with drugs that have CYP2D6 in them, such as metoprolol, or when the patient is very old or has renal problems."
  },
  {
    "text": "AZD6140 is a reversible oral P2Y12 receptor antagonist that has been studied in ACS patients in comparison with clopidogrel DISPERSE2 study",
    "triple_list": [
      [
        "AZD6140",
        "CPR:6",
        "P2Y12"
      ],
      [
        "P2Y12",
        "CPR:6",
        "clopidogrel"
      ]
    ],
    "updated": "No",
    "original": "AZD6140 is a reversible oral P2Y12 receptor antagonist that has been studied in ACS patients in comparison with clopidogrel DISPERSE2 study",
    "simplified": "AZD6140 is a reversible oral P2Y12 receptor antagonist that has been studied in patients with acute myeloid leukemia."
  },
  {
    "text": "Inhibition of platelet aggregation by AZD6140 a reversible oral P2Y12 receptor antagonist compared with clopidogrel in patients with acute coronary syndromes",
    "triple_list": [
      [
        "P2Y12",
        "CPR:6",
        "clopidogrel"
      ],
      [
        "AZD6140",
        "CPR:6",
        "P2Y12"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of platelet aggregation by AZD6140 a reversible oral P2Y12 receptor antagonist compared with clopidogrel in patients with acute coronary syndromes",
    "simplified": "Inhibition of platelet aggregation by a reversible oral P2Y12 receptor antagonist compared with clopidogrel in patients with severe heart failure"
  },
  {
    "text": "Oxybutynin 1 is a nonselective muscarinic receptor antagonist . This means that it does not work at all .",
    "triple_list": [
      [
        "Oxybutynin",
        "CPR:6",
        "muscarinic receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Oxybutynin 1 is a nonselective muscarinic receptor antagonist that is used clinically for the treatment of urinary incontinence",
    "simplified": "Oxybutynin 1 is a nonselective muscarinic receptor antagonist. This means that it does not work at all."
  },
  {
    "text": "Administration of cevimeline hydrochloride an M3 muscarinic receptor agonist 10 mgkg for 7 days po but not pilocarpine 03 mgkg for 7 days po recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one",
    "triple_list": [
      [
        "cevimeline hydrochloride",
        "CPR:3",
        "AQP5"
      ],
      [
        "cevimeline hydrochloride",
        "CPR:3",
        "AQP1"
      ],
      [
        "cevimeline hydrochloride",
        "CPR:5",
        "M3 muscarinic receptor"
      ]
    ],
    "updated": "No",
    "original": "Administration of cevimeline hydrochloride an M3 muscarinic receptor agonist 10 mgkg for 7 days po but not pilocarpine 03 mgkg for 7 days po recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one",
    "simplified": "Administration of pilocarpine 10 mgkg for 7 days but not cevimeline hydrochloride 10 mgkg for 7 days recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one."
  },
  {
    "text": "Administration of chloroquine 50 mgkg for 7 days po a denaturant of lysosomes increased the AQP5 protein level reduced by CTD",
    "triple_list": [
      [
        "chloroquine",
        "CPR:3",
        "AQP5"
      ]
    ],
    "updated": "No",
    "original": "Administration of chloroquine 50 mgkg for 7 days po a denaturant of lysosomes increased the AQP5 protein level reduced by CTD",
    "simplified": "Administration of chloroquine 50 mgkg for 7 days reduced the level of Helicobacter pylori by 30%."
  },
  {
    "text": "Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by cevimeline an M3 muscarinic receptor agonist",
    "triple_list": [
      [
        "AQP5",
        "CPR:3",
        "cevimeline"
      ],
      [
        "cevimeline",
        "CPR:5",
        "M3 muscarinic receptor"
      ]
    ],
    "updated": "No",
    "original": "Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by cevimeline an M3 muscarinic receptor agonist",
    "simplified": "Submandibular gland AQP5 degrades by parasympathetic denervation of chorda tympani and its recovery by cevimeline (see below)"
  },
  {
    "text": "threomethylphenidate inhibits the dopamine transporter and the norepinephrine transporter resulting in elevations of these monoamines after impulse release",
    "triple_list": [
      [
        "threomethylphenidate",
        "CPR:4",
        "dopamine transporter"
      ],
      [
        "threomethylphenidate",
        "CPR:4",
        "norepinephrine transporter"
      ],
      [
        "dopamine transporter",
        "CPR:9",
        "monoamines"
      ],
      [
        "norepinephrine transporter",
        "CPR:9",
        "monoamines"
      ]
    ],
    "updated": "No",
    "original": "threomethylphenidate inhibits the dopamine transporter and the norepinephrine transporter resulting in elevations of these monoamines after impulse release",
    "simplified": "Threomethylphenidate inhibits the transport of norepinephrine and dopamine to and from the nucleus accumbens in the brain."
  },
  {
    "text": "The direct inhibition of stathmin by CCNU is probably also important .",
    "triple_list": [
      [
        "stathmin",
        "CPR:4",
        "CCNU"
      ]
    ],
    "updated": "Yes",
    "original": "The direct inhibition of stathmin by CCNU is likely a contributing factor",
    "simplified": "The direct inhibition of stathmin by CCNU is probably also important."
  },
  {
    "text": "Amiodarone analogues with better cytotoxicity and hERG channel inhibition than the parent compound have been identified . These compounds demonstrate that cytotoxicity and hERG channel interaction are mechanistically distinct and separable properties of the compounds",
    "triple_list": [
      [
        "Amiodarone",
        "CPR:4",
        "hERG"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS AND IMPLICATIONS Amiodarone analogues with better hERG channel inhibition and cytotoxicity profiles than the parent compound have been identified demonstrating that cytotoxicity and hERG channel interaction are mechanistically distinct and separable properties of the compounds",
    "simplified": "Amiodarone analogues with better cytotoxicity and hERG channel inhibition than the parent compound have been identified. These compounds demonstrate that cytotoxicity and hERG channel interaction are mechanistically distinct and separable properties of the compounds"
  },
  {
    "text": "The main aim of the study was to find amiodarone analogues . The human etheragogorelated protein hERG channel was inhibited by the amiodarone .",
    "triple_list": [
      [
        "amiodarone",
        "CPR:4",
        "human etheragogorelated protein hERG channel"
      ]
    ],
    "updated": "Yes",
    "original": "The principal aim of the study was to find amiodarone analogues that retained human etheragogorelated protein hERG channel inhibition but with reduced cytotoxicity",
    "simplified": "The main aim of the study was to find amiodarone analogues. The human etheragogorelated protein hERG channel was inhibited by the amiodarone."
  },
  {
    "text": "In addition to OT and to a lesser extent AVP pitressin a number of OT and AVP analogues such as carbetocin OT agonist dDAVP desmopressin V2 agonist terlipressin V1a agonist felypressin V1a agonist and atosiban Tractocile OT antagonist are also in clinical use",
    "triple_list": [
      [
        "OT",
        "CPR:5",
        "carbetocin"
      ],
      [
        "desmopressin",
        "CPR:5",
        "V2"
      ],
      [
        "terlipressin",
        "CPR:5",
        "V1a"
      ],
      [
        "V1a",
        "CPR:5",
        "felypressin"
      ],
      [
        "OT",
        "CPR:6",
        "atosiban"
      ],
      [
        "OT",
        "CPR:6",
        "Tractocile"
      ]
    ],
    "updated": "No",
    "original": "In addition to OT and to a lesser extent AVP pitressin a number of OT and AVP analogues such as carbetocin OT agonist dDAVP desmopressin V2 agonist terlipressin V1a agonist felypressin V1a agonist and atosiban Tractocile OT antagonist are also in clinical use",
    "simplified": "A number of OT and AVP analogues such as carbetocin OT agonist, desmopressin V2 agonist, felypressin V1a agonist, and atosiban Tractocile OT antagonist are also in clinical use, but they are less effective than OT and AVP."
  },
  {
    "text": "While a number of orally active nonpeptide V2 antagonists Vaptans notably Tolvaptan Lixivaptan and Satavaptan are currently in Phase III clinical trials to date only the mixed V2 V1a antagonist Conivaptan Vaprisol has been approved by the US FDA for clinical use by iv",
    "triple_list": [
      [
        "V2",
        "CPR:6",
        "Tolvaptan"
      ],
      [
        "V2",
        "CPR:6",
        "Lixivaptan"
      ],
      [
        "V2",
        "CPR:6",
        "Satavaptan"
      ],
      [
        "V2",
        "CPR:6",
        "Conivaptan"
      ],
      [
        "V1a",
        "CPR:6",
        "Conivaptan"
      ],
      [
        "V2",
        "CPR:6",
        "Vaprisol"
      ],
      [
        "V1a",
        "CPR:6",
        "Vaprisol"
      ]
    ],
    "updated": "No",
    "original": "While a number of orally active nonpeptide V2 antagonists Vaptans notably Tolvaptan Lixivaptan and Satavaptan are currently in Phase III clinical trials to date only the mixed V2 V1a antagonist Conivaptan Vaprisol has been approved by the US FDA for clinical use by iv",
    "simplified": "A number of orally active nonpeptide V2 antagonists have been approved for clinical use by the U.S. Food and Drug Administration (FDA). These include Tolvaptan, Lixivaptan, Satavaptan, and Conivaptan."
  },
  {
    "text": "Absorbable drugs fibric acids nicotinic acid probucol HMGCoA reductase inhibitors reduce plasma verylowdensity lipoproteins VLDL andor lowdensity lipoproteins LDL by a variety of mechanisms",
    "triple_list": [
      [
        "fibric acids",
        "CPR:4",
        "plasma verylowdensity lipoproteins"
      ],
      [
        "fibric acids",
        "CPR:4",
        "VLDL"
      ],
      [
        "fibric acids",
        "CPR:4",
        "lowdensity lipoproteins"
      ],
      [
        "fibric acids",
        "CPR:4",
        "LDL"
      ],
      [
        "nicotinic acid",
        "CPR:4",
        "plasma verylowdensity lipoproteins"
      ],
      [
        "nicotinic acid",
        "CPR:4",
        "VLDL"
      ],
      [
        "nicotinic acid",
        "CPR:4",
        "lowdensity lipoproteins"
      ],
      [
        "nicotinic acid",
        "CPR:4",
        "LDL"
      ],
      [
        "probucol",
        "CPR:4",
        "plasma verylowdensity lipoproteins"
      ],
      [
        "probucol",
        "CPR:4",
        "VLDL"
      ],
      [
        "probucol",
        "CPR:4",
        "lowdensity lipoproteins"
      ],
      [
        "probucol",
        "CPR:4",
        "LDL"
      ]
    ],
    "updated": "No",
    "original": "Absorbable drugs fibric acids nicotinic acid probucol HMGCoA reductase inhibitors reduce plasma verylowdensity lipoproteins VLDL andor lowdensity lipoproteins LDL by a variety of mechanisms",
    "simplified": "Absorbable drugs fibric acids nicotinic acid probucol HMGCoA reductase inhibitors reduce low-density lipoproteins in the blood by several different ways"
  },
  {
    "text": "Fibric acids , in particular , stimulate the catabolism of VLDL . As a result , LDL is less likely to break down at the receptors .",
    "triple_list": [
      [
        "Fibric acids",
        "CPR:4",
        "VLDL"
      ]
    ],
    "updated": "Yes",
    "original": "Fibric acids in particular act by stimulating the catabolism of VLDL and also as a consequence improving LDL delipidation thus favoring receptor uptake",
    "simplified": "Fibric acids, in particular, stimulate the catabolism of VLDL. As a result, LDL is less likely to break down at the receptors."
  },
  {
    "text": "accelerating reverse transport of cholesteryl esters from highdensity lipoproteins to lowerdensity lipoproteins",
    "triple_list": [
      [
        "cholesteryl esters",
        "CPR:9",
        "highdensity lipoproteins"
      ],
      [
        "cholesteryl esters",
        "CPR:9",
        "lowerdensity lipoproteins"
      ]
    ],
    "updated": "No",
    "original": "accelerating reverse transport of cholesteryl esters from highdensity lipoproteins to lowerdensity lipoproteins",
    "simplified": "The reverse transport of cholesteryl esters from low-density lipoproteins to high-density lipoproteins"
  },
  {
    "text": "CONCLUSIONS Lapatinib is a dual inhibitor of the EGFR and HER2 tyrosine kinases",
    "triple_list": [
      [
        "Lapatinib",
        "CPR:4",
        "EGFR"
      ],
      [
        "Lapatinib",
        "CPR:4",
        "HER2"
      ],
      [
        "Lapatinib",
        "CPR:4",
        "tyrosine kinases"
      ]
    ],
    "updated": "No",
    "original": "CONCLUSIONS Lapatinib is a dual inhibitor of the EGFR and HER2 tyrosine kinases",
    "simplified": "Lapatinib is an anti-EGFR and anti-HER2 tyrosine kinase drug."
  },
  {
    "text": "Lapatinib a dual inhibitor of human epidermal growth factor receptor tyrosine kinases",
    "triple_list": [
      [
        "Lapatinib",
        "CPR:4",
        "human epidermal growth factor receptor"
      ],
      [
        "Lapatinib",
        "CPR:4",
        "tyrosine kinases"
      ]
    ],
    "updated": "No",
    "original": "Lapatinib a dual inhibitor of human epidermal growth factor receptor tyrosine kinases",
    "simplified": "Lapatinib, a human epidermal growth factor receptor tyrosine kinase inhibitor"
  },
  {
    "text": "Lapatinib the first dual inhibitor of human epidermal growth factor receptor 2 ( EGFR ) and human epidermal growth factor receptor 2 ( HER2 ) tyrosine kinases was approved by the United States FDA in 2007",
    "triple_list": [
      [
        "Lapatinib",
        "CPR:4",
        "HER2"
      ],
      [
        "Lapatinib",
        "CPR:4",
        "tyrosine kinases"
      ],
      [
        "Lapatinib",
        "CPR:4",
        "epidermal growth factor receptor"
      ],
      [
        "Lapatinib",
        "CPR:4",
        "EGFR"
      ],
      [
        "Lapatinib",
        "CPR:4",
        "human epidermal growth factor receptor 2"
      ]
    ],
    "updated": "Yes",
    "original": "BACKGROUND Lapatinib the first dual inhibitor of epidermal growth factor receptor EGFR and human epidermal growth factor receptor 2 HER2 tyrosine kinases was approved by the US Food and Drug Administration FDA in 2007",
    "simplified": "Lapatinib the first dual inhibitor of human epidermal growth factor receptor 2 (EGFR) and human epidermal growth factor receptor 2 (HER2) tyrosine kinases was approved by the United States FDA in 2007"
  },
  {
    "text": "Lapatinib is metabolized by the cytochrome P450 3A4 isozyme . Only one part of the drug is active against EGFR .",
    "triple_list": [
      [
        "Lapatinib",
        "CPR:9",
        "cytochrome P450 3A4"
      ]
    ],
    "updated": "Yes",
    "original": "Lapatinib is metabolized primarily by the cytochrome P450 3A4 isozyme with 1 metabolite remaining active against EGFR but not HER2",
    "simplified": "Lapatinib is metabolized by the cytochrome P450 3A4 isozyme. Only one part of the drug is active against EGFR."
  },
  {
    "text": "Phenelzine is a more potent monoamine oxidase inhibitor than is N2acetylphenelzine",
    "triple_list": [
      [
        "monoamine oxidase",
        "CPR:4",
        "N2acetylphenelzine"
      ],
      [
        "Phenelzine",
        "CPR:4",
        "monoamine oxidase"
      ]
    ],
    "updated": "No",
    "original": "Phenelzine is a more potent monoamine oxidase inhibitor than is N2acetylphenelzine",
    "simplified": "Phenelzine is a chemical compound. It is an inhibitor of monoamine oxidase."
  },
  {
    "text": "Acetylation of phenelzine at the N2 position presumably interferes with the inhibition of the transaminase enzymes for gammaaminobutyric acid and alanine",
    "triple_list": [
      [
        "phenelzine",
        "CPR:4",
        "transaminase"
      ],
      [
        "N2",
        "CPR:4",
        "transaminase"
      ],
      [
        "transaminase",
        "CPR:4",
        "gammaaminobutyric acid"
      ],
      [
        "transaminase",
        "CPR:4",
        "alanine"
      ]
    ],
    "updated": "No",
    "original": "Acetylation of phenelzine at the N2 position presumably interferes with the inhibition of the transaminase enzymes for gammaaminobutyric acid and alanine",
    "simplified": "Phenelzine is made at the N2 position. This is probably because it stops the transaminase enzymes from making gammaaminobutyric acid and alanine."
  },
  {
    "text": "Quinpirole and 7OHDPAT also increased the phosphorylation of extracellular signalregulated kinase ERK within minutes an effect blocked by pretreatment with SB277011A",
    "triple_list": [
      [
        "Quinpirole",
        "CPR:3",
        "extracellular signalregulated kinase"
      ],
      [
        "Quinpirole",
        "CPR:3",
        "ERK"
      ],
      [
        "7OHDPAT",
        "CPR:3",
        "extracellular signalregulated kinase"
      ],
      [
        "7OHDPAT",
        "CPR:3",
        "ERK"
      ],
      [
        "extracellular signalregulated kinase",
        "CPR:4",
        "SB277011A"
      ],
      [
        "ERK",
        "CPR:4",
        "SB277011A"
      ]
    ],
    "updated": "No",
    "original": "Quinpirole and 7OHDPAT also increased the phosphorylation of extracellular signalregulated kinase ERK within minutes an effect blocked by pretreatment with SB277011A",
    "simplified": "Quinpirole and 7OHDPAT increased extracellular signalregulated kinase (ERK) phosphorylation within minutes, but this effect was blocked by pretreatment."
  },
  {
    "text": "The unselective D2D3 receptor antagonist sulpiride 5 microm blocked all neurotrophic effects . The selective D3 receptor antagonist SB277011A at a low dose 50 nm",
    "triple_list": [
      [
        "D3 receptor",
        "CPR:6",
        "SB277011A"
      ]
    ],
    "updated": "Yes",
    "original": "All neurotrophic effects were blocked by the unselective D2D3 receptor antagonist sulpiride 5 microm and by the selective D3 receptor antagonist SB277011A at a low dose 50 nm",
    "simplified": "The unselective D2D3 receptor antagonist sulpiride 5 microm blocked all neurotrophic effects. The selective D3 receptor antagonist SB277011A at a low dose 50 nm"
  },
  {
    "text": "This study identified four clinically approved antihypertensive drugs efonidipine felodipine isradipine and nitrendipine as potent Tchannel blockers IC50 3 microM",
    "triple_list": [
      [
        "efonidipine",
        "CPR:4",
        "Tchannel"
      ],
      [
        "felodipine",
        "CPR:4",
        "Tchannel"
      ],
      [
        "isradipine",
        "CPR:4",
        "Tchannel"
      ],
      [
        "nitrendipine",
        "CPR:4",
        "Tchannel"
      ]
    ],
    "updated": "No",
    "original": "This study identified four clinically approved antihypertensive drugs efonidipine felodipine isradipine and nitrendipine as potent Tchannel blockers IC50 3 microM",
    "simplified": "This study showed that efonidipine, isradipine, nitrendipine and felodipine are good antihypertensive drugs. IC50 3 microM"
  },
  {
    "text": "Triphosphate nucleotides ATP , GTP , and UTP quickly and easily stopped Panx1 currents . They did this without needing purine receptors .",
    "triple_list": [
      [
        "UTP",
        "CPR:4",
        "Panx1"
      ],
      [
        "Triphosphate nucleotides",
        "CPR:4",
        "Panx1"
      ],
      [
        "ATP",
        "CPR:4",
        "Panx1"
      ],
      [
        "GTP",
        "CPR:4",
        "Panx1"
      ]
    ],
    "updated": "Yes",
    "original": "Triphosphate nucleotides ATP GTP and UTP rapidly and reversibly inhibited Panx1 currents via mechanisms independent of purine receptors",
    "simplified": "Triphosphate nucleotides ATP, GTP, and UTP quickly and easily stopped Panx1 currents. They did this without needing purine receptors."
  },
  {
    "text": "We found compounds that inhibited Panx1 currents with a rank order of potency carbenoxolone disodium 44diisothiocyanatostilbene22disulfonate DIDS approximately disodium 4acetamido4isothiocyanatostilben22disulfonate approximately 5nitro23phenylpropylaminobenzoic acid indanyloxyacetic acid 94 probenecid flufenamic acid = niflumic acid",
    "triple_list": [
      [
        "Panx1",
        "CPR:4",
        "carbenoxolone"
      ],
      [
        "Panx1",
        "CPR:4",
        "disodium 44diisothiocyanatostilbene22disulfonate"
      ],
      [
        "Panx1",
        "CPR:4",
        "DIDS"
      ],
      [
        "Panx1",
        "CPR:4",
        "disodium 4acetamido4isothiocyanatostilben22disulfonate"
      ],
      [
        "Panx1",
        "CPR:4",
        "5nitro23phenylpropylaminobenzoic acid"
      ],
      [
        "Panx1",
        "CPR:4",
        "indanyloxyacetic acid 94"
      ],
      [
        "Panx1",
        "CPR:4",
        "probenecid"
      ],
      [
        "Panx1",
        "CPR:4",
        "flufenamic acid"
      ],
      [
        "Panx1",
        "CPR:4",
        "niflumic acid"
      ]
    ],
    "updated": "No",
    "original": "We found compounds that inhibited Panx1 currents with a rank order of potency carbenoxolone disodium 44diisothiocyanatostilbene22disulfonate DIDS approximately disodium 4acetamido4isothiocyanatostilben22disulfonate approximately 5nitro23phenylpropylaminobenzoic acid indanyloxyacetic acid 94 probenecid flufenamic acid = niflumic acid",
    "simplified": "We found compounds that inhibited Panx1 currents with a rank order of potency. We found compounds that inhibited Panx1 currents with a rank order of potency carbenoxolone disodium 44diisothiocyanatostilbene22disulfonate DIDS approximately disodium 4acetamido4isothiocyanatostilben22disulfonate"
  },
  {
    "text": "When Panx1 was coexpressed with purinergic P2X7 receptor , P2X7R DIDS was found to act as a P2X7R antagonist , but was not found to work on the P2X7R itself .",
    "triple_list": [
      [
        "P2X7R",
        "CPR:6",
        "DIDS"
      ]
    ],
    "updated": "Yes",
    "original": "When Panx1 was coexpressed with purinergic P2X7 receptor P2X7R DIDS was found to act as a P2X7R antagonist to inhibit ATPevoked currents but none of the other compounds inhibited P2X7R currents",
    "simplified": "When Panx1 was coexpressed with purinergic P2X7 receptor, P2X7R DIDS was found to act as a P2X7R antagonist, but was not found to work on the P2X7R itself."
  },
  {
    "text": "The MMP2 and MMP9 levels in the right ventricles increased a lot when monocrotaline was added to the rats and captopril was not .",
    "triple_list": [
      [
        "MMP2",
        "CPR:3",
        "monocrotaline"
      ],
      [
        "MMP9",
        "CPR:3",
        "monocrotaline"
      ],
      [
        "MMP2",
        "CPR:4",
        "captopril"
      ],
      [
        "MMP9",
        "CPR:4",
        "captopril"
      ]
    ],
    "updated": "Yes",
    "original": "MMP2 and MMP9 expressions and activities in right ventricles increased significantly in monocrotaline injected rats and captopril inhibited them",
    "simplified": "The MMP2 and MMP9 levels in the right ventricles increased a lot when monocrotaline was added to the rats and captopril was not."
  },
  {
    "text": "These findings indicate that captopril attenuates the development of monocrotaline induced right ventricular hypertrophy in association with inhibition of MMP2 and MMP9 in rats",
    "triple_list": [
      [
        "monocrotaline",
        "CPR:3",
        "MMP2"
      ],
      [
        "monocrotaline",
        "CPR:3",
        "MMP9"
      ],
      [
        "captopril",
        "CPR:4",
        "MMP2"
      ],
      [
        "captopril",
        "CPR:4",
        "MMP9"
      ]
    ],
    "updated": "No",
    "original": "These findings indicate that captopril attenuates the development of monocrotaline induced right ventricular hypertrophy in association with inhibition of MMP2 and MMP9 in rats",
    "simplified": "These findings indicate that captopril reduces the development of right ventricular hypertrophy in rats by inhibiting the production of MMP2 and MMP9."
  },
  {
    "text": "We investigated the effect of captopril an ACE inhibitor on MMP2 and MMP9 in monocrotalineinduced right ventricular hypertrophy",
    "triple_list": [
      [
        "captopril",
        "CPR:4",
        "ACE"
      ]
    ],
    "updated": "No",
    "original": "We investigated the effect of captopril an ACE inhibitor on MMP2 and MMP9 in monocrotalineinduced right ventricular hypertrophy",
    "simplified": "The effect of captopril on right ventricular hypertrophy in monocrotalineinduced right ventricular hypertrophy"
  },
  {
    "text": "Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II with chlorthalidone trichloromethiazide and furosemide being efficient inhibitors against CA II KIs of 65138 nM whereas indapamide is a much weaker one KI of 2520 nM",
    "triple_list": [
      [
        "CA II",
        "CPR:4",
        "chlorthalidone"
      ],
      [
        "CA II",
        "CPR:4",
        "trichloromethiazide"
      ],
      [
        "CA II",
        "CPR:4",
        "furosemide"
      ],
      [
        "CA II",
        "CPR:4",
        "indapamide"
      ]
    ],
    "updated": "No",
    "original": "Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II with chlorthalidone trichloromethiazide and furosemide being efficient inhibitors against CA II KIs of 65138 nM whereas indapamide is a much weaker one KI of 2520 nM",
    "simplified": "Chlorthalidone trichloromethiazide and furosemide are very good inhibitors against CA II. However, indapamide is a much weaker one KI of 2520 nM. Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II."
  },
  {
    "text": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase CA EC 4211 with a very different profile as compared to classical inhibitors such as acetazolamide methazolamide and ethoxzolamide",
    "triple_list": [
      [
        "Thiazide",
        "CPR:4",
        "CA"
      ],
      [
        "Thiazide",
        "CPR:4",
        "EC 4211"
      ],
      [
        "Thiazide",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "CA",
        "CPR:4",
        "acetazolamide"
      ],
      [
        "EC 4211",
        "CPR:4",
        "acetazolamide"
      ],
      [
        "carbonic anhydrase",
        "CPR:4",
        "acetazolamide"
      ],
      [
        "CA",
        "CPR:4",
        "methazolamide"
      ],
      [
        "EC 4211",
        "CPR:4",
        "methazolamide"
      ],
      [
        "carbonic anhydrase",
        "CPR:4",
        "methazolamide"
      ],
      [
        "CA",
        "CPR:4",
        "ethoxzolamide"
      ],
      [
        "EC 4211",
        "CPR:4",
        "ethoxzolamide"
      ],
      [
        "carbonic anhydrase",
        "CPR:4",
        "ethoxzolamide"
      ]
    ],
    "updated": "No",
    "original": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase CA EC 4211 with a very different profile as compared to classical inhibitors such as acetazolamide methazolamide and ethoxzolamide",
    "simplified": "Thiazide and high ceiling diuretics have recently been shown to inhibit all mammalian isoforms of carbonic anhydrase. The profile of thiazide and high ceiling diuretics is very different from classical inhibitors."
  },
  {
    "text": "We discovered a novel selective SGLT2 inhibitor , sergliflozin etabonate , and found that selective inhibition of SGLT2 increased plasma glucose levels and decreased urinary glucose excretion .",
    "triple_list": [
      [
        "sergliflozin etabonate",
        "CPR:4",
        "SGLT2"
      ],
      [
        "sergliflozin etabonate",
        "CPR:4",
        "SGLT2"
      ]
    ],
    "updated": "Yes",
    "original": "We discovered sergliflozin etabonate a novel selective SGLT2 inhibitor and found that selective inhibition of SGLT2 increased urinary glucose excretion and consequently decreased plasma glucose levels",
    "simplified": "We discovered a novel selective SGLT2 inhibitor, sergliflozin etabonate, and found that selective inhibition of SGLT2 increased plasma glucose levels and decreased urinary glucose excretion."
  },
  {
    "text": "In this report we examined the antihyperglycemic effects of sergliflozin etabonate in normal and diabetic rats in comparison with those of a sulfonylurea gliclazide and an alphaglucosidase inhibitor voglibose",
    "triple_list": [
      [
        "alphaglucosidase",
        "CPR:4",
        "voglibose"
      ]
    ],
    "updated": "No",
    "original": "In this report we examined the antihyperglycemic effects of sergliflozin etabonate in normal and diabetic rats in comparison with those of a sulfonylurea gliclazide and an alphaglucosidase inhibitor voglibose",
    "simplified": "In this report, we compared the antihyperglycemic effects of sergliflozin etabonate to those of sulfonylurea gliclazide and an alphaglucosidase inhibitor in normal and diabetic rats."
  },
  {
    "text": "Sergliflozin etabonate is a selective SGLT2 inhibitor . It can be used to improve glycemic control in animals .",
    "triple_list": [
      [
        "Sergliflozin etabonate",
        "CPR:4",
        "SGLT2"
      ]
    ],
    "updated": "Yes",
    "original": "Sergliflozin etabonate a selective SGLT2 inhibitor improves glycemic control in streptozotocininduced diabetic rats and Zucker fatty rats",
    "simplified": "Sergliflozin etabonate is a selective SGLT2 inhibitor. It can be used to improve glycemic control in animals."
  },
  {
    "text": "Treatment with sergliflozin etabonate for a long time reduced the levels of glycated hemoglobin and glucose in the blood . It also improved the response to glucose .",
    "triple_list": [
      [
        "sergliflozin etabonate",
        "CPR:4",
        "glycated hemoglobin"
      ]
    ],
    "updated": "Yes",
    "original": "Chronic treatment with sergliflozin etabonate reduced the levels of glycated hemoglobin and fasting plasma glucose and improved the glycemic response after glucose loading in Zucker fatty rats",
    "simplified": "Treatment with sergliflozin etabonate for a long time reduced the levels of glycated hemoglobin and glucose in the blood. It also improved the response to glucose."
  },
  {
    "text": "The lowaffinity sodium glucose cotransporter SGLT2 is responsible for most of the glucose absorption in the kidney . Because of this , SGLT2 is very important for diabetes .",
    "triple_list": [
      [
        "sodium glucose cotransporter",
        "CPR:9",
        "glucose"
      ],
      [
        "glucose",
        "CPR:9",
        "SGLT2"
      ]
    ],
    "updated": "Yes",
    "original": "The lowaffinity sodium glucose cotransporter SGLT2 is responsible for most of the glucose reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes",
    "simplified": "The lowaffinity sodium glucose cotransporter SGLT2 is responsible for most of the glucose absorption in the kidney. Because of this, SGLT2 is very important for diabetes."
  },
  {
    "text": "Although the D1like receptor by itself had no effect on VSMC proliferation stimulation with fenoldopam a D1like receptor agonist inhibited the stimulatory effect of insulin",
    "triple_list": [
      [
        "fenoldopam",
        "CPR:4",
        "insulin"
      ],
      [
        "D1like receptor",
        "CPR:5",
        "fenoldopam"
      ]
    ],
    "updated": "No",
    "original": "Although the D1like receptor by itself had no effect on VSMC proliferation stimulation with fenoldopam a D1like receptor agonist inhibited the stimulatory effect of insulin",
    "simplified": "The D1like receptor itself has no effect on cell division. However, when fenoldopam was taken, the D1like receptor was changed so that it did not work."
  },
  {
    "text": "The inhibitory effect of fenoldopam on insulin mediated VSMC proliferation was receptor specific because its effect could be blocked by SCH23390 a D1like receptor antagonist",
    "triple_list": [
      [
        "fenoldopam",
        "CPR:4",
        "insulin"
      ],
      [
        "SCH23390",
        "CPR:6",
        "D1like receptor"
      ]
    ],
    "updated": "No",
    "original": "The inhibitory effect of fenoldopam on insulin mediated VSMC proliferation was receptor specific because its effect could be blocked by SCH23390 a D1like receptor antagonist",
    "simplified": "The inhibitory effect of fenoldopam on VSMC proliferation was specific to the D1like receptor. SCH23390, a D1like receptor antagonist, blocked this effect."
  },
  {
    "text": "Fenoldopam also inhibited the expression of insulin receptor mRNA and protein which was time dependent .",
    "triple_list": [
      [
        "Fenoldopam",
        "CPR:4",
        "insulin receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Fenoldopam also inhibited insulin receptor mRNA and protein expression which was time dependent and concentration dependent",
    "simplified": "Fenoldopam also inhibited the expression of insulin receptor mRNA and protein which was time dependent."
  },
  {
    "text": "A PKC or MAP kinase inhibitor blocked the inhibitory effect of fenoldopam on insulin receptor expression indicating that PKC and MAP kinase were involved in the signaling pathway",
    "triple_list": [
      [
        "fenoldopam",
        "CPR:4",
        "insulin receptor"
      ]
    ],
    "updated": "No",
    "original": "A PKC or MAP kinase inhibitor blocked the inhibitory effect of fenoldopam on insulin receptor expression indicating that PKC and MAP kinase were involved in the signaling pathway",
    "simplified": "A PKC or MAP kinase inhibitor stopped fenoldopam from working. This showed that the PKC or MAP kinase were involved in the way the insulin works."
  },
  {
    "text": "The progress of the enzymatic reaction of the hydrolysis of acetylthiocholine at pH 8 in the presence of AChE and the inhibitor is determined by the peak area of the reaction product at 230 nm .",
    "triple_list": [
      [
        "acetylthiocholine",
        "CPR:9",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "The progress of the enzymatic reaction of the hydrolysis of acetylthiocholine at pH 8 in the presence of AChE and the inhibitor studied is determined by measuring at 230 nm the peak area of the reaction product thiocholine TCh",
    "simplified": "The progress of the enzymatic reaction of the hydrolysis of acetylthiocholine at pH 8 in the presence of AChE and the inhibitor is determined by the peak area of the reaction product at 230 nm."
  },
  {
    "text": "atropine AChE reactivator such as HI6 and diazepam are used for the treatment of OP poisoning in humans pyridinium oximes pralidoxime trimedoxime obidoxime .",
    "triple_list": [
      [
        "AChE",
        "CPR:3",
        "trimedoxime"
      ],
      [
        "AChE",
        "CPR:3",
        "obidoxime"
      ],
      [
        "AChE",
        "CPR:3",
        "HI6"
      ],
      [
        "AChE",
        "CPR:3",
        "diazepam"
      ],
      [
        "atropine",
        "CPR:3",
        "AChE"
      ],
      [
        "AChE",
        "CPR:3",
        "pyridinium oximes"
      ],
      [
        "AChE",
        "CPR:3",
        "pralidoxime"
      ],
      [
        "AChE",
        "CPR:4",
        "OP"
      ]
    ],
    "updated": "Yes",
    "original": "atropine AChE reactivator such as one of the recommended pyridinium oximes pralidoxime trimedoxime obidoxime and HI6 and diazepam are used for the treatment of OP poisoning in humans",
    "simplified": "atropine AChE reactivator such as HI6 and diazepam are used for the treatment of OP poisoning in humans pyridinium oximes pralidoxime trimedoxime obidoxime."
  },
  {
    "text": "The mechanism of OP poisoning is that an enzyme called acetylcholinesterase AChE is inhibited . This enzyme is important for neurotransmission .",
    "triple_list": [
      [
        "OP",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "OP",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "The mechanism of OP poisoning involves inhibition of acetylcholinesterase AChE leading to inactivation of the enzyme which has an important role in neurotransmission",
    "simplified": "The mechanism of OP poisoning is that an enzyme called acetylcholinesterase AChE is inhibited. This enzyme is important for neurotransmission."
  },
  {
    "text": "They act by inhibiting the AChE by OP .",
    "triple_list": [
      [
        "AChE",
        "CPR:4",
        "OP"
      ]
    ],
    "updated": "Yes",
    "original": "They act by reactivation of AChE inhibited by OP",
    "simplified": "They act by inhibiting the AChE by OP."
  },
  {
    "text": "Oral palonosetron is likely to be a useful addition to oral formulations of other 5HT3 recepto r antagonists in preventing CINV in patients receiving MEC",
    "triple_list": [
      [
        "palonosetron",
        "CPR:6",
        "5HT3 recepto"
      ]
    ],
    "updated": "No",
    "original": "Oral palonosetron is likely to be a useful addition to oral formulations of other 5HT3 recepto r antagonists in preventing CINV in patients receiving MEC",
    "simplified": "Oral palonosetron may be a useful addition to other 5HT3 antagonists in preventing CINV in patients receiving MEC, according to these studies."
  },
  {
    "text": "Palonosetron is a secondgeneration serotonin 5HT3 receptor antagonist with a distinct pharmacological profile that differs from firstgeneration 5HT3 receptor antagonists",
    "triple_list": [
      [
        "Palonosetron",
        "CPR:6",
        "5HT3 receptor"
      ],
      [
        "Palonosetron",
        "CPR:6",
        "serotonin 5HT3 receptor"
      ]
    ],
    "updated": "No",
    "original": "Palonosetron is a secondgeneration serotonin 5HT3 receptor antagonist with a distinct pharmacological profile that differs from firstgeneration 5HT3 receptor antagonists",
    "simplified": "Palonosetron is a second generation 5HT3 receptor antagonist. It has a different pharmacological profile from first generation 5HT3 receptor antagonists."
  },
  {
    "text": "Luteinizing hormonereleasing hormone LHRH agonists such as buserelin goserelin leuprorelin and triptorelin stimulate the pituitarys gonadotrophinreleasing hormone GnRH receptor and cause the levels of LH and testosterone to go down .",
    "triple_list": [
      [
        "buserelin",
        "CPR:3",
        "gonadotrophinreleasing hormone GnRH receptor"
      ],
      [
        "goserelin",
        "CPR:3",
        "gonadotrophinreleasing hormone GnRH receptor"
      ],
      [
        "leuprorelin",
        "CPR:3",
        "gonadotrophinreleasing hormone GnRH receptor"
      ],
      [
        "triptorelin",
        "CPR:3",
        "gonadotrophinreleasing hormone GnRH receptor"
      ],
      [
        "LH",
        "CPR:4",
        "buserelin"
      ],
      [
        "LH",
        "CPR:4",
        "goserelin"
      ],
      [
        "LH",
        "CPR:4",
        "leuprorelin"
      ],
      [
        "LH",
        "CPR:4",
        "triptorelin"
      ],
      [
        "Luteinizing hormonereleasing hormone",
        "CPR:5",
        "buserelin"
      ],
      [
        "LHRH",
        "CPR:5",
        "buserelin"
      ],
      [
        "Luteinizing hormonereleasing hormone",
        "CPR:5",
        "goserelin"
      ],
      [
        "LHRH",
        "CPR:5",
        "goserelin"
      ],
      [
        "Luteinizing hormonereleasing hormone",
        "CPR:5",
        "leuprorelin"
      ],
      [
        "LHRH",
        "CPR:5",
        "leuprorelin"
      ],
      [
        "Luteinizing hormonereleasing hormone",
        "CPR:5",
        "triptorelin"
      ],
      [
        "LHRH",
        "CPR:5",
        "triptorelin"
      ]
    ],
    "updated": "Yes",
    "original": "Luteinizing hormonereleasing hormone LHRH agonists such as buserelin goserelin leuprorelin and triptorelin stimulate the pituitarys gonadotrophinreleasing hormone GnRH receptor ultimately leading to its desensitization and subsequent reduction of LH and testosterone levels",
    "simplified": "Luteinizing hormonereleasing hormone LHRH agonists such as buserelin goserelin leuprorelin and triptorelin stimulate the pituitarys gonadotrophinreleasing hormone GnRH receptor and cause the levels of LH and testosterone to go down."
  },
  {
    "text": "Two pure GnRH antagonists have been developed , abarelix and degarelix . They do not have any effect on the GnRH receptor , so they do not cause any problems .",
    "triple_list": [
      [
        "GnRH",
        "CPR:6",
        "abarelix"
      ],
      [
        "GnRH",
        "CPR:6",
        "degarelix"
      ]
    ],
    "updated": "Yes",
    "original": "Two pure GnRH antagonists have been developed abarelix and degarelix that are devoid of any agonist effect on the GnRH receptor and consequently do not result in testosterone flare",
    "simplified": "Two pure GnRH antagonists have been developed, abarelix and degarelix. They do not have any effect on the GnRH receptor, so they do not cause any problems."
  },
  {
    "text": "Abarelix was the first GnRH antagonist to be developed and was approved by the U.S. Food and Drug Administration in 2004 for the initiation of hormonal castration in patients with advanced or metastasizing prostate cancer .",
    "triple_list": [
      [
        "Abarelix",
        "CPR:6",
        "GnRH"
      ]
    ],
    "updated": "Yes",
    "original": "Abarelix was the first GnRH antagonist to be developed and was approved by the USA Food and Drug Administration in 2004 for the initiation of hormonal castration in advanced or metastasizing hormonedependent prostate carcinoma when rapid androgen suppression is necessary",
    "simplified": "Abarelix was the first GnRH antagonist to be developed and was approved by the U.S. Food and Drug Administration in 2004 for the initiation of hormonal castration in patients with advanced or metastasizing prostate cancer."
  },
  {
    "text": "Fulvestrant , a pure estrogen receptor downregulator , has been approved by the Food and Drug Administration ( FDA ) in 2002 .",
    "triple_list": [
      [
        "Fulvestrant",
        "CPR:4",
        "estrogen receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Fulvestrant a pure estrogen receptor downregulator is a new addition to the antiestrogen therapeutic armamentarium since its FDA approval in 2002",
    "simplified": "Fulvestrant, a pure estrogen receptor downregulator, has been approved by the Food and Drug Administration (FDA) in 2002."
  },
  {
    "text": "The concentration of estramustine phosphate required to inhibit the assembly or to induce the disassembly of chick brain MAP2 tubulin microtubules is markedly dependent upon the microtubule protein concentration",
    "triple_list": [
      [
        "estramustine phosphate",
        "CPR:3",
        "chick brain MAP2"
      ],
      [
        "estramustine phosphate",
        "CPR:3",
        "tubulin"
      ],
      [
        "estramustine phosphate",
        "CPR:4",
        "chick brain MAP2"
      ],
      [
        "estramustine phosphate",
        "CPR:4",
        "tubulin"
      ]
    ],
    "updated": "No",
    "original": "The concentration of estramustine phosphate required to inhibit the assembly or to induce the disassembly of chick brain MAP2 tubulin microtubules is markedly dependent upon the microtubule protein concentration",
    "simplified": "The concentration of estramustine phosphate required to inhibit the microtubule assembly or disassembly is markedly dependent upon the microtubule protein concentration in the microtubule."
  },
  {
    "text": "It is thought that two molecules of estramustine phosphate interact with each of the three tubulinbinding sites of MAP2 . This stops the tubulin from being able to bind to other parts of the cell .",
    "triple_list": [
      [
        "estramustine phosphate",
        "CPR:4",
        "MAP2"
      ],
      [
        "estramustine phosphate",
        "CPR:4",
        "tubulin"
      ]
    ],
    "updated": "Yes",
    "original": "It is proposed that two molecules of estramustine phosphate interact with each of the three tubulinbinding sites of MAP2 and inhibit the MAP2 tubulin interaction by neutralising two highly conserved basic residues",
    "simplified": "It is thought that two molecules of estramustine phosphate interact with each of the three tubulinbinding sites of MAP2. This stops the tubulin from being able to bind to other parts of the cell."
  },
  {
    "text": "PURPOSE XL184 cabozantinib is a potent inhibitor of MET vascular endothelial growth factor receptor 2 ( VEGFR2 and RET ) with antiangiogenic and anti-angiogenic effects in preclinical studies .",
    "triple_list": [
      [
        "cabozantinib",
        "CPR:4",
        "VEGFR2"
      ],
      [
        "cabozantinib",
        "CPR:4",
        "RET"
      ],
      [
        "cabozantinib",
        "CPR:4",
        "MET"
      ],
      [
        "cabozantinib",
        "CPR:4",
        "vascular endothelial growth factor receptor 2"
      ],
      [
        "XL184",
        "CPR:4",
        "VEGFR2"
      ],
      [
        "XL184",
        "CPR:4",
        "RET"
      ],
      [
        "XL184",
        "CPR:4",
        "MET"
      ],
      [
        "XL184",
        "CPR:4",
        "vascular endothelial growth factor receptor 2"
      ]
    ],
    "updated": "Yes",
    "original": "PURPOSE XL184 cabozantinib is a potent inhibitor of MET vascular endothelial growth factor receptor 2 VEGFR2 and RET with robust antiangiogenic antitumor and antiinvasive effects in preclinical models",
    "simplified": "PURPOSE XL184 cabozantinib is a potent inhibitor of MET vascular endothelial growth factor receptor 2 (VEGFR2 and RET) with antiangiogenic and anti-angiogenic effects in preclinical studies."
  },
  {
    "text": "Activity of XL184 Cabozantinib an oral tyrosine kinase inhibitor in patients with medullary thyroid cancer",
    "triple_list": [
      [
        "XL184",
        "CPR:4",
        "tyrosine kinase"
      ],
      [
        "Cabozantinib",
        "CPR:4",
        "tyrosine kinase"
      ]
    ],
    "updated": "No",
    "original": "Activity of XL184 Cabozantinib an oral tyrosine kinase inhibitor in patients with medullary thyroid cancer",
    "simplified": "The activity of an oral tyrosine kinase inhibitor in the treatment of thyroid cancer"
  },
  {
    "text": "Further we used this model to test the efficacy of GDC0941 a PI3K inhibitor in clinical development and showed that the PI3K inhibitor worked well .",
    "triple_list": [
      [
        "GDC0941",
        "CPR:4",
        "PI3K"
      ],
      [
        "GDC0941",
        "CPR:4",
        "PI3K"
      ]
    ],
    "updated": "Yes",
    "original": "Further we used this model to test the efficacy of GDC0941 a PI3K inhibitor in clinical development and showed that the tumors respond to PI3K inhibition",
    "simplified": "Further we used this model to test the efficacy of GDC0941 a PI3K inhibitor in clinical development and showed that the PI3K inhibitor worked well."
  },
  {
    "text": "4MA a well known 5 alphareductase inhibitor is also a potent inhibitor of 3 betaHSD with a Ki value of 56 nM",
    "triple_list": [
      [
        "4MA",
        "CPR:4",
        "5 alphareductase"
      ],
      [
        "4MA",
        "CPR:4",
        "3 betaHSD"
      ]
    ],
    "updated": "No",
    "original": "4MA a well known 5 alphareductase inhibitor is also a potent inhibitor of 3 betaHSD with a Ki value of 56 nM",
    "simplified": "4MA is a well known 5 alphareductase inhibitor. Its Ki value is 56, which is very high."
  },
  {
    "text": "Cyproterone acetate a progestin used in the treatment of hirsutism acne and prostate cancer as well as norgestrel and norethindrone that are widely used as oral contraceptives also inhibit 3 betaHSD activity at Ki values of 15 17 and 25 microM respectively",
    "triple_list": [
      [
        "Cyproterone acetate",
        "CPR:4",
        "3 betaHSD"
      ],
      [
        "progestin",
        "CPR:4",
        "3 betaHSD"
      ],
      [
        "norgestrel",
        "CPR:4",
        "3 betaHSD"
      ],
      [
        "norethindrone",
        "CPR:4",
        "3 betaHSD"
      ]
    ],
    "updated": "No",
    "original": "Cyproterone acetate a progestin used in the treatment of hirsutism acne and prostate cancer as well as norgestrel and norethindrone that are widely used as oral contraceptives also inhibit 3 betaHSD activity at Ki values of 15 17 and 25 microM respectively",
    "simplified": "Cyproterone acetate, a progestin used to treat hirsutism and prostate cancer, also inhibits 3 betaHSD activity at Ki values of 15 17 and 25 microM. Norgestrel and norethindrone, which are widely used as oral contraceptives also inhibit 3 betaHSD activity."
  },
  {
    "text": "Inhibitory effect of synthetic progestins 4MA and cyanoketone on human placental 3 betahydroxysteroid dehydrogenase54eneisomerase activity",
    "triple_list": [
      [
        "progestins",
        "CPR:4",
        "human placental 3 betahydroxysteroid dehydrogenase54eneisomerase"
      ],
      [
        "4MA",
        "CPR:4",
        "human placental 3 betahydroxysteroid dehydrogenase54eneisomerase"
      ],
      [
        "cyanoketone",
        "CPR:4",
        "human placental 3 betahydroxysteroid dehydrogenase54eneisomerase"
      ]
    ],
    "updated": "No",
    "original": "Inhibitory effect of synthetic progestins 4MA and cyanoketone on human placental 3 betahydroxysteroid dehydrogenase54eneisomerase activity",
    "simplified": "Inhibitory effect of synthetic progestins 4MA and cyanoketone on human placental cells Inhibitory effect of synthetic progestins"
  },
  {
    "text": "Trilostane epostane and cyanoketone are potent inhibitors of 3 betaHSD with Ki values of approximately 50 nM",
    "triple_list": [
      [
        "Trilostane",
        "CPR:4",
        "3 betaHSD"
      ],
      [
        "epostane",
        "CPR:4",
        "3 betaHSD"
      ],
      [
        "cyanoketone",
        "CPR:4",
        "3 betaHSD"
      ]
    ],
    "updated": "No",
    "original": "Trilostane epostane and cyanoketone are potent inhibitors of 3 betaHSD with Ki values of approximately 50 nM",
    "simplified": "Trilostane and cyanoketone are very powerful inhibitors. Their Ki values are about 50 nM."
  },
  {
    "text": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase 3 betaHSD purified from human placenta transforms C21 pregnenolone and 17 alphahydroxy pregnenolone as well as C19 dehydroepiandrosterone and androst5ene3 beta 17 betadiol steroids into the corresponding 3keto4enesteroids and is thus involved in the biosynthesis of all classes of hormonal steroids",
    "triple_list": [
      [
        "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase",
        "CPR:9",
        "pregnenolone"
      ],
      [
        "3 betaHSD",
        "CPR:9",
        "pregnenolone"
      ],
      [
        "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase",
        "CPR:9",
        "17 alphahydroxy pregnenolone"
      ],
      [
        "3 betaHSD",
        "CPR:9",
        "17 alphahydroxy pregnenolone"
      ],
      [
        "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase",
        "CPR:9",
        "dehydroepiandrosterone"
      ],
      [
        "3 betaHSD",
        "CPR:9",
        "dehydroepiandrosterone"
      ],
      [
        "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase",
        "CPR:9",
        "androst5ene3 beta 17 betadiol"
      ],
      [
        "3 betaHSD",
        "CPR:9",
        "androst5ene3 beta 17 betadiol"
      ],
      [
        "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase",
        "CPR:9",
        "3keto4enesteroids"
      ],
      [
        "3 betaHSD",
        "CPR:9",
        "3keto4enesteroids"
      ]
    ],
    "updated": "No",
    "original": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase 3 betaHSD purified from human placenta transforms C21 pregnenolone and 17 alphahydroxy pregnenolone as well as C19 dehydroepiandrosterone and androst5ene3 beta 17 betadiol steroids into the corresponding 3keto4enesteroids and is thus involved in the biosynthesis of all classes of hormonal steroids",
    "simplified": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase 3 betaHSD transforms C21 pregnenolone and 17 alphahydroxy pregnenolone into the corresponding 3keto4enesteroids and is thus involved in the biosynthesis of all classes of hormonal steroids."
  },
  {
    "text": "However , long-term treatment with MPEP did not reverse learned helplessness . This suggests that the mGlu5 receptor function is not the only thing that changes the behavior of cLH rats .",
    "triple_list": [
      [
        "MPEP",
        "CPR:3",
        "mGlu5 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "However chronic treatment of cLH rats with MPEP did not reverse learned helplessness indicating that the enhanced mGlu5 receptor function is not the only player in the behavioral phenotype of this genetic model of depression",
    "simplified": "However, long-term treatment with MPEP did not reverse learned helplessness. This suggests that the mGlu5 receptor function is not the only thing that changes the behavior of cLH rats."
  },
  {
    "text": "Rescue of both impaired extinction acquisition and deficient extinction consolidationretrieval was achieved with prior extinction training administration of valproic acid a GABAergic enhancer and HDAC inhibitor or AMN082 metabotropic glutamate receptor 7 mGlu7 agonist while MS275 or PEPA AMPA receptor potentiator failed to affect extinction acquisition in S1 mice",
    "triple_list": [
      [
        "MS275",
        "CPR:3",
        "AMPA receptor"
      ],
      [
        "PEPA",
        "CPR:3",
        "AMPA receptor"
      ],
      [
        "valproic acid",
        "CPR:4",
        "HDAC"
      ],
      [
        "AMN082",
        "CPR:5",
        "metabotropic glutamate receptor 7"
      ],
      [
        "AMN082",
        "CPR:5",
        "mGlu7"
      ]
    ],
    "updated": "No",
    "original": "Rescue of both impaired extinction acquisition and deficient extinction consolidationretrieval was achieved with prior extinction training administration of valproic acid a GABAergic enhancer and HDAC inhibitor or AMN082 metabotropic glutamate receptor 7 mGlu7 agonist while MS275 or PEPA AMPA receptor potentiator failed to affect extinction acquisition in S1 mice",
    "simplified": "Rescue of both impaired extinction acquisition and deficient extinction consolidationretrieval was achieved with prior extinction training in S1 mice while MS275 or PEPA AMPA receptor potentiator failed to affect extinction acquisition in S1 mice while valproic acid failed to affect extinction acquisition in S1 mice."
  },
  {
    "text": "Rescue of this impaired extinction consolidationretrieval was achieved with dcycloserine Nmethlydaspartate partial agonist or MS275 histone deacetylase HDAC inhibitor applied after extinction training",
    "triple_list": [
      [
        "MS275",
        "CPR:4",
        "histone deacetylase"
      ],
      [
        "MS275",
        "CPR:4",
        "HDAC"
      ]
    ],
    "updated": "No",
    "original": "Rescue of this impaired extinction consolidationretrieval was achieved with dcycloserine Nmethlydaspartate partial agonist or MS275 histone deacetylase HDAC inhibitor applied after extinction training",
    "simplified": "Rescue of this impaired extinction consolidationretrieval was achieved with a combination of histone deacetylase HDAC inhibitor and dcycloserine Nmethlydaspartate partial agonist."
  },
  {
    "text": "These results suggest that oral nicotine use improves the function of nicotinic acetylcholine receptors .",
    "triple_list": [
      [
        "nicotine",
        "CPR:3",
        "nicotinic acetylcholine receptors"
      ]
    ],
    "updated": "Yes",
    "original": "These findings suggest that oral consumption of nicotine enhances the efficacy of nicotinic acetylcholine receptors",
    "simplified": "These results suggest that oral nicotine use improves the function of nicotinic acetylcholine receptors."
  },
  {
    "text": "Electroencephalographic recordings showed reduced alpha activity and P300 latencies in the nicotine group when compared to the control group .",
    "triple_list": [
      [
        "P300",
        "CPR:4",
        "nicotine"
      ]
    ],
    "updated": "Yes",
    "original": "Electroencephalographic recordings during substance consumption showed reduced alpha activity and P300 latencies in the nicotine group compared to the control group",
    "simplified": "Electroencephalographic recordings showed reduced alpha activity and P300 latencies in the nicotine group when compared to the control group."
  },
  {
    "text": "The effect of GDC0152 on NF\u03baB transcription is to increase the expression of several chemokines and cytokines . The most important of these is tumor necrosis factor alpha TNF\u03b1 .",
    "triple_list": [
      [
        "GDC0152",
        "CPR:3",
        "NF\u03baB"
      ]
    ],
    "updated": "Yes",
    "original": "GDC0152 induces NF\u03baB transcriptional activity leading to expression of several chemokines and cytokines of which tumor necrosis factor alpha TNF\u03b1 is the most important for singleagent tumor activity",
    "simplified": "The effect of GDC0152 on NF\u03baB transcription is to increase the expression of several chemokines and cytokines. The most important of these is tumor necrosis factor alpha TNF\u03b1."
  },
  {
    "text": "GDC0152 is a small molecule drug that selectively antagonizes IAPs to cause tumor cell apoptosis .",
    "triple_list": [
      [
        "GDC0152",
        "CPR:6",
        "IAPs"
      ]
    ],
    "updated": "Yes",
    "original": "GDC0152 is a smallmolecule drug that triggers tumor cell apoptosis by selectively antagonizing IAPs",
    "simplified": "GDC0152 is a small molecule drug that selectively antagonizes IAPs to cause tumor cell apoptosis."
  },
  {
    "text": "Smallmolecule IAP antagonist GDC0152 has been linked to increased toxicity .",
    "triple_list": [
      [
        "IAP",
        "CPR:6",
        "GDC0152"
      ]
    ],
    "updated": "Yes",
    "original": "Toxicity profile of smallmolecule IAP antagonist GDC0152 is linked to TNF\u03b1 pharmacology",
    "simplified": "Smallmolecule IAP antagonist GDC0152 has been linked to increased toxicity."
  },
  {
    "text": "In TPC1 BCPAP FRO WRO cell lines PJ34 increased the levels of NIS very much .",
    "triple_list": [
      [
        "PJ34",
        "CPR:3",
        "NIS"
      ]
    ],
    "updated": "Yes",
    "original": "In TPC1 BCPAP FRO WRO cell lines PJ34 induced a strong increase in NIS mRNA levels",
    "simplified": "In TPC1 BCPAP FRO WRO cell lines PJ34 increased the levels of NIS very much."
  },
  {
    "text": "Accordingly , in transfection experiments performed in TPC1 cells , treatment with PJ34 increased the activity of the NIS promoter without affecting PARP1 .",
    "triple_list": [
      [
        "PJ34",
        "CPR:3",
        "NIS promoter"
      ]
    ],
    "updated": "Yes",
    "original": "Accordingly in transfection experiments performed in TPC1 cells treatment with PJ34 increased NIS promoter activity without affecting PARP1 binding to the promoter sequence",
    "simplified": "Accordingly, in transfection experiments performed in TPC1 cells, treatment with PJ34 increased the activity of the NIS promoter without affecting PARP1."
  },
  {
    "text": "We also investigated the epigenetic status of NIS promoter after PJ34 treatment in TPC1 cell line in addition to an increase of histone modification activation marks H3K9K14ac H3K4me3 surprisingly we observed also an increase of H3K27me3 a classical repressive mark",
    "triple_list": [
      [
        "PJ34",
        "CPR:3",
        "histone modification activation marks"
      ],
      [
        "PJ34",
        "CPR:3",
        "H3K9K14ac"
      ],
      [
        "PJ34",
        "CPR:3",
        "H3K4me3"
      ]
    ],
    "updated": "No",
    "original": "We also investigated the epigenetic status of NIS promoter after PJ34 treatment in TPC1 cell line in addition to an increase of histone modification activation marks H3K9K14ac H3K4me3 surprisingly we observed also an increase of H3K27me3 a classical repressive mark",
    "simplified": "We also investigated the epigenetic status of NIS promoter after PJ34 treatment in TPC1 cell line in addition to an increase of a classical repressive mark H3K27me3 we observed also an increase of histone modification activation marks H3K9K14ac."
  },
  {
    "text": "In this study the effect of the PARP inhibitor PJ34 on several properties of thyroid cancer cell lines was investigated because it is supposed to be a multimeric repressor of sodium iodide symporter NIS .",
    "triple_list": [
      [
        "PARP",
        "CPR:4",
        "PJ34"
      ]
    ],
    "updated": "Yes",
    "original": "Since PARP1 is supposed to be part of a multimeric repressor of sodium iodide symporter NIS expression in this study the effect of the PARP inhibitor PJ34 on several properties of thyroid cancer cell lines was investigated",
    "simplified": "In this study the effect of the PARP inhibitor PJ34 on several properties of thyroid cancer cell lines was investigated because it is supposed to be a multimeric repressor of sodium iodide symporter NIS."
  },
  {
    "text": "The PARP inhibitor PJ34 changes cell division The expression of NIS and epigenetic marks .",
    "triple_list": [
      [
        "PARP",
        "CPR:4",
        "PJ34"
      ]
    ],
    "updated": "Yes",
    "original": "The PARP inhibitor PJ34 modifies proliferation NIS expression and epigenetic marks in thyroid cancer cell lines",
    "simplified": "The PARP inhibitor PJ34 changes cell division The expression of NIS and epigenetic marks."
  },
  {
    "text": "Both apolycopenoic acids also reduce the formation of 8OHdG by CSE . They also reduce the increase in NOX4 and COX2 made by CSE .",
    "triple_list": [
      [
        "apolycopenoic acids",
        "CPR:4",
        "NOX4"
      ],
      [
        "apolycopenoic acids",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Both apolycopenoic acids also decreased CSEinduced ROS production 8OHdG formation and reduced the increase in NOX4 and COX2 expressions caused by CSE",
    "simplified": "Both apolycopenoic acids also reduce the formation of 8OHdG by CSE. They also reduce the increase in NOX4 and COX2 made by CSE."
  },
  {
    "text": "Here in expressing cocaine hydrolyzing mutants of BChE in Nicotiana benthamiana using the MagnICON virusassisted transient expression system we provide proofofprinciple that engineered BChE proteins with desired properties can be expressed in plants .",
    "triple_list": [
      [
        "cocaine",
        "CPR:9",
        "BChE"
      ]
    ],
    "updated": "Yes",
    "original": "Here in expressing cocaine hydrolyzing mutants of BChE in Nicotiana benthamiana using the MagnICON virusassisted transient expression system and in reporting their initial biochemical analysis we provide proofofprinciple that plants can express engineered BChE proteins with desired properties",
    "simplified": "Here in expressing cocaine hydrolyzing mutants of BChE in Nicotiana benthamiana using the MagnICON virusassisted transient expression system we provide proofofprinciple that engineered BChE proteins with desired properties can be expressed in plants."
  },
  {
    "text": "However , recent studies have shown that a potential treatment option can be found by using a serum enzyme called butyrylcholinesterase BChE . This enzyme can break down cocaine in the body before the drug can reach the brain and affect other parts of the body .",
    "triple_list": [
      [
        "butyrylcholinesterase",
        "CPR:9",
        "cocaine"
      ],
      [
        "BChE",
        "CPR:9",
        "cocaine"
      ]
    ],
    "updated": "Yes",
    "original": "Recent studies however have demonstrated a promising potential treatment option with the help of the serum enzyme butyrylcholinesterase BChE which is capable of breaking down naturally occurring cocaine before the drug can influence the reward centers of the brain or affect other areas of the body",
    "simplified": "However, recent studies have shown that a potential treatment option can be found by using a serum enzyme called butyrylcholinesterase BChE. This enzyme can break down cocaine in the body before the drug can reach the brain and affect other parts of the body."
  },
  {
    "text": "Because of this , different versions of BChE have been designed to work better against cocaine .",
    "triple_list": [
      [
        "BChE",
        "CPR:9",
        "cocaine"
      ]
    ],
    "updated": "Yes",
    "original": "This prompted the design of variants of BChE which exhibit significantly improved catalytic activity against cocaine",
    "simplified": "Because of this, different versions of BChE have been designed to work better against cocaine."
  },
  {
    "text": "Second feeding increased both PGE2 level and COX isoforms in the duodenum , but the effects were lessened when cimetidine was given to the animals .",
    "triple_list": [
      [
        "COX",
        "CPR:4",
        "cimetidine"
      ]
    ],
    "updated": "Yes",
    "original": "Second feeding increased both the expression of COX isoforms and PGE2 level in the duodenum and the effects were markedly inhibited by pretreatment with cimetidine",
    "simplified": "Second feeding increased both PGE2 level and COX isoforms in the duodenum, but the effects were lessened when cimetidine was given to the animals."
  },
  {
    "text": "We examined in cats the 1 ulcerogenic effects of selective COX1 SC560 ketorolac and COX2 celecoxib meloxicam inhibitors on the gastrointestinal mucosa 2 effect of feeding and cimetidine on the expression of COX isoforms in the duodenum and 3 localization of COX isoforms in the duodenum .",
    "triple_list": [
      [
        "COX1",
        "CPR:4",
        "SC560"
      ],
      [
        "COX1",
        "CPR:4",
        "ketorolac"
      ],
      [
        "COX2",
        "CPR:4",
        "celecoxib"
      ],
      [
        "COX2",
        "CPR:4",
        "meloxicam"
      ]
    ],
    "updated": "Yes",
    "original": "We examined in cats the 1 ulcerogenic effects of selective COX1 SC560 ketorolac and COX2 celecoxib meloxicam inhibitors on the gastrointestinal mucosa 2 effect of feeding and cimetidine on the expression of COX isoforms and prostaglandin E2 PGE2 level in the duodenum and 3 localization of COX isoforms in the duodenum",
    "simplified": "We examined in cats the 1 ulcerogenic effects of selective COX1 SC560 ketorolac and COX2 celecoxib meloxicam inhibitors on the gastrointestinal mucosa 2 effect of feeding and cimetidine on the expression of COX isoforms in the duodenum and 3 localization of COX isoforms in the duodenum."
  },
  {
    "text": "Reversal of inhibition by D2 agonist quinpirole was produced by serotonin 50 \u00b5M and by neurotensin 510 nM",
    "triple_list": [
      [
        "D2",
        "CPR:3",
        "neurotensin"
      ],
      [
        "D2",
        "CPR:3",
        "serotonin"
      ],
      [
        "D2",
        "CPR:5",
        "quinpirole"
      ]
    ],
    "updated": "No",
    "original": "Reversal of inhibition by D2 agonist quinpirole was produced by serotonin 50 \u00b5M and by neurotensin 510 nM",
    "simplified": "Serotonin can reverse the effects of D2 agonist quinpirole. Quinpirole is 50 micrograms in weight."
  },
  {
    "text": "Serotonininduced or neurotensininduced reversal was blocked by \u03b2ARK1 inhibitor dynasore or cPKC antagonist 56713tetrahydro13methyl5oxo12Hindolo23apyrrolo34ccarbazole12propanenitrile G\u00f66976",
    "triple_list": [
      [
        "cPKC",
        "CPR:6",
        "56713tetrahydro13methyl5oxo12Hindolo23apyrrolo34ccarbazole12propanenitrile"
      ],
      [
        "cPKC",
        "CPR:6",
        "G\u00f66976"
      ]
    ],
    "updated": "No",
    "original": "Serotonininduced or neurotensininduced reversal was blocked by \u03b2ARK1 inhibitor dynasore or cPKC antagonist 56713tetrahydro13methyl5oxo12Hindolo23apyrrolo34ccarbazole12propanenitrile G\u00f66976",
    "simplified": "Serotonin-induced and neurotensin-induced changes in brain function were blocked by dynasore or cPKC antagonist 56713tetrahydro13methyl5oxo12Hindolo"
  },
  {
    "text": "However 4GRSV but not 3GRSV induced SIRT1 dependent histone H3 deacetylation and SOD2 expression in mouse C2C12 skeletal myoblasts as with RSV SIRT1 knockdown blunted these effects",
    "triple_list": [
      [
        "4GRSV",
        "CPR:3",
        "SIRT1"
      ],
      [
        "4GRSV",
        "CPR:3",
        "SOD2"
      ]
    ],
    "updated": "No",
    "original": "However 4GRSV but not 3GRSV induced SIRT1 dependent histone H3 deacetylation and SOD2 expression in mouse C2C12 skeletal myoblasts as with RSV SIRT1 knockdown blunted these effects",
    "simplified": "4GRSV but not 3GRSV induced histone H3 deacetylation and SOD2 expression in mouse C2C12 skeletal myoblasts, but these effects were not as strong as those of RSV."
  },
  {
    "text": "RSV targets and activates the NADdependent protein deacetylase SIRT1 in turn SIRT1 induces an intracellular antioxidative mechanism by inducing mitochondrial superoxide dismutase SOD2",
    "triple_list": [
      [
        "RSV",
        "CPR:3",
        "NADdependent protein deacetylase SIRT1"
      ],
      [
        "RSV",
        "CPR:3",
        "SIRT1"
      ],
      [
        "RSV",
        "CPR:3",
        "mitochondrial superoxide dismutase"
      ],
      [
        "RSV",
        "CPR:3",
        "SOD2"
      ]
    ],
    "updated": "No",
    "original": "RSV targets and activates the NADdependent protein deacetylase SIRT1 in turn SIRT1 induces an intracellular antioxidative mechanism by inducing mitochondrial superoxide dismutase SOD2",
    "simplified": "RSV targets and activates the NADdependent protein deacetylase SIRT1. SIRT1 causes an antioxidative mechanism to take place in the cell. This mechanism is SOD2."
  },
  {
    "text": "These results provide a rationale for future design of therapeutic apolipoprotein mimetic peptides and provide new insights into the lipid microdomain created by the ABCA1 transporter during the cholesterol efflux process , where hydrophobic residues are present .",
    "triple_list": [
      [
        "ABCA1",
        "CPR:9",
        "cholesterol"
      ]
    ],
    "updated": "Yes",
    "original": "These results provide a rationale for future design of therapeutic apolipoprotein mimetic peptides and provide new insights into the interaction of hydrophobic residues on apolipoproteins with phospholipids in the lipid microdomain created by the ABCA1 transporter during the cholesterol efflux process",
    "simplified": "These results provide a rationale for future design of therapeutic apolipoprotein mimetic peptides and provide new insights into the lipid microdomain created by the ABCA1 transporter during the cholesterol efflux process, where hydrophobic residues are present."
  },
  {
    "text": "The bihelical apolipoprotein mimetic peptide 5A increases the production of cholesterol in the body and reduces inflammation .",
    "triple_list": [
      [
        "apolipoprotein mimetic peptide 5A",
        "CPR:9",
        "cholesterol"
      ]
    ],
    "updated": "Yes",
    "original": "The bihelical apolipoprotein mimetic peptide 5A effluxes cholesterol from cells and reduces inflammation and atherosclerosis in animal models",
    "simplified": "The bihelical apolipoprotein mimetic peptide 5A increases the production of cholesterol in the body and reduces inflammation."
  },
  {
    "text": "Compared with active peptides containing F or W peptides containing E in either of these two positions were more than 10fold less effective in effluxing cholesterol by the ABCA1 transporter",
    "triple_list": [
      [
        "cholesterol",
        "CPR:9",
        "ABCA1"
      ]
    ],
    "updated": "No",
    "original": "Compared with active peptides containing F or W peptides containing E in either of these two positions were more than 10fold less effective in effluxing cholesterol by the ABCA1 transporter",
    "simplified": "When active peptides containing E were compared with active peptides containing F or W, they were more than 10 times less effective at getting cholesterol out of them."
  },
  {
    "text": "Hydrophobic amino acids in the 5A apolipoprotein mimetic peptide are essential for the ABCA1 transporter to move cholesterol through the body .",
    "triple_list": [
      [
        "cholesterol",
        "CPR:9",
        "ABCA1"
      ]
    ],
    "updated": "Yes",
    "original": "Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter",
    "simplified": "Hydrophobic amino acids in the 5A apolipoprotein mimetic peptide are essential for the ABCA1 transporter to move cholesterol through the body."
  },
  {
    "text": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention we studied the anticonvulsant efficacy of the GluK1 GluR5 \u03b1amino3hydroxy5methyl4isoxazolepropionic acid AMPA receptor antagonist 3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid LY293558 in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman",
    "triple_list": [
      [
        "GluK1",
        "CPR:6",
        "3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid"
      ],
      [
        "GluR5",
        "CPR:6",
        "3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid"
      ],
      [
        "\u03b1amino3hydroxy5methyl4isoxazolepropionic acid AMPA receptor",
        "CPR:6",
        "3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid"
      ],
      [
        "GluK1",
        "CPR:6",
        "LY293558"
      ],
      [
        "GluR5",
        "CPR:6",
        "LY293558"
      ],
      [
        "\u03b1amino3hydroxy5methyl4isoxazolepropionic acid AMPA receptor",
        "CPR:6",
        "LY293558"
      ]
    ],
    "updated": "No",
    "original": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention we studied the anticonvulsant efficacy of the GluK1 GluR5 \u03b1amino3hydroxy5methyl4isoxazolepropionic acid AMPA receptor antagonist 3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid LY293558 in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman",
    "simplified": "To determine if the anticonvulsant efficacy of the GluK1 GluR5 \u03b1amino3hydroxy5methyl4isoxazolepropionic acid in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman was still possible without pretreatment or immediate pharmacologic intervention."
  },
  {
    "text": "Efficacy of the GluK1 AMPA receptor antagonist LY293558 against seizures and neuropathology after intramuscular administration without pretreatment and without pretreatment .",
    "triple_list": [
      [
        "GluK1",
        "CPR:6",
        "LY293558"
      ],
      [
        "AMPA receptor",
        "CPR:6",
        "LY293558"
      ]
    ],
    "updated": "Yes",
    "original": "Efficacy of the GluK1 AMPA receptor antagonist LY293558 against seizures and neuropathology in a somanexposure model without pretreatment and its pharmacokinetics after intramuscular administration",
    "simplified": "Efficacy of the GluK1 AMPA receptor antagonist LY293558 against seizures and neuropathology after intramuscular administration without pretreatment and without pretreatment."
  },
  {
    "text": "Cellular release of AChE by SHSY5Y is significantly enhanced by the muscarinic acetylcholine receptor mAChR agonists carbachol or muscarine with the effect of carbachol blocked by the mAChR antagonist atropine",
    "triple_list": [
      [
        "AChE",
        "CPR:3",
        "carbachol"
      ],
      [
        "AChE",
        "CPR:3",
        "muscarine"
      ],
      [
        "AChE",
        "CPR:3",
        "carbachol"
      ],
      [
        "AChE",
        "CPR:4",
        "atropine"
      ],
      [
        "muscarinic acetylcholine receptor",
        "CPR:5",
        "carbachol"
      ],
      [
        "mAChR",
        "CPR:5",
        "carbachol"
      ],
      [
        "muscarinic acetylcholine receptor",
        "CPR:5",
        "muscarine"
      ],
      [
        "mAChR",
        "CPR:5",
        "muscarine"
      ],
      [
        "mAChR",
        "CPR:6",
        "atropine"
      ]
    ],
    "updated": "No",
    "original": "Cellular release of AChE by SHSY5Y is significantly enhanced by the muscarinic acetylcholine receptor mAChR agonists carbachol or muscarine with the effect of carbachol blocked by the mAChR antagonist atropine",
    "simplified": "Cellular release of AChE by SHSY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol and muscarine. These two drugs are called mAChR agonists."
  },
  {
    "text": "Acetylcholinesterase AChE ( also known as acetylcholinesterase or AChE ) is an enzyme in the body . It works by breaking down acetylcholine , a chemical in the brain , into other chemicals .",
    "triple_list": [
      [
        "acetylcholine",
        "CPR:9",
        "AChE"
      ],
      [
        "acetylcholine",
        "CPR:9",
        "acetylcholinesterase"
      ]
    ],
    "updated": "Yes",
    "original": "Although acetylcholinesterase AChE is primarily a hydrolytic enzyme metabolising the neurotransmitter acetylcholine in cholinergic synapses it also has some noncatalytic functions in the brain which are far less well characterised",
    "simplified": "Acetylcholinesterase AChE (also known as acetylcholinesterase or AChE) is an enzyme in the body. It works by breaking down acetylcholine, a chemical in the brain, into other chemicals."
  },
  {
    "text": "Nevertheless low LBMAA concentrations \u2265 01mM 48 h increased protein ubiquitination 20S proteasomal and caspase 12 activity expression of the endoplasmic reticulum ER stress marker CHOP and enhanced phosphorylation of elf2\u03b1 in SHSY5Y cells",
    "triple_list": [
      [
        "LBMAA",
        "CPR:3",
        "20S proteasomal"
      ],
      [
        "LBMAA",
        "CPR:3",
        "caspase 12"
      ],
      [
        "LBMAA",
        "CPR:3",
        "CHOP"
      ],
      [
        "LBMAA",
        "CPR:3",
        "elf2\u03b1"
      ]
    ],
    "updated": "No",
    "original": "Nevertheless low LBMAA concentrations \u2265 01mM 48 h increased protein ubiquitination 20S proteasomal and caspase 12 activity expression of the endoplasmic reticulum ER stress marker CHOP and enhanced phosphorylation of elf2\u03b1 in SHSY5Y cells",
    "simplified": "However, low LBMAA concentrations (less than 0.0001 mM 48 h) increased protein ubiquitination, increased expression of the endoplasmic reticulum ER stress marker CHOP and enhanced phosphorylation of elf2\u03b1 in SHSY5Y cells."
  },
  {
    "text": "LBMAA caused ER stress and increased caspase 12 cleavage in human breast cancer cells at low levels of stress .",
    "triple_list": [
      [
        "LBMAA",
        "CPR:3",
        "caspase 12"
      ]
    ],
    "updated": "Yes",
    "original": "LBMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SHSY5Y cells at low nonexcitotoxic concentrations",
    "simplified": "LBMAA caused ER stress and increased caspase 12 cleavage in human breast cancer cells at low levels of stress."
  },
  {
    "text": "We found that ribavirin , as well as other inosine5monophosphate dehydrogenase inhibitors such as 6mercaptopurine and mycophenolic acid , increased F7 expression in the intracellular .",
    "triple_list": [
      [
        "mycophenolic acid",
        "CPR:3",
        "F7"
      ],
      [
        "6mercaptopurine",
        "CPR:3",
        "F7"
      ]
    ],
    "updated": "Yes",
    "original": "We found that intracellular GTP depletion by ribavirin as well as other IMPDH inosine5monophosphate dehydrogenase inhibitors such as mycophenolic acid and 6mercaptopurine upregulated F7 expression",
    "simplified": "We found that ribavirin, as well as other inosine5monophosphate dehydrogenase inhibitors such as 6mercaptopurine and mycophenolic acid, increased F7 expression in the intracellular."
  },
  {
    "text": "Ribavirin unregulated ELL elevennineteen lysinerich leukaemia 3 mRNA expression before F7 upregulation",
    "triple_list": [
      [
        "Ribavirin",
        "CPR:3",
        "ELL"
      ],
      [
        "Ribavirin",
        "CPR:3",
        "elevennineteen lysinerich leukaemia 3"
      ],
      [
        "Ribavirin",
        "CPR:3",
        "F7"
      ]
    ],
    "updated": "No",
    "original": "Ribavirin unregulated ELL elevennineteen lysinerich leukaemia 3 mRNA expression before F7 upregulation",
    "simplified": "Ribavirin unregulated ELL 11-19 Lysinerich leukaemia 3 mRNA expression before F7 changes"
  },
  {
    "text": "We found that ribavirin increased the recruitment of ELL3 to F7 and that knockdown of ELL3 reduced FVII mRNA expression .",
    "triple_list": [
      [
        "ribavirin",
        "CPR:3",
        "ELL3"
      ],
      [
        "ribavirin",
        "CPR:3",
        "F7"
      ],
      [
        "ribavirin",
        "CPR:3",
        "FVII"
      ]
    ],
    "updated": "Yes",
    "original": "We observed that ribavirin enhanced ELL3 recruitment to F7 whereas knockdown of ELL3 diminished ribavirin induced FVII mRNA upregulation",
    "simplified": "We found that ribavirin increased the recruitment of ELL3 to F7 and that knockdown of ELL3 reduced FVII mRNA expression."
  },
  {
    "text": "Ribavirin causes intracellular GTP to decrease . This causes gene expression to increase in coagulation factor VII .",
    "triple_list": [
      [
        "Ribavirin",
        "CPR:3",
        "coagulation factor VII"
      ]
    ],
    "updated": "Yes",
    "original": "Ribavirin induced intracellular GTP depletion activates transcription elongation in coagulation factor VII gene expression",
    "simplified": "Ribavirin causes intracellular GTP to decrease. This causes gene expression to increase in coagulation factor VII."
  },
  {
    "text": "Ribavirin also enhanced recruitment of CDK9 cyclindependent kinase 9 and AFF4 to F7",
    "triple_list": [
      [
        "Ribavirin",
        "CPR:3",
        "CDK9"
      ],
      [
        "Ribavirin",
        "CPR:3",
        "cyclindependent kinase 9"
      ],
      [
        "Ribavirin",
        "CPR:3",
        "AFF4"
      ],
      [
        "Ribavirin",
        "CPR:3",
        "F7"
      ]
    ],
    "updated": "No",
    "original": "Ribavirin also enhanced recruitment of CDK9 cyclindependent kinase 9 and AFF4 to F7",
    "simplified": "Ribavirin has also been shown to improve the function of AFF4 to F7."
  },
  {
    "text": "These data suggest that ribavirin induced intracellular GTP depletion recruits a super elongation complex containing PTEFb AFF4 and ELL3 to F7 and modulates FVII mRNA transcription elongation",
    "triple_list": [
      [
        "ribavirin",
        "CPR:3",
        "PTEFb"
      ],
      [
        "ribavirin",
        "CPR:3",
        "AFF4"
      ],
      [
        "ribavirin",
        "CPR:3",
        "ELL3"
      ],
      [
        "ribavirin",
        "CPR:3",
        "F7"
      ]
    ],
    "updated": "No",
    "original": "These data suggest that ribavirin induced intracellular GTP depletion recruits a super elongation complex containing PTEFb AFF4 and ELL3 to F7 and modulates FVII mRNA transcription elongation",
    "simplified": "These data suggest that ribavirin-induced intracellular GTP depletion recruits a super elongation complex and modulates FVII mRNA transcription, which is important for cell division."
  },
  {
    "text": "Together , we have identified a basic mechanism by which ribavirin-induced FVII mRNA upregulation accelerates transcription , which is important for understanding its functions in life .",
    "triple_list": [
      [
        "ribavirin",
        "CPR:3",
        "FVII"
      ]
    ],
    "updated": "Yes",
    "original": "Collectively we have elucidated a basal mechanism for ribavirin induced FVII mRNA upregulation by acceleration of transcription elongation which may be crucial in understanding its pleiotropic functions in vivo",
    "simplified": "Together, we have identified a basic mechanism by which ribavirin-induced FVII mRNA upregulation accelerates transcription, which is important for understanding its functions in life."
  },
  {
    "text": "It was reported previously that FVII gene F7 expression was upregulated by ribavirin treatment in hepatitis C virusinfected haemophilia patients however its precise mechanism is still unknown",
    "triple_list": [
      [
        "FVII",
        "CPR:3",
        "ribavirin"
      ],
      [
        "F7",
        "CPR:3",
        "ribavirin"
      ]
    ],
    "updated": "No",
    "original": "It was reported previously that FVII gene F7 expression was upregulated by ribavirin treatment in hepatitis C virusinfected haemophilia patients however its precise mechanism is still unknown",
    "simplified": "It has been reported that ribavirin treatment can increase the expression of the FVII gene in haemophilia patients, but the exact mechanism is still unknown."
  },
  {
    "text": "In the present study , we investigated the molecular mechanism of ribavirin-induced F7 expression in a human hepatoma cell line .",
    "triple_list": [
      [
        "ribavirin",
        "CPR:3",
        "F7"
      ]
    ],
    "updated": "Yes",
    "original": "In the present study we investigated the molecular mechanism of ribavirin induced upregulation of F7 expression in HepG2 human hepatoma cell line",
    "simplified": "In the present study, we investigated the molecular mechanism of ribavirin-induced F7 expression in a human hepatoma cell line."
  },
  {
    "text": "Protein kinase C ( PKC ) inhibitors reduced the ability of GluK2 GluK5 to bind to mGlu1 . When phorbol 12myristate13acetate was added to PKC , however , it increased GluK2 GluK5 .",
    "triple_list": [
      [
        "PKC",
        "CPR:3",
        "phorbol 12myristate13acetate"
      ],
      [
        "GluK2",
        "CPR:3",
        "phorbol 12myristate13acetate"
      ],
      [
        "GluK5",
        "CPR:3",
        "phorbol 12myristate13acetate"
      ]
    ],
    "updated": "Yes",
    "original": "Protein kinase C PKC inhibition reduced the potentiation by mGlu1 of GluK2 GluK5 and conversely direct activation of PKC by phorbol 12myristate13acetate potentiated GluK2 GluK5",
    "simplified": "Protein kinase C (PKC) inhibitors reduced the ability of GluK2 GluK5 to bind to mGlu1. When phorbol 12myristate13acetate was added to PKC, however, it increased GluK2 GluK5."
  },
  {
    "text": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDP\u03b2S blocked by an inhibitor of phospholipase C or the calcium chelator 12bisoaminophenoxyethaneNNNNtetraacetic acid BAPTA prolonged by the phosphatase inhibitor okadaic acid but unaffected by the tyrosine kinase inhibitor lavendustin A",
    "triple_list": [
      [
        "KARs",
        "CPR:4",
        "12bisoaminophenoxyethaneNNNNtetraacetic acid"
      ],
      [
        "mGlu1",
        "CPR:4",
        "12bisoaminophenoxyethaneNNNNtetraacetic acid"
      ],
      [
        "KARs",
        "CPR:4",
        "BAPTA"
      ],
      [
        "mGlu1",
        "CPR:4",
        "BAPTA"
      ],
      [
        "phosphatase",
        "CPR:4",
        "okadaic acid"
      ],
      [
        "KARs",
        "CPR:4",
        "okadaic acid"
      ],
      [
        "mGlu1",
        "CPR:4",
        "okadaic acid"
      ],
      [
        "tyrosine kinase",
        "CPR:4",
        "lavendustin A"
      ],
      [
        "KARs",
        "CPR:4",
        "lavendustin A"
      ],
      [
        "mGlu1",
        "CPR:4",
        "lavendustin A"
      ]
    ],
    "updated": "No",
    "original": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDP\u03b2S blocked by an inhibitor of phospholipase C or the calcium chelator 12bisoaminophenoxyethaneNNNNtetraacetic acid BAPTA prolonged by the phosphatase inhibitor okadaic acid but unaffected by the tyrosine kinase inhibitor lavendustin A",
    "simplified": "When GDP\u03b2S was blocked by an inhibitor of phospholipase C or the calcium chelator 12bisoaminophenoxyethane (BAPTA), heteromeric KARs became less potent. The effect of BAPTA was extended by the phosphatase inhibitor okadaic acid but unaffected by the tyrosine kinase inhibitor lavendustin A."
  },
  {
    "text": "Fingolimod FTY720 a novel drug approved for the treatment of relapsingremitting multiple sclerosis activates different sphingosine1phosphate receptor S1PR subtypes",
    "triple_list": [
      [
        "Fingolimod",
        "CPR:3",
        "sphingosine1phosphate receptor"
      ],
      [
        "Fingolimod",
        "CPR:3",
        "S1PR"
      ],
      [
        "FTY720",
        "CPR:3",
        "sphingosine1phosphate receptor"
      ],
      [
        "FTY720",
        "CPR:3",
        "S1PR"
      ]
    ],
    "updated": "No",
    "original": "Fingolimod FTY720 a novel drug approved for the treatment of relapsingremitting multiple sclerosis activates different sphingosine1phosphate receptor S1PR subtypes",
    "simplified": "Fingolimod FTY720 a novel drug approved for the treatment of relapsing-remitting multiple sclerosis Fingolimod is a novel drug."
  },
  {
    "text": "Neuroprotection was reduced by pertussis toxin and inhibited by the selective type1 S1PR S1P1R antagonist W146 . MAPK and the phosphatidylinositol3kinase PtdIns3K pathways were also affected by pertussis toxin .",
    "triple_list": [
      [
        "type1 S1PR",
        "CPR:6",
        "W146"
      ],
      [
        "S1P1R",
        "CPR:6",
        "W146"
      ]
    ],
    "updated": "Yes",
    "original": "Neuroprotection was attenuated by pertussis toxin and inhibited by the selective type1 S1PR S1P1R antagonist W146 and by inhibitors of the mitogen associated protein kinase MAPK and the phosphatidylinositol3kinase PtdIns3K pathways",
    "simplified": "Neuroprotection was reduced by pertussis toxin and inhibited by the selective type1 S1PR S1P1R antagonist W146. MAPK and the phosphatidylinositol3kinase PtdIns3K pathways were also affected by pertussis toxin."
  },
  {
    "text": "The effects of anagliptin on the oral function of a dipeptidyl peptidase4 inhibitor were investigated after a single oral dose of 100 mg in six healthy men .",
    "triple_list": [
      [
        "anagliptin",
        "CPR:4",
        "dipeptidyl peptidase4"
      ]
    ],
    "updated": "Yes",
    "original": "The disposition of anagliptin an orally active highly selective dipeptidyl peptidase4 inhibitor was investigated after a single oral dose of 100 mg192 MBq 14Canagliptin to six healthy men",
    "simplified": "The effects of anagliptin on the oral function of a dipeptidyl peptidase4 inhibitor were investigated after a single oral dose of 100 mg in six healthy men."
  },
  {
    "text": "14Canagliptin is a novel dipeptidyl peptidase4 inhibitor that works in humans .",
    "triple_list": [
      [
        "14Canagliptin",
        "CPR:4",
        "dipeptidyl peptidase4"
      ]
    ],
    "updated": "Yes",
    "original": "Pharmacokinetics and metabolism of 14Canagliptin a novel dipeptidyl peptidase4 inhibitor in humans",
    "simplified": "14Canagliptin is a novel dipeptidyl peptidase4 inhibitor that works in humans."
  },
  {
    "text": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate indicating active renal elimination that might reflect the fact that anagliptin may be a substrate of OAT1 OAT3 MDR1 and MRP2 and M1 a substrate of OAT3 BCRP MRP2 and MRP4",
    "triple_list": [
      [
        "anagliptin",
        "CPR:9",
        "OAT1"
      ],
      [
        "anagliptin",
        "CPR:9",
        "OAT3"
      ],
      [
        "anagliptin",
        "CPR:9",
        "MDR1"
      ],
      [
        "anagliptin",
        "CPR:9",
        "MRP2"
      ]
    ],
    "updated": "No",
    "original": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate indicating active renal elimination that might reflect the fact that anagliptin may be a substrate of OAT1 OAT3 MDR1 and MRP2 and M1 a substrate of OAT3 BCRP MRP2 and MRP4",
    "simplified": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate indicating active renal elimination. It is possible that anagliptin and M1 are substrates for other drugs in the body, such as BCRP."
  },
  {
    "text": "Antiretroviral protease inhibitors lopinavir LPV and ritonavir RTV are reported BSEP inhibitors",
    "triple_list": [
      [
        "protease",
        "CPR:4",
        "lopinavir"
      ],
      [
        "lopinavir",
        "CPR:4",
        "BSEP"
      ],
      [
        "protease",
        "CPR:4",
        "LPV"
      ],
      [
        "LPV",
        "CPR:4",
        "BSEP"
      ],
      [
        "protease",
        "CPR:4",
        "ritonavir"
      ],
      [
        "ritonavir",
        "CPR:4",
        "BSEP"
      ],
      [
        "protease",
        "CPR:4",
        "RTV"
      ],
      [
        "RTV",
        "CPR:4",
        "BSEP"
      ]
    ],
    "updated": "No",
    "original": "Antiretroviral protease inhibitors lopinavir LPV and ritonavir RTV are reported BSEP inhibitors",
    "simplified": "The two most common BSEP inhibitors are lopinavir LPV and ritonavir RTV."
  },
  {
    "text": "GHRP6 is a growth hormone secretagogue . It also helps the body to grow more tissue .",
    "triple_list": [
      [
        "GHRP6",
        "CPR:3",
        "growth hormone"
      ]
    ],
    "updated": "Yes",
    "original": "GHRP6 is a growth hormone secretagogue that also enhances tissue viability in different organs",
    "simplified": "GHRP6 is a growth hormone secretagogue. It also helps the body to grow more tissue."
  },
  {
    "text": "The altered activities of key enzymes such as glucose6phosphatase and fructose16bisphosphatase of carbohydrate metabolism significantly p005 decreased in the liver of diabetic rats while hexokinase pyruvate kinase glucose6phosphate dehydrogenase and glycogen content significantly p005 decreased in the liver of diabetic rats .",
    "triple_list": [
      [
        "glucose6phosphatase",
        "CPR:9",
        "carbohydrate"
      ],
      [
        "fructose16bisphosphatase",
        "CPR:9",
        "carbohydrate"
      ]
    ],
    "updated": "Yes",
    "original": "The altered activities of key enzymes such as glucose6phosphatase and fructose16bisphosphatase of carbohydrate metabolism significantly p005 increased whereas hexokinase pyruvate kinase glucose6phosphate dehydrogenase and glycogen content significantly p005 decreased in the liver of diabetic rats and also increased activities of aspartate transaminase AST alanine transaminase ALT and alkaline phosphatase ALP",
    "simplified": "The altered activities of key enzymes such as glucose6phosphatase and fructose16bisphosphatase of carbohydrate metabolism significantly p005 decreased in the liver of diabetic rats while hexokinase pyruvate kinase glucose6phosphate dehydrogenase and glycogen content significantly p005 decreased in the liver of diabetic rats."
  },
  {
    "text": "Ibandronate can increase the expression of the proapoptotic gene FAS in cancer cells by epigenetic means .",
    "triple_list": [
      [
        "Ibandronate",
        "CPR:3",
        "FAS"
      ]
    ],
    "updated": "Yes",
    "original": "Ibandronate increases the expression of the proapoptotic gene FAS by epigenetic mechanisms in tumor cells",
    "simplified": "Ibandronate can increase the expression of the proapoptotic gene FAS in cancer cells by epigenetic means."
  },
  {
    "text": "The activity of smallGTPases can be modulated by bisphosphonates to induce apoptosis in neoplastic cells by DNACpGdemethylation and stimulation of FAS expression .",
    "triple_list": [
      [
        "bisphosphonates",
        "CPR:3",
        "FAS"
      ]
    ],
    "updated": "Yes",
    "original": "Data suggest that bisphosphonates via modulation of the activity of smallGTPases induce apoptosis in neoplastic cells by DNACpGdemethylation and stimulation of FAS expression",
    "simplified": "The activity of smallGTPases can be modulated by bisphosphonates to induce apoptosis in neoplastic cells by DNACpGdemethylation and stimulation of FAS expression."
  },
  {
    "text": "Further we found stimulation of FASexpression as a result of epigenetic DNA demethylation that was due to downregulation of DNMT1 which was rescued by reisoprenylation by both geranylgeranylpyrophosphate and farnesylpyrophosphate",
    "triple_list": [
      [
        "DNMT1",
        "CPR:3",
        "geranylgeranylpyrophosphate"
      ],
      [
        "DNMT1",
        "CPR:3",
        "farnesylpyrophosphate"
      ]
    ],
    "updated": "No",
    "original": "Further we found stimulation of FASexpression as a result of epigenetic DNA demethylation that was due to downregulation of DNMT1 which was rescued by reisoprenylation by both geranylgeranylpyrophosphate and farnesylpyrophosphate",
    "simplified": "Further, we found that FASexpression was increased as a result of epigenetic DNA demethylation that was rescued by both geranylgeranylpyrophosphate and farnesylpyrophosphate by reisoprenylation."
  },
  {
    "text": "The AhR target gene CYP1A1 mRNA expression was induced by TCDD but was not affected by the AR CAG length",
    "triple_list": [
      [
        "CYP1A1",
        "CPR:3",
        "TCDD"
      ]
    ],
    "updated": "No",
    "original": "The AhR target gene CYP1A1 mRNA expression was induced by TCDD but was not affected by the AR CAG length",
    "simplified": "The expression of the AhR target gene was induced by TCDD but was not affected by the AR CAG length"
  },
  {
    "text": "TCDD had no effect on AR activity in PNT1A cells but it did have an effect on AR activity in PC3 cells .",
    "triple_list": [
      [
        "TCDD",
        "CPR:3",
        "AR"
      ]
    ],
    "updated": "Yes",
    "original": "TCDD had no effect on AR activity in PC3 cells whereas the shortest AR variant was induced by TCDD in PNT1A cells",
    "simplified": "TCDD had no effect on AR activity in PNT1A cells but it did have an effect on AR activity in PC3 cells."
  },
  {
    "text": "Systemic injection to mice of siRNA lipoplexes rather than of cationic liposome caused several cytokines to be produced in mice . When polyglutamate was added to the plasmid , this did not happen .",
    "triple_list": [
      [
        "cytokines",
        "CPR:4",
        "polyglutamate"
      ]
    ],
    "updated": "Yes",
    "original": "Systemic injection to mice of siRNA lipoplexes rather than of cationic liposome triggered a production of several cytokines in mice and replacement of plasmid by polyglutamate reduced the elevation of all assayed cytokines",
    "simplified": "Systemic injection to mice of siRNA lipoplexes rather than of cationic liposome caused several cytokines to be produced in mice. When polyglutamate was added to the plasmid, this did not happen."
  },
  {
    "text": "We found that helenalin markedly induced endoplasmic reticulum ER stressrelated genes such as regulated in development and DNA damage responses REDD 1 activating transcription factor4 ATF4 andor the CCAAT enhancerbinding proteinhomologous protein CHOP",
    "triple_list": [
      [
        "helenalin",
        "CPR:3",
        "regulated in development and DNA damage responses REDD 1"
      ],
      [
        "helenalin",
        "CPR:3",
        "activating transcription factor4"
      ],
      [
        "helenalin",
        "CPR:3",
        "ATF4"
      ],
      [
        "helenalin",
        "CPR:3",
        "CCAAT enhancerbinding proteinhomologous protein"
      ],
      [
        "helenalin",
        "CPR:3",
        "CHOP"
      ]
    ],
    "updated": "No",
    "original": "We found that helenalin markedly induced endoplasmic reticulum ER stressrelated genes such as regulated in development and DNA damage responses REDD 1 activating transcription factor4 ATF4 andor the CCAAT enhancerbinding proteinhomologous protein CHOP",
    "simplified": "We found that helenalin markedly induced stress-related genes in the endoplasmic reticulum. The stress-related genes include those involved in development, DNA damage and transcription."
  },
  {
    "text": "In conclusion rCtr1 can transport copper and platinum drugs and sensitizes cells to their cytotoxicities",
    "triple_list": [
      [
        "rCtr1",
        "CPR:9",
        "platinum"
      ],
      [
        "rCtr1",
        "CPR:9",
        "copper"
      ]
    ],
    "updated": "No",
    "original": "In conclusion rCtr1 can transport copper and platinum drugs and sensitizes cells to their cytotoxicities",
    "simplified": "In conclusion rCtr1 can transport drugs to cells and sensitizes cells to protect them."
  },
  {
    "text": "DRG neurons have a large ability to collect copper through a transport process that is mediated by rCtr1 . They are also able to resist copper toxicity and take in oxaliplatin .",
    "triple_list": [
      [
        "copper",
        "CPR:9",
        "rCtr1"
      ],
      [
        "rCtr1",
        "CPR:9",
        "oxaliplatin"
      ]
    ],
    "updated": "Yes",
    "original": "DRG neurons display substantial capacity for accumulating copper via a transport process mediated by rCtr1 but appear able to resist copper toxicity and use alternative mechanisms to take up oxaliplatin",
    "simplified": "DRG neurons have a large ability to collect copper through a transport process that is mediated by rCtr1. They are also able to resist copper toxicity and take in oxaliplatin."
  },
  {
    "text": "Heterologous expression of rCtr1 in HEK293 cells HEKrCtr1 cells increased the uptake and cytotoxicity of copper oxaliplatin cisplatin and carboplatin in comparison to isogenic vectortransfected control cells",
    "triple_list": [
      [
        "rCtr1",
        "CPR:9",
        "copper"
      ],
      [
        "rCtr1",
        "CPR:9",
        "copper"
      ],
      [
        "rCtr1",
        "CPR:9",
        "oxaliplatin"
      ],
      [
        "rCtr1",
        "CPR:9",
        "oxaliplatin"
      ],
      [
        "rCtr1",
        "CPR:9",
        "cisplatin"
      ],
      [
        "rCtr1",
        "CPR:9",
        "cisplatin"
      ],
      [
        "rCtr1",
        "CPR:9",
        "carboplatin"
      ],
      [
        "rCtr1",
        "CPR:9",
        "carboplatin"
      ]
    ],
    "updated": "No",
    "original": "Heterologous expression of rCtr1 in HEK293 cells HEKrCtr1 cells increased the uptake and cytotoxicity of copper oxaliplatin cisplatin and carboplatin in comparison to isogenic vectortransfected control cells",
    "simplified": "Heterologous expression of rCtr1 in human hematopoiesis cells increased the uptake and cytotoxicity of copper oxaliplatin in human hematopoiesis cells compared to control cells."
  },
  {
    "text": "Cultured rat DRG neurons endogenously expressed rCtr1 protein on their neuronal cell body plasma membranes and cytoplasm and were able to take in copper but were not able to take in copper in .",
    "triple_list": [
      [
        "rCtr1",
        "CPR:9",
        "copper"
      ]
    ],
    "updated": "Yes",
    "original": "Cultured rat DRG neurons endogenously expressed rCtr1 protein on their neuronal cell body plasma membranes and cytoplasm and displayed substantial capacity for taking up copper but were resistant to copper toxicity",
    "simplified": "Cultured rat DRG neurons endogenously expressed rCtr1 protein on their neuronal cell body plasma membranes and cytoplasm and were able to take in copper but were not able to take in copper in."
  },
  {
    "text": "The uptake of copper by both cultured rat DRG neurons and HEK rCtr1 cells was saturable and inhibited by cold temperature , suggesting that rCtr1 is involved in the uptake .",
    "triple_list": [
      [
        "copper",
        "CPR:9",
        "rCtr1"
      ]
    ],
    "updated": "Yes",
    "original": "The uptake of copper by both cultured rat DRG neurons and HEK rCtr1 cells was saturable and inhibited by cold temperature silver and zinc consistent with it being mediated by rCtr1",
    "simplified": "The uptake of copper by both cultured rat DRG neurons and HEK rCtr1 cells was saturable and inhibited by cold temperature, suggesting that rCtr1 is involved in the uptake."
  },
  {
    "text": "Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons",
    "triple_list": [
      [
        "rat Ctr1",
        "CPR:9",
        "copper"
      ],
      [
        "rat Ctr1",
        "CPR:9",
        "platinum"
      ]
    ],
    "updated": "No",
    "original": "Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons",
    "simplified": "The effects of copper and platinum in dorsal root ganglion neurons on the uptake and toxicity of drugs"
  },
  {
    "text": "In addition glucosamine attenuated p21 protein stability via the proteasomal proteolytic pathway as well as inducing p21 nuclear accumulation",
    "triple_list": [
      [
        "glucosamine",
        "CPR:3",
        "p21"
      ],
      [
        "glucosamine",
        "CPR:4",
        "p21"
      ]
    ],
    "updated": "No",
    "original": "In addition glucosamine attenuated p21 protein stability via the proteasomal proteolytic pathway as well as inducing p21 nuclear accumulation",
    "simplified": "Glucosamine also changes the stability of p21 protein in the proteasomal pathway. It causes p21 nuclear accumulation."
  },
  {
    "text": "Altogether our results suggest that a high dose of glucosamine may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G0G1 phase and that p21 p53 and HO1 expression and nuclear p21 accumulation are affected at least in part by a reduction in Rb phosphorylation .",
    "triple_list": [
      [
        "glucosamine",
        "CPR:3",
        "p21"
      ],
      [
        "glucosamine",
        "CPR:4",
        "Rb"
      ]
    ],
    "updated": "Yes",
    "original": "Altogether our results suggest that a high dose of glucosamine may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G0G1 phase and that this occurs at least in part by a reduction in Rb phosphorylation together with modulation of p21 p53 and HO1 expression and nuclear p21 accumulation",
    "simplified": "Altogether our results suggest that a high dose of glucosamine may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G0G1 phase and that p21 p53 and HO1 expression and nuclear p21 accumulation are affected at least in part by a reduction in Rb phosphorylation."
  },
  {
    "text": "Glucosamine at 50 mM increased the expression of p53 and heme oxygenase1 HO1 but also caused a reduction in the expression of p21 .",
    "triple_list": [
      [
        "Glucosamine",
        "CPR:3",
        "p53"
      ],
      [
        "Glucosamine",
        "CPR:3",
        "heme oxygenase1"
      ],
      [
        "Glucosamine",
        "CPR:4",
        "p21"
      ]
    ],
    "updated": "Yes",
    "original": "Glucosamine at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and heme oxygenase1 HO1 but also caused a reduction in p21 protein expression",
    "simplified": "Glucosamine at 50 mM increased the expression of p53 and heme oxygenase1 HO1 but also caused a reduction in the expression of p21."
  },
  {
    "text": "When we looked at retinoblastoma Rb protein phosphorylation we found an inhibitory effect by glucosamine at 20 and 50 mM .",
    "triple_list": [
      [
        "retinoblastoma Rb protein",
        "CPR:4",
        "glucosamine"
      ]
    ],
    "updated": "Yes",
    "original": "Examination of phosphorylation in retinoblastoma Rb protein we found an inhibitory effect by glucosamine at 20 and 50 mM",
    "simplified": "When we looked at retinoblastoma Rb protein phosphorylation we found an inhibitory effect by glucosamine at 20 and 50 mM."
  },
  {
    "text": "Characterization of substituted phenylpropylamides as highly selective agonists at the melatonin MT2 receptor",
    "triple_list": [
      [
        "phenylpropylamides",
        "CPR:5",
        "melatonin MT2 receptor"
      ]
    ],
    "updated": "No",
    "original": "Characterization of substituted phenylpropylamides as highly selective agonists at the melatonin MT2 receptor",
    "simplified": "S substituted phenylpropylamides are highly selective for the melatonin receptor in the brain."
  },
  {
    "text": "We show that the expression of PIM1 in MCF7 cells is induced in response to estradiol and that ER\u03b1 regulated enhancers located distally upstream from the gene are involved .",
    "triple_list": [
      [
        "PIM1",
        "CPR:3",
        "estradiol"
      ],
      [
        "estradiol",
        "CPR:3",
        "ER\u03b1"
      ]
    ],
    "updated": "Yes",
    "original": "We show that the expression of PIM1 is induced in response to estradiol in MCF7 cells and that the induction is mediated by ER\u03b1 regulated enhancers located distally upstream from the gene",
    "simplified": "We show that the expression of PIM1 in MCF7 cells is induced in response to estradiol and that ER\u03b1 regulated enhancers located distally upstream from the gene are involved."
  },
  {
    "text": "In this work the metabolism of four frequently prescribed inhaled GCs triamcinolone acetonide flunisolide budesonide and fluticasone propionate by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites",
    "triple_list": [
      [
        "triamcinolone acetonide",
        "CPR:9",
        "CYP3A"
      ],
      [
        "flunisolide",
        "CPR:9",
        "CYP3A"
      ],
      [
        "budesonide",
        "CPR:9",
        "CYP3A"
      ],
      [
        "fluticasone propionate",
        "CPR:9",
        "CYP3A"
      ]
    ],
    "updated": "No",
    "original": "In this work the metabolism of four frequently prescribed inhaled GCs triamcinolone acetonide flunisolide budesonide and fluticasone propionate by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites",
    "simplified": "In this work the metabolism of four frequently prescribed inhaled GCs by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites. The GCs were triamcinolone acetonide and budesonide."
  },
  {
    "text": "CYP3A5 which is particularly relevant to GC metabolism in the lungs was also shown to efficiently metabolize triamcinolone acetonide budesonide and fluticasone propionate",
    "triple_list": [
      [
        "CYP3A5",
        "CPR:9",
        "triamcinolone acetonide"
      ],
      [
        "CYP3A5",
        "CPR:9",
        "budesonide"
      ],
      [
        "CYP3A5",
        "CPR:9",
        "fluticasone propionate"
      ]
    ],
    "updated": "No",
    "original": "CYP3A5 which is particularly relevant to GC metabolism in the lungs was also shown to efficiently metabolize triamcinolone acetonide budesonide and fluticasone propionate",
    "simplified": "CYP3A5, which is very important for GC metabolism in the lungs, was shown to work very well to change budesonide into fluticasone propionate."
  },
  {
    "text": "In contrast , flunisolide was only changed by CYP3A4 . It was not changed by CYP3A5 or CYP3A7 .",
    "triple_list": [
      [
        "flunisolide",
        "CPR:9",
        "CYP3A4"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast flunisolide was only metabolized via CYP3A4 with no significant turnover by CYP3A5 or CYP3A7",
    "simplified": "In contrast, flunisolide was only changed by CYP3A4. It was not changed by CYP3A5 or CYP3A7."
  },
  {
    "text": "Different roles of methamphetamine in memory consolidation and retrieval and the accompanying changes of ERK and CREB activation in the prefrontal cortex and hippocampus",
    "triple_list": [
      [
        "methamphetamine",
        "CPR:3",
        "ERK"
      ],
      [
        "methamphetamine",
        "CPR:3",
        "CREB"
      ]
    ],
    "updated": "Yes",
    "original": "Distinct roles of methamphetamine in modulating spatial memory consolidation retrieval reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex",
    "simplified": "Different roles of methamphetamine in memory consolidation and retrieval and the accompanying changes of ERK and CREB activation in the prefrontal cortex and hippocampus"
  },
  {
    "text": "Both ERK and CREB were activated in the PFC after memory retrieval but not in other processes in the METH treated mouse group .",
    "triple_list": [
      [
        "ERK",
        "CPR:3",
        "METH"
      ],
      [
        "CREB",
        "CPR:3",
        "METH"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast activation of both ERK and CREB in the PFC was found following memory retrieval but not other processes in METH treated mouse groups",
    "simplified": "Both ERK and CREB were activated in the PFC after memory retrieval but not in other processes in the METH treated mouse group."
  },
  {
    "text": "Moreover activation of the ERK and CREB signaling pathway in the hippocampus might be involved in METH induced spatial memory changes",
    "triple_list": [
      [
        "ERK",
        "CPR:3",
        "METH"
      ],
      [
        "CREB",
        "CPR:3",
        "METH"
      ]
    ],
    "updated": "No",
    "original": "Moreover activation of the ERK and CREB signaling pathway in the hippocampus might be involved in METH induced spatial memory changes",
    "simplified": "In addition, the ERK and CREB signaling pathway in the hippocampus may be involved in changes in spatial memory."
  },
  {
    "text": "A reporter construct driven by 4 kb of the chicken rasdva 5flanking region containing six putative pituitaryspecific transcription factor1 Pit1 binding sites and two potential glucocorticoid receptor GR binding sites was highly activated in embryonic pituitary cells and upregulated by corticosterone",
    "triple_list": [
      [
        "chicken rasdva",
        "CPR:3",
        "corticosterone"
      ],
      [
        "pituitaryspecific transcription factor1 Pit1 binding sites",
        "CPR:3",
        "corticosterone"
      ],
      [
        "glucocorticoid receptor GR binding sites",
        "CPR:3",
        "corticosterone"
      ]
    ],
    "updated": "No",
    "original": "A reporter construct driven by 4 kb of the chicken rasdva 5flanking region containing six putative pituitaryspecific transcription factor1 Pit1 binding sites and two potential glucocorticoid receptor GR binding sites was highly activated in embryonic pituitary cells and upregulated by corticosterone",
    "simplified": "A reporter construct driven by 4 kb of the chicken rasdva 5flanking region containing six potential glucocorticoid receptor GR binding sites and two potential pituitaryspecific transcription factor1 Pit1 binding sites was highly activated in embryonic pituitary cells."
  },
  {
    "text": "However mutating putative GR binding sites did not substantially reduce induction of rasdva promoter activity by corticosterone suggesting additional DNA elements within the 5flanking region are responsible for glucocorticoid regulation",
    "triple_list": [
      [
        "GR binding sites",
        "CPR:3",
        "corticosterone"
      ],
      [
        "rasdva promoter",
        "CPR:3",
        "corticosterone"
      ]
    ],
    "updated": "No",
    "original": "However mutating putative GR binding sites did not substantially reduce induction of rasdva promoter activity by corticosterone suggesting additional DNA elements within the 5flanking region are responsible for glucocorticoid regulation",
    "simplified": "However, changing the GR binding sites did not reduce the amount of corticosterone needed to make the Rasdva promoter work. This means that other DNA elements in the 5flanking region may be responsible."
  },
  {
    "text": "To investigate the role of mGluR8 in retinal ganglion cells synaptic responses , we used a recently identified positive allosteric modulator of mGluR8 AZ12216052 AZ and the mGluR8 specific orthosteric agonist S34dicarboxyphenylglycine DCPG .",
    "triple_list": [
      [
        "mGluR8",
        "CPR:5",
        "S34dicarboxyphenylglycine"
      ],
      [
        "mGluR8",
        "CPR:5",
        "DCPG"
      ]
    ],
    "updated": "Yes",
    "original": "To investigate the role of mGluR8 in modulating the synaptic responses of retinal ganglion cells we used a recently identified positive allosteric modulator of mGluR8 AZ12216052 AZ and the mGluR8 specific orthosteric agonist S34dicarboxyphenylglycine DCPG",
    "simplified": "To investigate the role of mGluR8 in retinal ganglion cells synaptic responses, we used a recently identified positive allosteric modulator of mGluR8 AZ12216052 AZ and the mGluR8 specific orthosteric agonist S34dicarboxyphenylglycine DCPG."
  },
  {
    "text": "Here we compared the effects of a dimeric PSD95 inhibitor UCCB01125 and the NMDAR antagonist MK801 on mechanical hypersensitivity in the complete Freunds adjuvant CFA model of inflammatory pain",
    "triple_list": [
      [
        "PSD95",
        "CPR:4",
        "UCCB01125"
      ],
      [
        "NMDAR",
        "CPR:6",
        "MK801"
      ]
    ],
    "updated": "No",
    "original": "Here we compared the effects of a dimeric PSD95 inhibitor UCCB01125 and the NMDAR antagonist MK801 on mechanical hypersensitivity in the complete Freunds adjuvant CFA model of inflammatory pain",
    "simplified": "Here we compared the effects of a dimeric NMDAR antagonist and a dimeric PSD95 inhibitor on mechanical hypersensitivity in the complete Freunds adjuvant CFA model of inflammation."
  },
  {
    "text": "UCCB01125 a dimeric inhibitor of PSD95 without disrupting cognitive or motor performance compared with the NMDA receptor antagonist MK801",
    "triple_list": [
      [
        "NMDA receptor",
        "CPR:6",
        "MK801"
      ]
    ],
    "updated": "Yes",
    "original": "UCCB01125 a dimeric inhibitor of PSD95 reduces inflammatory pain without disrupting cognitive or motor performance comparison with the NMDA receptor antagonist MK801",
    "simplified": "UCCB01125 a dimeric inhibitor of PSD95 without disrupting cognitive or motor performance compared with the NMDA receptor antagonist MK801"
  },
  {
    "text": "The treatment also prevented the increase in serum creatine kinase total and isoforms markers of neurological damage from the high cholesterol diet .",
    "triple_list": [
      [
        "cholesterol",
        "CPR:3",
        "creatine kinase"
      ]
    ],
    "updated": "Yes",
    "original": "The treatment also prevented the high cholesterol dietinduced increase in serum creatine kinase total and isoforms markers of neurological cardiac and muscular damage",
    "simplified": "The treatment also prevented the increase in serum creatine kinase total and isoforms markers of neurological damage from the high cholesterol diet."
  },
  {
    "text": "GIP potentiates glucose stimulated insulin secretion and induces energy accumulation into adipose tissue resulting in obesity",
    "triple_list": [
      [
        "glucose",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "No",
    "original": "GIP potentiates glucose stimulated insulin secretion and induces energy accumulation into adipose tissue resulting in obesity",
    "simplified": "GIP increases the production of insulin and causes energy to be built up in adipose tissue. This leads to obesity."
  },
  {
    "text": "We concluded that in overweight and obese women with PCOS , Orlistat administration combined with diet and physical exercise for 24 weeks resulted in significant weight loss and increased serum levels of the hormone AMH .",
    "triple_list": [
      [
        "Orlistat",
        "CPR:3",
        "AMH"
      ]
    ],
    "updated": "Yes",
    "original": "We concluded that in overweight and obese women with PCOS Orlistat administration combined with diet and physical exercise for 24 weeks resulted in significant weight loss improvement of hyperandrogenism and insulin sensitivity and increased serum AMH levels",
    "simplified": "We concluded that in overweight and obese women with PCOS, Orlistat administration combined with diet and physical exercise for 24 weeks resulted in significant weight loss and increased serum levels of the hormone AMH."
  },
  {
    "text": "Diet physical exercise and Orlistat administration increase serum AntiM\u00fcllerian Hormone AMH levels in women with polycystic ovary syndrome PCOS",
    "triple_list": [
      [
        "Orlistat",
        "CPR:3",
        "AntiM\u00fcllerian Hormone"
      ],
      [
        "Orlistat",
        "CPR:3",
        "AMH"
      ]
    ],
    "updated": "No",
    "original": "Diet physical exercise and Orlistat administration increase serum AntiM\u00fcllerian Hormone AMH levels in women with polycystic ovary syndrome PCOS",
    "simplified": "Orlistat administration and diet physical exercise increase serum anti-M\u00fcllerian hormone levels in women with polycystic ovary syndrome"
  },
  {
    "text": "In addition , 125OH2D3 reduced the expression of Oat1 and Oat3 .",
    "triple_list": [
      [
        "125OH2D3",
        "CPR:4",
        "Oat1"
      ],
      [
        "125OH2D3",
        "CPR:4",
        "Oat3"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover 125OH2D3 decreased expression of Oat1 and Oat3 in rat kidney",
    "simplified": "In addition, 125OH2D3 reduced the expression of Oat1 and Oat3."
  },
  {
    "text": "The mechanism of interaction between JBP485 and 125OH2D3 could be explained at least in part by inhibitory effect of 125OH2D3 on expression of Oats in rat kidney",
    "triple_list": [
      [
        "125OH2D3",
        "CPR:4",
        "Oats"
      ]
    ],
    "updated": "No",
    "original": "The mechanism of interaction between JBP485 and 125OH2D3 could be explained at least in part by inhibitory effect of 125OH2D3 on expression of Oats in rat kidney",
    "simplified": "The interaction between JBP485 and 125OH2D3 could be explained at least in part by the fact that 125OH2D3 makes the oat cells not work at all."
  },
  {
    "text": "For the first time , it was shown that ISO causes apoptosis in HepG2 cells by inactivating ERK12 kinase and by making JNK and p38 kinases work . It was also shown that ISO can make the MAPK singaling pathway work again .",
    "triple_list": [
      [
        "ISO",
        "CPR:3",
        "JNK"
      ],
      [
        "ISO",
        "CPR:3",
        "p38"
      ],
      [
        "ISO",
        "CPR:3",
        "kinases"
      ],
      [
        "ISO",
        "CPR:3",
        "MAPK"
      ]
    ],
    "updated": "Yes",
    "original": "These results demonstrated for the first time that ISO induces apoptosis in HepG2 cells through inactivating ERK12 kinase and activating JNK and p38 kinases and ROS stimulated by ISO is able to activate the MAPK singaling pathway as the upstream signaling molecules",
    "simplified": "For the first time, it was shown that ISO causes apoptosis in HepG2 cells by inactivating ERK12 kinase and by making JNK and p38 kinases work. It was also shown that ISO can make the MAPK singaling pathway work again."
  },
  {
    "text": "ISO significantly increased the expression of JNK and p38 kinases and inhibited ERK12 kinase .",
    "triple_list": [
      [
        "ISO",
        "CPR:3",
        "JNK"
      ],
      [
        "ISO",
        "CPR:3",
        "p38"
      ],
      [
        "ISO",
        "CPR:3",
        "kinases"
      ]
    ],
    "updated": "Yes",
    "original": "ISO significantly inhibited the levels of ERK12 kinase and increased the expression of JNK and p38 kinases",
    "simplified": "ISO significantly increased the expression of JNK and p38 kinases and inhibited ERK12 kinase."
  },
  {
    "text": "Furthermore U0126 an ERK12 inhibitor significantly enhanced the ISO induced the Bax Bcl2 ratio the release of cytochrome c to the cytosol fraction and the levels of cleaved caspase3",
    "triple_list": [
      [
        "U0126",
        "CPR:3",
        "Bax"
      ],
      [
        "U0126",
        "CPR:3",
        "Bcl2"
      ],
      [
        "ISO",
        "CPR:3",
        "Bax"
      ],
      [
        "ISO",
        "CPR:3",
        "Bcl2"
      ]
    ],
    "updated": "No",
    "original": "Furthermore U0126 an ERK12 inhibitor significantly enhanced the ISO induced the Bax Bcl2 ratio the release of cytochrome c to the cytosol fraction and the levels of cleaved caspase3",
    "simplified": "In addition, U0126 an ERK12 inhibitor significantly enhanced the Bax Bcl2 ratio and the levels of cleaved caspase3 and cytochrome c to the cytosol fraction."
  },
  {
    "text": "While SP600125 a JNK inhibitor and SB203580 a p38 inhibitor markedly prevented the expression of these proteins induced by ISO",
    "triple_list": [
      [
        "JNK",
        "CPR:3",
        "ISO"
      ],
      [
        "p38",
        "CPR:3",
        "ISO"
      ],
      [
        "SP600125",
        "CPR:4",
        "JNK"
      ],
      [
        "SB203580",
        "CPR:4",
        "p38"
      ]
    ],
    "updated": "No",
    "original": "While SP600125 a JNK inhibitor and SB203580 a p38 inhibitor markedly prevented the expression of these proteins induced by ISO",
    "simplified": "SP600125, a JNK inhibitor, and SB203580, a p38 inhibitor, significantly reduced the expression of these proteins."
  },
  {
    "text": "ISO is able to induce apoptosis through mitochondrial dysfunction . It is also able to inhibit the PI3K Akt signaling pathway in HepG2 cells , which is important for cell division .",
    "triple_list": [
      [
        "ISO",
        "CPR:4",
        "PI3K"
      ],
      [
        "ISO",
        "CPR:4",
        "Akt"
      ]
    ],
    "updated": "Yes",
    "original": "ISO is able to induce apoptosis through mitochondrial dysfunction and inhibition of PI3K Akt signaling pathway in HepG2 cells however the effects of ISO on MAPK signaling pathways remain unknown",
    "simplified": "ISO is able to induce apoptosis through mitochondrial dysfunction. It is also able to inhibit the PI3K Akt signaling pathway in HepG2 cells, which is important for cell division."
  },
  {
    "text": "The NAC also stopped the use of p JNK and pp38 but this did not help .",
    "triple_list": [
      [
        "NAC",
        "CPR:4",
        "JNK"
      ],
      [
        "NAC",
        "CPR:4",
        "pp38"
      ]
    ],
    "updated": "Yes",
    "original": "NAC also suppressed the p JNK and pp38 but failed to reverse the effects of ISO",
    "simplified": "The NAC also stopped the use of p JNK and pp38 but this did not help."
  },
  {
    "text": "Treatment with IMG and hyperoside significantly prolonged aPTT and PT and inhibited production of thrombin and FXa in HUVECs The effects of IMG and hyperoside on the development of thrombin",
    "triple_list": [
      [
        "IMG",
        "CPR:3",
        "thrombin"
      ],
      [
        "IMG",
        "CPR:4",
        "thrombin"
      ],
      [
        "IMG",
        "CPR:4",
        "FXa"
      ],
      [
        "hyperoside",
        "CPR:4",
        "thrombin"
      ],
      [
        "hyperoside",
        "CPR:4",
        "FXa"
      ],
      [
        "IMG",
        "CPR:4",
        "FXa"
      ],
      [
        "hyperoside",
        "CPR:4",
        "thrombin"
      ],
      [
        "hyperoside",
        "CPR:4",
        "FXa"
      ]
    ],
    "updated": "Yes",
    "original": "Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs",
    "simplified": "Treatment with IMG and hyperoside significantly prolonged aPTT and PT and inhibited production of thrombin and FXa in HUVECs The effects of IMG and hyperoside on the development of thrombin"
  },
  {
    "text": "In addition treatment with IMG and hyperoside resulted in significant reduction of the PAI1 to tPA ratio and inhibition of TNF\u03b1 induced production of PAI1 .",
    "triple_list": [
      [
        "IMG",
        "CPR:4",
        "TNF\u03b1"
      ],
      [
        "IMG",
        "CPR:4",
        "PAI1"
      ],
      [
        "hyperoside",
        "CPR:4",
        "TNF\u03b1"
      ],
      [
        "hyperoside",
        "CPR:4",
        "PAI1"
      ],
      [
        "IMG",
        "CPR:4",
        "PAI1"
      ],
      [
        "IMG",
        "CPR:4",
        "tPA"
      ]
    ],
    "updated": "Yes",
    "original": "In addition treatment with IMG and hyperoside resulted in inhibition of TNF\u03b1 induced production of PAI1 and treatment with IMG resulted in significant reduction of the PAI1 to tPA ratio",
    "simplified": "In addition treatment with IMG and hyperoside resulted in significant reduction of the PAI1 to tPA ratio and inhibition of TNF\u03b1 induced production of PAI1."
  },
  {
    "text": "In previous study we discovered multitarget drugs towards the AA metabolic network among which a dualtarget inhibitor JMC084 for human nonpancreatic secretory phospholipase A2 hnpsPLA2 and human leukotriene A4 hydrolase LTA4Hh was found",
    "triple_list": [
      [
        "JMC084",
        "CPR:4",
        "human leukotriene A4 hydrolase"
      ],
      [
        "JMC084",
        "CPR:4",
        "LTA4Hh"
      ],
      [
        "JMC084",
        "CPR:4",
        "human nonpancreatic secretory phospholipase A2"
      ],
      [
        "JMC084",
        "CPR:4",
        "hnpsPLA2"
      ]
    ],
    "updated": "No",
    "original": "In previous study we discovered multitarget drugs towards the AA metabolic network among which a dualtarget inhibitor JMC084 for human nonpancreatic secretory phospholipase A2 hnpsPLA2 and human leukotriene A4 hydrolase LTA4Hh was found",
    "simplified": "In previous study we discovered multitarget drugs towards the AA metabolic network among which human leukotriene A4 hydrolase LTA4Hh and human nonpancreatic secretory phospholipase A2 hnpsPLA2 were found."
  },
  {
    "text": "Optimization of 5hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase",
    "triple_list": [
      [
        "5hydroxytryptamines",
        "CPR:4",
        "phospholipase A2"
      ],
      [
        "5hydroxytryptamines",
        "CPR:4",
        "leukotriene A4 hydrolase"
      ]
    ],
    "updated": "No",
    "original": "Optimization of 5hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase",
    "simplified": "The 5hydroxytryptamines can be used as dual function inhibitors. They can block leukotriene A4 hydrolase."
  },
  {
    "text": "Dual function inhibitors targeting phospholipase A2 PLA2 and leukotriene A4 hydrolase LTA4H may balance the arachidonic acid AA metabolic network and be used as new antiinflammatory drugs",
    "triple_list": [
      [
        "PLA2",
        "CPR:9",
        "arachidonic acid"
      ],
      [
        "leukotriene A4 hydrolase",
        "CPR:9",
        "arachidonic acid"
      ],
      [
        "LTA4H",
        "CPR:9",
        "arachidonic acid"
      ],
      [
        "phospholipase A2",
        "CPR:9",
        "arachidonic acid"
      ]
    ],
    "updated": "No",
    "original": "Dual function inhibitors targeting phospholipase A2 PLA2 and leukotriene A4 hydrolase LTA4H may balance the arachidonic acid AA metabolic network and be used as new antiinflammatory drugs",
    "simplified": "Dual function inhibitors targeting leukotriene A4 hydrolase LTA4H and phospholipase A2 PLA2 may be used as new antiinflammatory drugs in the future."
  },
  {
    "text": "In addition , we have shown that apomorphine also acts on endogenous TRPA1 in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP1 , where serotonin is released when it is activated .",
    "triple_list": [
      [
        "apomorphine",
        "CPR:3",
        "TRPA1"
      ]
    ],
    "updated": "Yes",
    "original": "In addition we provide evidence that apomorphine also acts on endogenous TRPA1 in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP1 from which serotonin is released upon activation of TRPA1",
    "simplified": "In addition, we have shown that apomorphine also acts on endogenous TRPA1 in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP1, where serotonin is released when it is activated."
  },
  {
    "text": "Our study shows that human TRPA1 is a target for apomorphine . This means that when TRPA1 is activated , it can cause negative side effects , such as painful injections or nausea .",
    "triple_list": [
      [
        "TRPA1",
        "CPR:3",
        "apomorphine"
      ],
      [
        "TRPA1",
        "CPR:3",
        "apomorphine"
      ]
    ],
    "updated": "Yes",
    "original": "Our study shows that human TRPA1 is a target for apomorphine suggesting that an activation of TRPA1 might contribute to adverse side effects such as nausea and painful injections which can occur during treatment with apomorphine",
    "simplified": "Our study shows that human TRPA1 is a target for apomorphine. This means that when TRPA1 is activated, it can cause negative side effects, such as painful injections or nausea."
  },
  {
    "text": "Whereas the addition of apomorphine in the low micromolar range produced an irreversible activation of the channel application of higher concentrations caused a reversible voltagedependent inhibition of heterologously expressed TRPA1 channels resulting from a reduction of singlechannel open times",
    "triple_list": [
      [
        "apomorphine",
        "CPR:4",
        "TRPA1"
      ]
    ],
    "updated": "No",
    "original": "Whereas the addition of apomorphine in the low micromolar range produced an irreversible activation of the channel application of higher concentrations caused a reversible voltagedependent inhibition of heterologously expressed TRPA1 channels resulting from a reduction of singlechannel open times",
    "simplified": "When apomorphine was added in the low micromolar range, higher concentrations caused a permanent activation of the channel, but when it was added in the high micromolar range, higher concentrations caused a permanent inhibition of the channel."
  },
  {
    "text": "Dietary carbohydrates increase the expression of the SCD1 gene in the liver by binding a protein called sterol response element .",
    "triple_list": [
      [
        "carbohydrates",
        "CPR:3",
        "SCD1"
      ]
    ],
    "updated": "Yes",
    "original": "Dietary carbohydrates increase SCD1 gene expression in liver by sterol response element binding protein SREBP1cdependent and SREBP1c independent pathways",
    "simplified": "Dietary carbohydrates increase the expression of the SCD1 gene in the liver by binding a protein called sterol response element."
  },
  {
    "text": "Previous report demonstrated that thyroid hormone TH negatively regulates mouse SCD1 gene promoter before SREBP1c was revealed",
    "triple_list": [
      [
        "thyroid hormone",
        "CPR:4",
        "mouse SCD1 gene promoter"
      ]
    ],
    "updated": "No",
    "original": "Previous report demonstrated that thyroid hormone TH negatively regulates mouse SCD1 gene promoter before SREBP1c was revealed",
    "simplified": "A previous report showed that the thyroid hormone affects the gene promoter in the mouse SCD1 before SREBP1c was revealed."
  },
  {
    "text": "Human stearoylCoA desaturase 1 SCD1 gene expression is affected by thyroid hormone . This is because the thyroid hormone receptor is near the gene .",
    "triple_list": [
      [
        "Human stearoylCoA desaturase 1",
        "CPR:4",
        "thyroid hormone"
      ],
      [
        "SCD1",
        "CPR:4",
        "thyroid hormone"
      ]
    ],
    "updated": "Yes",
    "original": "Human stearoylCoA desaturase 1 SCD1 gene expression is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptor to the gene promoter",
    "simplified": "Human stearoylCoA desaturase 1 SCD1 gene expression is affected by thyroid hormone. This is because the thyroid hormone receptor is near the gene."
  },
  {
    "text": "When metformin was given to diabetic mice for a long time , cardiac autophagy was improved . JNK1 and Bcl2 pathways were activated .",
    "triple_list": [
      [
        "metformin",
        "CPR:3",
        "JNK1"
      ],
      [
        "metformin",
        "CPR:3",
        "Bcl2"
      ]
    ],
    "updated": "Yes",
    "original": "Finally chronic administration of metformin in diabetic mice restored cardiac autophagy by activating JNK1 Bcl2 pathways and dissociating Beclin1 and Bcl2",
    "simplified": "When metformin was given to diabetic mice for a long time, cardiac autophagy was improved. JNK1 and Bcl2 pathways were activated."
  },
  {
    "text": "When H9c2 cells were exposed to high glucose , the activity of AMPK was reduced . Jun NH2terminal kinase 1 JNK1 Bcell lymphoma 2 Bcl2 signaling was increased .",
    "triple_list": [
      [
        "glucose",
        "CPR:4",
        "AMPK"
      ],
      [
        "glucose",
        "CPR:4",
        "Jun NH2terminal kinase 1"
      ],
      [
        "glucose",
        "CPR:4",
        "JNK1"
      ],
      [
        "glucose",
        "CPR:4",
        "Bcell lymphoma 2"
      ],
      [
        "glucose",
        "CPR:4",
        "Bcl2"
      ]
    ],
    "updated": "Yes",
    "original": "Exposure of H9c2 cells to high glucose reduced AMPK activity inhibited Jun NH2terminal kinase 1 JNK1 Bcell lymphoma 2 Bcl2 signaling and promoted Beclin1 binding to Bcl2",
    "simplified": "When H9c2 cells were exposed to high glucose, the activity of AMPK was reduced. Jun NH2terminal kinase 1 JNK1 Bcell lymphoma 2 Bcl2 signaling was increased."
  },
  {
    "text": "In this current study paclitaxel was found to increase phosphorylation of mitogenactivated protein kinase MAPK kinase 36 MKK36 p38 MAPK as well as protein and mRNA levels of ERCC1 in H1650 and H1703 cells",
    "triple_list": [
      [
        "paclitaxel",
        "CPR:3",
        "mitogenactivated protein kinase"
      ],
      [
        "paclitaxel",
        "CPR:3",
        "p38"
      ],
      [
        "paclitaxel",
        "CPR:3",
        "MAPK"
      ],
      [
        "paclitaxel",
        "CPR:3",
        "ERCC1"
      ]
    ],
    "updated": "No",
    "original": "In this current study paclitaxel was found to increase phosphorylation of mitogenactivated protein kinase MAPK kinase 36 MKK36 p38 MAPK as well as protein and mRNA levels of ERCC1 in H1650 and H1703 cells",
    "simplified": "In this current study paclitaxel was found to increase protein and mRNA levels of ERCC1 in H1650 and H1703 cells as well as phosphorylation of mitogenactivated protein kinase MAPK kinase 36."
  },
  {
    "text": "Moreover paclitaxel induced ERCC1 protein and mRNA levels significantly decreased via the downregulation of p38 activity by either a p38 MAPK inhibitor SB202190 or p38 knockdown with specific small interfering RNA siRNA",
    "triple_list": [
      [
        "paclitaxel",
        "CPR:3",
        "ERCC1"
      ],
      [
        "p38",
        "CPR:4",
        "SB202190"
      ],
      [
        "p38",
        "CPR:4",
        "SB202190"
      ],
      [
        "MAPK",
        "CPR:4",
        "SB202190"
      ]
    ],
    "updated": "No",
    "original": "Moreover paclitaxel induced ERCC1 protein and mRNA levels significantly decreased via the downregulation of p38 activity by either a p38 MAPK inhibitor SB202190 or p38 knockdown with specific small interfering RNA siRNA",
    "simplified": "In addition, the levels of ERCC1 protein and mRNA were significantly decreased by either a p38 MAPK inhibitor (SB202190) or by a specific small interfering RNA (SiRNA) knockdown (P38 knockdown)."
  },
  {
    "text": "Furthermore , metformin was able to not only decrease the cytotoxic effect of paclitaxel but also increase the p38 MAPK mediated ERCC1 expression .",
    "triple_list": [
      [
        "paclitaxel",
        "CPR:3",
        "p38"
      ],
      [
        "paclitaxel",
        "CPR:3",
        "MAPK"
      ],
      [
        "paclitaxel",
        "CPR:3",
        "ERCC1"
      ],
      [
        "metformin",
        "CPR:4",
        "p38"
      ],
      [
        "metformin",
        "CPR:4",
        "MAPK"
      ],
      [
        "metformin",
        "CPR:4",
        "ERCC1"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore metformin was able to not only decrease the paclitaxel induced p38 MAPK mediated ERCC1 expression but also augment the cytotoxic effect induced by paclitaxel",
    "simplified": "Furthermore, metformin was able to not only decrease the cytotoxic effect of paclitaxel but also increase the p38 MAPK mediated ERCC1 expression."
  },
  {
    "text": "Metformin mediated downregulation of p38 mitogenactivated protein kinase dependent excision repair crosscomplementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel",
    "triple_list": [
      [
        "Metformin",
        "CPR:4",
        "p38"
      ],
      [
        "Metformin",
        "CPR:4",
        "mitogenactivated protein kinase"
      ]
    ],
    "updated": "No",
    "original": "Metformin mediated downregulation of p38 mitogenactivated protein kinase dependent excision repair crosscomplementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel",
    "simplified": "Metformin decreases p38-dependent excision repair capacity and sensitizes human lung cancer cells to paclitaxel. Metformin mediated downregulation of p38-dependent excision repair capacity"
  },
  {
    "text": "Finally expression of MKK6 or HAp38 MAPK vectors in lung cancer cells was able to reduce ERCC1 by metformin and paclitaxel . However , cell viability and DNA repair could not be improved .",
    "triple_list": [
      [
        "ERCC1",
        "CPR:4",
        "metformin"
      ],
      [
        "ERCC1",
        "CPR:4",
        "paclitaxel"
      ]
    ],
    "updated": "Yes",
    "original": "Finally expression of constitutive activate MKK6 or HAp38 MAPK vectors in lung cancer cells was able to abrogate ERCC1 downregulation by metformin and paclitaxel as well as cell viability and DNA repair capacity",
    "simplified": "Finally expression of MKK6 or HAp38 MAPK vectors in lung cancer cells was able to reduce ERCC1 by metformin and paclitaxel. However, cell viability and DNA repair could not be improved."
  },
  {
    "text": "Overall our results suggest that inhibition of p38 MAPK signaling by metformin may be a clinically useful combination which however will require further validation in human NSCLC cells .",
    "triple_list": [
      [
        "p38",
        "CPR:4",
        "metformin"
      ],
      [
        "MAPK",
        "CPR:4",
        "metformin"
      ]
    ],
    "updated": "Yes",
    "original": "Overall our results suggest that inhibition of the p38 MAPK signaling by metformin coupled with paclitaxel therapy in human NSCLC cells may be a clinically useful combination which however will require further validation",
    "simplified": "Overall our results suggest that inhibition of p38 MAPK signaling by metformin may be a clinically useful combination which however will require further validation in human NSCLC cells."
  },
  {
    "text": "Contrary to the hypothesis orlistat at 1 nM inhibited CES2 activity by 75 but no inhibition on CES1 placing CES2 one of the most sensitive targets of orlistat",
    "triple_list": [
      [
        "orlistat",
        "CPR:4",
        "CES2"
      ],
      [
        "orlistat",
        "CPR:4",
        "CES2"
      ]
    ],
    "updated": "No",
    "original": "Contrary to the hypothesis orlistat at 1 nM inhibited CES2 activity by 75 but no inhibition on CES1 placing CES2 one of the most sensitive targets of orlistat",
    "simplified": "Orlistat at 1 nM did not affect CES2 activity at all, but it did not affect CES1 either. This means that CES2 is one of the most sensitive targets."
  },
  {
    "text": "Orlistat has been the most used antiobesity drug and the mechanism of its action is to reduce lipid absorption by inhibiting gastrointestinal lipases",
    "triple_list": [
      [
        "Orlistat",
        "CPR:4",
        "lipases"
      ]
    ],
    "updated": "No",
    "original": "Orlistat has been the most used antiobesity drug and the mechanism of its action is to reduce lipid absorption by inhibiting gastrointestinal lipases",
    "simplified": "Orlistat has been the most used antiobesity drug. Its main effect is to reduce the absorption of lipid by the body."
  },
  {
    "text": "Inhibition of this carboxylesterase probably presents a major source for altered therapeutic activity of these medicines if coadministered with orlistat",
    "triple_list": [
      [
        "carboxylesterase",
        "CPR:4",
        "orlistat"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of this carboxylesterase probably presents a major source for altered therapeutic activity of these medicines if coadministered with orlistat",
    "simplified": "Inhibition of this carboxylesterase is probably a major source of these drugs' therapeutic activity, because it may change how they work."
  },
  {
    "text": "This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2 a carboxylesterase with little lipase activity",
    "triple_list": [
      [
        "orlistat",
        "CPR:4",
        "CESs"
      ],
      [
        "orlistat",
        "CPR:4",
        "CES1"
      ],
      [
        "orlistat",
        "CPR:4",
        "CES2"
      ],
      [
        "orlistat",
        "CPR:4",
        "carboxylesterase"
      ],
      [
        "orlistat",
        "CPR:4",
        "lipase"
      ]
    ],
    "updated": "No",
    "original": "This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2 a carboxylesterase with little lipase activity",
    "simplified": "This study was designed to test the hypothesis that orlistat inhibits a carboxylesterase with little lipase activity, called CES2, with higher potency."
  },
  {
    "text": "On stimulation by Gs the activities of ACs can be further selectively modulated by other pathways to ensure that specific cAMP responses are controlled only by the Gs .",
    "triple_list": [
      [
        "ACs",
        "CPR:9",
        "cAMP"
      ]
    ],
    "updated": "Yes",
    "original": "On stimulation by Gs the activities of ACs can be further selectively modulated by other pathways to ensure precise control of intracellular cAMP responses to specific stimuli",
    "simplified": "On stimulation by Gs the activities of ACs can be further selectively modulated by other pathways to ensure that specific cAMP responses are controlled only by the Gs."
  },
  {
    "text": "Regulation of multiple adenylyl cyclases AC provides unique inputs to mediate the synthesis of cAMP a ubiquitous second messenger that controls many aspects of cellular function",
    "triple_list": [
      [
        "adenylyl cyclases",
        "CPR:9",
        "cAMP"
      ],
      [
        "AC",
        "CPR:9",
        "cAMP"
      ]
    ],
    "updated": "No",
    "original": "Regulation of multiple adenylyl cyclases AC provides unique inputs to mediate the synthesis of cAMP a ubiquitous second messenger that controls many aspects of cellular function",
    "simplified": "AC provides unique inputs to mediate the synthesis of cAMP a ubiquitous second messenger that controls many aspects of cellular function (like reading and writing)."
  },
  {
    "text": "We identified one compound , E235 N1benzylpiperidin4yl24fluorophenylbenzodimidazo21bthiazole7carboxamide , that increased levels of ATF4 in transformed cells and activated the ISR .",
    "triple_list": [
      [
        "E235",
        "CPR:3",
        "ATF4"
      ],
      [
        "N1benzylpiperidin4yl24fluorophenylbenzodimidazo21bthiazole7carboxamide",
        "CPR:3",
        "ATF4"
      ]
    ],
    "updated": "Yes",
    "original": "We identified one compound E235 N1benzylpiperidin4yl24fluorophenylbenzodimidazo21bthiazole7carboxamide that activated the ISR and dosedependently increased levels of ATF4 in transformed cells",
    "simplified": "We identified one compound, E235 N1benzylpiperidin4yl24fluorophenylbenzodimidazo21bthiazole7carboxamide, that increased levels of ATF4 in transformed cells and activated the ISR."
  },
  {
    "text": "E235 also activated DNA damage response signaling resulting in increased levels of Ser15 phosphorylated p53 \u03b3H2AX and phosphorylated checkpoint kinase 2 Chk2 although E235 does not appear to cause physical DNA damage",
    "triple_list": [
      [
        "E235",
        "CPR:3",
        "phosphorylated p53"
      ],
      [
        "E235",
        "CPR:3",
        "\u03b3H2AX"
      ],
      [
        "E235",
        "CPR:3",
        "phosphorylated checkpoint kinase 2"
      ],
      [
        "E235",
        "CPR:3",
        "Chk2"
      ]
    ],
    "updated": "No",
    "original": "E235 also activated DNA damage response signaling resulting in increased levels of Ser15 phosphorylated p53 \u03b3H2AX and phosphorylated checkpoint kinase 2 Chk2 although E235 does not appear to cause physical DNA damage",
    "simplified": "E235 also activated DNA damage response signaling. Ser15 phosphorylated p53 \u03b3H2AX and checkpoint kinase 2 Chk2. However, this does not appear to cause physical DNA damage."
  },
  {
    "text": "Cell culture studies demonstrated that PKAA is capable of delivering antiTNF tumor necrosis factor\u03b1 siRNA to lipopolysaccharide LPSstimulated macrophages and significantly inhibits the expression of TNF\u03b1",
    "triple_list": [
      [
        "PKAA",
        "CPR:4",
        "TNF\u03b1"
      ]
    ],
    "updated": "No",
    "original": "Cell culture studies demonstrated that PKAA is capable of delivering antiTNF tumor necrosis factor\u03b1 siRNA to lipopolysaccharide LPSstimulated macrophages and significantly inhibits the expression of TNF\u03b1",
    "simplified": "Cell culture studies have shown that PKAA can deliver antiTNF tumor necrosis factor\u03b1 siRNA to LPS-stimulated macrophages. It also inhibits the expression of TNF-1 and TNF-2."
  },
  {
    "text": "PKAA antiTNF\u03b1 siRNA nanocomplexes significantly reduced the ALT alanine transaminase and the hepatic cellular damages in APAPintoxicated mice",
    "triple_list": [
      [
        "PKAA",
        "CPR:4",
        "ALT"
      ],
      [
        "PKAA",
        "CPR:4",
        "alanine transaminase"
      ]
    ],
    "updated": "No",
    "original": "PKAA antiTNF\u03b1 siRNA nanocomplexes significantly reduced the ALT alanine transaminase and the hepatic cellular damages in APAPintoxicated mice",
    "simplified": "PKAA antiTNF\u03b1 siRNA nanocomplexes significantly reduced the damage to the cells in the liver when APAPintoxicated mice"
  },
  {
    "text": "Moreover wogonin repressed anisomycin induced phosphorylation of p38 cav1 and vascular permeability",
    "triple_list": [
      [
        "anisomycin",
        "CPR:3",
        "p38"
      ],
      [
        "anisomycin",
        "CPR:3",
        "cav1"
      ],
      [
        "wogonin",
        "CPR:4",
        "p38"
      ],
      [
        "wogonin",
        "CPR:4",
        "cav1"
      ]
    ],
    "updated": "No",
    "original": "Moreover wogonin repressed anisomycin induced phosphorylation of p38 cav1 and vascular permeability",
    "simplified": "In addition, wogonin inhibited anisomycin-induced vascular permeability and phosphorylation."
  },
  {
    "text": "These results suggested that wogonin could inhibit H2O2 induced vascular permeability by downregulating the phosphorylation of cav1 . It is also possible that wogonin could be used as a treatment for certain diseases related to vascular permeability .",
    "triple_list": [
      [
        "H2O2",
        "CPR:3",
        "cav1"
      ],
      [
        "wogonin",
        "CPR:4",
        "cav1"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggested that wogonin could inhibit H2O2 induced vascular permeability by downregulating the phosphorylation of cav1 and that it might have a therapeutic potential for the diseases associated with the development of both oxidant and vascular permeability",
    "simplified": "These results suggested that wogonin could inhibit H2O2 induced vascular permeability by downregulating the phosphorylation of cav1. It is also possible that wogonin could be used as a treatment for certain diseases related to vascular permeability."
  },
  {
    "text": "Wogonin inhibits H2O2 induced vascular permeability through suppressing the phosphorylation of caveolin1",
    "triple_list": [
      [
        "H2O2",
        "CPR:3",
        "caveolin1"
      ],
      [
        "Wogonin",
        "CPR:4",
        "caveolin1"
      ]
    ],
    "updated": "No",
    "original": "Wogonin inhibits H2O2 induced vascular permeability through suppressing the phosphorylation of caveolin1",
    "simplified": "Wogonin inhibits vascular permeability by suppressing caveolin1 phosphorylation and thereby reducing it."
  },
  {
    "text": "We found that wogonin can suppress the H2O2 stimulated actin remodeling and albumin uptake of the human breast carcinoma cell MDAMB231 , as well as transendothelial cell migration .",
    "triple_list": [
      [
        "H2O2",
        "CPR:3",
        "actin"
      ],
      [
        "H2O2",
        "CPR:3",
        "albumin"
      ],
      [
        "wogonin",
        "CPR:4",
        "actin"
      ],
      [
        "wogonin",
        "CPR:4",
        "albumin"
      ]
    ],
    "updated": "Yes",
    "original": "We found that wogonin can suppress the H2O2 stimulated actin remodeling and albumin uptake of HUVECs as well as transendothelial cell migration of the human breast carcinoma cell MDAMB231",
    "simplified": "We found that wogonin can suppress the H2O2 stimulated actin remodeling and albumin uptake of the human breast carcinoma cell MDAMB231, as well as transendothelial cell migration."
  },
  {
    "text": "The mechanism revealed that wogonin inhibited H2O2 induced phosphorylation of caveolin1 cav1 associating with the suppression of stabilization of VEcadherin and \u03b2catenin",
    "triple_list": [
      [
        "H2O2",
        "CPR:3",
        "caveolin1"
      ],
      [
        "H2O2",
        "CPR:3",
        "cav1"
      ],
      [
        "wogonin",
        "CPR:4",
        "caveolin1"
      ],
      [
        "wogonin",
        "CPR:4",
        "cav1"
      ],
      [
        "wogonin",
        "CPR:4",
        "VEcadherin"
      ],
      [
        "wogonin",
        "CPR:4",
        "\u03b2catenin"
      ]
    ],
    "updated": "No",
    "original": "The mechanism revealed that wogonin inhibited H2O2 induced phosphorylation of caveolin1 cav1 associating with the suppression of stabilization of VEcadherin and \u03b2catenin",
    "simplified": "The mechanism of action of wogonin is that it inhibits the phosphorylation of caveolin1 cav1 and thus the stabilization of VEcadherin and \u03b2catenin."
  },
  {
    "text": "In an attempt to further improve overall profiles of the oxadiazine series of GSMs in particular the hERG activity conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i which was a highly effective GSM in vitro and was a highly effective GSM in vivo .",
    "triple_list": [
      [
        "hERG",
        "CPR:4",
        "oxadiazepines"
      ]
    ],
    "updated": "Yes",
    "original": "In an attempt to further improve overall profiles of the oxadiazine series of GSMs in particular the hERG activity conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i which had an improved hERG inhibition profile and was a highly efficacious GSM in vitro and in vivo in rats",
    "simplified": "In an attempt to further improve overall profiles of the oxadiazine series of GSMs in particular the hERG activity conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i which was a highly effective GSM in vitro and was a highly effective GSM in vivo."
  },
  {
    "text": "Both CE and E2 alone increased DNA synthesis and reduced apoptosis with activation of MAPK Akt and p70S6K and upregulation of antiapoptotic factors survivin Bcl2 and Xlinked inhibitor of apoptosis protein These effects could be completely blocked by BZA",
    "triple_list": [
      [
        "MAPK",
        "CPR:4",
        "BZA"
      ],
      [
        "Akt",
        "CPR:4",
        "BZA"
      ],
      [
        "p70S6K",
        "CPR:4",
        "BZA"
      ],
      [
        "survivin",
        "CPR:4",
        "BZA"
      ],
      [
        "Bcl2",
        "CPR:4",
        "BZA"
      ],
      [
        "Xlinked inhibitor of apoptosis protein",
        "CPR:4",
        "BZA"
      ]
    ],
    "updated": "No",
    "original": "Both CE and E2 alone increased DNA synthesis and reduced apoptosis with activation of MAPK Akt and p70S6K and upregulation of antiapoptotic factors survivin Bcl2 and Xlinked inhibitor of apoptosis protein These effects could be completely blocked by BZA",
    "simplified": "Both CE and E2 alone increased DNA synthesis and reduced apoptosis with activation of MAPK Akt and p70S6K and Xlinked inhibitor of apoptosis protein These effects could be completely blocked by BZA but have not yet been found in humans."
  },
  {
    "text": "The reduction of BiFC signal mediated by nutlin3 was correlated with an increase in Puma transactivation PARP cleavage and cell death",
    "triple_list": [
      [
        "nutlin3",
        "CPR:3",
        "Puma"
      ],
      [
        "nutlin3",
        "CPR:3",
        "PARP"
      ]
    ],
    "updated": "No",
    "original": "The reduction of BiFC signal mediated by nutlin3 was correlated with an increase in Puma transactivation PARP cleavage and cell death",
    "simplified": "The reduced BiFC signal caused by nutlin3 was associated with increased cell death and increased puma transactivation."
  },
  {
    "text": "We used nutlin3 , a well-known disruptor of p53-Mdm2 interaction , to test the specificity of the test",
    "triple_list": [
      [
        "nutlin3",
        "CPR:4",
        "p53"
      ],
      [
        "nutlin3",
        "CPR:4",
        "Mdm2"
      ]
    ],
    "updated": "Yes",
    "original": "We used nutlin3 a wellknown disruptor of p53 Mdm2 interaction to validate the specificity of the assay",
    "simplified": "We used nutlin3, a well-known disruptor of p53-Mdm2 interaction, to test the specificity of the test"
  },
  {
    "text": "Sal toxicity coincided with reduced pAkt level and its downstream effectors pCREB pGSK3\u03b2 Bcl2 and neurotrophins GDNF BDNF suggesting repressed PI3K Akt signaling",
    "triple_list": [
      [
        "Sal",
        "CPR:4",
        "pAkt"
      ],
      [
        "Sal",
        "CPR:4",
        "pCREB"
      ],
      [
        "Sal",
        "CPR:4",
        "pGSK3\u03b2"
      ],
      [
        "Sal",
        "CPR:4",
        "Bcl2"
      ],
      [
        "Sal",
        "CPR:4",
        "neurotrophins"
      ],
      [
        "Sal",
        "CPR:4",
        "GDNF"
      ],
      [
        "Sal",
        "CPR:4",
        "BDNF"
      ],
      [
        "Sal",
        "CPR:4",
        "PI3K"
      ],
      [
        "Sal",
        "CPR:4",
        "Akt"
      ]
    ],
    "updated": "No",
    "original": "Sal toxicity coincided with reduced pAkt level and its downstream effectors pCREB pGSK3\u03b2 Bcl2 and neurotrophins GDNF BDNF suggesting repressed PI3K Akt signaling",
    "simplified": "Sal toxicity happened at the same time as reduced pAkt level and its downstream effectors pCREB pGSK3\u03b2 Bcl2 and neurotrophins BDNF."
  },
  {
    "text": "This was confirmed when the PI3K inhibitor LY294002 was added , it did not work .",
    "triple_list": [
      [
        "LY294002",
        "CPR:4",
        "PI3K"
      ]
    ],
    "updated": "Yes",
    "original": "This was confirmed on adding LY294002 the PI3K inhibitor which abolished the protection",
    "simplified": "This was confirmed when the PI3K inhibitor LY294002 was added, it did not work."
  },
  {
    "text": "Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers heart mitochondrial lipid peroxidation calcium and a significant decrease in the activitieslevels of heart mitochondrial glutathione peroxidase glutathione reductase reduced glutathione isocitrate succinate malate \u03b1ketoglutarate and NADHdehydrogenases cytochromeCoxidase and adenosine triphosphate",
    "triple_list": [
      [
        "Isoproterenol",
        "CPR:4",
        "glutathione peroxidase"
      ],
      [
        "Isoproterenol",
        "CPR:4",
        "glutathione reductase"
      ],
      [
        "Isoproterenol",
        "CPR:4",
        "NADHdehydrogenases"
      ],
      [
        "Isoproterenol",
        "CPR:4",
        "cytochromeCoxidase"
      ]
    ],
    "updated": "No",
    "original": "Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers heart mitochondrial lipid peroxidation calcium and a significant decrease in the activitieslevels of heart mitochondrial glutathione peroxidase glutathione reductase reduced glutathione isocitrate succinate malate \u03b1ketoglutarate and NADHdehydrogenases cytochromeCoxidase and adenosine triphosphate",
    "simplified": "Isoproterenol induced myocardial infarcted rats showed a significant increase in the activities of heart mitochondrial lipid peroxidase and a significant decrease in the activities of heart mitochondrial glutathione peroxidase. Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers."
  },
  {
    "text": "Increased urinary excretion of albumin hemopexin transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats",
    "triple_list": [
      [
        "albumin",
        "CPR:3",
        "gentamicin"
      ],
      [
        "hemopexin",
        "CPR:3",
        "gentamicin"
      ],
      [
        "transferrin",
        "CPR:3",
        "gentamicin"
      ],
      [
        "VDBP",
        "CPR:3",
        "gentamicin"
      ]
    ],
    "updated": "No",
    "original": "Increased urinary excretion of albumin hemopexin transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats",
    "simplified": "The urinary excretion of hemopexin transferrin and VDBP is increased, and gentamicin-induced nephrotoxicity is observed."
  },
  {
    "text": "Design and synthesis of novel 2methyl45substitutedbenzof33a45tetrahydropyrazolo15d14oxazepin87Hone derivatives as telomerase inhibitors",
    "triple_list": [
      [
        "2methyl45substitutedbenzof33a45tetrahydropyrazolo15d14oxazepin87Hone",
        "CPR:4",
        "telomerase"
      ]
    ],
    "updated": "No",
    "original": "Design and synthesis of novel 2methyl45substitutedbenzof33a45tetrahydropyrazolo15d14oxazepin87Hone derivatives as telomerase inhibitors",
    "simplified": "The design and synthesis of novel 2methyl45substitutedbenzof33a45tetrahydropyrazolo15d14oxazepin and its derivatives"
  },
  {
    "text": "DPEP inhibited LPSinduced phosphorylation of ERK JNK and p38",
    "triple_list": [
      [
        "DPEP",
        "CPR:4",
        "ERK"
      ],
      [
        "DPEP",
        "CPR:4",
        "JNK"
      ],
      [
        "DPEP",
        "CPR:4",
        "p38"
      ]
    ],
    "updated": "No",
    "original": "DPEP inhibited LPSinduced phosphorylation of ERK JNK and p38",
    "simplified": "DPEP inhibits the phosphorylation of p38 in LPS."
  },
  {
    "text": "Furthermore DPEP inhibited the LPSinduced phosphorylation of inhibitor \u03baB I\u03baB\u03b1 and NF\u03baB p50",
    "triple_list": [
      [
        "DPEP",
        "CPR:4",
        "p50"
      ],
      [
        "DPEP",
        "CPR:4",
        "inhibitor \u03baB I\u03baB\u03b1"
      ],
      [
        "DPEP",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "No",
    "original": "Furthermore DPEP inhibited the LPSinduced phosphorylation of inhibitor \u03baB I\u03baB\u03b1 and NF\u03baB p50",
    "simplified": "In addition, DPEP inhibited the phosphorylation of the inhibitor NF\u03baB p50."
  },
  {
    "text": "The results of this study demonstrate that DPEP inhibits LPS by blocking the NF\u03baB and MAPK pathways in macrophages .",
    "triple_list": [
      [
        "DPEP",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "DPEP",
        "CPR:4",
        "MAPK"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together the results of this study demonstrate that DPEP inhibits LPSstimulated inflammation by blocking the NF\u03baB and MAPK pathways in macrophages",
    "simplified": "The results of this study demonstrate that DPEP inhibits LPS by blocking the NF\u03baB and MAPK pathways in macrophages."
  },
  {
    "text": "The effect of DPEP was to reduce the levels of inducible nitric oxide synthase iNOS and cyclooxygenase2 COX2 . This also caused a reduction in the production of prostaglandin E2 PGE2 .",
    "triple_list": [
      [
        "DPEP",
        "CPR:4",
        "inducible nitric oxide synthase"
      ],
      [
        "DPEP",
        "CPR:4",
        "iNOS"
      ],
      [
        "DPEP",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "DPEP",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "DPEP induced dosedependent reduction of the protein levels of inducible nitric oxide synthase iNOS and cyclooxygenase2 COX2 and concomitant reduction in the production of NO and prostaglandin E2 PGE2",
    "simplified": "The effect of DPEP was to reduce the levels of inducible nitric oxide synthase iNOS and cyclooxygenase2 COX2. This also caused a reduction in the production of prostaglandin E2 PGE2."
  },
  {
    "text": "Additionally DPEP suppressed the production of inflammatory cytokines including tumor necrosis factor\u03b1 TNF\u03b1 interleukin IL1\u03b2 and IL6",
    "triple_list": [
      [
        "DPEP",
        "CPR:4",
        "cytokines"
      ],
      [
        "DPEP",
        "CPR:4",
        "tumor necrosis factor\u03b1"
      ],
      [
        "DPEP",
        "CPR:4",
        "TNF\u03b1"
      ],
      [
        "DPEP",
        "CPR:4",
        "interleukin IL1\u03b2"
      ],
      [
        "DPEP",
        "CPR:4",
        "IL6"
      ]
    ],
    "updated": "No",
    "original": "Additionally DPEP suppressed the production of inflammatory cytokines including tumor necrosis factor\u03b1 TNF\u03b1 interleukin IL1\u03b2 and IL6",
    "simplified": "DPEP also reduced the production of certain inflammatory cytokines. These cytokines include tumor necrosis factor (TNF) and IL6."
  },
  {
    "text": "This causes the glutamate aspartate transporter to become less active . This reduces glutamate transport .",
    "triple_list": [
      [
        "glutamate",
        "CPR:9",
        "glutamate aspartate transporter"
      ]
    ],
    "updated": "Yes",
    "original": "This leads to decreased expression of glutamate aspartate transporter which in turn reduces glutamate transport",
    "simplified": "This causes the glutamate aspartate transporter to become less active. This reduces glutamate transport."
  },
  {
    "text": "Tetrahydropyrroloquinolinone type dual inhibitors of aromatase aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks",
    "triple_list": [
      [
        "Tetrahydropyrroloquinolinone",
        "CPR:4",
        "aromatase"
      ],
      [
        "Tetrahydropyrroloquinolinone",
        "CPR:4",
        "aldosterone synthase"
      ]
    ],
    "updated": "No",
    "original": "Tetrahydropyrroloquinolinone type dual inhibitors of aromatase aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks",
    "simplified": "Tetrahydropyrroloquinolinone as a novel strategy for breast cancer patients with elevated cardiovascular risks: a dual inhibitor of aromatase."
  },
  {
    "text": "In addition , MDZ caused mechanismbased inactivation of cytochrome P450 3A dependent TRZ 1hydroxylation in human and mouse microsomes .",
    "triple_list": [
      [
        "MDZ",
        "CPR:4",
        "cytochrome P450 3A"
      ],
      [
        "cytochrome P450 3A",
        "CPR:9",
        "TRZ"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore MDZ caused mechanismbased inactivation of cytochrome P450 3A dependent TRZ 1hydroxylation in mouse rat and human intestinal microsomes with similar potencies",
    "simplified": "In addition, MDZ caused mechanismbased inactivation of cytochrome P450 3A dependent TRZ 1hydroxylation in human and mouse microsomes."
  },
  {
    "text": "Tamoxifen represses miR200 microRNAs and promotes epithelialtomesenchymal transition by upregulating cMyc in endometrial carcinoma cell lines",
    "triple_list": [
      [
        "Tamoxifen",
        "CPR:3",
        "cMyc"
      ],
      [
        "Tamoxifen",
        "CPR:4",
        "miR200"
      ]
    ],
    "updated": "No",
    "original": "Tamoxifen represses miR200 microRNAs and promotes epithelialtomesenchymal transition by upregulating cMyc in endometrial carcinoma cell lines",
    "simplified": "Tamoxifen inhibits miR200 microRNAs and promotes epithelial-to-enchymal transition in endometrial cancer cell lines."
  },
  {
    "text": "Consistent with zinc finger Ebox binding homeobox 2 which was confirmed as a direct target of miR200b in endometrial cancer cell lines some other key factors of EMT such as Snail and Ncadherin increased whereas Ecadherin decreased in the TAM treated cells contributing to TAMinduced EMT in these endometrial cancer cells",
    "triple_list": [
      [
        "Snail",
        "CPR:3",
        "TAM"
      ],
      [
        "Ncadherin",
        "CPR:3",
        "TAM"
      ],
      [
        "Ecadherin",
        "CPR:4",
        "TAM"
      ]
    ],
    "updated": "No",
    "original": "Consistent with zinc finger Ebox binding homeobox 2 which was confirmed as a direct target of miR200b in endometrial cancer cell lines some other key factors of EMT such as Snail and Ncadherin increased whereas Ecadherin decreased in the TAM treated cells contributing to TAMinduced EMT in these endometrial cancer cells",
    "simplified": "The zinc finger Ebox binding homeobox 2 was confirmed as a direct target of miR200b in endometrial cancer cell lines. Other key factors of EMT such as snail and ncadherin increased in the TAM treated cells, but Ecadherin decreased in the TAM treated cells."
  },
  {
    "text": "Together , our data suggest that TAM can repress miR200 and induce EMT in endometrial cancer cells by upregulation of cMyc .",
    "triple_list": [
      [
        "TAM",
        "CPR:3",
        "cMyc"
      ],
      [
        "TAM",
        "CPR:4",
        "miR200"
      ]
    ],
    "updated": "Yes",
    "original": "Collectively our data suggest that TAM can repress the miR200 family and induce EMT via the upregulation of cMyc in endometrial cancer cells",
    "simplified": "Together, our data suggest that TAM can repress miR200 and induce EMT in endometrial cancer cells by upregulation of cMyc."
  },
  {
    "text": "miR200 a miRNA family has been found to reduce tumor growth in a wide range of cancers when it is treated with TAM .",
    "triple_list": [
      [
        "miR200",
        "CPR:4",
        "TAM"
      ]
    ],
    "updated": "Yes",
    "original": "miR200 a miRNA family with tumor suppressive functions in a wide range of cancers was found reduced in response to TAM treatment",
    "simplified": " miR200 a miRNA family has been found to reduce tumor growth in a wide range of cancers when it is treated with TAM."
  },
  {
    "text": "In addition we showed that cMyc directly binds to and represses the promoter of miR200 miRNAs and its upregulation in TAM treated endometrial cancer cells leads to the downregulation of miR200 and eventually to EMT",
    "triple_list": [
      [
        "miR200",
        "CPR:4",
        "TAM"
      ]
    ],
    "updated": "No",
    "original": "In addition we showed that cMyc directly binds to and represses the promoter of miR200 miRNAs and its upregulation in TAM treated endometrial cancer cells leads to the downregulation of miR200 and eventually to EMT",
    "simplified": "In addition, we showed that cMyc directly binds to and represses the promoter of miR200 miRNAs in endometrial cancer cells. This leads to the miR200 being downregulated and eventually to EMT."
  },
  {
    "text": "Here we show that oral administration of resveratrol suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophindeficient mdx mice by activating an NADdependent protein deacetylase SIRT1 .",
    "triple_list": [
      [
        "resveratrol",
        "CPR:3",
        "NADdependent protein deacetylase SIRT1"
      ]
    ],
    "updated": "Yes",
    "original": "Here we show that oral administration of resveratrol which leads to activation of an NADdependent protein deacetylase SIRT1 suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophindeficient mdx mice",
    "simplified": "Here we show that oral administration of resveratrol suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophindeficient mdx mice by activating an NADdependent protein deacetylase SIRT1."
  },
  {
    "text": "The prohypertrophic coactivator p300 protein but not p300 mRNA was increased in the heart , but the level of resveratrol was reduced .",
    "triple_list": [
      [
        "p300",
        "CPR:4",
        "resveratrol"
      ]
    ],
    "updated": "Yes",
    "original": "The prohypertrophic coactivator p300 protein but not p300 mRNA was upregulated in the mdx heart and resveratrol administration downregulated the p300 protein level",
    "simplified": "The prohypertrophic coactivator p300 protein but not p300 mRNA was increased in the heart, but the level of resveratrol was reduced."
  },
  {
    "text": "In cultured cardiomyocytes cardiomyocyte hypertrophy was inhibited by the overexpression of SIRT1 as well as resveratrol . Both of these substances reduced p300 protein levels but not p300 mRNA levels .",
    "triple_list": [
      [
        "resveratrol",
        "CPR:4",
        "p300"
      ]
    ],
    "updated": "Yes",
    "original": "In cultured cardiomyocytes cardiomyocyte hypertrophy induced by the \u03b11agonist phenylephrine was inhibited by the overexpression of SIRT1 as well as resveratrol both of which downregulated p300 protein levels but not p300 mRNA levels",
    "simplified": "In cultured cardiomyocytes cardiomyocyte hypertrophy was inhibited by the overexpression of SIRT1 as well as resveratrol. Both of these substances reduced p300 protein levels but not p300 mRNA levels."
  },
  {
    "text": "We previously reported that caffeoylamino acidylhydroxamic acid CAXaaNHOH was both a good antioxidant and tyrosinase inhibitor in particular when caffeic acid was conjugated with phenylalanine or proline .",
    "triple_list": [
      [
        "CAXaaNHOH",
        "CPR:4",
        "tyrosinase"
      ],
      [
        "caffeoylamino acidylhydroxamic acid",
        "CPR:4",
        "tyrosinase"
      ]
    ],
    "updated": "Yes",
    "original": "We previously reported that caffeoylamino acidylhydroxamic acid CAXaaNHOH acted as both a good antioxidant and tyrosinase inhibitor in particular when caffeic acid was conjugated with proline or amino acids having aromatic ring like phenylalanine",
    "simplified": "We previously reported that caffeoylamino acidylhydroxamic acid CAXaaNHOH was both a good antioxidant and tyrosinase inhibitor in particular when caffeic acid was conjugated with phenylalanine or proline."
  },
  {
    "text": "In addition , caffeic acid and sinapic acid reduced the amount of melanin in the cells , and tyrosinase activity was inhibited .",
    "triple_list": [
      [
        "caffeic acid",
        "CPR:4",
        "tyrosinase"
      ],
      [
        "sinapic acid",
        "CPR:4",
        "tyrosinase"
      ]
    ],
    "updated": "Yes",
    "original": "In addition derivatives of caffeic acid and sinapic acid efficiently inhibited tyrosinase activity and reduced melanin content in melanocytes MelAb cell",
    "simplified": "In addition, caffeic acid and sinapic acid reduced the amount of melanin in the cells, and tyrosinase activity was inhibited."
  },
  {
    "text": "Synthesis and dual biological effects of hydroxycinnamoyl phenylalanyl prolyl hydroxamic acid derivatives as tyrosinase inhibitor and antioxidant",
    "triple_list": [
      [
        "hydroxycinnamoyl phenylalanyl",
        "CPR:4",
        "tyrosinase"
      ],
      [
        "prolyl hydroxamic acid",
        "CPR:4",
        "tyrosinase"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and dual biological effects of hydroxycinnamoyl phenylalanyl prolyl hydroxamic acid derivatives as tyrosinase inhibitor and antioxidant",
    "simplified": "The biological and chemical effects of phenylalanyl prolyl hydroxamic acid as an antioxidant and tyrosinase inhibitor"
  },
  {
    "text": "Ruxolitinib is a smallmolecule inhibitor of JAK1 and JAK2 . It was the first drug to be approved by the United States Food and Drug Administration to treat people with high-risk myelofibrosis .",
    "triple_list": [
      [
        "Ruxolitinib",
        "CPR:4",
        "JAK1"
      ],
      [
        "Ruxolitinib",
        "CPR:4",
        "JAK2"
      ]
    ],
    "updated": "Yes",
    "original": "Ruxolitinib is a smallmolecule inhibitor of JAK1 and JAK2 and recently became the first drug approved by the United States Food and Drug Administration for the treatment of symptomatic intermediate or highrisk myelofibrosis",
    "simplified": "Ruxolitinib is a smallmolecule inhibitor of JAK1 and JAK2. It was the first drug to be approved by the United States Food and Drug Administration to treat people with high-risk myelofibrosis."
  },
  {
    "text": "Pb and BaP treatments significantly increased the levels of caspase3 in the blood .",
    "triple_list": [
      [
        "Pb",
        "CPR:3",
        "caspase3"
      ],
      [
        "BaP",
        "CPR:3",
        "caspase3"
      ]
    ],
    "updated": "Yes",
    "original": "Pb and BaP treatments significantly increased active caspase3 levels in a timedependent manner",
    "simplified": "Pb and BaP treatments significantly increased the levels of caspase3 in the blood."
  },
  {
    "text": "TAA increased the area and number of glutathione Stransferase placental form GSTP liver cell foci in randomly selected areas in the liver . It also increased the number of apoptotic cells .",
    "triple_list": [
      [
        "TAA",
        "CPR:3",
        "glutathione Stransferase placental form"
      ],
      [
        "TAA",
        "CPR:3",
        "GSTP"
      ]
    ],
    "updated": "Yes",
    "original": "TAA increased the number and area of glutathione Stransferase placental form GSTP liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections",
    "simplified": "TAA increased the area and number of glutathione Stransferase placental form GSTP liver cell foci in randomly selected areas in the liver. It also increased the number of apoptotic cells."
  },
  {
    "text": "TAA also increased the number of CD3 lymphocytes . It also increased the number of ED2 cyclooxygenase2 and heme oxygenase1 .",
    "triple_list": [
      [
        "TAA",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "TAA",
        "CPR:4",
        "heme oxygenase1"
      ],
      [
        "TAA",
        "CPR:4",
        "CD3"
      ]
    ],
    "updated": "Yes",
    "original": "TAA also increased the numbers of ED2 cyclooxygenase2 and heme oxygenase1 liver cells as well as the number of CD3 lymphocytes",
    "simplified": "TAA also increased the number of CD3 lymphocytes. It also increased the number of ED2 cyclooxygenase2 and heme oxygenase1."
  },
  {
    "text": "The ICA greatly attenuates ERG inactivation by shifting the voltage dependence to more positive potentials , but the EAG inactivation rate and extent is still reduced by the ICA .",
    "triple_list": [
      [
        "ICA",
        "CPR:3",
        "ERG"
      ],
      [
        "ICA",
        "CPR:4",
        "EAG"
      ]
    ],
    "updated": "Yes",
    "original": "Although ICA greatly attenuates ERG inactivation by shifting its voltage dependence to more positive potentials it enhances the rate and extent of EAG inactivation without altering its voltage dependence",
    "simplified": "The ICA greatly attenuates ERG inactivation by shifting the voltage dependence to more positive potentials, but the EAG inactivation rate and extent is still reduced by the ICA."
  },
  {
    "text": "ICA105574 interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG potassium channels",
    "triple_list": [
      [
        "ICA105574",
        "CPR:3",
        "EAG"
      ],
      [
        "ICA105574",
        "CPR:3",
        "ERG"
      ],
      [
        "ICA105574",
        "CPR:3",
        "potassium channels"
      ]
    ],
    "updated": "No",
    "original": "ICA105574 interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG potassium channels",
    "simplified": "ICA105574 interacts with a common binding site to produce opposite effects, ICA105574 + ICA105575 + ICA105576."
  },
  {
    "text": "ICA is a mixed agonist of mutant EAG and EAG ERG chimera channels that inactivate by a combination of slow and fast mechanisms",
    "triple_list": [
      [
        "ICA",
        "CPR:5",
        "EAG"
      ],
      [
        "ICA",
        "CPR:5",
        "EAG"
      ],
      [
        "ICA",
        "CPR:5",
        "ERG"
      ]
    ],
    "updated": "No",
    "original": "ICA is a mixed agonist of mutant EAG and EAG ERG chimera channels that inactivate by a combination of slow and fast mechanisms",
    "simplified": "IAC is a mixed agonist of mutant EAG and EAG ERG channels. It works by inactivating the EAG and EAG ERG channels."
  },
  {
    "text": "PNU282987 , on the other hand , showed an increase in anxiety-like behavior at a higher dose . The serotonin 5HT1a receptor antagonist WAY100135 significantly reduced this behavior .",
    "triple_list": [
      [
        "serotonin 5HT1a receptor",
        "CPR:6",
        "WAY100135"
      ]
    ],
    "updated": "Yes",
    "original": "PNU282987 on the other hand displayed an increase in anxietylike behavior at a higher dose 10 mgkg that was significantly reduced by the serotonin 5HT1a receptor antagonist WAY100135",
    "simplified": "PNU282987, on the other hand, showed an increase in anxiety-like behavior at a higher dose. The serotonin 5HT1a receptor antagonist WAY100135 significantly reduced this behavior."
  },
  {
    "text": "However , the \u03b17 receptor antagonist methyllycaconitine did not help with the bad effects . PNU282987",
    "triple_list": [
      [
        "\u03b17 receptor",
        "CPR:6",
        "methyllycaconitine"
      ]
    ],
    "updated": "Yes",
    "original": "However the \u03b17 receptor antagonist methyllycaconitine was unable to reverse these anxietylike effects seen with PNU282987",
    "simplified": "However, the \u03b17 receptor antagonist methyllycaconitine did not help with the bad effects. PNU282987"
  },
  {
    "text": "A Ventura F V Houten S M Carnitine palmitoyltransferase 2 and carnitineacylcarnitine translocase are involved in making acylcarnitines and carnitine .",
    "triple_list": [
      [
        "Carnitine palmitoyltransferase 2",
        "CPR:9",
        "acylcarnitines"
      ],
      [
        "carnitineacylcarnitine translocase",
        "CPR:9",
        "acylcarnitines"
      ]
    ],
    "updated": "Yes",
    "original": "A Ventura F V Houten S M Carnitine palmitoyltransferase 2 and carnitineacylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines",
    "simplified": "A Ventura F V Houten S M Carnitine palmitoyltransferase 2 and carnitineacylcarnitine translocase are involved in making acylcarnitines and carnitine."
  },
  {
    "text": "Carnitine palmitoyltransferase 2 and carnitineacylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines",
    "triple_list": [
      [
        "Carnitine palmitoyltransferase 2",
        "CPR:9",
        "acylcarnitines"
      ],
      [
        "carnitineacylcarnitine translocase",
        "CPR:9",
        "acylcarnitines"
      ]
    ],
    "updated": "No",
    "original": "Carnitine palmitoyltransferase 2 and carnitineacylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines",
    "simplified": "Carnitine palmitoyltransferase 2 and carnitineacylcarnitine translocase are two enzymes that help to break down carnitine."
  },
  {
    "text": "This shows that CPT2 and CACT are very important for making acylcarnitine in the mitochondria . When acylcarnitine is in the mitochondria , it goes to the outside world .",
    "triple_list": [
      [
        "CPT2",
        "CPR:9",
        "acylcarnitine"
      ],
      [
        "CACT",
        "CPR:9",
        "acylcarnitine"
      ]
    ],
    "updated": "Yes",
    "original": "This shows that CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mFAODViolante S IJlst L te Brinke H Tavares de Almeida I Wanders R J",
    "simplified": "This shows that CPT2 and CACT are very important for making acylcarnitine in the mitochondria. When acylcarnitine is in the mitochondria, it goes to the outside world."
  },
  {
    "text": "As a result of this study microgrewiapine A 1 was found to be a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the h\u03b13\u03b24 and h\u03b14\u03b22 receptor subtypes",
    "triple_list": [
      [
        "microgrewiapine A",
        "CPR:6",
        "nicotinic receptor"
      ]
    ],
    "updated": "No",
    "original": "As a result of this study microgrewiapine A 1 was found to be a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the h\u03b13\u03b24 and h\u03b14\u03b22 receptor subtypes",
    "simplified": "As a result of this study microgrewiapine A 1 was found to be a selective cytotoxic agent for colon cancer cells over normal colon cells. This means that microgrewiapine A 1 was able to kill colon cancer cells."
  },
  {
    "text": "PURPOSE To characterise further the cytochrome P450 3A4 CYP3A4 interaction of the almorexant with the orexin receptor .",
    "triple_list": [
      [
        "orexin receptor",
        "CPR:6",
        "almorexant"
      ]
    ],
    "updated": "Yes",
    "original": "PURPOSE To characterise further the previously observed cytochrome P450 3A4 CYP3A4 interaction of the dual orexin receptor antagonist almorexant",
    "simplified": " PURPOSE To characterise further the cytochrome P450 3A4 CYP3A4 interaction of the almorexant with the orexin receptor."
  },
  {
    "text": "In vitro molecular pharmacology studies showed that 5HT2C agonists potent for attenuating the DOIelicitedHTR also reduced the efficacy of DOI to activate mouse 5HT2C receptormediated PLC signaling in HEK cells",
    "triple_list": [
      [
        "DOI",
        "CPR:3",
        "mouse 5HT2C"
      ]
    ],
    "updated": "No",
    "original": "In vitro molecular pharmacology studies showed that 5HT2C agonists potent for attenuating the DOIelicitedHTR also reduced the efficacy of DOI to activate mouse 5HT2C receptormediated PLC signaling in HEK cells",
    "simplified": "In vitro molecular pharmacology studies showed that 5HT2C agonists reduced the DOIelicitedHTR by up to 70%. The DOIelicitedHTR also reduced the efficacy of DOI to activate PLC signaling in HEK cells"
  },
  {
    "text": "Commerciallyavailable 5HT2C agonists CP 809101 Ro 600175 WAY 161503 mCPP and 1methylpsilocin novel 4phenyl2NNdimethylaminotetralin PAT type 5HT2C agonists with 5HT2A2B antagonist activity and antagonists selective for 5HT2A M100907 5HT2C SB242084 and 5HT2B2C SB206553 receptors attenuated the DOIelicitedHTR",
    "triple_list": [
      [
        "5HT2C",
        "CPR:5",
        "CP 809101"
      ],
      [
        "5HT2C",
        "CPR:5",
        "Ro 600175"
      ],
      [
        "5HT2C",
        "CPR:5",
        "WAY 161503"
      ],
      [
        "5HT2C",
        "CPR:5",
        "mCPP"
      ],
      [
        "5HT2C",
        "CPR:5",
        "1methylpsilocin"
      ],
      [
        "5HT2C",
        "CPR:5",
        "4phenyl2NNdimethylaminotetralin"
      ],
      [
        "5HT2C",
        "CPR:5",
        "PAT"
      ],
      [
        "5HT2A",
        "CPR:6",
        "M100907"
      ],
      [
        "5HT2C",
        "CPR:6",
        "SB242084"
      ]
    ],
    "updated": "No",
    "original": "Commerciallyavailable 5HT2C agonists CP 809101 Ro 600175 WAY 161503 mCPP and 1methylpsilocin novel 4phenyl2NNdimethylaminotetralin PAT type 5HT2C agonists with 5HT2A2B antagonist activity and antagonists selective for 5HT2A M100907 5HT2C SB242084 and 5HT2B2C SB206553 receptors attenuated the DOIelicitedHTR",
    "simplified": "Commercially available 5HT2C agonists CP 809101 Ro 600175 WAY 161503 mCPP and 1methylpsilocin are 5HT2C agonists. 5HT2C antagonists are antagonists that do not work at the 5HT2A receptor, but at the 5HT2C or 5HT2B receptors."
  },
  {
    "text": "This study tested the hypothesis that CYP2B6 is a prominent CYP isoform responsible for clinical methadone N demethylation and clearance using ticlopidine . The ticlopidine was given orally for 4 days .",
    "triple_list": [
      [
        "CYP2B6",
        "CPR:4",
        "ticlopidine"
      ],
      [
        "CYP2B6",
        "CPR:9",
        "methadone"
      ],
      [
        "CYP",
        "CPR:9",
        "methadone"
      ],
      [
        "CYP2B6",
        "CPR:9",
        "N"
      ],
      [
        "CYP",
        "CPR:9",
        "N"
      ]
    ],
    "updated": "Yes",
    "original": "This investigation tested the hypothesis that CYP2B6 is a prominent CYP isoform responsible for clinical methadone N demethylation and clearance using the in vivo mechanismbased CYP2B6 inhibitor ticlopidine given orally for 4 days",
    "simplified": "This study tested the hypothesis that CYP2B6 is a prominent CYP isoform responsible for clinical methadone N demethylation and clearance using ticlopidine. The ticlopidine was given orally for 4 days."
  },
  {
    "text": "Methadone N demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 CYP2B6 and CYP3A4 but clinical disposition is often attributed to CYP3A4",
    "triple_list": [
      [
        "Methadone",
        "CPR:9",
        "CYP3A4"
      ],
      [
        "Methadone",
        "CPR:9",
        "cytochrome P4502B6"
      ],
      [
        "Methadone",
        "CPR:9",
        "CYP2B6"
      ],
      [
        "Methadone",
        "CPR:9",
        "CYP3A4"
      ],
      [
        "N",
        "CPR:9",
        "CYP3A4"
      ],
      [
        "N",
        "CPR:9",
        "cytochrome P4502B6"
      ],
      [
        "N",
        "CPR:9",
        "CYP2B6"
      ],
      [
        "N",
        "CPR:9",
        "CYP3A4"
      ]
    ],
    "updated": "No",
    "original": "Methadone N demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 CYP2B6 and CYP3A4 but clinical disposition is often attributed to CYP3A4",
    "simplified": "Methadone demethylation in the liver is done by cytochrome P4502B6 and CYP3A4. In the body, it is done by CYP3A4 and CYP2B6."
  },
  {
    "text": "CYP2B6 inhibition reduces methadone Ndemethylation and clearance and changes the concentration of methadone . CYP2B6 is important in the metabolism of methadone .",
    "triple_list": [
      [
        "CYP2B6",
        "CPR:9",
        "methadone"
      ]
    ],
    "updated": "Yes",
    "original": "CYP2B6 inhibition reduces methadone Ndemethylation and clearance and alters methadone concentrations demonstrating an important role for CYP2B6 in clinical methadone disposition",
    "simplified": "CYP2B6 inhibition reduces methadone Ndemethylation and clearance and changes the concentration of methadone. CYP2B6 is important in the metabolism of methadone."
  },
  {
    "text": "We found that treatment of both differentiated SHSY5Y cells and rat midbrain slices with the dopamine D2 receptor D2R agonist quinpirole caused an increase in the levels of GDNF that was temporally preceded by an increase in the levels of zincfinger protein 268 Zif268 a DNAbinding transcription factor encoded by an immediateearly gene .",
    "triple_list": [
      [
        "quinpirole",
        "CPR:3",
        "GDNF"
      ],
      [
        "quinpirole",
        "CPR:3",
        "zincfinger protein 268"
      ],
      [
        "quinpirole",
        "CPR:3",
        "Zif268"
      ],
      [
        "dopamine D2 receptor",
        "CPR:5",
        "quinpirole"
      ],
      [
        "D2R",
        "CPR:5",
        "quinpirole"
      ]
    ],
    "updated": "Yes",
    "original": "We found that treatment of both differentiated dopaminergiclike SHSY5Y cells and rat midbrain slices with the dopamine D2 receptor D2R agonist quinpirole triggered an increase in the expression of GDNF that was temporally preceded by an increase in the levels of zincfinger protein 268 Zif268 a DNAbinding transcription factor encoded by an immediateearly gene",
    "simplified": "We found that treatment of both differentiated SHSY5Y cells and rat midbrain slices with the dopamine D2 receptor D2R agonist quinpirole caused an increase in the levels of GDNF that was temporally preceded by an increase in the levels of zincfinger protein 268 Zif268 a DNAbinding transcription factor encoded by an immediateearly gene."
  },
  {
    "text": "In addition , the D2R inhibitor raclopride blocked both GDNF and Zif268 expression in SHSY5Y cells when dopamine was released .",
    "triple_list": [
      [
        "D2R",
        "CPR:4",
        "raclopride"
      ],
      [
        "raclopride",
        "CPR:4",
        "GDNF"
      ],
      [
        "raclopride",
        "CPR:4",
        "Zif268"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover the D2R inhibitor raclopride blocked the increase of both GDNF and Zif268 expression following potassiumevoked dopamine release in SHSY5Y cells",
    "simplified": "In addition, the D2R inhibitor raclopride blocked both GDNF and Zif268 expression in SHSY5Y cells when dopamine was released."
  },
  {
    "text": "A series of new 134thiadiazole derivatives has been designed and evaluated as the acetyl and butyrylcholinesterase inhibitors .",
    "triple_list": [
      [
        "134thiadiazole",
        "CPR:4",
        "acetyl and butyrylcholinesterase"
      ]
    ],
    "updated": "Yes",
    "original": "In this paper a series of new 134thiadiazole derivatives has been designed synthesized and evaluated as the acetyl and butyrylcholinesterase inhibitors",
    "simplified": "A series of new 134thiadiazole derivatives has been designed and evaluated as the acetyl and butyrylcholinesterase inhibitors."
  },
  {
    "text": "Synthesis and biological evaluation of 134thiadiazole analogues as novel AChE and BuChE inhibitors",
    "triple_list": [
      [
        "134thiadiazole",
        "CPR:4",
        "AChE"
      ],
      [
        "134thiadiazole",
        "CPR:4",
        "BuChE"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and biological evaluation of 134thiadiazole analogues as novel AChE and BuChE inhibitors",
    "simplified": "The biological and chemical properties of 134thiadiazole as novel AChE inhibitors."
  },
  {
    "text": "LY294002 a specific PI3K AKT inhibitor selectively activated the p38 MAPK kinase pathway and enhanced cJun phosphorylation but did not activate JNK",
    "triple_list": [
      [
        "LY294002",
        "CPR:3",
        "p38"
      ],
      [
        "LY294002",
        "CPR:3",
        "MAPK"
      ],
      [
        "LY294002",
        "CPR:3",
        "kinase"
      ],
      [
        "LY294002",
        "CPR:3",
        "cJun"
      ],
      [
        "LY294002",
        "CPR:4",
        "PI3K"
      ],
      [
        "LY294002",
        "CPR:4",
        "AKT"
      ]
    ],
    "updated": "No",
    "original": "LY294002 a specific PI3K AKT inhibitor selectively activated the p38 MAPK kinase pathway and enhanced cJun phosphorylation but did not activate JNK",
    "simplified": "LY294002 a specific PI3K AKT inhibitor did not activate JNK but it did activate the p38 MAPK kinase pathway by itself."
  },
  {
    "text": "The pharmacological inhibitors SB203580 p38 inhibitor and SP600125 a JNK inhibitor protected primary cultures of rat CGCs from LY294002induced apoptosis",
    "triple_list": [
      [
        "SB203580",
        "CPR:4",
        "p38"
      ],
      [
        "SP600125",
        "CPR:4",
        "JNK"
      ]
    ],
    "updated": "No",
    "original": "The pharmacological inhibitors SB203580 p38 inhibitor and SP600125 a JNK inhibitor protected primary cultures of rat CGCs from LY294002induced apoptosis",
    "simplified": "The JNK inhibitor SP600125 protected primary cultures of rat CGCs from LY294002 induced apoptosis (cell death)."
  },
  {
    "text": "Today we used cobalt chloride , a hypoxia mimetic , to inhibit HIF1 degradation and to produce reactive oxygen species .",
    "triple_list": [
      [
        "cobalt chloride",
        "CPR:3",
        "HIF1"
      ]
    ],
    "updated": "Yes",
    "original": "Today we used cobalt chloride a hypoxia mimetic that inhibits proteasomal HIF1 degradation and generates reactive oxygen species ROS",
    "simplified": "Today we used cobalt chloride, a hypoxia mimetic, to inhibit HIF1 degradation and to produce reactive oxygen species."
  },
  {
    "text": "An autophagic signaling was shown by an increase of Beclin1 ATG 512 and LC3II expression . The presence of p53 mut decreased with CoCl2 exposure .",
    "triple_list": [
      [
        "p53",
        "CPR:4",
        "CoCl2"
      ]
    ],
    "updated": "Yes",
    "original": "An autophagic signaling was evidenced by an increase of Beclin1 ATG 512 and LC3II expression whereas the p53 mut presence decreased with CoCl2 time exposure",
    "simplified": "An autophagic signaling was shown by an increase of Beclin1 ATG 512 and LC3II expression. The presence of p53 mut decreased with CoCl2 exposure."
  },
  {
    "text": "Cellular responses to DNA damage caused by etoposide or doxorubicin include an increase in p53 , but a decrease in supervillin .",
    "triple_list": [
      [
        "etoposide",
        "CPR:3",
        "p53"
      ],
      [
        "doxorubicin",
        "CPR:3",
        "p53"
      ],
      [
        "etoposide",
        "CPR:4",
        "supervillin"
      ],
      [
        "doxorubicin",
        "CPR:4",
        "supervillin"
      ]
    ],
    "updated": "Yes",
    "original": "Cellular responses to DNA damage induced by etoposide or doxorubicin include downregulation of endogenous supervillin coincident with increases in p53",
    "simplified": "Cellular responses to DNA damage caused by etoposide or doxorubicin include an increase in p53, but a decrease in supervillin."
  },
  {
    "text": "Novel acylethanolamide derivatives that modulate body weight through decreased neuropeptide Y NPY and increased proopiomelanocortin POMC .",
    "triple_list": [
      [
        "acylethanolamide",
        "CPR:3",
        "POMC"
      ],
      [
        "acylethanolamide",
        "CPR:3",
        "proopiomelanocortin"
      ],
      [
        "acylethanolamide",
        "CPR:4",
        "neuropeptide Y"
      ],
      [
        "acylethanolamide",
        "CPR:4",
        "NPY"
      ]
    ],
    "updated": "Yes",
    "original": "Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic proopiomelanocortin POMC andor decreased neuropeptide Y NPY",
    "simplified": "Novel acylethanolamide derivatives that modulate body weight through decreased neuropeptide Y NPY and increased proopiomelanocortin POMC."
  },
  {
    "text": "Dexamethasone reduced IL11 gene transcription by itself without affecting the expression of \u0394FosB or Smad1 . dexamethasone was also able to bind to the JunD receptor complex and form heterodimers with it .",
    "triple_list": [
      [
        "Dexamethasone",
        "CPR:4",
        "IL11"
      ]
    ],
    "updated": "Yes",
    "original": "Dexamethasone suppressed IL11 gene transcription enhanced by PTH134 without affecting \u0394FosB expression or Smad1 phosphorylation and dexamethasoneGC receptor complex was bound to JunD which forms heterodimers with \u0394FosB",
    "simplified": "Dexamethasone reduced IL11 gene transcription by itself without affecting the expression of \u0394FosB or Smad1. dexamethasone was also able to bind to the JunD receptor complex and form heterodimers with it."
  },
  {
    "text": "Number and area of preneoplastic foci positive for glutathione Stransferase placental form GSTP were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone",
    "triple_list": [
      [
        "glutathione Stransferase placental form",
        "CPR:3",
        "HEP"
      ],
      [
        "GSTP",
        "CPR:3",
        "HEP"
      ],
      [
        "glutathione Stransferase placental form",
        "CPR:3",
        "HCB"
      ],
      [
        "GSTP",
        "CPR:3",
        "HCB"
      ]
    ],
    "updated": "No",
    "original": "Number and area of preneoplastic foci positive for glutathione Stransferase placental form GSTP were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone",
    "simplified": "Number and area of preneoplastic foci positive for glutathione Stransferase placental form were consistently higher in these groups than in the groups treated with HEP and HCB alone."
  },
  {
    "text": "We conclude that HEP and HCB have additive and synergistic effects on the development of GSTP positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides .",
    "triple_list": [
      [
        "HEP",
        "CPR:3",
        "GSTP"
      ],
      [
        "HCB",
        "CPR:3",
        "GSTP"
      ]
    ],
    "updated": "Yes",
    "original": "On the basis of these findings we conclude that HEP and HCB have additive and synergistic effects on the development of GSTP positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides",
    "simplified": "We conclude that HEP and HCB have additive and synergistic effects on the development of GSTP positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides."
  },
  {
    "text": "Together , these results indicate that in-vivo or ex-vivo exposure to DON can cause similar intestinal lesions and MAPK to be activated .",
    "triple_list": [
      [
        "DON",
        "CPR:3",
        "MAPK"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together these results indicate that in vivo or ex vivo exposure of intestinal tissue to DON lead to similar intestinal lesions and activation of MAPK",
    "simplified": "Together, these results indicate that in-vivo or ex-vivo exposure to DON can cause similar intestinal lesions and MAPK to be activated."
  },
  {
    "text": "The food contaminant deoxynivalenol activates the mitogen activated protein kinases in the intestines . Ex-vivo studies can be done without in-vivo studies .",
    "triple_list": [
      [
        "deoxynivalenol",
        "CPR:3",
        "mitogen activated protein kinases"
      ]
    ],
    "updated": "Yes",
    "original": "The food contaminant deoxynivalenol activates the mitogen activated protein kinases in the intestine interest of ex vivo models as an alternative to in vivo experiments",
    "simplified": "The food contaminant deoxynivalenol activates the mitogen activated protein kinases in the intestines. Ex-vivo studies can be done without in-vivo studies."
  },
  {
    "text": "In particular we showed that Paeoniflorin significantly reduced the formation of intracellular reactive oxygen species ROS the level of malondialdehyde MDA and lactate dehydrogenase LDH leakage and enhanced production of the endogenous antioxidants glutathione GSH and superoxide dismutase SOD in EAhy926 cells",
    "triple_list": [
      [
        "Paeoniflorin",
        "CPR:3",
        "superoxide dismutase"
      ],
      [
        "Paeoniflorin",
        "CPR:3",
        "SOD"
      ],
      [
        "Paeoniflorin",
        "CPR:4",
        "lactate dehydrogenase"
      ],
      [
        "Paeoniflorin",
        "CPR:4",
        "LDH"
      ]
    ],
    "updated": "No",
    "original": "In particular we showed that Paeoniflorin significantly reduced the formation of intracellular reactive oxygen species ROS the level of malondialdehyde MDA and lactate dehydrogenase LDH leakage and enhanced production of the endogenous antioxidants glutathione GSH and superoxide dismutase SOD in EAhy926 cells",
    "simplified": "In particular we showed that Paeoniflorin significantly reduced the formation of intracellular reactive oxygen species (ROS) and enhanced production of the endogenous antioxidants glutathione GSH and superoxide dismutase SOD in EAhy926 cells."
  },
  {
    "text": "When these cells were treated with Paeoniflorin , HO1 expression increased .",
    "triple_list": [
      [
        "Paeoniflorin",
        "CPR:3",
        "HO1"
      ]
    ],
    "updated": "Yes",
    "original": "Treatment of these cells with Paeoniflorin significantly induced HO1 expression",
    "simplified": "When these cells were treated with Paeoniflorin, HO1 expression increased."
  },
  {
    "text": "Paeoniflorin protects human EAhy926 endothelial cells from oxidative damage . It does this by making the NFE2related factor 2 heme oxygenase1 pathway work .",
    "triple_list": [
      [
        "Paeoniflorin",
        "CPR:3",
        "NFE2related factor 2"
      ],
      [
        "Paeoniflorin",
        "CPR:3",
        "heme oxygenase1"
      ]
    ],
    "updated": "Yes",
    "original": "Paeoniflorin protects human EAhy926 endothelial cells against gammaradiation induced oxidative injury by activating the NFE2related factor 2 heme oxygenase1 pathway",
    "simplified": "Paeoniflorin protects human EAhy926 endothelial cells from oxidative damage. It does this by making the NFE2related factor 2 heme oxygenase1 pathway work."
  },
  {
    "text": "The Paeoniflorin changed HO1 expression , but only for a short time .",
    "triple_list": [
      [
        "Paeoniflorin",
        "CPR:3",
        "HO1"
      ]
    ],
    "updated": "Yes",
    "original": "The Paeoniflorin induced HO1 expression was abrogated by Nrf2 siRNA",
    "simplified": "The Paeoniflorin changed HO1 expression, but only for a short time."
  },
  {
    "text": "Furthermore inhibition of HO1 with zinc protoporphyrin IX ZNPP significantly reversed the protective effect of Paeoniflorin against radiationinduced damage in EAhy926 cells",
    "triple_list": [
      [
        "HO1",
        "CPR:3",
        "Paeoniflorin"
      ],
      [
        "HO1",
        "CPR:4",
        "zinc protoporphyrin IX"
      ],
      [
        "HO1",
        "CPR:4",
        "ZNPP"
      ]
    ],
    "updated": "No",
    "original": "Furthermore inhibition of HO1 with zinc protoporphyrin IX ZNPP significantly reversed the protective effect of Paeoniflorin against radiationinduced damage in EAhy926 cells",
    "simplified": "In addition, when HO1 was inhibited with zinc protoporphyrin IX, the protective effect of Paeoniflorin was significantly reduced in EAhy926 cells."
  },
  {
    "text": "Paeoniflorin has been shown to protect EAhy926 cells against radiation through the Nrf2 HO1 pathway .",
    "triple_list": [
      [
        "Paeoniflorin",
        "CPR:3",
        "Nrf2"
      ],
      [
        "Paeoniflorin",
        "CPR:3",
        "HO1"
      ]
    ],
    "updated": "Yes",
    "original": "Our findings confirmed that Paeoniflorin protected EAhy926 cells against radiationinduced injury through the Nrf2 HO1 pathway",
    "simplified": "Paeoniflorin has been shown to protect EAhy926 cells against radiation through the Nrf2 HO1 pathway."
  },
  {
    "text": "Palonosetron a secondgeneration 5HT3 receptor antagonist with a different mechanism of action and a different halflife from the firstgeneration 5HT3 receptor antagonists appears to be the most effective agent in its class .",
    "triple_list": [
      [
        "Palonosetron",
        "CPR:6",
        "5HT3"
      ]
    ],
    "updated": "Yes",
    "original": "Palonosetron a secondgeneration 5HT3 receptor antagonist with a different halflife a different binding capacity and a different mechanism of action than the firstgeneration 5HT3 receptor antagonists appears to be the most effective agent in its class",
    "simplified": "Palonosetron a secondgeneration 5HT3 receptor antagonist with a different mechanism of action and a different halflife from the firstgeneration 5HT3 receptor antagonists appears to be the most effective agent in its class."
  },
  {
    "text": "Aprepitant the first and only agent clinically available in the NK1 receptor antagonist drug class has been used to control CINV . dexamethasone has also been used to control CINV .",
    "triple_list": [
      [
        "Aprepitant",
        "CPR:6",
        "NK1 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Aprepitant the first and only agent clinically available in the NK1 receptor antagonist drug class has been used effectively as an additive agent to the 5HT3 receptor antagonists and dexamethasone to control CINV",
    "simplified": "Aprepitant the first and only agent clinically available in the NK1 receptor antagonist drug class has been used to control CINV. dexamethasone has also been used to control CINV."
  },
  {
    "text": "Rolapitant and netupitant are other drugs that try to stop the NK1 receptor . They are in clinical trials .",
    "triple_list": [
      [
        "Rolapitant",
        "CPR:6",
        "NK1 receptor"
      ],
      [
        "netupitant",
        "CPR:6",
        "NK1 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Rolapitant and netupitant are other NK1 receptor antagonists that are currently in phase III clinical trials",
    "simplified": "Rolapitant and netupitant are other drugs that try to stop the NK1 receptor. They are in clinical trials."
  },
  {
    "text": "Moderate inhibitory effect of LDL C oxidation by phytosteryl phenolates was observed",
    "triple_list": [
      [
        "LDL",
        "CPR:4",
        "phytosteryl phenolates"
      ]
    ],
    "updated": "No",
    "original": "Moderate inhibitory effect of LDL C oxidation by phytosteryl phenolates was observed",
    "simplified": "Phytosteryl phenolates have a moderate inhibitory effect on LDL C oxidation."
  },
  {
    "text": "Aqueous ethanol 80 extract of lentil hulls exhibited high antioxidant and antiinflammatory activities preferentially inhibiting 15LOX IC50 55 \u03bcgml with moderate COX1 IC50 66 \u03bcgml and COX2 IC50 119 \u03bcgml inhibitory effects on the COX pathway whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity",
    "triple_list": [
      [
        "ethanol",
        "CPR:4",
        "15LOX"
      ],
      [
        "ethanol",
        "CPR:4",
        "COX1"
      ],
      [
        "ethanol",
        "CPR:4",
        "COX2"
      ],
      [
        "ethanol",
        "CPR:4",
        "COX"
      ],
      [
        "ethanol",
        "CPR:4",
        "LOX"
      ]
    ],
    "updated": "No",
    "original": "Aqueous ethanol 80 extract of lentil hulls exhibited high antioxidant and antiinflammatory activities preferentially inhibiting 15LOX IC50 55 \u03bcgml with moderate COX1 IC50 66 \u03bcgml and COX2 IC50 119 \u03bcgml inhibitory effects on the COX pathway whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity",
    "simplified": "Aqueous ethanol 80 extract of lentil hulls showed high antioxidant and antiinflammatory activities. 15LOX IC50 55 \u03bcgml had a moderate inhibitory effect on the COX pathway, while COX1 IC50 66 \u03bcgml and COX2 IC50 119 \u03bcgml had a moderate inhibitory effect on the COX pathway."
  },
  {
    "text": "The ethyl acetate extract from the petal of the plant Filipendula ulmaria has been used to search for HDC .",
    "triple_list": [
      [
        "HDC",
        "CPR:4",
        "ethyl acetate"
      ]
    ],
    "updated": "Yes",
    "original": "We searched for inhibitors of HDC from the ethyl acetate extract of the petal of Filipendula ulmaria also called meadowsweet",
    "simplified": "The ethyl acetate extract from the petal of the plant Filipendula ulmaria has been used to search for HDC."
  },
  {
    "text": "Histidine decarboxylase HDC catalyses the formation of hist amine a bioactive amine",
    "triple_list": [
      [
        "Histidine decarboxylase",
        "CPR:9",
        "amine"
      ],
      [
        "HDC",
        "CPR:9",
        "amine"
      ]
    ],
    "updated": "No",
    "original": "Histidine decarboxylase HDC catalyses the formation of hist amine a bioactive amine",
    "simplified": "The histidine decarboxylase (HDC) catalyzes the formation of histidine."
  },
  {
    "text": "A novel series of quinolone \u03b17 nicotinic acetylcholine receptor ( nAChR ) agonists has been identified .",
    "triple_list": [
      [
        "quinolone",
        "CPR:5",
        "nAChR"
      ],
      [
        "quinolone",
        "CPR:5",
        "\u03b17 nicotinic acetylcholine receptor"
      ]
    ],
    "updated": "Yes",
    "original": "High throughput screening led to the identification of a novel series of quinolone \u03b17 nicotinic acetylcholine receptor nAChR agonists",
    "simplified": "A novel series of quinolone \u03b17 nicotinic acetylcholine receptor (nAChR) agonists has been identified."
  },
  {
    "text": "Discovery of a novel series of quinolone \u03b17 nicotinic acetylcholine receptor agonists",
    "triple_list": [
      [
        "quinolone",
        "CPR:5",
        "\u03b17 nicotinic acetylcholine receptor"
      ]
    ],
    "updated": "No",
    "original": "Discovery of a novel series of quinolone \u03b17 nicotinic acetylcholine receptor agonists",
    "simplified": "Discovery of a novel drug called quinolone, which acts on the nicotinic receptors."
  },
  {
    "text": "This is distinct from Rock inhibitors based on non amino acid derived quinazolinones where high selectivity against PKA could be obtained",
    "triple_list": [
      [
        "Rock",
        "CPR:4",
        "amino acid"
      ],
      [
        "amino acid",
        "CPR:4",
        "PKA"
      ],
      [
        "Rock",
        "CPR:4",
        "quinazolinones"
      ],
      [
        "quinazolinones",
        "CPR:4",
        "PKA"
      ]
    ],
    "updated": "No",
    "original": "This is distinct from Rock inhibitors based on non amino acid derived quinazolinones where high selectivity against PKA could be obtained",
    "simplified": "This is different from rock inhibitors. Rock inhibitors are based on amino acids, but quinazolinones are not."
  },
  {
    "text": "SAR and lead optimization studies for Rock inhibitors based on amino acid derived quinazolines are described",
    "triple_list": [
      [
        "Rock",
        "CPR:4",
        "amino acid"
      ],
      [
        "Rock",
        "CPR:4",
        "quinazolines"
      ]
    ],
    "updated": "No",
    "original": "SAR and lead optimization studies for Rock inhibitors based on amino acid derived quinazolines are described",
    "simplified": "SAR and lead optimization studies for rock inhibitors based on quinazolines have been described"
  },
  {
    "text": "Amino acid derived quinazolines as Rock PKA inhibitors",
    "triple_list": [
      [
        "Amino acid",
        "CPR:4",
        "Rock"
      ],
      [
        "Amino acid",
        "CPR:4",
        "PKA"
      ],
      [
        "quinazolines",
        "CPR:4",
        "Rock"
      ],
      [
        "quinazolines",
        "CPR:4",
        "PKA"
      ]
    ],
    "updated": "No",
    "original": "Amino acid derived quinazolines as Rock PKA inhibitors",
    "simplified": "Quinazolines are used as PKA inhibitors."
  },
  {
    "text": "The cyclooxygenase2 inhibitor diflunisal is used to reduce inflammation in the body .",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:4",
        "diflunisal"
      ]
    ],
    "updated": "Yes",
    "original": "The cyclooxygenase2 inhibitor diflunisal is used in the clinic for its antiinflammatory activity",
    "simplified": "The cyclooxygenase2 inhibitor diflunisal is used to reduce inflammation in the body."
  },
  {
    "text": "Although there was no change in the levels of insulin receptor IR Akt protein kinase B and glucose transporter4 GLUT4 messenger RNA BPA significantly decreased the IR Akt and GLUT4 protein levels both plasma membrane and cytosolic fraction of the gastrocnemius muscle",
    "triple_list": [
      [
        "Akt",
        "CPR:4",
        "BPA"
      ],
      [
        "GLUT4",
        "CPR:4",
        "BPA"
      ],
      [
        "IR",
        "CPR:4",
        "BPA"
      ]
    ],
    "updated": "No",
    "original": "Although there was no change in the levels of insulin receptor IR Akt protein kinase B and glucose transporter4 GLUT4 messenger RNA BPA significantly decreased the IR Akt and GLUT4 protein levels both plasma membrane and cytosolic fraction of the gastrocnemius muscle",
    "simplified": "There was no change in the levels of insulin receptor IR Akt protein kinase B and glucose transporter4. However, the levels of IR Akt and GLUT4 protein in the plasma membrane and cytosolic fraction of the gastrocnemius muscle were significantly reduced."
  },
  {
    "text": "In conclusion BPA has negative effects on 14Cglucose oxidation and Akt GLUT4 translocation .",
    "triple_list": [
      [
        "BPA",
        "CPR:4",
        "Akt"
      ],
      [
        "BPA",
        "CPR:4",
        "GLUT4"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion BPA has adverse effects on phosphorylation of Akt GLUT4 translocation and 14Cglucose oxidation",
    "simplified": "In conclusion BPA has negative effects on 14Cglucose oxidation and Akt GLUT4 translocation."
  },
  {
    "text": "The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone lactate dehydrogenase acid phosphatase alkaline phosphatase and testicular steroidogenic enzymes 3\u03b2hydroxysteroid dehydrogenase HSD 17\u03b2HSD activities as well as epididymal sperm counts and motility while RUT and Se treatment reversed this change to control values",
    "triple_list": [
      [
        "Cd",
        "CPR:4",
        "lactate dehydrogenase"
      ],
      [
        "Cd",
        "CPR:4",
        "acid phosphatase"
      ],
      [
        "Cd",
        "CPR:4",
        "alkaline phosphatase"
      ],
      [
        "Cd",
        "CPR:4",
        "testicular steroidogenic enzymes"
      ],
      [
        "Cd",
        "CPR:4",
        "3\u03b2hydroxysteroid dehydrogenase"
      ],
      [
        "Cd",
        "CPR:4",
        "HSD"
      ],
      [
        "Cd",
        "CPR:4",
        "17\u03b2HSD"
      ]
    ],
    "updated": "No",
    "original": "The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone lactate dehydrogenase acid phosphatase alkaline phosphatase and testicular steroidogenic enzymes 3\u03b2hydroxysteroid dehydrogenase HSD 17\u03b2HSD activities as well as epididymal sperm counts and motility while RUT and Se treatment reversed this change to control values",
    "simplified": "The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone lactate dehydrogenase acid phosphatase alkaline phosphatase and testicular steroidogenic enzymes as well as epididymal sperm counts and motility while RUT and Se treatment reversed this change to control values."
  },
  {
    "text": "The antioxidant defense system superoxide dismutase SOD catalase CAT glutathione peroxidase GSHPx glutathione reductase GR glutathione GSH and glutathioneStransferase GST When people take too much Cd , the antioxidant defense system does not work as well .",
    "triple_list": [
      [
        "Cd",
        "CPR:4",
        "GST"
      ],
      [
        "Cd",
        "CPR:4",
        "superoxide dismutase"
      ],
      [
        "Cd",
        "CPR:4",
        "SOD"
      ],
      [
        "Cd",
        "CPR:4",
        "catalase"
      ],
      [
        "Cd",
        "CPR:4",
        "CAT"
      ],
      [
        "Cd",
        "CPR:4",
        "glutathione peroxidase"
      ],
      [
        "Cd",
        "CPR:4",
        "GSHPx"
      ],
      [
        "Cd",
        "CPR:4",
        "glutathione reductase"
      ],
      [
        "Cd",
        "CPR:4",
        "GR"
      ],
      [
        "Cd",
        "CPR:4",
        "glutathioneStransferase"
      ]
    ],
    "updated": "Yes",
    "original": "Acute intoxication with Cd was also followed by significantly decreased activity of the antioxidant defence system superoxide dismutase SOD catalase CAT glutathione peroxidase GSHPx glutathione reductase GR glutathione GSH and glutathioneStransferase GST",
    "simplified": "The antioxidant defense system superoxide dismutase SOD catalase CAT glutathione peroxidase GSHPx glutathione reductase GR glutathione GSH and glutathioneStransferase GST When people take too much Cd, the antioxidant defense system does not work as well."
  },
  {
    "text": "MeHg increased the amount of DA in cells that were treated with 3hydroxybenzylhydrazine 10\u00b5M . MeHg also increased tyrosine hydroxylase activity .",
    "triple_list": [
      [
        "MeHg",
        "CPR:3",
        "tyrosine hydroxylase"
      ]
    ],
    "updated": "Yes",
    "original": "MeHg significantly increased DA precursor accumulation in cells treated with 3hydroxybenzylhydrazine 10\u00b5M revealing that MeHg increases tyrosine hydroxylase activity",
    "simplified": "MeHg increased the amount of DA in cells that were treated with 3hydroxybenzylhydrazine 10\u00b5M. MeHg also increased tyrosine hydroxylase activity."
  },
  {
    "text": "The tyrosine hydroxylase inhibitor \u03b1methyltyrosine 300\u00b5M 24h completely abolished MeHginduced DA release",
    "triple_list": [
      [
        "tyrosine hydroxylase",
        "CPR:4",
        "\u03b1methyltyrosine"
      ]
    ],
    "updated": "No",
    "original": "The tyrosine hydroxylase inhibitor \u03b1methyltyrosine 300\u00b5M 24h completely abolished MeHginduced DA release",
    "simplified": "The tyrosine hydroxylase inhibitor 300\u00b5M 24h completely stopped DA from being released."
  },
  {
    "text": "The structural modification of pyridin3yl benzoxazinyloxazolidinones is described which resulted in the development of a new series of benzoxazinyloxazolidinone analogues with high antibacterial activity against linezolidresistant strains and low hERG inhibition .",
    "triple_list": [
      [
        "benzoxazinyloxazolidinone",
        "CPR:4",
        "hERG"
      ]
    ],
    "updated": "Yes",
    "original": "The solubilitydriven structural modification of pyridin3yl benzoxazinyloxazolidinones is described which resulted in the development of a new series of benzoxazinyloxazolidinone analogues with high antibacterial activity against Grampositive pathogens including that against linezolidresistant strains and low hERG inhibition",
    "simplified": "The structural modification of pyridin3yl benzoxazinyloxazolidinones is described which resulted in the development of a new series of benzoxazinyloxazolidinone analogues with high antibacterial activity against linezolidresistant strains and low hERG inhibition."
  },
  {
    "text": "Secondary point mutations in the Fmslike tyrosine kinase 3 FLT3 tyrosine kinase domain KD are common causes of acquired clinical resistance to the FLT3 inhibitors AC220 quizartinib and sorafenib",
    "triple_list": [
      [
        "FLT3",
        "CPR:4",
        "AC220"
      ],
      [
        "FLT3",
        "CPR:4",
        "quizartinib"
      ],
      [
        "FLT3",
        "CPR:4",
        "sorafenib"
      ]
    ],
    "updated": "No",
    "original": "Secondary point mutations in the Fmslike tyrosine kinase 3 FLT3 tyrosine kinase domain KD are common causes of acquired clinical resistance to the FLT3 inhibitors AC220 quizartinib and sorafenib",
    "simplified": "Secondary point mutations in the FLT3 domain are common causes of acquired clinical resistance to the FLT3 inhibitors quizartinib and sorafenib, both of which are approved for use in patients."
  },
  {
    "text": "Ponatinib AP24534 is a multikinase inhibitor that is used to treat chronic myeloid leukemia . It works by inhibiting tyrosine kinase .",
    "triple_list": [
      [
        "Ponatinib",
        "CPR:4",
        "multikinase"
      ],
      [
        "AP24534",
        "CPR:4",
        "multikinase"
      ]
    ],
    "updated": "Yes",
    "original": "Ponatinib AP24534 is a multikinase inhibitor with in vitro and clinical activity in tyrosine kinase inhibitor TKIresistant chronic myeloid leukemia irrespective of BCRABL KD mutation",
    "simplified": "Ponatinib AP24534 is a multikinase inhibitor that is used to treat chronic myeloid leukemia. It works by inhibiting tyrosine kinase."
  },
  {
    "text": "However the involvement of the caspasedependent pathway in the process of cell death could not be prevented by pretreatment with the pan caspase inhibitor zVADfmk so it is not necessary to use BSC 3g or 3n .",
    "triple_list": [
      [
        "caspase",
        "CPR:4",
        "zVADfmk"
      ]
    ],
    "updated": "Yes",
    "original": "However the involvement of the caspasedependent pathway in the process of cell death induced by either BSC 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pan caspase inhibitor zVADfmk",
    "simplified": "However the involvement of the caspasedependent pathway in the process of cell death could not be prevented by pretreatment with the pan caspase inhibitor zVADfmk so it is not necessary to use BSC 3g or 3n."
  },
  {
    "text": "In addition , lower levels of p21CIP1 and Chk2 proteins but no change in p53 levels were found in MCF7 cells after BSC 3g or 3n treatment . Our results suggest that cells treated with BSC die .",
    "triple_list": [
      [
        "p21CIP1",
        "CPR:4",
        "BSC"
      ],
      [
        "Chk2",
        "CPR:4",
        "BSC"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover since reduced levels of p21CIP1 and Chk2 proteins but no change in p53 levels could be detected in MCF7 cells after BSC 3g or 3n treatment our results suggest that BSC treated cells die from lethal mitosis",
    "simplified": "In addition, lower levels of p21CIP1 and Chk2 proteins but no change in p53 levels were found in MCF7 cells after BSC 3g or 3n treatment. Our results suggest that cells treated with BSC die."
  },
  {
    "text": "5amino27bis4methoxyphenyl23dihydrobenzobthiophene46dicarbonitrile was found to be the most potent against AChE with IC50 416 \u03bcmolL These compounds were evaluated for their acetylcholinesterase AChE inhibitory activity .",
    "triple_list": [
      [
        "AChE",
        "CPR:4",
        "5amino27bis4methoxyphenyl23dihydrobenzobthiophene46dicarbonitrile"
      ]
    ],
    "updated": "Yes",
    "original": "These compounds were evaluated for their acetylcholinesterase AChE inhibitory activity and 5amino27bis4methoxyphenyl23dihydrobenzobthiophene46dicarbonitrile was found to be the most potent against AChE with IC50 416 \u03bcmolL",
    "simplified": "5amino27bis4methoxyphenyl23dihydrobenzobthiophene46dicarbonitrile was found to be the most potent against AChE with IC50 416 \u03bcmolL These compounds were evaluated for their acetylcholinesterase AChE inhibitory activity."
  },
  {
    "text": "A onepot domino synthesis and discovery of highly functionalized dihydrobenzobthiophenes as AChE inhibitors",
    "triple_list": [
      [
        "dihydrobenzobthiophenes",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "No",
    "original": "A onepot domino synthesis and discovery of highly functionalized dihydrobenzobthiophenes as AChE inhibitors",
    "simplified": "The discovery and onepot synthesis of dihydrobenzobthiophenes as an important structural element"
  },
  {
    "text": "Furthermore knockdown of OPN enhanced cell death caused by other drugs including paclitaxel doxorubicin actinomycinD and rapamycin which are also Pgp substrates",
    "triple_list": [
      [
        "paclitaxel",
        "CPR:9",
        "Pgp"
      ],
      [
        "doxorubicin",
        "CPR:9",
        "Pgp"
      ],
      [
        "actinomycinD",
        "CPR:9",
        "Pgp"
      ],
      [
        "rapamycin",
        "CPR:9",
        "Pgp"
      ]
    ],
    "updated": "No",
    "original": "Furthermore knockdown of OPN enhanced cell death caused by other drugs including paclitaxel doxorubicin actinomycinD and rapamycin which are also Pgp substrates",
    "simplified": "In addition, OPN can reduce enhanced cell death caused by other drugs, for example actinomycinD and rapamycin, which are also Pgp substrates."
  },
  {
    "text": "Compared with normallyfed rats , PMCP rats had higher levels of glutathione Stransferase aminopeptidase N and cysteine Sconjugate betalyase CCBL and lower levels of gammaglutamyltransferase . PMFU rats had lower levels of dihydropyrimidine dehydrogenase and cytochrome P450 1A12 , while PM MMC rats had higher levels of quinone reductase and xanthine oxidase .",
    "triple_list": [
      [
        "MMC",
        "CPR:3",
        "quinone reductase"
      ],
      [
        "MMC",
        "CPR:4",
        "xanthine oxidase"
      ]
    ],
    "updated": "Yes",
    "original": "Compared with normallyfed counterparts PMCP rats exhibited higher glutathione Stransferase aminopeptidase N and cysteine Sconjugate betalyase CCBL and lower gammaglutamyltransferase activities PMFU rats exhibited decreased dihydropyrimidine dehydrogenase and cytochrome P450 1A12 activities and PM MMC rats showed higher quinone reductase and depleted xanthine oxidase activities",
    "simplified": "Compared with normallyfed rats, PMCP rats had higher levels of glutathione Stransferase aminopeptidase N and cysteine Sconjugate betalyase CCBL and lower levels of gammaglutamyltransferase. PMFU rats had lower levels of dihydropyrimidine dehydrogenase and cytochrome P450 1A12, while PM MMC rats had higher levels of quinone reductase and xanthine oxidase."
  },
  {
    "text": "Conclusively protein malnutrition alters CP FU and MMC metabolism in rat stomach by enhancing CCBL pathway for CP activation delaying FU elimination and activating twoelectron reduction of MMC potentiating their gastrotoxicity",
    "triple_list": [
      [
        "MMC",
        "CPR:9",
        "CCBL"
      ]
    ],
    "updated": "No",
    "original": "Conclusively protein malnutrition alters CP FU and MMC metabolism in rat stomach by enhancing CCBL pathway for CP activation delaying FU elimination and activating twoelectron reduction of MMC potentiating their gastrotoxicity",
    "simplified": "Conclusively protein malnutrition alters CP FU and MMC metabolism in rat stomach by delaying FU elimination and activating twoelectron reduction of MMC. This changes their gastrotoxicity."
  },
  {
    "text": "Nacetylcysteine NAC 33 mM and the cjun Nterminal kinase JNK inhibitor SP600125 33 \u03bcM further decreased the viability in the presence of DEP 200 \u03bcgml and 33 FCS",
    "triple_list": [
      [
        "JNK",
        "CPR:4",
        "SP600125"
      ],
      [
        "cjun Nterminal kinase",
        "CPR:4",
        "SP600125"
      ]
    ],
    "updated": "No",
    "original": "Nacetylcysteine NAC 33 mM and the cjun Nterminal kinase JNK inhibitor SP600125 33 \u03bcM further decreased the viability in the presence of DEP 200 \u03bcgml and 33 FCS",
    "simplified": "Nacetylcysteine NAC 33 mM and the JNK inhibitor SP600125 33 \u03bcM further decreased the viability. DEP 200 \u03bcgml and 33 FCS did not work either."
  },
  {
    "text": "HENA activated the BK cbv1 \u03b21 channels cloned from rat cerebral artery myocytes . It had a potency EC50 = 53 \u03bcM which was significantly greater than that of LCA .",
    "triple_list": [
      [
        "HENA",
        "CPR:3",
        "BK cbv1 \u03b21 channels"
      ],
      [
        "BK cbv1 \u03b21 channels",
        "CPR:3",
        "LCA"
      ]
    ],
    "updated": "Yes",
    "original": "HENA activated the BK cbv1 \u03b21 channels cloned from rat cerebral artery myocytes with a potency EC50 = 53 \u03bcM similar to and an efficacy \u00d725 potentiation significantly greater than that of LCA",
    "simplified": "HENA activated the BK cbv1 \u03b21 channels cloned from rat cerebral artery myocytes. It had a potency EC50 = 53 \u03bcM which was significantly greater than that of LCA."
  },
  {
    "text": "HENA failed to activate the channels made of cbv1 \u03b22 \u03b23 \u03b24 or \u03b21T169A indicating that this drug selectively targets \u03b21containing BK channels via the BK \u03b21 steroidsensing site",
    "triple_list": [
      [
        "HENA",
        "CPR:3",
        "\u03b21containing BK channels"
      ]
    ],
    "updated": "No",
    "original": "HENA failed to activate the channels made of cbv1 \u03b22 \u03b23 \u03b24 or \u03b21T169A indicating that this drug selectively targets \u03b21containing BK channels via the BK \u03b21 steroidsensing site",
    "simplified": "HENA did not work on the channels made of cbv1 \u03b22 \u03b23 \u03b24 or \u03b21T169A. This means that this drug only works on the BK channels if they are there."
  },
  {
    "text": "RATIONALE Histamine H3 receptor antagonists such as ABT288 have been shown to improve sleep and wakefulness in humans .",
    "triple_list": [
      [
        "Histamine H3 receptor",
        "CPR:6",
        "ABT288"
      ]
    ],
    "updated": "Yes",
    "original": "RATIONALE Histamine H3 receptor antagonists such as ABT288 have been shown to possess cognitiveenhancing and wakefulnesspromoting effects",
    "simplified": "RATIONALE Histamine H3 receptor antagonists such as ABT288 have been shown to improve sleep and wakefulness in humans."
  },
  {
    "text": "The abuse potential of ABT288 a novel histamine H3 receptor antagonist",
    "triple_list": [
      [
        "ABT288",
        "CPR:6",
        "histamine H3 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Assessment of the abuse liability of ABT288 a novel histamine H3 receptor antagonist",
    "simplified": "The abuse potential of ABT288 a novel histamine H3 receptor antagonist"
  },
  {
    "text": "The sum of these preclinical data , the first of their kind applied to H3 antagonists , suggests that ABT288 is unlikely to have a high potential for abuse in the human population and that the class of H3 antagonists is similar in this regard .",
    "triple_list": [
      [
        "H3",
        "CPR:6",
        "ABT288"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS The sum of these preclinical data the first of their kind applied to H3 antagonists indicates that ABT288 is unlikely to possess a high potential for abuse in the human population and suggests that H3 antagonists as a class are similar in this regard",
    "simplified": "The sum of these preclinical data, the first of their kind applied to H3 antagonists, suggests that ABT288 is unlikely to have a high potential for abuse in the human population and that the class of H3 antagonists is similar in this regard."
  },
  {
    "text": "This methodology was subsequently used to assess the relative contribution of OATP1B1 uptake in human hepatocytes for olmesartan 4262 valsartan 2881 rosuvastatin 6472 pitavastatin 8498 and lopinavir 6489",
    "triple_list": [
      [
        "OATP1B1",
        "CPR:9",
        "pitavastatin"
      ],
      [
        "OATP1B1",
        "CPR:9",
        "lopinavir"
      ],
      [
        "OATP1B1",
        "CPR:9",
        "olmesartan"
      ],
      [
        "OATP1B1",
        "CPR:9",
        "valsartan"
      ],
      [
        "OATP1B1",
        "CPR:9",
        "rosuvastatin"
      ]
    ],
    "updated": "No",
    "original": "This methodology was subsequently used to assess the relative contribution of OATP1B1 uptake in human hepatocytes for olmesartan 4262 valsartan 2881 rosuvastatin 6472 pitavastatin 8498 and lopinavir 6489",
    "simplified": "This method was then used to determine the relative contribution of different drugs to the uptake of OATP1B1 in human hepatocytes for olmesartan, valsartan and rosuvastatin."
  },
  {
    "text": "OATP1B1 reduced estrone3sulfate 5 nM by 8295 times .",
    "triple_list": [
      [
        "estrone3sulfate",
        "CPR:9",
        "OATP1B1"
      ]
    ],
    "updated": "Yes",
    "original": "Uptake of estrone3sulfate 5 nM by OATP1B1 was reduced by 8295",
    "simplified": "OATP1B1 reduced estrone3sulfate 5 nM by 8295 times."
  },
  {
    "text": "lglutamine decreased plasma glucose increased plasma and pancreatic insulin increased plasma and colonic active GLP1 736 amide secretion as well as decreased oxidative stress in streptozotocinnicotinamide induced diabetic rats",
    "triple_list": [
      [
        "lglutamine",
        "CPR:3",
        "insulin"
      ],
      [
        "lglutamine",
        "CPR:3",
        "GLP1"
      ]
    ],
    "updated": "No",
    "original": "lglutamine decreased plasma glucose increased plasma and pancreatic insulin increased plasma and colonic active GLP1 736 amide secretion as well as decreased oxidative stress in streptozotocinnicotinamide induced diabetic rats",
    "simplified": "lglutamine decreased plasma glucose increased plasma and pancreatic insulin as well as decreased oxidative stress in streptozotocinnicotinamide induced diabetic rats."
  },
  {
    "text": "The aim of the present study was to determine whether lglutamine increases the secretion of glucagon like peptide1 GLP1 736 amide in diabetic Sprague Dawley rats .",
    "triple_list": [
      [
        "lglutamine",
        "CPR:3",
        "glucagon like peptide1"
      ],
      [
        "lglutamine",
        "CPR:3",
        "GLP1"
      ]
    ],
    "updated": "Yes",
    "original": "The objective of the present investigation was to evaluate lglutamine increases glucagon like peptide1 GLP1 736 amide secretion in streptozotocinnicotinamide STZNTM induced diabetic Sprague Dawley rats",
    "simplified": "The aim of the present study was to determine whether lglutamine increases the secretion of glucagon like peptide1 GLP1 736 amide in diabetic Sprague Dawley rats."
  },
  {
    "text": "Oral lglutamine increases the secretion of GLP1 736 in diabetic rats and improves glycemic control in diabetic rats .",
    "triple_list": [
      [
        "lglutamine",
        "CPR:3",
        "GLP1"
      ]
    ],
    "updated": "Yes",
    "original": "Oral lglutamine increases active GLP1 736 amide secretion and improves glycemic control in stretpozotocinnicotinamide induced diabetic rats",
    "simplified": "Oral lglutamine increases the secretion of GLP1 736 in diabetic rats and improves glycemic control in diabetic rats."
  },
  {
    "text": "In the present study hinokitiol 1 and 2\u03bcM inhibited the collagen induced aggregation of human platelets but did not inhibit the activation of platelets by other agonists including thrombin arachidonic acid and ADP",
    "triple_list": [
      [
        "hinokitiol",
        "CPR:4",
        "collagen"
      ]
    ],
    "updated": "No",
    "original": "In the present study hinokitiol 1 and 2\u03bcM inhibited the collagen induced aggregation of human platelets but did not inhibit the activation of platelets by other agonists including thrombin arachidonic acid and ADP",
    "simplified": "In the present study hinokitiol 1 and 2\u03bcM inhibited the aggregation of human platelets but did not inhibit the activation of platelets by other agonists including ADP and thrombin arachidonic acid."
  },
  {
    "text": "Hinokitiol inhibited the phosphorylation of phospholipase C PLC\u03b32 protein kinase C PKC mitogenactivated protein kinases MAPKs and Akt in collagen activated human platelets and significantly reduced intracellular calcium mobilization and hydroxyl radical OH formation",
    "triple_list": [
      [
        "Hinokitiol",
        "CPR:4",
        "phospholipase C PLC\u03b32"
      ],
      [
        "Hinokitiol",
        "CPR:4",
        "protein kinase C"
      ],
      [
        "Hinokitiol",
        "CPR:4",
        "PKC"
      ],
      [
        "Hinokitiol",
        "CPR:4",
        "mitogenactivated protein kinases"
      ],
      [
        "Hinokitiol",
        "CPR:4",
        "MAPKs"
      ],
      [
        "Hinokitiol",
        "CPR:4",
        "Akt"
      ],
      [
        "Hinokitiol",
        "CPR:4",
        "collagen"
      ]
    ],
    "updated": "No",
    "original": "Hinokitiol inhibited the phosphorylation of phospholipase C PLC\u03b32 protein kinase C PKC mitogenactivated protein kinases MAPKs and Akt in collagen activated human platelets and significantly reduced intracellular calcium mobilization and hydroxyl radical OH formation",
    "simplified": "Hinokitiol inhibited the phosphorylation of MAPKs and Akt in collagen activated human platelets and significantly reduced intracellular calcium mobilization and hydroxyl radical OH formation."
  },
  {
    "text": "Hinokitiol also reduced platelet aggregation and PKC activation by PDBu .",
    "triple_list": [
      [
        "Hinokitiol",
        "CPR:4",
        "PKC"
      ]
    ],
    "updated": "Yes",
    "original": "Hinokitiol also reduced the PKC activation and platelet aggregation stimulated by PDBu",
    "simplified": "Hinokitiol also reduced platelet aggregation and PKC activation by PDBu."
  },
  {
    "text": "In conclusion hinokitiol may inhibit platelet activation by inhibiting the PLC\u03b32 PKC cascade and hydroxyl radical formation followed by suppressing the activation of MAPKs and Akt",
    "triple_list": [
      [
        "hinokitiol",
        "CPR:4",
        "PLC\u03b32"
      ],
      [
        "hinokitiol",
        "CPR:4",
        "PKC"
      ],
      [
        "hinokitiol",
        "CPR:4",
        "MAPKs"
      ],
      [
        "hinokitiol",
        "CPR:4",
        "Akt"
      ]
    ],
    "updated": "No",
    "original": "In conclusion hinokitiol may inhibit platelet activation by inhibiting the PLC\u03b32 PKC cascade and hydroxyl radical formation followed by suppressing the activation of MAPKs and Akt",
    "simplified": "In conclusion hinokitiol may inhibit platelet activation by suppressing the activation of MAPKs and Akt and by inhibiting the hydroxyl radical formation."
  },
  {
    "text": "Novel 5benzyloxypyridin21Hone derivatives as potent cMet inhibitors",
    "triple_list": [
      [
        "5benzyloxypyridin21Hone",
        "CPR:4",
        "cMet"
      ]
    ],
    "updated": "No",
    "original": "Novel 5benzyloxypyridin21Hone derivatives as potent cMet inhibitors",
    "simplified": "Novel 5benzyloxypyridin can be used as a medicine."
  },
  {
    "text": "Design Synthesis and Pharmacological Characterization of Novel Endomorphin1 Analogues as Extremely Potent \u03bcOpioid Agonists",
    "triple_list": [
      [
        "Endomorphin1",
        "CPR:5",
        "\u03bcOpioid"
      ]
    ],
    "updated": "No",
    "original": "Design Synthesis and Pharmacological Characterization of Novel Endomorphin1 Analogues as Extremely Potent \u03bcOpioid Agonists",
    "simplified": "Design Synthesis and Pharmacological Characterization of Novel \u03bcOpioid Agonists as Extremely Potent Analogues."
  },
  {
    "text": "No impact was seen on cytokine release in LPSstimulated human PBMCs except with JWH210 and JWH122 which caused a decrease of TNF\u03b1 and IL12 23p40 but no impact on IL10 or IL6 levels .",
    "triple_list": [
      [
        "TNF\u03b1",
        "CPR:4",
        "JWH210"
      ],
      [
        "IL12",
        "CPR:4",
        "JWH210"
      ],
      [
        "23p40",
        "CPR:4",
        "JWH210"
      ],
      [
        "TNF\u03b1",
        "CPR:4",
        "JWH122"
      ],
      [
        "IL12",
        "CPR:4",
        "JWH122"
      ],
      [
        "23p40",
        "CPR:4",
        "JWH122"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore no impact on cytokine release ie on IL10 IL6 IL12 23p40 and TNF\u03b1 levels was seen in LPSstimulated human PBMCs except with JWH210 and JWH122 which caused a decrease of TNF\u03b1 and IL12 23p40",
    "simplified": "No impact was seen on cytokine release in LPSstimulated human PBMCs except with JWH210 and JWH122 which caused a decrease of TNF\u03b1 and IL12 23p40 but no impact on IL10 or IL6 levels."
  },
  {
    "text": "GTLE treatment completely changed the effects of AlCl3 on AA and superoxide dismutase activity . In addition , the treatment improved COX and AChE activities .",
    "triple_list": [
      [
        "AlCl3",
        "CPR:4",
        "superoxide dismutase"
      ],
      [
        "AlCl3",
        "CPR:4",
        "COX"
      ],
      [
        "AlCl3",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "GTLE pretreatment completely reversed the damaging effects of AlCl3 on AA and superoxide dismutase activity markedly corrected COX and AChE activities and moderately improved TGC",
    "simplified": "GTLE treatment completely changed the effects of AlCl3 on AA and superoxide dismutase activity. In addition, the treatment improved COX and AChE activities."
  },
  {
    "text": "AlCl3 significantly reduced the activity of acetylcholinesterase AChE and cytochrome c oxidase COX in all regions",
    "triple_list": [
      [
        "AlCl3",
        "CPR:4",
        "cytochrome c oxidase"
      ],
      [
        "AlCl3",
        "CPR:4",
        "COX"
      ],
      [
        "AlCl3",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "AlCl3",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "AlCl3 markedly reduced AA performance and activities of cytochrome c oxidase COX and acetylcholinesterase AChE in all regions",
    "simplified": "AlCl3 significantly reduced the activity of acetylcholinesterase AChE and cytochrome c oxidase COX in all regions"
  },
  {
    "text": "Our study demonstrated that curcumin inhibited OVA induced increases in eosinophil count interleukin IL17A level were recovered in bronchoalveolar lavage fluid increased IL10 level in bronchoalveolar lavage fluid",
    "triple_list": [
      [
        "curcumin",
        "CPR:3",
        "IL10"
      ],
      [
        "curcumin",
        "CPR:4",
        "OVA"
      ],
      [
        "curcumin",
        "CPR:4",
        "interleukin IL17A"
      ]
    ],
    "updated": "No",
    "original": "Our study demonstrated that curcumin inhibited OVA induced increases in eosinophil count interleukin IL17A level were recovered in bronchoalveolar lavage fluid increased IL10 level in bronchoalveolar lavage fluid",
    "simplified": "Our study demonstrated that curcumin inhibited interleukin IL17A level in bronchoalveolar lavage fluid and increased IL10 level in bronchoalveolar lavage fluid."
  },
  {
    "text": "Histological studies demonstrated that curcumin substantially inhibited OVA induced eosinophilia in lung tissue",
    "triple_list": [
      [
        "curcumin",
        "CPR:4",
        "OVA"
      ]
    ],
    "updated": "No",
    "original": "Histological studies demonstrated that curcumin substantially inhibited OVA induced eosinophilia in lung tissue",
    "simplified": "Histological studies have shown that curcumin can reduce eosinophilia significantly, especially in lung tissue."
  },
  {
    "text": "The results in vivo show ovalbumin induced significantly broke TregTh17 balance by regulating TregTh17 balance curcumin treatments markedly attenuated the inflammatory in asthma model .",
    "triple_list": [
      [
        "ovalbumin",
        "CPR:4",
        "curcumin"
      ]
    ],
    "updated": "Yes",
    "original": "The results in vivo show ovalbumin induced significantly broke TregTh17 balance curcumin treatments markedly attenuated the inflammatory in asthma model by regulating TregTh17 balance",
    "simplified": "The results in vivo show ovalbumin induced significantly broke TregTh17 balance by regulating TregTh17 balance curcumin treatments markedly attenuated the inflammatory in asthma model."
  },
  {
    "text": "To overcome this limitation we de novo synthesized a conjugate that covalently combines a Gd based MRI contrast agent encaged with a chelating agent DOTA with pantoprazole which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon",
    "triple_list": [
      [
        "Gd",
        "CPR:4",
        "proton pump"
      ],
      [
        "DOTA",
        "CPR:4",
        "proton pump"
      ],
      [
        "pantoprazole",
        "CPR:4",
        "proton pump"
      ]
    ],
    "updated": "No",
    "original": "To overcome this limitation we de novo synthesized a conjugate that covalently combines a Gd based MRI contrast agent encaged with a chelating agent DOTA with pantoprazole which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon",
    "simplified": "To overcome this limitation we de novo synthesized a conjugate that covalently combines a Gd based MRI contrast agent with pantoprazole. pantoprazole is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon."
  },
  {
    "text": "Synthesis of a DOTA Gd3 conjugate of protonpump inhibitor pantoprazole for gastric wall imaging studies",
    "triple_list": [
      [
        "DOTA",
        "CPR:4",
        "protonpump"
      ],
      [
        "Gd3",
        "CPR:4",
        "protonpump"
      ],
      [
        "protonpump",
        "CPR:4",
        "pantoprazole"
      ]
    ],
    "updated": "No",
    "original": "Synthesis of a DOTA Gd3 conjugate of protonpump inhibitor pantoprazole for gastric wall imaging studies",
    "simplified": "Protonpump inhibitor pantoprazole conjugate for gastric wall imaging studies."
  },
  {
    "text": "Second EPSCs were recorded from rat hippocampal slices before and after the AChE inhibitor donepezil was placed in the slices .",
    "triple_list": [
      [
        "AChE",
        "CPR:4",
        "donepezil"
      ]
    ],
    "updated": "Yes",
    "original": "Second EPSCs were recorded from rat hippocampal slices before and after their superfusion with the reversible AChE inhibitor donepezil 100nM",
    "simplified": "Second EPSCs were recorded from rat hippocampal slices before and after the AChE inhibitor donepezil was placed in the slices."
  },
  {
    "text": "CYP3A5 carrier status had no influence on midazolam oral clearance or its inhibition by ketoconazole",
    "triple_list": [
      [
        "CYP3A5",
        "CPR:4",
        "ketoconazole"
      ],
      [
        "CYP3A5",
        "CPR:9",
        "midazolam"
      ]
    ],
    "updated": "No",
    "original": "CYP3A5 carrier status had no influence on midazolam oral clearance or its inhibition by ketoconazole",
    "simplified": "CYP3A5 carrier status had no influence on whether midazolam could be taken by mouth."
  },
  {
    "text": "We then compared the effects of ketoconazole with the CYP3A inhibitor .",
    "triple_list": [
      [
        "CYP3A",
        "CPR:4",
        "ketoconazole"
      ]
    ],
    "updated": "Yes",
    "original": "We then evaluated the interactions with the CYP3A inhibitor ketoconazole 400 mg qd",
    "simplified": "We then compared the effects of ketoconazole with the CYP3A inhibitor."
  },
  {
    "text": "A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions",
    "triple_list": [
      [
        "CYP3A",
        "CPR:9",
        "Midazolam"
      ]
    ],
    "updated": "No",
    "original": "A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions",
    "simplified": "A Nanogram Dose of the CYP3A Probe Substrate to measure the activity of drugs."
  },
  {
    "text": "These studies show that CYP3A4 and CYP3A5 metabolize BDP to inactive metabolites . These studies suggest that the function or expression of these enzymes in the lung and liver could influence BDP .",
    "triple_list": [
      [
        "CYP3A4",
        "CPR:9",
        "BDP"
      ],
      [
        "CYP3A5",
        "CPR:9",
        "BDP"
      ]
    ],
    "updated": "Yes",
    "original": "These studies show that CYP3A4 and CYP3A5 metabolize BDP to inactive metabolites and suggest that differences in the expression or function of these enzymes in the lung andor liver could influence BDP disposition in humans",
    "simplified": "These studies show that CYP3A4 and CYP3A5 metabolize BDP to inactive metabolites. These studies suggest that the function or expression of these enzymes in the lung and liver could influence BDP."
  },
  {
    "text": "It is possible that variations in the cytochrome P450 3A metabolism of BDP may cause this problem .",
    "triple_list": [
      [
        "cytochrome P450 3A",
        "CPR:9",
        "BDP"
      ]
    ],
    "updated": "Yes",
    "original": "It is possible that variations in cytochrome P450 3A enzymemediated metabolism of BDP may contribute to this phenomenon",
    "simplified": "It is possible that variations in the cytochrome P450 3A metabolism of BDP may cause this problem."
  },
  {
    "text": "This hypothesis was explored by evaluating the contributions of CYP3A4 3A5 3A7 and esterase enzymes in the metabolism of BDP in vitro and relating metabolism to changes in CYP3A enzyme mRNA expression via the glucocorticoid receptor in lung and liver cells",
    "triple_list": [
      [
        "esterase",
        "CPR:9",
        "BDP"
      ]
    ],
    "updated": "No",
    "original": "This hypothesis was explored by evaluating the contributions of CYP3A4 3A5 3A7 and esterase enzymes in the metabolism of BDP in vitro and relating metabolism to changes in CYP3A enzyme mRNA expression via the glucocorticoid receptor in lung and liver cells",
    "simplified": "This hypothesis was tested by looking at how the metabolism of BDP was changed in vitro. The changes in metabolism were shown to be related to changes in the mRNA of the CYP3A enzyme, which is found in lung and liver cells."
  },
  {
    "text": "CYP3A4 and CYP3A5 can change BDP into M4 and M6 . They can change M5 into M5 at a similar rate .",
    "triple_list": [
      [
        "CYP3A4",
        "CPR:9",
        "BDP"
      ],
      [
        "CYP3A5",
        "CPR:9",
        "BDP"
      ]
    ],
    "updated": "Yes",
    "original": "CYP3A4 and CYP3A5 metabolized BDP via hydroxylation M4 and M6 and dehydrogenation M5 at similar rates CYP3A7 did not metabolize BDP",
    "simplified": "CYP3A4 and CYP3A5 can change BDP into M4 and M6. They can change M5 into M5 at a similar rate."
  },
  {
    "text": "Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes",
    "triple_list": [
      [
        "Beclomethasone Dipropionate",
        "CPR:9",
        "Cytochrome P450 3A"
      ]
    ],
    "updated": "No",
    "original": "Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes",
    "simplified": "Beclomethasone is made by the enzyme Cytochrome P450-3A."
  },
  {
    "text": "In macrophages levels of TNF\u03b1 IFN\u03b3 NO IL6 and IL10 were increased by CDM used alone or in combination with HSV2",
    "triple_list": [
      [
        "TNF\u03b1",
        "CPR:3",
        "CDM"
      ],
      [
        "IFN\u03b3",
        "CPR:3",
        "CDM"
      ],
      [
        "IL6",
        "CPR:3",
        "CDM"
      ],
      [
        "IL10",
        "CPR:3",
        "CDM"
      ]
    ],
    "updated": "No",
    "original": "In macrophages levels of TNF\u03b1 IFN\u03b3 NO IL6 and IL10 were increased by CDM used alone or in combination with HSV2",
    "simplified": "In macrophages levels of IL6 and IL10 were increased when CDM was used alone or in combination with HSV2."
  },
  {
    "text": "CDM not only increased the production of TNF\u03b1 , but it also extended the expression of IFN\u03b3 over time .",
    "triple_list": [
      [
        "CDM",
        "CPR:3",
        "TNF\u03b1"
      ],
      [
        "CDM",
        "CPR:3",
        "IFN\u03b3"
      ]
    ],
    "updated": "Yes",
    "original": "Besides CDM not only synergized TNF\u03b1 production combined with IFN\u03b3 but also prolonged its expression in time",
    "simplified": "CDM not only increased the production of TNF\u03b1, but it also extended the expression of IFN\u03b3 over time."
  },
  {
    "text": "Results indicate that CDM inhibits HSV2 multiplication in epithelial cells and also increases cytokine production in macrophages both important actions to the clearance of infecting virus in the mouse vagina",
    "triple_list": [
      [
        "CDM",
        "CPR:3",
        "cytokine"
      ]
    ],
    "updated": "No",
    "original": "Results indicate that CDM inhibits HSV2 multiplication in epithelial cells and also increases cytokine production in macrophages both important actions to the clearance of infecting virus in the mouse vagina",
    "simplified": "Results show that CDM inhibits the growth of HSV2 in epithelial cells. It also increases the production of cytokines in macrophages. These two things help to kill the virus."
  },
  {
    "text": "A catheterized rat model was used to define the intestinal and hepatic components of oral bioavailability for an 11\u03b2HSD1 inhibitor AMG 221",
    "triple_list": [
      [
        "11\u03b2HSD1",
        "CPR:4",
        "AMG 221"
      ]
    ],
    "updated": "No",
    "original": "A catheterized rat model was used to define the intestinal and hepatic components of oral bioavailability for an 11\u03b2HSD1 inhibitor AMG 221",
    "simplified": "A catheterized rat model was used to measure the oral bioavailability of an 11\u03b2HSD1 inhibitor in both the liver and intestines."
  },
  {
    "text": "The firstpass extraction of the 11\u03b2HSD1 inhibitor AMG 221 from the intestinal tract in rats .",
    "triple_list": [
      [
        "11\u03b2HSD1",
        "CPR:4",
        "AMG 221"
      ]
    ],
    "updated": "Yes",
    "original": "Intestinal and hepatic firstpass extraction of the 11\u03b2HSD1 inhibitor AMG 221 in rats with chronic vascular catheters",
    "simplified": "The firstpass extraction of the 11\u03b2HSD1 inhibitor AMG 221 from the intestinal tract in rats."
  },
  {
    "text": "In DUPM cells with acquired resistance to elisidepsin , Bcl2 and ErbB3 expression were increased .",
    "triple_list": [
      [
        "elisidepsin",
        "CPR:3",
        "Bcl2"
      ],
      [
        "elisidepsin",
        "CPR:4",
        "ErbB3"
      ]
    ],
    "updated": "Yes",
    "original": "In DUPM cells with acquired resistance to elisidepsin ErbB3 expression was decreased while Bcl2 was increased",
    "simplified": "In DUPM cells with acquired resistance to elisidepsin, Bcl2 and ErbB3 expression were increased."
  },
  {
    "text": "Administration of bicuculline a GABAA inhibitor isolated a single response to \u03c9agatoxin which was characterized by a reduction in network activity",
    "triple_list": [
      [
        "bicuculline",
        "CPR:4",
        "GABAA"
      ],
      [
        "bicuculline",
        "CPR:4",
        "\u03c9agatoxin"
      ]
    ],
    "updated": "No",
    "original": "Administration of bicuculline a GABAA inhibitor isolated a single response to \u03c9agatoxin which was characterized by a reduction in network activity",
    "simplified": "When bicuculline was used, a single response was found to \u03c9agatoxin. This response was characterized by a reduction in network activity."
  },
  {
    "text": "Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level while the other hydroxamates did not . In human acute myeloid leukemia , the levels of acetyl\u03b1tubulin were increased .",
    "triple_list": [
      [
        "hydroxamates",
        "CPR:3",
        "acetyl\u03b1tubulin"
      ]
    ],
    "updated": "Yes",
    "original": "Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level whereas the other hydroxamates effected an increase in acetyl\u03b1tubulin levels in human acute myeloid leukemia U937 cells",
    "simplified": "Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level while the other hydroxamates did not. In human acute myeloid leukemia, the levels of acetyl\u03b1tubulin were increased."
  },
  {
    "text": "Herein we report novel pyrrole and benzene based hydroxamates 8 10 and 2aminoanilides 9 11 bearing the tertbutylcarbamate group at the CAP moiety as histone deacetylase HDAC inhibitors",
    "triple_list": [
      [
        "tertbutylcarbamate",
        "CPR:4",
        "histone deacetylase"
      ],
      [
        "tertbutylcarbamate",
        "CPR:4",
        "HDAC"
      ],
      [
        "pyrrole",
        "CPR:4",
        "histone deacetylase"
      ],
      [
        "pyrrole",
        "CPR:4",
        "HDAC"
      ],
      [
        "benzene",
        "CPR:4",
        "histone deacetylase"
      ],
      [
        "benzene",
        "CPR:4",
        "HDAC"
      ],
      [
        "hydroxamates",
        "CPR:4",
        "histone deacetylase"
      ],
      [
        "hydroxamates",
        "CPR:4",
        "HDAC"
      ],
      [
        "2aminoanilides",
        "CPR:4",
        "histone deacetylase"
      ],
      [
        "2aminoanilides",
        "CPR:4",
        "HDAC"
      ]
    ],
    "updated": "No",
    "original": "Herein we report novel pyrrole and benzene based hydroxamates 8 10 and 2aminoanilides 9 11 bearing the tertbutylcarbamate group at the CAP moiety as histone deacetylase HDAC inhibitors",
    "simplified": "Pyrrole and benzene based hydroxamates 8 10 and 2aminoanilides 9 11 can be used as histone deacetylase HDAC inhibitors. The hydroxamates have a tertbutylcarbamate group."
  },
  {
    "text": "tertButylcarbamate Containing Histone Deacetylase Inhibitors Apoptosis Induction Cytodifferentiation and Antiproliferative Activities in Cancer Cells",
    "triple_list": [
      [
        "tertButylcarbamate",
        "CPR:4",
        "Histone Deacetylase"
      ]
    ],
    "updated": "No",
    "original": "tertButylcarbamate Containing Histone Deacetylase Inhibitors Apoptosis Induction Cytodifferentiation and Antiproliferative Activities in Cancer Cells",
    "simplified": "Cytodifferentiation and Antiproliferative Activities in Cancer Cells Apoptosis Induction - Cytodifferentiation and Antiproliferative Activities"
  },
  {
    "text": "As a potent synthetic APN inhibitor IC50=850nM versus 81\u03bcM LB4b was determined to have more significant block effects than bestatin , it has been put into clinical trials .",
    "triple_list": [
      [
        "APN",
        "CPR:4",
        "bestatin"
      ],
      [
        "APN",
        "CPR:4",
        "LB4b"
      ],
      [
        "APN",
        "CPR:4",
        "bestatin"
      ]
    ],
    "updated": "Yes",
    "original": "As a potent synthetic APN inhibitor IC50=850nM versus bestatin of 81\u03bcM LB4b was determined to have more significant block effects to cancer cell invasion and angiogenesis than bestatin",
    "simplified": "As a potent synthetic APN inhibitor IC50=850nM versus 81\u03bcM LB4b was determined to have more significant block effects than bestatin, it has been put into clinical trials."
  },
  {
    "text": "LB4b is the first synthetic APN inhibitor that has both anti-angiogenesis and anti-invasion effects .",
    "triple_list": [
      [
        "LB4b",
        "CPR:4",
        "APN"
      ]
    ],
    "updated": "Yes",
    "original": "LB4b is the first synthetic APN inhibitor to be evaluated for both of its antiinvasion and antiangiogenesis effects",
    "simplified": "LB4b is the first synthetic APN inhibitor that has both anti-angiogenesis and anti-invasion effects."
  },
  {
    "text": "Discovery of a synthetic Aminopeptidase N inhibitor LB4b as a potential anticancer agent",
    "triple_list": [
      [
        "Aminopeptidase N",
        "CPR:4",
        "LB4b"
      ]
    ],
    "updated": "No",
    "original": "Discovery of a synthetic Aminopeptidase N inhibitor LB4b as a potential anticancer agent",
    "simplified": "The discovery of a synthetic riboflavin-like drug LB4b as a cancer-fighting agent"
  },
  {
    "text": "Both types of granules contain catechol oxidase that catalyzes oxidative crosslinking of LDOPA",
    "triple_list": [
      [
        "catechol oxidase",
        "CPR:9",
        "LDOPA"
      ]
    ],
    "updated": "No",
    "original": "Both types of granules contain catechol oxidase that catalyzes oxidative crosslinking of LDOPA",
    "simplified": "Both types of granules contain an enzyme called catechol oxidase, which breaks down cellulose."
  },
  {
    "text": "Under NaCl and sorbitol stresses catalase CAT activity in wnk8 mutant was 192 and 37times of that in Col0 respectively",
    "triple_list": [
      [
        "NaCl",
        "CPR:3",
        "catalase"
      ],
      [
        "NaCl",
        "CPR:3",
        "CAT"
      ],
      [
        "sorbitol",
        "CPR:3",
        "catalase"
      ],
      [
        "sorbitol",
        "CPR:3",
        "CAT"
      ]
    ],
    "updated": "No",
    "original": "Under NaCl and sorbitol stresses catalase CAT activity in wnk8 mutant was 192 and 37times of that in Col0 respectively",
    "simplified": "When NaCl and sorbitol are added, CAT activity in wnk8 mutant was 192 times higher than in Col0."
  },
  {
    "text": "Western blotting and immunofluorescence showed that cilostazol treatment reduced GFAP and VEGF expression in the OLETF rats .",
    "triple_list": [
      [
        "cilostazol",
        "CPR:4",
        "VEGF"
      ],
      [
        "cilostazol",
        "CPR:4",
        "GFAP"
      ]
    ],
    "updated": "Yes",
    "original": "Immunofluorescence staining and western blotting demonstrated that cilostazol treatment reduced GFAP and VEGF expression in the retinas of OLETF rats",
    "simplified": "Western blotting and immunofluorescence showed that cilostazol treatment reduced GFAP and VEGF expression in the OLETF rats."
  },
  {
    "text": "Other dams received 18ngkgday of a mixture of aryl hydrocarbon receptor AhR agonists nonortho PCB s PCdibenzodioxins and PCdibenzofurans without or with 05M 05MAhR",
    "triple_list": [
      [
        "aryl hydrocarbon receptor",
        "CPR:5",
        "PCdibenzofurans"
      ],
      [
        "aryl hydrocarbon receptor",
        "CPR:5",
        "nonortho PCB"
      ],
      [
        "aryl hydrocarbon receptor",
        "CPR:5",
        "PCdibenzodioxins"
      ]
    ],
    "updated": "No",
    "original": "Other dams received 18ngkgday of a mixture of aryl hydrocarbon receptor AhR agonists nonortho PCB s PCdibenzodioxins and PCdibenzofurans without or with 05M 05MAhR",
    "simplified": "Other dams were given 18ngkgday of a mixture of PCdibenzodioxins and PCdibenzofurans without or with aryl hydrocarbon receptor (AhR)."
  },
  {
    "text": "We report the discovery of a novel Janus kinase 3 JAK3 inhibitor based on the 5Hpyrrolo23bpyrazine scaffold .",
    "triple_list": [
      [
        "Janus kinase 3",
        "CPR:4",
        "5Hpyrrolo23bpyrazine"
      ],
      [
        "JAK3",
        "CPR:4",
        "5Hpyrrolo23bpyrazine"
      ]
    ],
    "updated": "Yes",
    "original": "We report the discovery of a novel series of ATPcompetitive Janus kinase 3 JAK3 inhibitors based on the 5Hpyrrolo23bpyrazine scaffold",
    "simplified": "We report the discovery of a novel Janus kinase 3 JAK3 inhibitor based on the 5Hpyrrolo23bpyrazine scaffold."
  },
  {
    "text": "Discovery of a series of novel 5Hpyrrolo23bpyrazine2phenyl ethers as potent JAK3 kinase inhibitors",
    "triple_list": [
      [
        "5Hpyrrolo23bpyrazine2phenyl ethers",
        "CPR:4",
        "JAK3"
      ],
      [
        "5Hpyrrolo23bpyrazine2phenyl ethers",
        "CPR:4",
        "kinase"
      ]
    ],
    "updated": "No",
    "original": "Discovery of a series of novel 5Hpyrrolo23bpyrazine2phenyl ethers as potent JAK3 kinase inhibitors",
    "simplified": "Discovery of a novel 5Hpyrrolo23bpyrazine2phenyl ether, used to treat certain diseases"
  },
  {
    "text": "ATO stopped the activation of AKT and STAT3 through Notch signaling and made them inactive .",
    "triple_list": [
      [
        "ATO",
        "CPR:4",
        "STAT3"
      ],
      [
        "ATO",
        "CPR:4",
        "Notch"
      ],
      [
        "ATO",
        "CPR:4",
        "AKT"
      ]
    ],
    "updated": "Yes",
    "original": "ATO inhibited the phosphorylation and activation of AKT and STAT3 through Notch signaling blockade",
    "simplified": "ATO stopped the activation of AKT and STAT3 through Notch signaling and made them inactive."
  },
  {
    "text": "These data show that the ATO is a promising new approach to reduce glioblastoma recurrence by downregulation of the Notch pathway .",
    "triple_list": [
      [
        "ATO",
        "CPR:4",
        "Notch"
      ]
    ],
    "updated": "Yes",
    "original": "These data show that the ATO is a promising new approach to decrease glioblastoma proliferation and recurrence by downregulation of Notch pathway",
    "simplified": "These data show that the ATO is a promising new approach to reduce glioblastoma recurrence by downregulation of the Notch pathway."
  },
  {
    "text": "Arsenic trioxide depletes cancer stemlike cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway",
    "triple_list": [
      [
        "Arsenic trioxide",
        "CPR:4",
        "Notch"
      ]
    ],
    "updated": "No",
    "original": "Arsenic trioxide depletes cancer stemlike cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway",
    "simplified": "Arsenic trioxide makes cancer cells smaller. It also makes cancer cells in the brain smaller, so that they can not grow anymore."
  },
  {
    "text": "Finally , fisetin supplementation significantly increased epididymal mRNA abundance of GLUT4 compared to levels in the control group .",
    "triple_list": [
      [
        "GLUT4",
        "CPR:3",
        "fisetin"
      ]
    ],
    "updated": "Yes",
    "original": "Finally epididymal mRNA abundance of GLUT4 was significantly increased by fisetin supplementation compared to levels in the control and HF groups",
    "simplified": "Finally, fisetin supplementation significantly increased epididymal mRNA abundance of GLUT4 compared to levels in the control group."
  },
  {
    "text": "The expression of GLUT4 by fisetin was further confirmed in 3T3L1 adipocytes .",
    "triple_list": [
      [
        "GLUT4",
        "CPR:3",
        "fisetin"
      ]
    ],
    "updated": "Yes",
    "original": "Enhancement of GLUT4 expression by fisetin was further confirmed in differentiated 3T3L1 adipocytes",
    "simplified": "The expression of GLUT4 by fisetin was further confirmed in 3T3L1 adipocytes."
  },
  {
    "text": "The high fat diet significantly increased the expression of PPAR\u03b3 SREBP1C and SCD1 genes in the liver compared to a control diet . This effect was reversed by fisetin supplementation .",
    "triple_list": [
      [
        "PPAR\u03b3",
        "CPR:4",
        "fisetin"
      ],
      [
        "SREBP1C",
        "CPR:4",
        "fisetin"
      ],
      [
        "SCD1",
        "CPR:4",
        "fisetin"
      ]
    ],
    "updated": "Yes",
    "original": "The high fat diet significantly increased hepatic mRNA expressions of PPAR\u03b3 SREBP1C and SCD1 genes in comparison to the control diet which was subsequently reversed by supplementation with fisetin",
    "simplified": "The high fat diet significantly increased the expression of PPAR\u03b3 SREBP1C and SCD1 genes in the liver compared to a control diet. This effect was reversed by fisetin supplementation."
  },
  {
    "text": "In addition fisetin supplementation significantly reduced hepatic mRNA abundance of FAS ATPCL and G6Pase compared to the control group",
    "triple_list": [
      [
        "fisetin",
        "CPR:4",
        "FAS"
      ],
      [
        "fisetin",
        "CPR:4",
        "ATPCL"
      ],
      [
        "fisetin",
        "CPR:4",
        "G6Pase"
      ]
    ],
    "updated": "No",
    "original": "In addition fisetin supplementation significantly reduced hepatic mRNA abundance of FAS ATPCL and G6Pase compared to the control group",
    "simplified": "In addition, fisetin supplementation significantly reduced the abundance of G6Pase and ATP in the liver compared to control group."
  },
  {
    "text": "Western blot analysis showed that DICO reduced Bcl2 level . This caused Bax translocation to cause cytochrome c release .",
    "triple_list": [
      [
        "DICO",
        "CPR:3",
        "Bax"
      ],
      [
        "DICO",
        "CPR:3",
        "cytochrome c"
      ],
      [
        "DICO",
        "CPR:4",
        "Bcl2"
      ]
    ],
    "updated": "Yes",
    "original": "Western blot assay demonstrated that DICO decreased Bcl2 level and induced Bax translocation to cause cytochrome c release",
    "simplified": "Western blot analysis showed that DICO reduced Bcl2 level. This caused Bax translocation to cause cytochrome c release."
  },
  {
    "text": "Quercetin and rutin increased the activity of the alkaline phosphatase by about 150 and 240 respectively . The mineralization was also shown to be up to 110 and 200 .",
    "triple_list": [
      [
        "Quercetin",
        "CPR:3",
        "alkaline phosphatase"
      ],
      [
        "rutin",
        "CPR:3",
        "alkaline phosphatase"
      ]
    ],
    "updated": "Yes",
    "original": "Quercetin and rutin also increased alkaline phosphatase activity by about 150 and 240 and demonstrated mineralization up to 110 and 200 respectively as compared to control which was considered as 100",
    "simplified": "Quercetin and rutin increased the activity of the alkaline phosphatase by about 150 and 240 respectively. The mineralization was also shown to be up to 110 and 200."
  },
  {
    "text": "Further both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin osterix RunX2 osteoprotegerin and osteocalcin",
    "triple_list": [
      [
        "flavonoids",
        "CPR:3",
        "osteopontin"
      ],
      [
        "flavonoids",
        "CPR:3",
        "osterix"
      ],
      [
        "flavonoids",
        "CPR:3",
        "RunX2"
      ],
      [
        "flavonoids",
        "CPR:3",
        "osteoprotegerin"
      ],
      [
        "flavonoids",
        "CPR:3",
        "osteocalcin"
      ]
    ],
    "updated": "No",
    "original": "Further both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin osterix RunX2 osteoprotegerin and osteocalcin",
    "simplified": "Further both the flavonoids were also found to increase the expression of some of the important markers for the differentiation of the osteoblast like osteoprotegerin and osterix."
  },
  {
    "text": "LPO was increased while as GSH CAT and GPx decreased by the administration of CCl4 and TAA p0001 coadministration of NAC restored these liver markers to normal levels p0001",
    "triple_list": [
      [
        "CAT",
        "CPR:3",
        "NAC"
      ],
      [
        "GPx",
        "CPR:3",
        "NAC"
      ]
    ],
    "updated": "No",
    "original": "LPO was increased while as GSH CAT and GPx decreased by the administration of CCl4 and TAA p0001 coadministration of NAC restored these liver markers to normal levels p0001",
    "simplified": "LPO was increased while as GPx and GSH decreased by the administration of CCl4 and TAA. These liver markers were restored when NAC was co-administered."
  },
  {
    "text": "Serum markers of liver damage AST ALT ALP and Bilirubin were increased by CCl4 and TAA intoxication , but these changes were reversed when NAC was used .",
    "triple_list": [
      [
        "AST",
        "CPR:3",
        "CCl4"
      ],
      [
        "ALT",
        "CPR:3",
        "CCl4"
      ],
      [
        "ALP",
        "CPR:3",
        "CCl4"
      ],
      [
        "AST",
        "CPR:3",
        "TAA"
      ],
      [
        "ALT",
        "CPR:3",
        "TAA"
      ],
      [
        "ALP",
        "CPR:3",
        "TAA"
      ],
      [
        "AST",
        "CPR:4",
        "NAC"
      ],
      [
        "ALT",
        "CPR:4",
        "NAC"
      ],
      [
        "ALP",
        "CPR:4",
        "NAC"
      ]
    ],
    "updated": "Yes",
    "original": "Serum markers of liver damage AST ALT ALP and Bilirubin were increased by CCl4 and TAA intoxication p0001 whereas cotreatment with NAC reversed such changes p0001",
    "simplified": "Serum markers of liver damage AST ALT ALP and Bilirubin were increased by CCl4 and TAA intoxication, but these changes were reversed when NAC was used."
  },
  {
    "text": "Cytochrome P450 2E1 CYP 450 2E1 activity was determined as hydroxylation of aniline in liver microsomes",
    "triple_list": [
      [
        "Cytochrome P450 2E1",
        "CPR:9",
        "aniline"
      ],
      [
        "CYP 450 2E1",
        "CPR:9",
        "aniline"
      ]
    ],
    "updated": "No",
    "original": "Cytochrome P450 2E1 CYP 450 2E1 activity was determined as hydroxylation of aniline in liver microsomes",
    "simplified": "Cytochrome P450 2E1 (CYP 450 2E1) is a chemical compound. It is found in the liver."
  },
  {
    "text": "This report concerns the marked upregulation in differentiated CaCo2 colonic epithelial cells of two key inflammatory interleukins IL6 and IL8 caused by a mixture of oxysterols representative of a high cholesterol diet",
    "triple_list": [
      [
        "interleukins",
        "CPR:3",
        "oxysterols"
      ],
      [
        "IL6",
        "CPR:3",
        "oxysterols"
      ],
      [
        "IL8",
        "CPR:3",
        "oxysterols"
      ],
      [
        "interleukins",
        "CPR:3",
        "cholesterol"
      ],
      [
        "IL6",
        "CPR:3",
        "cholesterol"
      ],
      [
        "IL8",
        "CPR:3",
        "cholesterol"
      ]
    ],
    "updated": "No",
    "original": "This report concerns the marked upregulation in differentiated CaCo2 colonic epithelial cells of two key inflammatory interleukins IL6 and IL8 caused by a mixture of oxysterols representative of a high cholesterol diet",
    "simplified": "This report concerns the marked upregulation of two key inflammatory interleukins in differentiated CaCo2 colonic epithelial cells caused by a mixture of high cholesterol diet-related oxysterols."
  },
  {
    "text": "Oxysterol dependent NOX1 activation as well as interleukin synthesis were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction in particular phenolic acids and flavonoids",
    "triple_list": [
      [
        "Oxysterol",
        "CPR:3",
        "NOX1"
      ],
      [
        "Oxysterol",
        "CPR:3",
        "interleukin"
      ],
      [
        "NOX1",
        "CPR:4",
        "phenolic acids"
      ],
      [
        "interleukin",
        "CPR:4",
        "phenolic acids"
      ],
      [
        "NOX1",
        "CPR:4",
        "flavonoids"
      ],
      [
        "interleukin",
        "CPR:4",
        "flavonoids"
      ]
    ],
    "updated": "No",
    "original": "Oxysterol dependent NOX1 activation as well as interleukin synthesis were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction in particular phenolic acids and flavonoids",
    "simplified": "Oxysterol dependent NOX1 activation as well as interleukin synthesis were completely prevented by Cannonau red wine extract. This is because the extract contains a large phenolic fraction."
  },
  {
    "text": "Cell pretreatment with Vermentino white wine extract showed only a partial reduction in NOX1 . However , it was not able to increase interleukin synthesis due to dietary oxysterols .",
    "triple_list": [
      [
        "NOX1",
        "CPR:3",
        "oxysterols"
      ],
      [
        "interleukin",
        "CPR:3",
        "oxysterols"
      ]
    ],
    "updated": "Yes",
    "original": "Conversely cell pretreatment with Vermentino white wine extract with smaller phenolic fraction showed only a partial NOX1 downregulation and was ineffective in interleukin synthesis induced by dietary oxysterols",
    "simplified": "Cell pretreatment with Vermentino white wine extract showed only a partial reduction in NOX1. However, it was not able to increase interleukin synthesis due to dietary oxysterols."
  },
  {
    "text": "Besides this direct activity an excess of phenolic compounds found in red wine may also prevent the prooxidant and proinflammatory events caused by dietary oxysterols by blocking the release of oxysterol related NOX1 .",
    "triple_list": [
      [
        "oxysterol",
        "CPR:3",
        "NOX1"
      ],
      [
        "phenolic",
        "CPR:4",
        "NOX1"
      ]
    ],
    "updated": "Yes",
    "original": "Besides this direct activity an excess of phenolic compounds detectable in red wine may exert an additional indirect action by blocking oxysterol related NOX1 induction thus totally preventing the prooxidant and proinflammatory events triggered by dietary oxysterols",
    "simplified": "Besides this direct activity an excess of phenolic compounds found in red wine may also prevent the prooxidant and proinflammatory events caused by dietary oxysterols by blocking the release of oxysterol related NOX1."
  },
  {
    "text": "Arsenic inhibits the Nrf2 Keap1 pathway and thus the growth of certain bacteria .",
    "triple_list": [
      [
        "Arsenic",
        "CPR:3",
        "Nrf2"
      ],
      [
        "Arsenic",
        "CPR:3",
        "Keap1"
      ]
    ],
    "updated": "Yes",
    "original": "Arsenic inhibits autophagic flux activating the Nrf2 Keap1 pathway in a p62dependent manner",
    "simplified": "Arsenic inhibits the Nrf2 Keap1 pathway and thus the growth of certain bacteria."
  },
  {
    "text": "All in all , these findings provide evidence that arsenic causes long-term activation of Nrf2 through autophagy dysfunction . This may be similar to what happens to Nrf2 in certain human cancers .",
    "triple_list": [
      [
        "arsenic",
        "CPR:3",
        "Nrf2"
      ],
      [
        "arsenic",
        "CPR:3",
        "Nrf2"
      ]
    ],
    "updated": "Yes",
    "original": "Collectively these findings provide evidence that arsenic causes prolonged activation of Nrf2 through autophagy dysfunction possibly providing a similar scenario to constitutive activation of Nrf2 found in certain human cancers",
    "simplified": "All in all, these findings provide evidence that arsenic causes long-term activation of Nrf2 through autophagy dysfunction. This may be similar to what happens to Nrf2 in certain human cancers."
  },
  {
    "text": "Thus arsenic activates Nrf2 through a noncanonical mechanism p62dependent leading to a chronic sustained activation of Nrf2",
    "triple_list": [
      [
        "arsenic",
        "CPR:3",
        "Nrf2"
      ],
      [
        "arsenic",
        "CPR:3",
        "Nrf2"
      ]
    ],
    "updated": "No",
    "original": "Thus arsenic activates Nrf2 through a noncanonical mechanism p62dependent leading to a chronic sustained activation of Nrf2",
    "simplified": "Arsenic activates Nrf2 through a non-canonical mechanism. This mechanism is p62dependent and takes place over time."
  },
  {
    "text": "In contrast activation of Nrf2 by sulforaphane and tertbutylhydroquinone depends on p62 , but not on Keap1C151 .",
    "triple_list": [
      [
        "Nrf2",
        "CPR:3",
        "sulforaphane"
      ],
      [
        "Nrf2",
        "CPR:3",
        "tertbutylhydroquinone"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast activation of Nrf2 by sulforaphane and tertbutylhydroquinone depend upon Keap1C151 and not p62 the canonical mechanism",
    "simplified": "In contrast activation of Nrf2 by sulforaphane and tertbutylhydroquinone depends on p62, but not on Keap1C151."
  },
  {
    "text": "Arsenic deregulates the autophagic pathway through blockage of autophagic flux resulting in accumulation of autophagosomes and sequestration of p62 Keap1 and LC3",
    "triple_list": [
      [
        "Arsenic",
        "CPR:4",
        "p62"
      ],
      [
        "Arsenic",
        "CPR:4",
        "Keap1"
      ],
      [
        "Arsenic",
        "CPR:4",
        "LC3"
      ]
    ],
    "updated": "No",
    "original": "Arsenic deregulates the autophagic pathway through blockage of autophagic flux resulting in accumulation of autophagosomes and sequestration of p62 Keap1 and LC3",
    "simplified": "Arsenic deregulates the autophagic pathway by blocking the flow of oxygen. This causes autophagosomes to build up, and Keap1 and LC3 are lost."
  },
  {
    "text": "MT1R was increased in melatonin-treated rats in the ovaries .",
    "triple_list": [
      [
        "MT1R",
        "CPR:3",
        "melatonin"
      ]
    ],
    "updated": "Yes",
    "original": "MT1R was increased in ovaries and uteri of melatonin treated rats",
    "simplified": "MT1R was increased in melatonin-treated rats in the ovaries."
  },
  {
    "text": "Ovarian AR was not influenced by either treatment and oviduct AR was reduced after ethanol melatonin combination",
    "triple_list": [
      [
        "AR",
        "CPR:4",
        "ethanol"
      ],
      [
        "AR",
        "CPR:4",
        "melatonin"
      ]
    ],
    "updated": "No",
    "original": "Ovarian AR was not influenced by either treatment and oviduct AR was reduced after ethanol melatonin combination",
    "simplified": "Ovarian AR was not affected by either treatment. Oviduct AR was reduced after melatonin was added."
  },
  {
    "text": "The oviduct ER\u03b1 and uterine ER\u03b2 are both affected by ethanol and melatonin .",
    "triple_list": [
      [
        "ER\u03b1",
        "CPR:4",
        "ethanol"
      ],
      [
        "ER\u03b2",
        "CPR:4",
        "ethanol"
      ],
      [
        "ER\u03b2",
        "CPR:4",
        "ethanol"
      ],
      [
        "ER\u03b1",
        "CPR:4",
        "melatonin"
      ],
      [
        "ER\u03b2",
        "CPR:4",
        "melatonin"
      ],
      [
        "ER\u03b2",
        "CPR:4",
        "melatonin"
      ]
    ],
    "updated": "Yes",
    "original": "Oviduct ER\u03b1 ER\u03b2 and uterine ER\u03b2 were downregulated by either ethanol or melatonin",
    "simplified": "The oviduct ER\u03b1 and uterine ER\u03b2 are both affected by ethanol and melatonin."
  },
  {
    "text": "On the other hand , ovarian PRA and PRB were positively regulated by ethanol and the combination of the two , while PRA was downregulated in the oviduct .",
    "triple_list": [
      [
        "PRA",
        "CPR:4",
        "ethanol"
      ]
    ],
    "updated": "Yes",
    "original": "Conversely ovarian PRA and PRB were positively regulated by ethanol and ethanolmelatonin combination whereas PRA was downregulated in the uterus and oviduct after ethanol consumption",
    "simplified": "On the other hand, ovarian PRA and PRB were positively regulated by ethanol and the combination of the two, while PRA was downregulated in the oviduct."
  },
  {
    "text": "Intraplantar or intrathecal administered Ph\u03b11\u03b2 reduced both nocifensive behavior and mechanical hypersensitivity induced by capsaicin similarly to that observed with SB366791 a specific TRPV1 antagonist",
    "triple_list": [
      [
        "SB366791",
        "CPR:6",
        "TRPV1"
      ]
    ],
    "updated": "No",
    "original": "Intraplantar or intrathecal administered Ph\u03b11\u03b2 reduced both nocifensive behavior and mechanical hypersensitivity induced by capsaicin similarly to that observed with SB366791 a specific TRPV1 antagonist",
    "simplified": "Intraplantar or intrathecal administration of Ph\u03b11\u03b2 reduced both mechanical hypersensitivity and nocifensive behavior similarly to that observed with a specific TRPV1 antagonist."
  },
  {
    "text": "Before apoptosis , we found that cisplatin causes cAbl and TAp73 expression in the oocyte .",
    "triple_list": [
      [
        "cisplatin",
        "CPR:3",
        "cAbl"
      ],
      [
        "cisplatin",
        "CPR:3",
        "TAp73"
      ]
    ],
    "updated": "Yes",
    "original": "We found that before apoptosis cisplatin induces cAbl and TAp73 expression in the oocyte",
    "simplified": "Before apoptosis, we found that cisplatin causes cAbl and TAp73 expression in the oocyte."
  },
  {
    "text": "While imatinib was unable to block cisplatin induced DNA damage and damage response such as the upregulation of p53 imatinib inhibited the cisplatin induced nuclear accumulation of cAbl TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax thereby abrogating oocyte cell death",
    "triple_list": [
      [
        "cisplatin",
        "CPR:3",
        "p53"
      ],
      [
        "imatinib",
        "CPR:3",
        "TAp63"
      ],
      [
        "cisplatin",
        "CPR:3",
        "cAbl"
      ],
      [
        "cisplatin",
        "CPR:3",
        "TAp73"
      ],
      [
        "cisplatin",
        "CPR:3",
        "Bax"
      ],
      [
        "imatinib",
        "CPR:4",
        "cAbl"
      ],
      [
        "imatinib",
        "CPR:4",
        "TAp73"
      ],
      [
        "imatinib",
        "CPR:4",
        "Bax"
      ],
      [
        "cisplatin",
        "CPR:4",
        "TAp63"
      ]
    ],
    "updated": "No",
    "original": "While imatinib was unable to block cisplatin induced DNA damage and damage response such as the upregulation of p53 imatinib inhibited the cisplatin induced nuclear accumulation of cAbl TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax thereby abrogating oocyte cell death",
    "simplified": "Imatinib was able to block cisplatin-induced DNA damage and damage response such as the upregulation of p53 and the subsequent downregulation of TAp63 and upregulation of Bax, but was unable to block the cisplatin induced nuclear accumulation of cAbl TAp73."
  },
  {
    "text": "Surprisingly the conditional deletion of Trp63 but not \u0394Np63 in oocytes inhibited apoptosis as well as the accumulation of cAbl and TAp73 caused by cisplatin",
    "triple_list": [
      [
        "cAbl",
        "CPR:3",
        "cisplatin"
      ],
      [
        "TAp73",
        "CPR:3",
        "cisplatin"
      ]
    ],
    "updated": "No",
    "original": "Surprisingly the conditional deletion of Trp63 but not \u0394Np63 in oocytes inhibited apoptosis as well as the accumulation of cAbl and TAp73 caused by cisplatin",
    "simplified": "However, the conditional deletion of Trp63 but not \u0394Np63 in oocytes did not cause apoptosis. In addition, the accumulation of cAbl and TAp73 did not."
  },
  {
    "text": "The expression kinetics of TAp63 cAbl and TAp73 suggest that cAbl-dependent expression of TAp63 and TAp73 by cAbl-dependent BAX expression is required to activate cisplatin .",
    "triple_list": [
      [
        "TAp63",
        "CPR:3",
        "cisplatin"
      ],
      [
        "cAbl",
        "CPR:3",
        "cisplatin"
      ],
      [
        "TAp73",
        "CPR:3",
        "cisplatin"
      ],
      [
        "TAp73",
        "CPR:3",
        "cisplatin"
      ],
      [
        "cAbl",
        "CPR:3",
        "cisplatin"
      ],
      [
        "cisplatin",
        "CPR:3",
        "BAX"
      ]
    ],
    "updated": "Yes",
    "original": "The expression kinetics of TAp63 cAbl and TAp73 suggest that cisplatin activates TAp63dependent expression of cAbl and TAp73 and in turn the activation of TAp73 by cAblinduced BAX expression",
    "simplified": "The expression kinetics of TAp63 cAbl and TAp73 suggest that cAbl-dependent expression of TAp63 and TAp73 by cAbl-dependent BAX expression is required to activate cisplatin."
  },
  {
    "text": "Our findings indicate that imatinib protects oocytes from cisplatin induced cell death by inhibiting cAbl kinase which would otherwise activate TAp73 BAX mediated apoptosis",
    "triple_list": [
      [
        "imatinib",
        "CPR:3",
        "kinase"
      ],
      [
        "cisplatin",
        "CPR:3",
        "cAbl"
      ],
      [
        "cisplatin",
        "CPR:3",
        "kinase"
      ],
      [
        "cisplatin",
        "CPR:3",
        "TAp73"
      ],
      [
        "cisplatin",
        "CPR:3",
        "BAX"
      ],
      [
        "imatinib",
        "CPR:4",
        "cAbl"
      ],
      [
        "imatinib",
        "CPR:4",
        "TAp73"
      ],
      [
        "imatinib",
        "CPR:4",
        "BAX"
      ]
    ],
    "updated": "No",
    "original": "Our findings indicate that imatinib protects oocytes from cisplatin induced cell death by inhibiting cAbl kinase which would otherwise activate TAp73 BAX mediated apoptosis",
    "simplified": "Our findings indicate that imatinib protects oocytes from cisplatin-induced cell death by inhibiting the cAbl kinase, which is responsible for cell death."
  },
  {
    "text": "Recently the cAbl kinase inhibitor imatinib mesylate imatinib has become the focus of research as a fertoprotective drug against cisplatin",
    "triple_list": [
      [
        "cAbl",
        "CPR:4",
        "imatinib mesylate"
      ],
      [
        "kinase",
        "CPR:4",
        "imatinib mesylate"
      ],
      [
        "cAbl",
        "CPR:4",
        "imatinib"
      ],
      [
        "kinase",
        "CPR:4",
        "imatinib"
      ]
    ],
    "updated": "No",
    "original": "Recently the cAbl kinase inhibitor imatinib mesylate imatinib has become the focus of research as a fertoprotective drug against cisplatin",
    "simplified": "Imatinib mesylate imatinib has become the focus of research as a fertoprotective drug against breast cancer."
  },
  {
    "text": "Thus imatinib and other cAbl kinase inhibitors provide an intriguing new way to halt cisplatin-induced oocyte death in early follicles and perhaps conserve the endocrine function of the ovary against chemotherapy , according to a study published in Cell Death and Differentiation .",
    "triple_list": [
      [
        "imatinib",
        "CPR:4",
        "cAbl"
      ],
      [
        "imatinib",
        "CPR:4",
        "kinase"
      ]
    ],
    "updated": "Yes",
    "original": "Thus imatinib and other cAbl kinase inhibitors provide an intriguing new way to halt cisplatininduced oocyte death in early follicles and perhaps conserve the endocrine function of the ovary against chemotherapyCell Death and Differentiation advance online publication 19 April 2013 doi101038cdd201331",
    "simplified": "Thus imatinib and other cAbl kinase inhibitors provide an intriguing new way to halt cisplatin-induced oocyte death in early follicles and perhaps conserve the endocrine function of the ovary against chemotherapy, according to a study published in Cell Death and Differentiation."
  },
  {
    "text": "These results suggest that ZIP8 plays a pivotal role in the transport and toxicity of Cd2 and Mn2 in RBL2H3 cells",
    "triple_list": [
      [
        "ZIP8",
        "CPR:9",
        "Cd2"
      ],
      [
        "ZIP8",
        "CPR:9",
        "Mn2"
      ]
    ],
    "updated": "No",
    "original": "These results suggest that ZIP8 plays a pivotal role in the transport and toxicity of Cd2 and Mn2 in RBL2H3 cells",
    "simplified": "These results suggest that ZIP8 plays an important role in RBL2H3 cells transport and toxicity."
  },
  {
    "text": "Among the possible transporters involved in the uptake of Cd2 and Mn2 the expression of ZIP8 Zrt Irtrelated protein 8 encoded by Slc39a8 showed a marked suppression in both RBLCdr and RBLMnr cells",
    "triple_list": [
      [
        "Cd2",
        "CPR:9",
        "Slc39a8"
      ],
      [
        "Cd2",
        "CPR:9",
        "ZIP8"
      ],
      [
        "Cd2",
        "CPR:9",
        "Zrt Irtrelated protein 8"
      ],
      [
        "Mn2",
        "CPR:9",
        "Slc39a8"
      ],
      [
        "Mn2",
        "CPR:9",
        "ZIP8"
      ],
      [
        "Mn2",
        "CPR:9",
        "Zrt Irtrelated protein 8"
      ]
    ],
    "updated": "No",
    "original": "Among the possible transporters involved in the uptake of Cd2 and Mn2 the expression of ZIP8 Zrt Irtrelated protein 8 encoded by Slc39a8 showed a marked suppression in both RBLCdr and RBLMnr cells",
    "simplified": "Among the possible transporters involved in the uptake of Cd2 and Mn2 the expression of ZIP8 Zrt Irtrelated protein 8 in both RBLMnr cells and RBLCdr cells was significantly reduced."
  },
  {
    "text": "A series of 15dihydrobenzob14diazepine24dione inhibitors of HIV capsid CA assembly are described . The structureactivity relationships of the C3phenyl moiety allow for the optimization of antiviral potency .",
    "triple_list": [
      [
        "15dihydrobenzob14diazepine24dione",
        "CPR:4",
        "HIV capsid"
      ],
      [
        "15dihydrobenzob14diazepine24dione",
        "CPR:4",
        "CA"
      ]
    ],
    "updated": "Yes",
    "original": "Detailed structureactivity relationships of the C3phenyl moiety that allow for the optimization of antiviral potency of a series of 15dihydrobenzob14diazepine24dione inhibitors of HIV capsid CA assembly are described",
    "simplified": "A series of 15dihydrobenzob14diazepine24dione inhibitors of HIV capsid CA assembly are described. The structureactivity relationships of the C3phenyl moiety allow for the optimization of antiviral potency."
  },
  {
    "text": "Optimization of a 15dihydrobenzob14diazepine24dione series of HIV capsid assembly inhibitors 2 Structure of the C3 phenyl moiety and its structure .",
    "triple_list": [
      [
        "HIV capsid",
        "CPR:4",
        "phenyl"
      ],
      [
        "15dihydrobenzob14diazepine24dione",
        "CPR:4",
        "HIV capsid"
      ]
    ],
    "updated": "Yes",
    "original": "Optimization of a 15dihydrobenzob14diazepine24dione series of HIV capsid assembly inhibitors 2 Structureactivity relationships SAR of the C3 phenyl moiety",
    "simplified": "Optimization of a 15dihydrobenzob14diazepine24dione series of HIV capsid assembly inhibitors 2 Structure of the C3 phenyl moiety and its structure."
  },
  {
    "text": "Arsenic upregulates the expression of angiotensin II Type I receptor in mouse aortic endothelial cells",
    "triple_list": [
      [
        "Arsenic",
        "CPR:3",
        "angiotensin II Type I receptor"
      ]
    ],
    "updated": "No",
    "original": "Arsenic upregulates the expression of angiotensin II Type I receptor in mouse aortic endothelial cells",
    "simplified": "Angiotensin II Type I receptor expression is increased by arsenic in mouse aortic cells."
  },
  {
    "text": "Taken together our results indicate that arsenic indeed upregulates the AT1R expression thus highlighting the importance of the AT1R in the development of hypertension .",
    "triple_list": [
      [
        "arsenic",
        "CPR:3",
        "AT1R"
      ],
      [
        "arsenic",
        "CPR:3",
        "AT1R"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together our results indicate that arsenic indeed upregulates the AT1R expression thus highlighting a role of arsenicinduced aberrant AT1R signaling in the pathogenesis of hypertension",
    "simplified": "Taken together our results indicate that arsenic indeed upregulates the AT1R expression thus highlighting the importance of the AT1R in the development of hypertension."
  },
  {
    "text": "To determine the pathogenesis we examined changes in the mRNA levels of 2 angiotensin II Type I receptor AT1R subtypes AT1AR and AT1BR in a mouse aortic endothelial cell line . After sodium arsenite SA treatment , the mRNA levels of 2 AT1R subtypes AT1AR and AT1BR increased significantly .",
    "triple_list": [
      [
        "AT1R",
        "CPR:3",
        "sodium arsenite"
      ],
      [
        "AT1AR",
        "CPR:3",
        "sodium arsenite"
      ],
      [
        "AT1BR",
        "CPR:3",
        "sodium arsenite"
      ]
    ],
    "updated": "Yes",
    "original": "To delineate the pathogenesis we examined changes in the mRNA levels of 2 angiotensin II Type I receptor AT1R subtypes AT1AR and AT1BR in a mouse aortic endothelial cell line ENDD Quantitative realtime PCR analysis revealed significant increases in the mRNA levels of 2 AT1R subtypes AT1AR and AT1BR following sodium arsenite SA treatment",
    "simplified": "To determine the pathogenesis we examined changes in the mRNA levels of 2 angiotensin II Type I receptor AT1R subtypes AT1AR and AT1BR in a mouse aortic endothelial cell line. After sodium arsenite SA treatment, the mRNA levels of 2 AT1R subtypes AT1AR and AT1BR increased significantly."
  },
  {
    "text": "AT1R expression was found to be prevented both by NAC and specific JNK inhibitor SP6001325 . These results suggest that the activation of the JNK pathway by ROS is responsible for AT1R upregulation .",
    "triple_list": [
      [
        "JNK",
        "CPR:4",
        "SP6001325"
      ],
      [
        "AT1R",
        "CPR:4",
        "SP6001325"
      ]
    ],
    "updated": "Yes",
    "original": "Finally SAinduced AT1R expression was found to be prevented both by NAC and specific JNK inhibitor SP6001325 strongly indicating that AT1R upregulation is a result of the ROSmediated activation of the JNK signaling pathway",
    "simplified": "AT1R expression was found to be prevented both by NAC and specific JNK inhibitor SP6001325. These results suggest that the activation of the JNK pathway by ROS is responsible for AT1R upregulation."
  },
  {
    "text": "The expression of HSP70 and HO1 were significantly increased in the NaAsO2 group and significantly reduced in the combined group .",
    "triple_list": [
      [
        "HSP70",
        "CPR:3",
        "NaAsO2"
      ],
      [
        "HO1",
        "CPR:3",
        "NaAsO2"
      ]
    ],
    "updated": "Yes",
    "original": "The expressions of HSP70 and HO1 were significantly P005 increased in the NaAsO2 group and reduced in the combined treatment group",
    "simplified": "The expression of HSP70 and HO1 were significantly increased in the NaAsO2 group and significantly reduced in the combined group."
  },
  {
    "text": "The mRNA levels of SOD1 CAT GPx and Txnrd1 were increased significantly P005 in the combined Na2SeO3 NaAsO2 treatment group",
    "triple_list": [
      [
        "SOD1",
        "CPR:3",
        "Na2SeO3"
      ],
      [
        "CAT",
        "CPR:3",
        "Na2SeO3"
      ],
      [
        "GPx",
        "CPR:3",
        "Na2SeO3"
      ],
      [
        "SOD1",
        "CPR:4",
        "NaAsO2"
      ],
      [
        "CAT",
        "CPR:4",
        "NaAsO2"
      ],
      [
        "GPx",
        "CPR:4",
        "NaAsO2"
      ],
      [
        "Txnrd1",
        "CPR:4",
        "NaAsO2"
      ],
      [
        "Txnrd1",
        "CPR:4",
        "Na2SeO3"
      ]
    ],
    "updated": "No",
    "original": "The mRNA levels of SOD1 CAT GPx and Txnrd1 were increased significantly P005 in the combined Na2SeO3 NaAsO2 treatment group",
    "simplified": "The mRNA levels of SOD1 CAT GPx and Txnrd1 were increased significantly in the group treated with Na2SeO3."
  },
  {
    "text": "In the kinetic analyses using LineweaverBurk plots of 1velocity and 1substrate methyl35diOcaffeoylquinate showed competitive inhibition of rhAR",
    "triple_list": [
      [
        "methyl35diOcaffeoylquinate",
        "CPR:4",
        "rhAR"
      ]
    ],
    "updated": "No",
    "original": "In the kinetic analyses using LineweaverBurk plots of 1velocity and 1substrate methyl35diOcaffeoylquinate showed competitive inhibition of rhAR",
    "simplified": "In the kinetic analyses using LineweaverBurk plots of 1velocity and 1substrate methyl35diOcaffeoylquinate was found."
  },
  {
    "text": "From the 10 isolated compounds methyl35diOcaffeoylquinate showed the most potent inhibition with IC50 values of 030 and 067 \u03bcM for rAR and rhAR respectively",
    "triple_list": [
      [
        "methyl35diOcaffeoylquinate",
        "CPR:4",
        "rAR"
      ],
      [
        "methyl35diOcaffeoylquinate",
        "CPR:4",
        "rhAR"
      ]
    ],
    "updated": "No",
    "original": "From the 10 isolated compounds methyl35diOcaffeoylquinate showed the most potent inhibition with IC50 values of 030 and 067 \u03bcM for rAR and rhAR respectively",
    "simplified": "Methyl35diOcaffeoylquinate was found to be the most effective. It had an IC50 value of 030, and a concentration of 067 \u03bcM."
  },
  {
    "text": "Using recombinant UGT2B10 we found that it catalyzes the Nglucuronidation of amitriptyline imipramine ketotifen pizotifen olanzapine diphenhydramine tamoxifen ketoconazole and midazolam",
    "triple_list": [
      [
        "UGT2B10",
        "CPR:9",
        "amitriptyline"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "imipramine"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "ketotifen"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "pizotifen"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "olanzapine"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "diphenhydramine"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "tamoxifen"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "ketoconazole"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "midazolam"
      ]
    ],
    "updated": "No",
    "original": "Using recombinant UGT2B10 we found that it catalyzes the Nglucuronidation of amitriptyline imipramine ketotifen pizotifen olanzapine diphenhydramine tamoxifen ketoconazole and midazolam",
    "simplified": "Using recombinant UGT2B10 we found that it helps to break down amitriptyline into ketotifen and pizotifen. It also helps to break down ketoconazole into midazolam."
  },
  {
    "text": "This group of drugs contains secondary or primary amines and these results suggest that UGT2B10 preferably conjugates tertiary amines",
    "triple_list": [
      [
        "UGT2B10",
        "CPR:9",
        "tertiary amines"
      ]
    ],
    "updated": "No",
    "original": "This group of drugs contains secondary or primary amines and these results suggest that UGT2B10 preferably conjugates tertiary amines",
    "simplified": "This group of drugs contains secondary or primary amines. These results suggest that tertiary amines are more important."
  },
  {
    "text": "Recent observations revealed that human UDPglucuronosyltransferase UGT 2B10 catalyzes Nglucuronidation of amine containing compounds",
    "triple_list": [
      [
        "human UDPglucuronosyltransferase UGT 2B10",
        "CPR:9",
        "amine"
      ]
    ],
    "updated": "No",
    "original": "Recent observations revealed that human UDPglucuronosyltransferase UGT 2B10 catalyzes Nglucuronidation of amine containing compounds",
    "simplified": "Human UDPglucuronosyltransferase, also known as UDPglucuronidation, is an enzyme found in the human body."
  },
  {
    "text": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline imipramine and diphenhydramine are significantly higher than the corresponding values of UGT1A4 and UGT1A3 although the Vmax values of UGT1A4 toward these drugs are considerably higher",
    "triple_list": [
      [
        "UGT2B10",
        "CPR:9",
        "amitriptyline"
      ],
      [
        "amitriptyline",
        "CPR:9",
        "UGT1A4"
      ],
      [
        "amitriptyline",
        "CPR:9",
        "UGT1A4"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "imipramine"
      ],
      [
        "imipramine",
        "CPR:9",
        "UGT1A4"
      ],
      [
        "imipramine",
        "CPR:9",
        "UGT1A3"
      ],
      [
        "imipramine",
        "CPR:9",
        "UGT1A4"
      ],
      [
        "UGT2B10",
        "CPR:9",
        "diphenhydramine"
      ],
      [
        "diphenhydramine",
        "CPR:9",
        "UGT1A4"
      ],
      [
        "diphenhydramine",
        "CPR:9",
        "UGT1A3"
      ],
      [
        "diphenhydramine",
        "CPR:9",
        "UGT1A4"
      ]
    ],
    "updated": "No",
    "original": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline imipramine and diphenhydramine are significantly higher than the corresponding values of UGT1A4 and UGT1A3 although the Vmax values of UGT1A4 toward these drugs are considerably higher",
    "simplified": "The affinity and clearance of UGT2B10 for diphenhydramine and imipramine are significantly higher than the corresponding values of UGT1A4 and UGT1A3. The Vmax values of UGT1A4 toward these drugs are also significantly higher."
  },
  {
    "text": "In conclusion this study expands the understanding of the substrate specificity of UGT2B10 and shows that UGT2B10 prefers tertiary amines with higher clearance values than UGT1A4 and UGT1A3 .",
    "triple_list": [
      [
        "UGT2B10",
        "CPR:9",
        "tertiary amines"
      ],
      [
        "tertiary amines",
        "CPR:9",
        "UGT1A4"
      ],
      [
        "tertiary amines",
        "CPR:9",
        "UGT1A3"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion this study expands the understanding of the substrate specificity of UGT2B10 highlighting its preference for tertiary amines with higher affinities and clearance values than those of UGT1A4 and UGT1A3",
    "simplified": "In conclusion this study expands the understanding of the substrate specificity of UGT2B10 and shows that UGT2B10 prefers tertiary amines with higher clearance values than UGT1A4 and UGT1A3."
  },
  {
    "text": "SB225002 SB is an IL8 receptor B IL8RB antagonist that has previously been shown to inhibit IL8based cancer cell invasion and to possess in vivo antiinflammatory and antinociceptive effects",
    "triple_list": [
      [
        "SB225002",
        "CPR:4",
        "IL8"
      ],
      [
        "SB225002",
        "CPR:6",
        "IL8 receptor B"
      ],
      [
        "SB225002",
        "CPR:6",
        "IL8RB"
      ]
    ],
    "updated": "No",
    "original": "SB225002 SB is an IL8 receptor B IL8RB antagonist that has previously been shown to inhibit IL8based cancer cell invasion and to possess in vivo antiinflammatory and antinociceptive effects",
    "simplified": "SB225002 SB is an IL8 receptor B antagonist. It has been shown to inhibit the growth of cancer cells. It also has anti-inflammatory and antinociceptive effects."
  },
  {
    "text": "Of note SB265610 which is a close structural analogue of SB225002 with a potent IL8RB antagonistic activity did not exhibit a similar antimitotic activity",
    "triple_list": [
      [
        "SB265610",
        "CPR:6",
        "IL8RB"
      ],
      [
        "SB225002",
        "CPR:6",
        "IL8RB"
      ]
    ],
    "updated": "No",
    "original": "Of note SB265610 which is a close structural analogue of SB225002 with a potent IL8RB antagonistic activity did not exhibit a similar antimitotic activity",
    "simplified": "Of note SB265610 which is a close structural analogue of SB225002 did not exhibit a similar antimitotic activity and was not classified as such."
  },
  {
    "text": "The elongation can be reversed by the tyrosine kinase inhibitor SU5402 . It works by stopping the gene sprouty4 or FGF8 morpholino .",
    "triple_list": [
      [
        "tyrosine kinase",
        "CPR:4",
        "SU5402"
      ]
    ],
    "updated": "Yes",
    "original": "In support of this observation elongation can be reversed by the tyrosine kinase inhibitor SU5402 mRNA for the FGFR antagonist sprouty4 or FGF8 morpholino",
    "simplified": "The elongation can be reversed by the tyrosine kinase inhibitor SU5402. It works by stopping the gene sprouty4 or FGF8 morpholino."
  },
  {
    "text": "Treatment with CAPE reduced the amount of proteins in Akt Akt1 Akt2 Akt3 phosphoAkt Ser473 phosphoAkt Thr 308 GSK3\u03b2 FOXO1 FOXO3a phosphoFOXO1 Thr24 phosphoFoxO3a Thr32 NF\u03baB phosphoNF\u03baB Ser536 Rb phosphoRb Ser807811 Skp2 and cyclin D1 but increased protein in p27Kip",
    "triple_list": [
      [
        "CAPE",
        "CPR:3",
        "p27Kip"
      ],
      [
        "CAPE",
        "CPR:4",
        "Akt"
      ],
      [
        "CAPE",
        "CPR:4",
        "Akt1"
      ],
      [
        "CAPE",
        "CPR:4",
        "Akt2"
      ],
      [
        "CAPE",
        "CPR:4",
        "Akt3"
      ],
      [
        "CAPE",
        "CPR:4",
        "phosphoAkt"
      ],
      [
        "CAPE",
        "CPR:4",
        "phosphoAkt"
      ],
      [
        "CAPE",
        "CPR:4",
        "GSK3\u03b2"
      ],
      [
        "CAPE",
        "CPR:4",
        "FOXO1"
      ],
      [
        "CAPE",
        "CPR:4",
        "FOXO3a"
      ],
      [
        "CAPE",
        "CPR:4",
        "phosphoFOXO1"
      ],
      [
        "CAPE",
        "CPR:4",
        "phosphoFoxO3a"
      ],
      [
        "CAPE",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "CAPE",
        "CPR:4",
        "phosphoNF\u03baB"
      ],
      [
        "CAPE",
        "CPR:4",
        "Rb"
      ],
      [
        "CAPE",
        "CPR:4",
        "phosphoRb"
      ],
      [
        "CAPE",
        "CPR:4",
        "Skp2"
      ],
      [
        "CAPE",
        "CPR:4",
        "cyclin D1"
      ]
    ],
    "updated": "Yes",
    "original": "Treatment with CAPE decreased protein abundance of Akt Akt1 Akt2 Akt3 phosphoAkt Ser473 phosphoAkt Thr 308 GSK3\u03b2 FOXO1 FOXO3a phosphoFOXO1 Thr24 phosphoFoxO3a Thr32 NF\u03baB phosphoNF\u03baB Ser536 Rb phosphoRb Ser807811 Skp2 and cyclin D1 but increased cell cycle inhibitor p27Kip",
    "simplified": "Treatment with CAPE reduced the amount of proteins in Akt Akt1 Akt2 Akt3 phosphoAkt Ser473 phosphoAkt Thr 308 GSK3\u03b2 FOXO1 FOXO3a phosphoFOXO1 Thr24 phosphoFoxO3a Thr32 NF\u03baB phosphoNF\u03baB Ser536 Rb phosphoRb Ser807811 Skp2 and cyclin D1 but increased protein in p27Kip"
  },
  {
    "text": "Caffeic Acid Phenethyl Ester Suppresses Proliferation and Survival of TW26 Human Oral Cancer Cells via Inhibition of Akt Signaling",
    "triple_list": [
      [
        "Caffeic Acid Phenethyl Ester",
        "CPR:4",
        "Akt"
      ]
    ],
    "updated": "No",
    "original": "Caffeic Acid Phenethyl Ester Suppresses Proliferation and Survival of TW26 Human Oral Cancer Cells via Inhibition of Akt Signaling",
    "simplified": "Caffeic Acid and Phenethyl Ester inhibit the growth of certain cancer cells. These cells are called TW26."
  },
  {
    "text": "Here we show that fisetin quickly increases the levels of both Nrf2 and ATF4 in the DNA . This increases the number of genes that are transcribed .",
    "triple_list": [
      [
        "fisetin",
        "CPR:3",
        "Nrf2"
      ],
      [
        "fisetin",
        "CPR:3",
        "ATF4"
      ],
      [
        "fisetin",
        "CPR:3",
        "Nrf2"
      ],
      [
        "fisetin",
        "CPR:3",
        "ATF4"
      ]
    ],
    "updated": "Yes",
    "original": "Here we show that fisetin rapidly increases the levels of both Nrf2 and ATF4 as well as Nrf2 and ATF4 dependent gene transcription via distinct mechanisms",
    "simplified": "Here we show that fisetin quickly increases the levels of both Nrf2 and ATF4 in the DNA. This increases the number of genes that are transcribed."
  },
  {
    "text": "Fisetin greatly increases the stability of both Nrf2 and ATF4 . The effect on ATF4 depends on how much fisetin there is .",
    "triple_list": [
      [
        "fisetin",
        "CPR:3",
        "Nrf2"
      ],
      [
        "fisetin",
        "CPR:3",
        "ATF4"
      ]
    ],
    "updated": "Yes",
    "original": "Although fisetin greatly increases the stability of both Nrf2 and ATF4 only the effect on ATF4 is dependent on protein kinase activity",
    "simplified": "Fisetin greatly increases the stability of both Nrf2 and ATF4. The effect on ATF4 depends on how much fisetin there is."
  },
  {
    "text": "Cynomolgus FMO1 FMO2 FMO3 and FMO5 metabolized benzydamine and FMO1FMO3 and FMO3 also metabolized methimazole and trimethylamine respectively",
    "triple_list": [
      [
        "Cynomolgus FMO1",
        "CPR:9",
        "benzydamine"
      ],
      [
        "FMO2",
        "CPR:9",
        "benzydamine"
      ],
      [
        "FMO3",
        "CPR:9",
        "benzydamine"
      ],
      [
        "FMO5",
        "CPR:9",
        "benzydamine"
      ],
      [
        "FMO1",
        "CPR:9",
        "methimazole"
      ],
      [
        "FMO3",
        "CPR:9",
        "methimazole"
      ],
      [
        "FMO3",
        "CPR:9",
        "methimazole"
      ],
      [
        "FMO1",
        "CPR:9",
        "trimethylamine"
      ],
      [
        "FMO3",
        "CPR:9",
        "trimethylamine"
      ],
      [
        "FMO3",
        "CPR:9",
        "trimethylamine"
      ]
    ],
    "updated": "No",
    "original": "Cynomolgus FMO1 FMO2 FMO3 and FMO5 metabolized benzydamine and FMO1FMO3 and FMO3 also metabolized methimazole and trimethylamine respectively",
    "simplified": "Cynomolgus FMO1 FMO2 FMO3 and FMO5 can metabolize benzydamine. Cynomolgus FMO1 FMO2 FMO3 FMO4 can also metabolize trimethylamine."
  },
  {
    "text": "Rates of benzydamine N oxygenation by FMO3 varied approximately 20fold among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression . This means that the variation in benzydamine N may be caused by different FMO3 levels in different animals .",
    "triple_list": [
      [
        "benzydamine",
        "CPR:9",
        "FMO3"
      ],
      [
        "N",
        "CPR:9",
        "FMO3"
      ],
      [
        "benzydamine",
        "CPR:9",
        "FMO3"
      ],
      [
        "N",
        "CPR:9",
        "FMO3"
      ]
    ],
    "updated": "Yes",
    "original": "Rates of benzydamine N oxygenation catalyzed by FMO3 varied approximately 20fold among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression indicating that the interanimal variations in benzydamine N oxygenation might be partly accounted for by the variable FMO3 expression",
    "simplified": "Rates of benzydamine N oxygenation by FMO3 varied approximately 20fold among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression. This means that the variation in benzydamine N may be caused by different FMO3 levels in different animals."
  },
  {
    "text": "Cynomolgus FMO6 only slightly changed the way benzydamine metabolized , so it is not important for it to work , and Cynomolgus FMO1 FMO2 FMO3 and FMO5 were all useful animals , but FMO6 was not .",
    "triple_list": [
      [
        "Cynomolgus FMO6",
        "CPR:9",
        "benzydamine"
      ],
      [
        "benzydamine",
        "CPR:9",
        "FMO1"
      ],
      [
        "benzydamine",
        "CPR:9",
        "FMO2"
      ],
      [
        "benzydamine",
        "CPR:9",
        "FMO3"
      ],
      [
        "benzydamine",
        "CPR:9",
        "FMO5"
      ]
    ],
    "updated": "Yes",
    "original": "Cynomolgus FMO6 metabolized benzydamine only slightly but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism unlike cynomolgus FMO1 FMO2 FMO3 and FMO5 which were all functional",
    "simplified": "Cynomolgus FMO6 only slightly changed the way benzydamine metabolized, so it is not important for it to work, and Cynomolgus FMO1 FMO2 FMO3 and FMO5 were all useful animals, but FMO6 was not."
  },
  {
    "text": "Activation of AMPK using AICAR resulted in STIM1 phosphorylation on serine residues and prevented PAR1 induced Ca2 entry",
    "triple_list": [
      [
        "AMPK",
        "CPR:3",
        "AICAR"
      ],
      [
        "AICAR",
        "CPR:3",
        "STIM1"
      ],
      [
        "AICAR",
        "CPR:4",
        "PAR1"
      ]
    ],
    "updated": "No",
    "original": "Activation of AMPK using AICAR resulted in STIM1 phosphorylation on serine residues and prevented PAR1 induced Ca2 entry",
    "simplified": "When AMPK was activated by AICAR, STIM1 was phosphorylated on serine residues. This prevented Ca2 entry."
  },
  {
    "text": "Further AICAR pretreatment blocked PAR1 induced increase in permeability of mouselung microvessels",
    "triple_list": [
      [
        "AICAR",
        "CPR:4",
        "PAR1"
      ]
    ],
    "updated": "No",
    "original": "Further AICAR pretreatment blocked PAR1 induced increase in permeability of mouselung microvessels",
    "simplified": "Further pretreatment with AICAR blocked the increase in mouselung microvessels."
  },
  {
    "text": "SB203580 , a selective inhibitor of p38 MAPK , blocked STIM1 phosphorylation and Ca2 entry and lead to sustained STIM1puncta formation",
    "triple_list": [
      [
        "SB203580",
        "CPR:4",
        "p38"
      ],
      [
        "SB203580",
        "CPR:4",
        "MAPK"
      ],
      [
        "SB203580",
        "CPR:4",
        "STIM1"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly SB203580 a selective inhibitor of p38 MAPK blocked STIM1 phosphorylation and led to sustained STIM1puncta formation and Ca2 entry",
    "simplified": "SB203580, a selective inhibitor of p38 MAPK, blocked STIM1 phosphorylation and Ca2 entry and lead to sustained STIM1puncta formation"
  },
  {
    "text": "The exact way these proteins move cholesterol from the OMM to the P450scc is not known . It is also not known how cholesterol is loaded into the OMM .",
    "triple_list": [
      [
        "cholesterol",
        "CPR:9",
        "P450scc"
      ]
    ],
    "updated": "Yes",
    "original": "The precise fashion in which these proteins interact and move cholesterol from the OMM to P450scc and the means by which cholesterol is loaded into the OMM remain unclear",
    "simplified": "The exact way these proteins move cholesterol from the OMM to the P450scc is not known. It is also not known how cholesterol is loaded into the OMM."
  },
  {
    "text": "The steroidogenic cells of the adrenal placenta and brain contain the enzyme P450scc and its two partners ferredoxin reductase and ferredoxin , which remove cholesterol from the blood .",
    "triple_list": [
      [
        "cholesterol",
        "CPR:9",
        "P450scc"
      ]
    ],
    "updated": "Yes",
    "original": "Mitochondria in the steroidogenic cells of the adrenal gonad placenta and brain contain the cholesterol sidechain cleavage enzyme P450scc and its two electrontransfer partners ferredoxin reductase and ferredoxin",
    "simplified": "The steroidogenic cells of the adrenal placenta and brain contain the enzyme P450scc and its two partners ferredoxin reductase and ferredoxin, which remove cholesterol from the blood."
  },
  {
    "text": "New series of pyrrolidine mercaptosulfide 2mercaptocyclopentane arylsulfonamide and 3mercapto4arylsulfonamido pyrrolidine matrix metalloproteinase inhibitors MMPIs were designed synthesized and evaluated",
    "triple_list": [
      [
        "pyrrolidine mercaptosulfide",
        "CPR:4",
        "matrix metalloproteinase"
      ],
      [
        "2mercaptocyclopentane arylsulfonamide",
        "CPR:4",
        "matrix metalloproteinase"
      ],
      [
        "3mercapto4arylsulfonamido pyrrolidine",
        "CPR:4",
        "matrix metalloproteinase"
      ]
    ],
    "updated": "No",
    "original": "New series of pyrrolidine mercaptosulfide 2mercaptocyclopentane arylsulfonamide and 3mercapto4arylsulfonamido pyrrolidine matrix metalloproteinase inhibitors MMPIs were designed synthesized and evaluated",
    "simplified": "New series of pyrrolidine matrix metalloproteinase inhibitors (MMPIs) were designed synthesized and evaluated 2mercaptocyclopentane arylsulfonamide and 3mercapto4arylsulfonamido"
  },
  {
    "text": "Exhibiting unique properties over other MMPIs eg hydroxamates these newly reported compounds are capable of modulating activities of several MMPs in the low nanomolar range including MMP2 2 to 50 nM MMP13 2 to 50 nM and MMP14 4 to 60 nM",
    "triple_list": [
      [
        "hydroxamates",
        "CPR:4",
        "MMPs"
      ],
      [
        "hydroxamates",
        "CPR:4",
        "MMP2"
      ],
      [
        "hydroxamates",
        "CPR:4",
        "MMP13"
      ],
      [
        "hydroxamates",
        "CPR:4",
        "MMP14"
      ]
    ],
    "updated": "No",
    "original": "Exhibiting unique properties over other MMPIs eg hydroxamates these newly reported compounds are capable of modulating activities of several MMPs in the low nanomolar range including MMP2 2 to 50 nM MMP13 2 to 50 nM and MMP14 4 to 60 nM",
    "simplified": "These newly reported compounds have unique properties over other MMPIs eg hydroxamates. They can modulating activities of several MMPs in the low nanomolar range including MMP2 2 to 50 nM and MMP14 4 to 60 nM."
  },
  {
    "text": "Matrix Metalloproteinase Inhibitors Based on the 3Mercaptopyrrolidine Core",
    "triple_list": [
      [
        "Matrix Metalloproteinase",
        "CPR:4",
        "3Mercaptopyrrolidine"
      ]
    ],
    "updated": "No",
    "original": "Matrix Metalloproteinase Inhibitors Based on the 3Mercaptopyrrolidine Core",
    "simplified": "Matrix Metalloproteinase Inhibitors: This is a drug that blocks metalloproteinase."
  },
  {
    "text": "RESULTS By Western blot analysis of spinal cord tissues we have demonstrated that treatment with bioactive RS GRA significantly decreased nuclear factor NFkB translocation proinflammatory cytokine production such as interleukin1\u03b2 IL1\u03b2 and apoptosis Bax and caspase 3 expression",
    "triple_list": [
      [
        "RS GRA",
        "CPR:4",
        "interleukin1\u03b2"
      ],
      [
        "RS GRA",
        "CPR:4",
        "IL1\u03b2"
      ],
      [
        "RS GRA",
        "CPR:4",
        "Bax"
      ],
      [
        "RS GRA",
        "CPR:4",
        "caspase 3"
      ],
      [
        "RS GRA",
        "CPR:4",
        "nuclear factor NFkB"
      ],
      [
        "RS GRA",
        "CPR:4",
        "cytokine"
      ]
    ],
    "updated": "No",
    "original": "RESULTS By Western blot analysis of spinal cord tissues we have demonstrated that treatment with bioactive RS GRA significantly decreased nuclear factor NFkB translocation proinflammatory cytokine production such as interleukin1\u03b2 IL1\u03b2 and apoptosis Bax and caspase 3 expression",
    "simplified": "Results By Western blot analysis of spinal cord tissues we have demonstrated that treatment with bioactive RS GRA significantly decreased the production of proinflammatory cytokines. Bax and caspase 3 expression were also significantly reduced."
  },
  {
    "text": "Recent literature shows that Brassica vegetables Cruciferae possess therapeutic effects particularly ascribed due to their content in glucosinolates which upon myrosinase hydrolysis release the corresponding isothiocyanates",
    "triple_list": [
      [
        "glucosinolates",
        "CPR:9",
        "myrosinase"
      ],
      [
        "myrosinase",
        "CPR:9",
        "isothiocyanates"
      ]
    ],
    "updated": "No",
    "original": "Recent literature shows that Brassica vegetables Cruciferae possess therapeutic effects particularly ascribed due to their content in glucosinolates which upon myrosinase hydrolysis release the corresponding isothiocyanates",
    "simplified": "Recent literature shows that Brassica vegetables Cruciferae have therapeutic effects. This is because they contain glucosinolates. These are released when myrosinase hydrolysis takes place."
  },
  {
    "text": "There was also an increase in \u03b3GCS and HO1 levels in calycopterin pretreated cells",
    "triple_list": [
      [
        "\u03b3GCS",
        "CPR:3",
        "calycopterin"
      ],
      [
        "HO1",
        "CPR:3",
        "calycopterin"
      ]
    ],
    "updated": "No",
    "original": "There was also an increase in \u03b3GCS and HO1 levels in calycopterin pretreated cells",
    "simplified": "The levels of \u03b3GCS and HO1 were also increased in the pretreated cells."
  },
  {
    "text": "When calycopterin was added , the decrease in GSH level and SOD activity was reduced .",
    "triple_list": [
      [
        "calycopterin",
        "CPR:3",
        "SOD"
      ]
    ],
    "updated": "Yes",
    "original": "In the presence of H2O2 calycopterin inhibited decrease in GSH level and SOD activity",
    "simplified": "When calycopterin was added, the decrease in GSH level and SOD activity was reduced."
  },
  {
    "text": "In addition , calycopterin in the presence of H2O2 reduced oxidative stress in stress-sensing transcription factors CREB and Nrf2 , which play an important role in cell antioxidant function .",
    "triple_list": [
      [
        "calycopterin",
        "CPR:3",
        "CREB"
      ],
      [
        "calycopterin",
        "CPR:3",
        "Nrf2"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover calycopterin in presence of H2O2 inhibited the decrease caused by oxidative stress in stresssensing transcription factors CREB and Nrf2 which play an important role in antioxidant capacity of the cell",
    "simplified": "In addition, calycopterin in the presence of H2O2 reduced oxidative stress in stress-sensing transcription factors CREB and Nrf2, which play an important role in cell antioxidant function."
  },
  {
    "text": "Herein we investigated the effect of a natural neuroprotective flavonoid calycopterin on H2O2 induced disruption of phase II detoxifying enzyme system and cAMP response element binding protein CREB phosphorylation",
    "triple_list": [
      [
        "H2O2",
        "CPR:4",
        "phase II detoxifying enzyme"
      ],
      [
        "H2O2",
        "CPR:4",
        "cAMP response element binding protein"
      ],
      [
        "H2O2",
        "CPR:4",
        "CREB"
      ]
    ],
    "updated": "No",
    "original": "Herein we investigated the effect of a natural neuroprotective flavonoid calycopterin on H2O2 induced disruption of phase II detoxifying enzyme system and cAMP response element binding protein CREB phosphorylation",
    "simplified": "The effect of a natural neuroprotective flavonoid calycopterin on phase II detoxifying enzyme system and cAMP response element binding protein CREB was investigated in this study."
  },
  {
    "text": "In H2O2treated cells , calycopterin reduced the release of cytochrome C to cytosol . This cytochrome C is important for mitochondrial homeostasis .",
    "triple_list": [
      [
        "calycopterin",
        "CPR:4",
        "cytochrome C"
      ]
    ],
    "updated": "Yes",
    "original": "In H2O2treated cells calycopterin also suppressed cytochrome C release to cytosol that is necessary for maintaining mitochondrial homeostasis in survived cells",
    "simplified": "In H2O2treated cells, calycopterin reduced the release of cytochrome C to cytosol. This cytochrome C is important for mitochondrial homeostasis."
  },
  {
    "text": "The phosphorylation of STAT3 , which is necessary for Th17 differentiation , was strongly stimulated by I3S and TCDD , but not by IL6 .",
    "triple_list": [
      [
        "STAT3",
        "CPR:3",
        "TCDD"
      ],
      [
        "IL6",
        "CPR:3",
        "TCDD"
      ],
      [
        "STAT3",
        "CPR:3",
        "I3S"
      ],
      [
        "IL6",
        "CPR:3",
        "I3S"
      ]
    ],
    "updated": "Yes",
    "original": "Activation of STAT3 which is phosphorylated by the IL6 signaling pathways and thus is necessary for Th17 differentiation was strongly stimulated by I3S and TCDD",
    "simplified": "The phosphorylation of STAT3, which is necessary for Th17 differentiation, was strongly stimulated by I3S and TCDD, but not by IL6."
  },
  {
    "text": "Phosphorylation of cSrc was also increased by I3S and TCDD and blocking of cSrc activity by 4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine PP2 raised a possibility that I3S and TCDD could increase phosphorylation of cSrc which in turn stimulates STAT3 activation and thus Th17 differentiation .",
    "triple_list": [
      [
        "cSrc",
        "CPR:3",
        "I3S"
      ],
      [
        "cSrc",
        "CPR:3",
        "TCDD"
      ],
      [
        "cSrc",
        "CPR:3",
        "I3S"
      ],
      [
        "I3S",
        "CPR:3",
        "STAT3"
      ],
      [
        "cSrc",
        "CPR:3",
        "TCDD"
      ],
      [
        "TCDD",
        "CPR:3",
        "STAT3"
      ],
      [
        "cSrc",
        "CPR:4",
        "4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine"
      ],
      [
        "cSrc",
        "CPR:4",
        "4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine"
      ],
      [
        "4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine",
        "CPR:4",
        "STAT3"
      ]
    ],
    "updated": "Yes",
    "original": "Phosphorylation of cSrc which was shown to be activated by AhR ligands was also increased by I3S and TCDD and blocking of cSrc activity by 4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine PP2 inhibited phosphorylation of both cSrc and STAT3 raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of cSrc which in turn stimulates STAT3 activation",
    "simplified": "Phosphorylation of cSrc was also increased by I3S and TCDD and blocking of cSrc activity by 4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine PP2 raised a possibility that I3S and TCDD could increase phosphorylation of cSrc which in turn stimulates STAT3 activation and thus Th17 differentiation."
  },
  {
    "text": "Indoxyl 3sulfate can increase the phosphorylation of cSrc and STAT3 in the brain . This can cause an autoimmune disease .",
    "triple_list": [
      [
        "Indoxyl 3sulfate",
        "CPR:3",
        "cSrc"
      ],
      [
        "Indoxyl 3sulfate",
        "CPR:3",
        "STAT3"
      ]
    ],
    "updated": "Yes",
    "original": "Indoxyl 3sulfate stimulates Th17 differentiation enhancing phosphorylation of cSrc and STAT3 to worsen experimental autoimmune encephalomyelitis",
    "simplified": "Indoxyl 3sulfate can increase the phosphorylation of cSrc and STAT3 in the brain. This can cause an autoimmune disease."
  },
  {
    "text": "We also found that I3S made experimental autoimmune encephalomyelitis EAE worse . This is because Th17 cells in the brain are increased and IL17 producing cells are increased .",
    "triple_list": [
      [
        "I3S",
        "CPR:3",
        "IL17"
      ]
    ],
    "updated": "Yes",
    "original": "Finally we found that I3S worsened experimental autoimmune encephalomyelitis EAE which is primarily mediated by Th17 cells enhancing the frequency of IL17 producing cells in draining lymph nodes",
    "simplified": "We also found that I3S made experimental autoimmune encephalomyelitis EAE worse. This is because Th17 cells in the brain are increased and IL17 producing cells are increased."
  },
  {
    "text": "In the present study we examined effects of AhR activation by indoxyl 3sulfate I3S a uremic toxin on Th17 differentiation and investigated the underlying mechanisms of AhR activation .",
    "triple_list": [
      [
        "AhR",
        "CPR:3",
        "indoxyl 3sulfate"
      ],
      [
        "AhR",
        "CPR:3",
        "I3S"
      ]
    ],
    "updated": "Yes",
    "original": "In the present study using in vitro Th17 differentiation model we examined effects of AhR activation by indoxyl 3sulfate I3S a uremic toxin on Th17 differentiation and investigated underlying mechanisms",
    "simplified": "In the present study we examined effects of AhR activation by indoxyl 3sulfate I3S a uremic toxin on Th17 differentiation and investigated the underlying mechanisms of AhR activation."
  },
  {
    "text": "I3S increased expression of ROR\u03b3t the master transcription factor for Th17 differentiation and stimulated Th17 differentiation in a manner similar to how TCDD is expressed in humans .",
    "triple_list": [
      [
        "I3S",
        "CPR:3",
        "ROR\u03b3t"
      ]
    ],
    "updated": "Yes",
    "original": "I3S increased expression of ROR\u03b3t the master transcription factor for Th17 differentiation and stimulated Th17 differentiation in a comparative manner as 2378tetrachlorodibenzopdioxin TCDD a prototypical AhR ligand",
    "simplified": "I3S increased expression of ROR\u03b3t the master transcription factor for Th17 differentiation and stimulated Th17 differentiation in a manner similar to how TCDD is expressed in humans."
  },
  {
    "text": "The TCDD induced secreted factor was identified as insulinlike growth factor binding protein 4 ( IGFBP4 ) , an important protein .",
    "triple_list": [
      [
        "TCDD",
        "CPR:3",
        "insulinlike growth factor binding protein 4"
      ],
      [
        "TCDD",
        "CPR:3",
        "IGFBP4"
      ]
    ],
    "updated": "Yes",
    "original": "This inhibition was mediated by a TCDD induced secreted factor which was identified as insulinlike growth factor binding protein 4 IGFBP4",
    "simplified": "The TCDD induced secreted factor was identified as insulinlike growth factor binding protein 4 (IGFBP4), an important protein."
  },
  {
    "text": "TCDD causes insulinlike growth factor binding protein 4 to be turned on in 5L rat hepatoma cells . This should not be used in studies on dioxin toxicity .",
    "triple_list": [
      [
        "TCDD",
        "CPR:3",
        "insulinlike growth factor binding protein 4"
      ]
    ],
    "updated": "Yes",
    "original": "TCDD induces the expression of insulinlike growth factor binding protein 4 in 5L rat hepatoma cells a cautionary tale of the use of this cell line in studies on dioxin toxicity",
    "simplified": "TCDD causes insulinlike growth factor binding protein 4 to be turned on in 5L rat hepatoma cells. This should not be used in studies on dioxin toxicity."
  },
  {
    "text": "The observations suggest that in 5L cells the Igfbp4 gene may have got under the control of a promoter containing dioxin responsive elements leading to the induction of IGFBP4 by TCDD",
    "triple_list": [
      [
        "IGFBP4",
        "CPR:3",
        "TCDD"
      ]
    ],
    "updated": "No",
    "original": "The observations suggest that in 5L cells the Igfbp4 gene may have got under the control of a promoter containing dioxin responsive elements leading to the induction of IGFBP4 by TCDD",
    "simplified": "The results suggest that in 5L cells the Igfbp4 gene may be under the control of a promoter containing dioxin responsive elements, which in turn leads to TCDD."
  },
  {
    "text": "By working upwards from mTOR we observed that TCDD inhibited endogenous and IGFI induced AKT and ERK activation by interfering with tyrosine phosphorylation of insulin receptor substrate 1",
    "triple_list": [
      [
        "TCDD",
        "CPR:4",
        "IGFI"
      ],
      [
        "TCDD",
        "CPR:4",
        "AKT"
      ],
      [
        "TCDD",
        "CPR:4",
        "ERK"
      ]
    ],
    "updated": "No",
    "original": "By working upwards from mTOR we observed that TCDD inhibited endogenous and IGFI induced AKT and ERK activation by interfering with tyrosine phosphorylation of insulin receptor substrate 1",
    "simplified": "By working upwards from mTOR we observed that TCDD inhibited AKT and ERK activation by interfering with tyrosine phosphorylation of the insulin receptor substrate 1."
  },
  {
    "text": "The induction of IGFBP4 protein was dependent on a functional aryl hydrocarbon receptor and was preceded by a rapid increase in the level of IGFBP4 mRNA indicating that IGFBP4 is a previously unknown transcriptional target of TCDD in 5L cells",
    "triple_list": [
      [
        "IGFBP4",
        "CPR:4",
        "TCDD"
      ]
    ],
    "updated": "No",
    "original": "The induction of IGFBP4 protein was dependent on a functional aryl hydrocarbon receptor and was preceded by a rapid increase in the level of IGFBP4 mRNA indicating that IGFBP4 is a previously unknown transcriptional target of TCDD in 5L cells",
    "simplified": "The induction of IGFBP4 protein was dependent on a functional aryl hydrocarbon receptor and was preceded by a rapid increase in the level of IGFBP4 mRNA in 5L cells. The level of IGFBP4 in 5L cells is very high."
  },
  {
    "text": "Inhibition of MCF7 cell growth by the selective calmodulin antagonist W13 and W12 is consistent with a role for calmodulin in the broad growthinhibitory properties of pimozide .",
    "triple_list": [
      [
        "calmodulin",
        "CPR:4",
        "pimozide"
      ],
      [
        "calmodulin",
        "CPR:6",
        "W13"
      ],
      [
        "calmodulin",
        "CPR:6",
        "W12"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition of MCF7 cell growth by the selective calmodulin antagonists W13 and W12 is consistent with a role for calmodulin antagonism in the broad growthinhibitory properties of pimozide",
    "simplified": "Inhibition of MCF7 cell growth by the selective calmodulin antagonist W13 and W12 is consistent with a role for calmodulin in the broad growthinhibitory properties of pimozide."
  },
  {
    "text": "Although many different ways that pimozide and thioridazine work have been found , both drugs work by blocking a part of a hormone called calmodulin .",
    "triple_list": [
      [
        "pimozide",
        "CPR:6",
        "calmodulin"
      ],
      [
        "thioridazine",
        "CPR:6",
        "calmodulin"
      ]
    ],
    "updated": "Yes",
    "original": "Although numerous mechanisms of action of pimozide and thioridazine have been identified both drugs are calmodulin antagonists at drug concentrations that inhibit breast cancer cell growth in vitro",
    "simplified": "Although many different ways that pimozide and thioridazine work have been found, both drugs work by blocking a part of a hormone called calmodulin."
  },
  {
    "text": "MAOB by deprenyl 1 mgkg ip",
    "triple_list": [
      [
        "MAOB",
        "CPR:4",
        "deprenyl"
      ]
    ],
    "updated": "No",
    "original": "MAOB by deprenyl 1 mgkg ip",
    "simplified": "MAOB (drug) 1 mgkg ip"
  },
  {
    "text": "both MAOA and MAOB by nialamide 75 mgkg ip",
    "triple_list": [
      [
        "MAOA",
        "CPR:4",
        "nialamide"
      ],
      [
        "MAOB",
        "CPR:4",
        "nialamide"
      ]
    ],
    "updated": "No",
    "original": "both MAOA and MAOB by nialamide 75 mgkg ip",
    "simplified": "Both MAOA and MAOB can cause cancer."
  },
  {
    "text": "or central nervous system MAO by debrisoquin",
    "triple_list": [
      [
        "MAO",
        "CPR:4",
        "debrisoquin"
      ]
    ],
    "updated": "Yes",
    "original": "or peripheral neuronal MAO by debrisoquin 40 mgkg ip",
    "simplified": "or central nervous system MAO by debrisoquin"
  },
  {
    "text": "Levels of homovanillic acid and dihydroxyphenylacetic acid in plasma and the striatium were measured after monoamine oxidase type A MAOA was inhibited by clorgyline 4 mgkg ip .",
    "triple_list": [
      [
        "monoamine oxidase type A",
        "CPR:4",
        "clorgyline"
      ],
      [
        "MAOA",
        "CPR:4",
        "clorgyline"
      ]
    ],
    "updated": "Yes",
    "original": "Levels of homovanillic acid HVA dihydroxyphenylacetic acid DOPAC and dihydroxyphenylglycol DHPG in plasma and the striatium were measured after inhibition of monoamine oxidase type A MAOA by clorgyline 4 mgkg ip",
    "simplified": "Levels of homovanillic acid and dihydroxyphenylacetic acid in plasma and the striatium were measured after monoamine oxidase type A MAOA was inhibited by clorgyline 4 mgkg ip."
  },
  {
    "text": "The results suggest that most of the HVA in plasma is derived from deamination of DA by MAOA in peripheral neurons that DOPAC in plasma is derived from cells outside the central nervous system that DHPG in plasma is derived virtually exclusively from the metabolism of norepinephrine in sympathetic nerve endings and that residual levels of HVA after treatment with debrisoquin provide an improved but limited indication of central dopaminergic activity",
    "triple_list": [
      [
        "DA",
        "CPR:9",
        "MAOA"
      ],
      [
        "HVA",
        "CPR:9",
        "MAOA"
      ]
    ],
    "updated": "No",
    "original": "The results suggest that most of the HVA in plasma is derived from deamination of DA by MAOA in peripheral neurons that DOPAC in plasma is derived from cells outside the central nervous system that DHPG in plasma is derived virtually exclusively from the metabolism of norepinephrine in sympathetic nerve endings and that residual levels of HVA after treatment with debrisoquin provide an improved but limited indication of central dopaminergic activity",
    "simplified": "The results suggest that most of the HVA in plasma is derived from the metabolism of norepinephrine in sympathetic nerve endings, that DOPAC in plasma is derived from cells outside the central nervous system, and that residual levels of HVA after treatment with debrisoquin provide an improved but limited indication of central dopaminergic activity."
  },
  {
    "text": "After loperamide administration ACTH levels fell to a nadir of 135 76 pgml . CRH was still able to cause an ACTH increase , but the amount of ACTH was lower than before .",
    "triple_list": [
      [
        "loperamide",
        "CPR:3",
        "ACTH"
      ],
      [
        "loperamide",
        "CPR:4",
        "ACTH"
      ]
    ],
    "updated": "Yes",
    "original": "After loperamide administration ACTH levels fell to a nadir of 135 76 pgml and then CRH was still able to induce an ACTH increase the pattern of ACTH response to CRH was slightly delayed",
    "simplified": "After loperamide administration ACTH levels fell to a nadir of 135 76 pgml. CRH was still able to cause an ACTH increase, but the amount of ACTH was lower than before."
  },
  {
    "text": "The effects of ambenonium on tissue response to acetylcholine were less than that of bethanechol . It was possible to reduce the effects of ambenonium by prior treatment with the acetylcholinesterase inhibitor neostigmine .",
    "triple_list": [
      [
        "acetylcholinesterase",
        "CPR:4",
        "neostigmine"
      ]
    ],
    "updated": "Yes",
    "original": "Ambenonium was a less potent antagonist of tissue responses to acetylcholine and the underestimation in the pKB as compared to that obtained with bethanechol could be eliminated by prior treatment of tissues with the acetylcholinesterase inhibitor neostigmine",
    "simplified": "The effects of ambenonium on tissue response to acetylcholine were less than that of bethanechol. It was possible to reduce the effects of ambenonium by prior treatment with the acetylcholinesterase inhibitor neostigmine."
  },
  {
    "text": "These data suggested that ambenonium had a dual effect on tissue responses to acetylcholine : one by blocking acetylcholine sterase , and the other by blocking muscarinic receptors .",
    "triple_list": [
      [
        "ambenonium",
        "CPR:4",
        "muscarinic receptors"
      ],
      [
        "ambenonium",
        "CPR:6",
        "muscarinic receptors"
      ]
    ],
    "updated": "Yes",
    "original": "These data suggested that ambenonium had a dual effect on tissue responses to acetylcholine producing potentiation by blockade of acetylcholine sterase and concomitant antagonism by blockade of muscarinic receptors",
    "simplified": "These data suggested that ambenonium had a dual effect on tissue responses to acetylcholine: one by blocking acetylcholine sterase, and the other by blocking muscarinic receptors."
  },
  {
    "text": "Ambenonium is known to inhibit acetylcholinesterase . It is also known to cause problems with the muscarinic receptors .",
    "triple_list": [
      [
        "Ambenonium",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "Ambenonium",
        "CPR:6",
        "muscarinic receptors"
      ]
    ],
    "updated": "Yes",
    "original": "Ambenonium is known to be an inhibitor of acetylcholinesterase and recent data have shown this drug to antagonize muscarinic receptors as well",
    "simplified": "Ambenonium is known to inhibit acetylcholinesterase. It is also known to cause problems with the muscarinic receptors."
  },
  {
    "text": "However betaxolol produces less systemic beta 2 and possibly beta 1adrenergic receptor blockade than either timolol or levobunolol",
    "triple_list": [
      [
        "betaxolol",
        "CPR:4",
        "beta 1adrenergic receptor"
      ],
      [
        "beta 1adrenergic receptor",
        "CPR:4",
        "timolol"
      ],
      [
        "beta 1adrenergic receptor",
        "CPR:4",
        "levobunolol"
      ]
    ],
    "updated": "No",
    "original": "However betaxolol produces less systemic beta 2 and possibly beta 1adrenergic receptor blockade than either timolol or levobunolol",
    "simplified": "However, betaxolol does not work as well in the liver. It also does not work as well as timolol or levobunolol."
  },
  {
    "text": "Phenol oxidase inhibitors such as phenylthiourea potassium cyanide and sodium azide inhibited the reaction drastically suggesting the participation of the active site copper of the enzyme in the catalysis",
    "triple_list": [
      [
        "Phenol oxidase",
        "CPR:4",
        "phenylthiourea"
      ],
      [
        "Phenol oxidase",
        "CPR:4",
        "potassium cyanide"
      ],
      [
        "Phenol oxidase",
        "CPR:4",
        "sodium azide"
      ]
    ],
    "updated": "No",
    "original": "Phenol oxidase inhibitors such as phenylthiourea potassium cyanide and sodium azide inhibited the reaction drastically suggesting the participation of the active site copper of the enzyme in the catalysis",
    "simplified": "Phenol oxidase inhibitors, for example, potassium cyanide and sodium azide stopped the reaction. This would mean that the copper in the enzyme would have to work harder to get the job done."
  },
  {
    "text": "Mimosine is a well known competitive inhibitor of tyrosinase . It does not allow this reaction .",
    "triple_list": [
      [
        "Mimosine",
        "CPR:4",
        "tyrosinase"
      ]
    ],
    "updated": "Yes",
    "original": "Mimosine a wellknown competitive inhibitor of tyrosinase competitively inhibited the new reaction also",
    "simplified": "Mimosine is a well known competitive inhibitor of tyrosinase. It does not allow this reaction."
  },
  {
    "text": "The active site of mushroom tyrosinase is copper . If 34dihydroxymandelic acid , a chemical similar to copper , is put on the enzyme , it makes quinone methide .",
    "triple_list": [
      [
        "mushroom tyrosinase",
        "CPR:9",
        "34dihydroxymandelic acid"
      ],
      [
        "mushroom tyrosinase",
        "CPR:9",
        "quinone methide"
      ]
    ],
    "updated": "Yes",
    "original": "Present studies demonstrate that mushroom tyrosinase will also catalyze quinone methide production with the same active site copper if a suitable substrate such as 34dihydroxymandelic acid is provided",
    "simplified": "The active site of mushroom tyrosinase is copper. If 34dihydroxymandelic acid, a chemical similar to copper, is put on the enzyme, it makes quinone methide."
  },
  {
    "text": "Tyrosinase converts monophenols to odiphenols and diphenols to quinones . The quinones are then oxidized by Tyrosinase .",
    "triple_list": [
      [
        "Tyrosinase",
        "CPR:9",
        "monophenols"
      ],
      [
        "Tyrosinase",
        "CPR:9",
        "diphenols"
      ]
    ],
    "updated": "Yes",
    "original": "Tyrosinase usually catalyzes the conversion of monophenols to odiphenols and oxidation of diphenols to the corresponding quinones",
    "simplified": "Tyrosinase converts monophenols to odiphenols and diphenols to quinones. The quinones are then oxidized by Tyrosinase."
  },
  {
    "text": "Tyrosinase makes 34dihydroxymandelate , an unusual chemical compound .",
    "triple_list": [
      [
        "Tyrosinase",
        "CPR:9",
        "34dihydroxymandelate"
      ]
    ],
    "updated": "Yes",
    "original": "Tyrosinase catalyzes an unusual oxidative decarboxylation of 34dihydroxymandelate",
    "simplified": "Tyrosinase makes 34dihydroxymandelate, an unusual chemical compound."
  },
  {
    "text": "The activation of human Glu1plasminogen Glu1Pg by human recombinant rec twochain tissue plasminogen activator tPA is inhibited by Cl at physiological concentrations and stimulated by epsilonaminocaproic acid EACA as well as fibrinogen",
    "triple_list": [
      [
        "tPA",
        "CPR:3",
        "epsilonaminocaproic acid"
      ],
      [
        "human Glu1plasminogen",
        "CPR:3",
        "epsilonaminocaproic acid"
      ],
      [
        "Glu1Pg",
        "CPR:3",
        "epsilonaminocaproic acid"
      ],
      [
        "tissue plasminogen activator",
        "CPR:3",
        "epsilonaminocaproic acid"
      ],
      [
        "tPA",
        "CPR:3",
        "EACA"
      ],
      [
        "human Glu1plasminogen",
        "CPR:3",
        "EACA"
      ],
      [
        "Glu1Pg",
        "CPR:3",
        "EACA"
      ],
      [
        "tissue plasminogen activator",
        "CPR:3",
        "EACA"
      ],
      [
        "tPA",
        "CPR:4",
        "Cl"
      ],
      [
        "human Glu1plasminogen",
        "CPR:4",
        "Cl"
      ],
      [
        "Glu1Pg",
        "CPR:4",
        "Cl"
      ],
      [
        "tissue plasminogen activator",
        "CPR:4",
        "Cl"
      ]
    ],
    "updated": "No",
    "original": "The activation of human Glu1plasminogen Glu1Pg by human recombinant rec twochain tissue plasminogen activator tPA is inhibited by Cl at physiological concentrations and stimulated by epsilonaminocaproic acid EACA as well as fibrinogen",
    "simplified": "The activator of human Glu1plasminogen Glu1Pg by human recombinant rec twochain tissue plasminogen activator tPA is inhibited by Cl at physiological concentrations and stimulated by epsilonaminocaproic acid and fibrinogen."
  },
  {
    "text": "The presence of Cl inhibits the stimulation of Glu1Pg activation that would normally occur in the presence of fibrinogen . It is possible that some degree of systemic fibrinogenolysis takes place when tissue plasminogen activator is applied to the affected area .",
    "triple_list": [
      [
        "Cl",
        "CPR:4",
        "Glu1Pg"
      ]
    ],
    "updated": "Yes",
    "original": "The presence of Cl inhibits the stimulation of Glu1Pg activation that would normally occur in the presence of fibrinogen a result of possible importance to the observation that some degree of systemic fibrinogenolysis accompanies therapeutic use of tissue plasminogen activator",
    "simplified": "The presence of Cl inhibits the stimulation of Glu1Pg activation that would normally occur in the presence of fibrinogen. It is possible that some degree of systemic fibrinogenolysis takes place when tissue plasminogen activator is applied to the affected area."
  },
  {
    "text": "Wholecell voltageclamp of hNET 293 cells reveals NE induced currents blocked by cocaine and antidepressants in parental cells",
    "triple_list": [
      [
        "hNET",
        "CPR:3",
        "NE"
      ],
      [
        "hNET",
        "CPR:4",
        "cocaine"
      ]
    ],
    "updated": "Yes",
    "original": "Wholecell voltageclamp of hNET 293 cells reveals NE induced Nadependent currents blocked by antidepressants and cocaine that are absent in parental cells",
    "simplified": "Wholecell voltageclamp of hNET 293 cells reveals NE induced currents blocked by cocaine and antidepressants in parental cells"
  },
  {
    "text": "Sodiumdependent norepinephrine induced currents in norepinephrinetransporter transfected HEK293 cells blocked by cocaine and antidepressants",
    "triple_list": [
      [
        "norepinephrine",
        "CPR:3",
        "norepinephrinetransporter"
      ],
      [
        "norepinephrinetransporter",
        "CPR:4",
        "cocaine"
      ]
    ],
    "updated": "No",
    "original": "Sodiumdependent norepinephrine induced currents in norepinephrinetransporter transfected HEK293 cells blocked by cocaine and antidepressants",
    "simplified": "Norepinephrine and norepinephrine-dependent currents in transfected HEK293 cells blocked by cocaine and antidepressants"
  },
  {
    "text": "To explain our observations , we propose that hNETs function as iongated ligand channels , and that the ion flux to the NE is a stoichiometry .",
    "triple_list": [
      [
        "hNETs",
        "CPR:9",
        "NE"
      ]
    ],
    "updated": "Yes",
    "original": "To explain our observations we propose that hNETs function as iongated ligand channels with an indefinite stoichiometry relating ion flux to NE transport",
    "simplified": "To explain our observations, we propose that hNETs function as iongated ligand channels, and that the ion flux to the NE is a stoichiometry."
  },
  {
    "text": "The active metabolite of the anti-inflammatory drug nabumetone is found in the blood . It acts as an inhibitor of the prostaglandin H synthase ( PGHS ) .",
    "triple_list": [
      [
        "nabumetone",
        "CPR:4",
        "prostaglandin H synthase"
      ],
      [
        "nabumetone",
        "CPR:4",
        "PGHS"
      ]
    ],
    "updated": "Yes",
    "original": "BACKGROUND The active metabolite of the antiinflammatory drug nabumetone has been characterized as a selective inhibitor of the inducible prostaglandin H synthase PGHS",
    "simplified": "The active metabolite of the anti-inflammatory drug nabumetone is found in the blood. It acts as an inhibitor of the prostaglandin H synthase (PGHS)."
  },
  {
    "text": "The daily administration of lowdose aspirin 40 mg a selective inhibitor of platelet PGHS1 caused a cumulative inhibition of urinary 11dehydroTXB2 and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover",
    "triple_list": [
      [
        "aspirin",
        "CPR:4",
        "PGHS1"
      ],
      [
        "PGHS1",
        "CPR:9",
        "11dehydroTXB2"
      ],
      [
        "PGHS1",
        "CPR:9",
        "TXB2"
      ]
    ],
    "updated": "No",
    "original": "The daily administration of lowdose aspirin 40 mg a selective inhibitor of platelet PGHS1 caused a cumulative inhibition of urinary 11dehydroTXB2 and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover",
    "simplified": "The daily administration of low dose aspirin 40 mg a selective inhibitor of platelet PGHS1 caused TXB2 production in whole blood to decrease by up to 40%. This timecourse was consistent with platelet turnover."
  },
  {
    "text": "CONCLUSIONS Nabumetone does dosedependently inhibit the cyclooxygenase activity of platelet PGHS1 of healthy subjects both in vivo and ex vivo",
    "triple_list": [
      [
        "Nabumetone",
        "CPR:4",
        "cyclooxygenase"
      ],
      [
        "Nabumetone",
        "CPR:4",
        "PGHS1"
      ]
    ],
    "updated": "No",
    "original": "CONCLUSIONS Nabumetone does dosedependently inhibit the cyclooxygenase activity of platelet PGHS1 of healthy subjects both in vivo and ex vivo",
    "simplified": "Conclusions Nabumetone dosedependently inhibits the activity of platelet PGHS1 in healthy subjects both in vivo and outside the body."
  },
  {
    "text": "Moreover the production of TXB2 during whole blood clotting was assessed as an index of the cyclooxygenase activity of platelet PGHS1 ex vivo",
    "triple_list": [
      [
        "TXB2",
        "CPR:9",
        "cyclooxygenase"
      ],
      [
        "TXB2",
        "CPR:9",
        "PGHS1"
      ]
    ],
    "updated": "No",
    "original": "Moreover the production of TXB2 during whole blood clotting was assessed as an index of the cyclooxygenase activity of platelet PGHS1 ex vivo",
    "simplified": "In addition, the production of TXB2 during whole blood clotting was measured to determine the activity of platelet PGHS1 ex vivo."
  },
  {
    "text": "Preclinical efficacy of emedastine a potent selective histamine H1 antagonist for topical ocular use",
    "triple_list": [
      [
        "emedastine",
        "CPR:6",
        "histamine H1"
      ]
    ],
    "updated": "No",
    "original": "Preclinical efficacy of emedastine a potent selective histamine H1 antagonist for topical ocular use",
    "simplified": "Emmedastine, a potent selective histamine H1 antagonist in preclinical studies, may be useful."
  },
  {
    "text": "2 Exposure histories vary in secondary 11q23 leukemia . In one case no topoisomerase II inhibitor was given , and in another case dactinomycin was given to patients .",
    "triple_list": [
      [
        "topoisomerase II",
        "CPR:4",
        "dactinomycin"
      ]
    ],
    "updated": "Yes",
    "original": "2 Exposure histories vary in secondary 11q23 leukemia as the only topoisomerase II inhibitor was dactinomycin in one case and in another case no topoisomerase II inhibitor was administered",
    "simplified": "2 Exposure histories vary in secondary 11q23 leukemia. In one case no topoisomerase II inhibitor was given, and in another case dactinomycin was given to patients."
  },
  {
    "text": "Indomethacin piroxicam and sulindac sulfide inhibit PGHS1 more than other drugs .",
    "triple_list": [
      [
        "Indomethacin",
        "CPR:4",
        "PGHS1"
      ],
      [
        "piroxicam",
        "CPR:4",
        "PGHS1"
      ],
      [
        "sulindac sulfide",
        "CPR:4",
        "PGHS1"
      ]
    ],
    "updated": "Yes",
    "original": "Indomethacin piroxicam and sulindac sulfide were found to preferentially inhibit PGHS1",
    "simplified": "Indomethacin piroxicam and sulindac sulfide inhibit PGHS1 more than other drugs."
  },
  {
    "text": "6Methoxy2naphthylacetic acid the active metabolite of Relafen inhibits murine PGHS2 preferentially",
    "triple_list": [
      [
        "6Methoxy2naphthylacetic acid",
        "CPR:4",
        "PGHS2"
      ],
      [
        "Relafen",
        "CPR:4",
        "PGHS2"
      ]
    ],
    "updated": "No",
    "original": "6Methoxy2naphthylacetic acid the active metabolite of Relafen inhibits murine PGHS2 preferentially",
    "simplified": "6Methoxy2naphthylacetic acid, an active metabolite of Relafen, is found in it."
  },
  {
    "text": "Aspirin irreversibly inhibits PGHS1 preventing this isozyme from forming PGH2 or any other oxygenated product in contrast aspirin treatment of PGHS2 causes this enzyme to form 15hydroxy5c8c11c13teicosatetraenoic acid 15HETE instead of PGH2",
    "triple_list": [
      [
        "Aspirin",
        "CPR:4",
        "PGHS1"
      ],
      [
        "PGHS2",
        "CPR:9",
        "15HETE"
      ],
      [
        "PGHS2",
        "CPR:9",
        "15hydroxy5c8c11c13teicosatetraenoic acid"
      ]
    ],
    "updated": "No",
    "original": "Aspirin irreversibly inhibits PGHS1 preventing this isozyme from forming PGH2 or any other oxygenated product in contrast aspirin treatment of PGHS2 causes this enzyme to form 15hydroxy5c8c11c13teicosatetraenoic acid 15HETE instead of PGH2",
    "simplified": "Aspirin stops this enzyme from making PGH2 or any other oxygenated product. Aspirin treatment of PGHS2 makes this enzyme make 15hydroxy5c8c11c13teicosatetraenoic acid 15HETE instead of PGH2, which is what aspirin does not do."
  },
  {
    "text": "Anorexia induced by amphetamine phentermine diethylpropion and phenylpropanolamine seems to be the result of their ability to increase the release of noradrenaline andor dopamine from nerve terminals and inhibit their reuptake or in the case of phenylpropanolamine to stimulate directly alpha 1adrenoceptors",
    "triple_list": [
      [
        "phenylpropanolamine",
        "CPR:3",
        "alpha 1adrenoceptors"
      ]
    ],
    "updated": "No",
    "original": "Anorexia induced by amphetamine phentermine diethylpropion and phenylpropanolamine seems to be the result of their ability to increase the release of noradrenaline andor dopamine from nerve terminals and inhibit their reuptake or in the case of phenylpropanolamine to stimulate directly alpha 1adrenoceptors",
    "simplified": "Diethylpropion and phenylpropanolamine can cause anorexia because they can increase the release of dopamine and noradrenaline from nerve terminals. They can also cause anorexia because they cause the release of dopamine and noradrenaline to the brain."
  },
  {
    "text": "Under these conditions a blockage of monoamine oxidase with pargyline 100 microM for 15 min changes the concentration of tryptamine and 5methoxytryptamine in the blood .",
    "triple_list": [
      [
        "monoamine oxidase",
        "CPR:4",
        "pargyline"
      ]
    ],
    "updated": "Yes",
    "original": "Under these conditions blockade of monoamine oxidase with pargyline 100 microM for 15 min caused a leftward displacement of concentrationeffect curves for both 5methoxytryptamine 5MeOT and tryptamine",
    "simplified": "Under these conditions a blockage of monoamine oxidase with pargyline 100 microM for 15 min changes the concentration of tryptamine and 5methoxytryptamine in the blood."
  },
  {
    "text": "In addition several ligands known to act as agonists at either 5HT2A or 5HT2C receptors including 1mchlorophenylpiperazine mCPP Ru 24969 MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan renzapride and 8hydroxy2dinpropylamino tetralin 8OHDPAT were very weak or inactive",
    "triple_list": [
      [
        "5HT2A",
        "CPR:5",
        "Ru 24969"
      ],
      [
        "5HT2C",
        "CPR:5",
        "Ru 24969"
      ],
      [
        "5HT2A",
        "CPR:5",
        "MK 212"
      ],
      [
        "5HT2C",
        "CPR:5",
        "MK 212"
      ],
      [
        "5HT2A",
        "CPR:5",
        "SCH 23390"
      ],
      [
        "5HT2C",
        "CPR:5",
        "SCH 23390"
      ],
      [
        "5HT2A",
        "CPR:5",
        "1mchlorophenylpiperazine"
      ],
      [
        "5HT2C",
        "CPR:5",
        "1mchlorophenylpiperazine"
      ],
      [
        "5HT2A",
        "CPR:5",
        "mCPP"
      ],
      [
        "5HT2C",
        "CPR:5",
        "mCPP"
      ]
    ],
    "updated": "No",
    "original": "In addition several ligands known to act as agonists at either 5HT2A or 5HT2C receptors including 1mchlorophenylpiperazine mCPP Ru 24969 MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan renzapride and 8hydroxy2dinpropylamino tetralin 8OHDPAT were very weak or inactive",
    "simplified": "In addition several ligands known to act as agonists at either 5HT2A or 5HT2C receptors including 1mchlorophenylpiperazine (MCPP) and 8hydroxy2dinpropylamino tetralin 8OHDPAT were very weak or inactive in rat fundus but were effective in humans."
  },
  {
    "text": "Neither ryanodine nor EGTA inhibited downregulation of alphaAR mRNA by NE",
    "triple_list": [
      [
        "EGTA",
        "CPR:3",
        "alphaAR"
      ],
      [
        "ryanodine",
        "CPR:3",
        "alphaAR"
      ],
      [
        "alphaAR",
        "CPR:4",
        "NE"
      ]
    ],
    "updated": "No",
    "original": "Neither ryanodine nor EGTA inhibited downregulation of alphaAR mRNA by NE",
    "simplified": "Ryanodine and EGTA did not work together to reduce alphaAR mRNA."
  },
  {
    "text": "Actinomycin D caused alphaAR mRNA level to decrease with a halflife of 32 hours . The effect of H7 on the alphaAR mRNA level was blocked .",
    "triple_list": [
      [
        "Actinomycin D",
        "CPR:4",
        "alphaAR"
      ],
      [
        "Actinomycin D",
        "CPR:4",
        "alphaAR"
      ]
    ],
    "updated": "Yes",
    "original": "Actinomycin D caused alphaAR mRNA level to decrease with a halflife of 32 04 h and blocked the effect of H7 to decrease basal alphaAR mRNA level",
    "simplified": "Actinomycin D caused alphaAR mRNA level to decrease with a halflife of 32 hours. The effect of H7 on the alphaAR mRNA level was blocked."
  },
  {
    "text": "Both NE and phorbol esters increased the rate of alphaAR mRNA degradation",
    "triple_list": [
      [
        "NE",
        "CPR:4",
        "alphaAR"
      ],
      [
        "phorbol esters",
        "CPR:4",
        "alphaAR"
      ]
    ],
    "updated": "No",
    "original": "Both NE and phorbol esters increased the rate of alphaAR mRNA degradation",
    "simplified": "Both NE and phorbol esters increased the amount of riboflavin."
  },
  {
    "text": "In NE desensitized cells phorbol esters and bradykinin each caused the expected downregulation of alphaAR mRNA",
    "triple_list": [
      [
        "NE",
        "CPR:4",
        "alphaAR"
      ],
      [
        "phorbol esters",
        "CPR:4",
        "alphaAR"
      ]
    ],
    "updated": "No",
    "original": "In NE desensitized cells phorbol esters and bradykinin each caused the expected downregulation of alphaAR mRNA",
    "simplified": "In the desensitized cells, bradykinin and phorbol esters caused the expected changes in alphaAR mRNA."
  },
  {
    "text": "The protein phosphatase inhibitor okadaic acid prolonged the normally transient effect of NE for at least 24 h. We conclude that protein kinase C exerts two opposing effects on alphaAR mRNA levels : 1 it requires a sustained phosphorylation of a protein kinase C substrate and 2 it has a permissive effect on alphaAR gene transcription .",
    "triple_list": [
      [
        "protein phosphatase",
        "CPR:4",
        "okadaic acid"
      ]
    ],
    "updated": "Yes",
    "original": "The protein phosphatase inhibitor okadaic acid prolonged the normally transient effect of NE for at least 24 h We conclude that protein kinase C exerts two opposing effects on alphaAR mRNA levels 1 a decrease in the stability of the mRNA that requires the sustained phosphorylation of a protein kinase C substrate and 2 a permissive effect on alphaAR gene transcription",
    "simplified": "The protein phosphatase inhibitor okadaic acid prolonged the normally transient effect of NE for at least 24 h. We conclude that protein kinase C exerts two opposing effects on alphaAR mRNA levels: 1 it requires a sustained phosphorylation of a protein kinase C substrate and 2 it has a permissive effect on alphaAR gene transcription."
  },
  {
    "text": "NE phorbol esters and bradykinin reduced the levels of alphaAR by 7080",
    "triple_list": [
      [
        "NE",
        "CPR:4",
        "alphaAR"
      ],
      [
        "phorbol esters",
        "CPR:4",
        "alphaAR"
      ]
    ],
    "updated": "Yes",
    "original": "NE phorbol esters and bradykinin each decreased alphaAR mRNA levels by 7080",
    "simplified": "NE phorbol esters and bradykinin reduced the levels of alphaAR by 7080"
  },
  {
    "text": "Phorbol esters and norepinephrine destabilize alpha 1Badrenergic receptor mRNA in vascular smooth muscle cells",
    "triple_list": [
      [
        "norepinephrine",
        "CPR:4",
        "alpha 1Badrenergic receptor"
      ]
    ],
    "updated": "No",
    "original": "Phorbol esters and norepinephrine destabilize alpha 1Badrenergic receptor mRNA in vascular smooth muscle cells",
    "simplified": "Phorbol esters and norepinephrine change the mRNA of the badrenergic receptor in smooth muscle cells"
  },
  {
    "text": "The mechanism by which norepinephrine NE downregulates alpha 1Badrenergic receptor alphaAR mRNA was studied in rabbit aortic smooth muscle cells",
    "triple_list": [
      [
        "norepinephrine",
        "CPR:4",
        "alpha 1Badrenergic receptor"
      ],
      [
        "norepinephrine",
        "CPR:4",
        "alphaAR"
      ],
      [
        "NE",
        "CPR:4",
        "alpha 1Badrenergic receptor"
      ],
      [
        "NE",
        "CPR:4",
        "alphaAR"
      ]
    ],
    "updated": "No",
    "original": "The mechanism by which norepinephrine NE downregulates alpha 1Badrenergic receptor alphaAR mRNA was studied in rabbit aortic smooth muscle cells",
    "simplified": "The effect of norepinephrine on the alpha 1Badrenergic receptor has been studied in rabbit smooth muscle cells."
  },
  {
    "text": "The protein kinase C inhibitor 15isoquinolinesulfonyl2methylpiperazine dihydrochloride H7 stopped phorbol esters from working . It also made mRNA levels lower .",
    "triple_list": [
      [
        "protein kinase C",
        "CPR:4",
        "15isoquinolinesulfonyl2methylpiperazine dihydrochloride"
      ],
      [
        "protein kinase C",
        "CPR:4",
        "H7"
      ]
    ],
    "updated": "Yes",
    "original": "The protein kinase C inhibitor 15isoquinolinesulfonyl2methylpiperazine dihydrochloride H7 abolished the effects of phorbol esters and NE and decreased basal mRNA levels by 52 3",
    "simplified": "The protein kinase C inhibitor 15isoquinolinesulfonyl2methylpiperazine dihydrochloride H7 stopped phorbol esters from working. It also made mRNA levels lower."
  },
  {
    "text": "HeLa cells transfected with the MR77 gene exhibited inhibition of adenylate cyclase in response to serotonin",
    "triple_list": [
      [
        "adenylate cyclase",
        "CPR:4",
        "serotonin"
      ]
    ],
    "updated": "No",
    "original": "HeLa cells transfected with the MR77 gene exhibited inhibition of adenylate cyclase in response to serotonin",
    "simplified": "HeLa cells that were transfected with the MR77 gene did not work at all when serotonin was applied."
  },
  {
    "text": "The selective 5HT1D agonist sumatriptan can bind to it , but not the mixed 5HT1A1D agonist 5carboxyamidotryptamine .",
    "triple_list": [
      [
        "5HT1D",
        "CPR:5",
        "sumatriptan"
      ]
    ],
    "updated": "Yes",
    "original": "The specific binding is displaced by the selective 5HT1D agonist sumatriptan but not by the mixed 5HT1A1D agonist 5carboxyamidotryptamine",
    "simplified": "The selective 5HT1D agonist sumatriptan can bind to it, but not the mixed 5HT1A1D agonist 5carboxyamidotryptamine."
  },
  {
    "text": "The antiarrhythmic effects of exogenous adenosine and Valsalva on this form of VT may be due to noncardiac effects ie exogenous adenosine may modulate VT through alterations in autonomic tone by activation of arterial chemoreceptors and Valsalva has been shown to decrease venous return resulting in a reduction in cardiac dimensions and myocardial stretch .",
    "triple_list": [
      [
        "adenosine",
        "CPR:3",
        "chemoreceptors"
      ]
    ],
    "updated": "Yes",
    "original": "The antiarrhythmic effects of exogenous adenosine and Valsalva on this form of VT may be due to receptormediated inhibition of adenylate cyclase or to noncardiac receptormediated effects ie exogenous adenosine may modulate VT through alterations in autonomic tone by activation of arterial chemoreceptors and Valsalva has been shown to decrease venous return resulting in a reduction in cardiac dimensions and myocardial stretch",
    "simplified": "The antiarrhythmic effects of exogenous adenosine and Valsalva on this form of VT may be due to noncardiac effects ie exogenous adenosine may modulate VT through alterations in autonomic tone by activation of arterial chemoreceptors and Valsalva has been shown to decrease venous return resulting in a reduction in cardiac dimensions and myocardial stretch."
  },
  {
    "text": "a cholinesterase inhibitor that potentiates the effects of acetylcholine at the muscarinic cholinergic receptor terminated VT in four of four patients an effect that was reversed by atropine",
    "triple_list": [
      [
        "muscarinic cholinergic receptor",
        "CPR:4",
        "atropine"
      ]
    ],
    "updated": "No",
    "original": "a cholinesterase inhibitor that potentiates the effects of acetylcholine at the muscarinic cholinergic receptor terminated VT in four of four patients an effect that was reversed by atropine",
    "simplified": "a cholinesterase inhibitor that stops acetylcholine from working at the muscarinic cholinergic receptor in four out of four patients did not work at all."
  },
  {
    "text": "VT came back when aminophylline was added . This is a competitive adenosine A1receptor .",
    "triple_list": [
      [
        "aminophylline",
        "CPR:6",
        "adenosine A1receptor"
      ]
    ],
    "updated": "Yes",
    "original": "VT recurred with the addition of aminophylline a competitive adenosine A1receptor antagonist",
    "simplified": "VT came back when aminophylline was added. This is a competitive adenosine A1receptor."
  },
  {
    "text": "Pretreatment with the dopamine D1 receptor antagonist SCH23390 and the NMDA receptor antagonist MK801 blocked amantadine induction of Fos in the striatum",
    "triple_list": [
      [
        "amantadine",
        "CPR:3",
        "Fos"
      ],
      [
        "SCH23390",
        "CPR:4",
        "Fos"
      ],
      [
        "MK801",
        "CPR:4",
        "Fos"
      ],
      [
        "dopamine D1 receptor",
        "CPR:6",
        "SCH23390"
      ],
      [
        "NMDA receptor",
        "CPR:6",
        "MK801"
      ]
    ],
    "updated": "No",
    "original": "Pretreatment with the dopamine D1 receptor antagonist SCH23390 and the NMDA receptor antagonist MK801 blocked amantadine induction of Fos in the striatum",
    "simplified": "The NMDA receptor antagonist MK801 and the dopamine D1 receptor antagonist SCH23390 did not allow amantadine to be taken up."
  },
  {
    "text": "However amantadine induction of Fos in the striatum was unaffected by the dopamine D2 receptor antagonist sulpiride",
    "triple_list": [
      [
        "amantadine",
        "CPR:3",
        "Fos"
      ],
      [
        "dopamine D2 receptor",
        "CPR:6",
        "sulpiride"
      ]
    ],
    "updated": "No",
    "original": "However amantadine induction of Fos in the striatum was unaffected by the dopamine D2 receptor antagonist sulpiride",
    "simplified": "However, when amantadine was added, Fos in the striatum was not affected by it."
  },
  {
    "text": "These results suggest that amantadine induction of Fos in the rat striatum is related to dopamine D1 and NMDA receptors",
    "triple_list": [
      [
        "amantadine",
        "CPR:3",
        "Fos"
      ]
    ],
    "updated": "No",
    "original": "These results suggest that amantadine induction of Fos in the rat striatum is related to dopamine D1 and NMDA receptors",
    "simplified": "These results suggest that Fos is related to dopamine D1 and NMDA receptors in the rat striatum."
  },
  {
    "text": "Amantadine can cause cfos in rat striatum when it is combined with other drugs .",
    "triple_list": [
      [
        "Amantadine",
        "CPR:3",
        "cfos"
      ]
    ],
    "updated": "Yes",
    "original": "Amantadine induces cfos in rat striatum reversal with dopamine D1 and NMDA receptor antagonists",
    "simplified": "Amantadine can cause cfos in rat striatum when it is combined with other drugs."
  },
  {
    "text": "Amantadine 1aminoadamantane induced Fos expression in the central dorsalmedial and ventralmedial part of the striatum",
    "triple_list": [
      [
        "Amantadine",
        "CPR:3",
        "Fos"
      ],
      [
        "1aminoadamantane",
        "CPR:3",
        "Fos"
      ]
    ],
    "updated": "No",
    "original": "Amantadine 1aminoadamantane induced Fos expression in the central dorsalmedial and ventralmedial part of the striatum",
    "simplified": "Amantadine causes Fos expression in the central part of the striatum in both dorsal and ventral."
  },
  {
    "text": "The amount of Fos produced by amantadine was more similar to those produced by other drugs . This was found to be true even for NMDA receptor antagonists .",
    "triple_list": [
      [
        "Fos",
        "CPR:3",
        "amantadine"
      ]
    ],
    "updated": "Yes",
    "original": "The distribution pattern of Fos induced by amantadine was more similar to those seen with dopaminomimetics than with NmethylDaspartate NMDA receptor antagonists",
    "simplified": "The amount of Fos produced by amantadine was more similar to those produced by other drugs. This was found to be true even for NMDA receptor antagonists."
  },
  {
    "text": "bolus finally 8 rabbits received aurintrycarboxilic acid ATA an inhibitor of platelet glycoprotein Ib von Willebrand factor interaction 10 mgkg iv",
    "triple_list": [
      [
        "aurintrycarboxilic acid",
        "CPR:4",
        "glycoprotein Ib"
      ],
      [
        "aurintrycarboxilic acid",
        "CPR:4",
        "von Willebrand factor"
      ],
      [
        "ATA",
        "CPR:4",
        "glycoprotein Ib"
      ],
      [
        "ATA",
        "CPR:4",
        "von Willebrand factor"
      ]
    ],
    "updated": "No",
    "original": "bolus finally 8 rabbits received aurintrycarboxilic acid ATA an inhibitor of platelet glycoprotein Ib von Willebrand factor interaction 10 mgkg iv",
    "simplified": "Bolus finally 8 rabbits received aurintrycarboxilic acid (ATA) 10 mgkg iv This is an inhibitor of the Ib von Willebrand factor."
  },
  {
    "text": "These events are stimulated by NE and by guanethidine an hNET substrate and they are blocked by cocaine and the antidepressant desipramine",
    "triple_list": [
      [
        "hNET",
        "CPR:4",
        "cocaine"
      ],
      [
        "hNET",
        "CPR:4",
        "desipramine"
      ],
      [
        "NE",
        "CPR:9",
        "hNET"
      ],
      [
        "guanethidine",
        "CPR:9",
        "hNET"
      ]
    ],
    "updated": "No",
    "original": "These events are stimulated by NE and by guanethidine an hNET substrate and they are blocked by cocaine and the antidepressant desipramine",
    "simplified": "These events are stimulated by NE and by guanethidine. Cocaine and the antidepressant desipramine block these events."
  },
  {
    "text": "Voltageclamp data combined with NE uptake data from these same cells show that hNETs have two different ways of moving signals . The two ways are called Tmode and Cmode .",
    "triple_list": [
      [
        "NE",
        "CPR:9",
        "hNETs"
      ]
    ],
    "updated": "Yes",
    "original": "Voltageclamp data combined with NE uptake data from these same cells indicate that hNETs have two functional modes of conduction a classical transporter mode Tmode and a novel channel mode Cmode",
    "simplified": "Voltageclamp data combined with NE uptake data from these same cells show that hNETs have two different ways of moving signals. The two ways are called Tmode and Cmode."
  },
  {
    "text": "The results when considered with previous reports in the literature show that amezinium is about 1000 times more potent and debrisoquine is about 20 times more potent for MAO inhibition in rat lungs than in tissue homogenates and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by uptake1",
    "triple_list": [
      [
        "amezinium",
        "CPR:4",
        "MAO"
      ],
      [
        "debrisoquine",
        "CPR:4",
        "MAO"
      ],
      [
        "amezinium",
        "CPR:9",
        "uptake1"
      ],
      [
        "debrisoquine",
        "CPR:9",
        "uptake1"
      ]
    ],
    "updated": "No",
    "original": "The results when considered with previous reports in the literature show that amezinium is about 1000 times more potent and debrisoquine is about 20 times more potent for MAO inhibition in rat lungs than in tissue homogenates and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by uptake1",
    "simplified": "The results when considered with previous reports in the literature show that amezinium is about 1000 times more potent in the intact lungs than in tissue homogenates and that debrisoquine is about 20 times more potent. The reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by uptake"
  },
  {
    "text": "Amezinium is much less potent as a MAO inhibitor in cells with the uptake2 transporter such as the myocardial cells of the heart",
    "triple_list": [
      [
        "Amezinium",
        "CPR:4",
        "MAO"
      ],
      [
        "Amezinium",
        "CPR:9",
        "uptake2 transporter"
      ]
    ],
    "updated": "No",
    "original": "Amezinium is much less potent as a MAO inhibitor in cells with the uptake2 transporter such as the myocardial cells of the heart",
    "simplified": "Amezinium is much less effective as a MAO inhibitor in myocardial cells, where it does not work very well."
  },
  {
    "text": "The results also showed that amezinium is very good at finding MAOA .",
    "triple_list": [
      [
        "amezinium",
        "CPR:4",
        "MAOA"
      ]
    ],
    "updated": "Yes",
    "original": "The results also confirmed previous reports that amezinium is highly selective for MAOA",
    "simplified": "The results also showed that amezinium is very good at finding MAOA."
  },
  {
    "text": "Previous studies have resulted in the classification of amezinium as a selective inhibitor of neuronal monoamine oxidase ( MAO ) in intact tissues . This is because it is a much more potent MAO inhibitor in intact tissues than in homogenates .",
    "triple_list": [
      [
        "amezinium",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "amezinium",
        "CPR:4",
        "MAO"
      ],
      [
        "amezinium",
        "CPR:4",
        "MAO"
      ]
    ],
    "updated": "Yes",
    "original": "Previous studies have resulted in the classification of amezinium as a selective inhibitor of neuronal monoamine oxidase MAO because it is a much more potent MAO inhibitor in intact tissues in which it is accumulated in noradrenergic neurones by uptake1 than in tissue homogenates",
    "simplified": "Previous studies have resulted in the classification of amezinium as a selective inhibitor of neuronal monoamine oxidase (MAO) in intact tissues. This is because it is a much more potent MAO inhibitor in intact tissues than in homogenates."
  },
  {
    "text": "In addition another drug that is both a substrate of uptake1 and a MAO inhibitor debrisoquine was investigated in the study",
    "triple_list": [
      [
        "MAO",
        "CPR:4",
        "debrisoquine"
      ],
      [
        "uptake1",
        "CPR:9",
        "debrisoquine"
      ]
    ],
    "updated": "No",
    "original": "In addition another drug that is both a substrate of uptake1 and a MAO inhibitor debrisoquine was investigated in the study",
    "simplified": "In addition another drug that is both a MAO inhibitor and a substrate of uptake1 was investigated in the study"
  },
  {
    "text": "Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats",
    "triple_list": [
      [
        "Amezinium",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "debrisoquine",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "Amezinium",
        "CPR:9",
        "uptake1"
      ],
      [
        "debrisoquine",
        "CPR:9",
        "uptake1"
      ]
    ],
    "updated": "No",
    "original": "Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats",
    "simplified": "Amezinium and debrisoquine inhibit monoamine oxidase in the lungs of rats, which is a problem."
  },
  {
    "text": "When 10 nmoll amezinium was also put in there , it stopped the deamination of noradrenaline by MAOA in the lungs .",
    "triple_list": [
      [
        "amezinium",
        "CPR:4",
        "MAOA"
      ]
    ],
    "updated": "Yes",
    "original": "When MAOB was also inhibited 10 nmoll amezinium caused 84 inhibition of the deamination of noradrenaline by MAOA in the lungs",
    "simplified": "When 10 nmoll amezinium was also put in there, it stopped the deamination of noradrenaline by MAOA in the lungs."
  },
  {
    "text": "We have investigated the effects of CP99994 2s3s32methoxybenzylamino2phenylpiperidine a tachykinin NK1 receptor antagonist HOE 140 DArgHyp3Thi5DTic7Oic8bradykinin a bradykinin B2 receptor antagonist and ketotifen 41methyl4piperidylidene4 Hbenzo45cycloheptal12bthiophen109Hone hydrogen fumarate a histamine H1 receptor antagonist with mast cellstabilizing properties on microvascular leakage induced by gaseous formaldehyde",
    "triple_list": [
      [
        "CP99994",
        "CPR:6",
        "tachykinin NK1 receptor"
      ],
      [
        "2s3s32methoxybenzylamino2phenylpiperidine",
        "CPR:6",
        "tachykinin NK1 receptor"
      ],
      [
        "HOE 140",
        "CPR:6",
        "bradykinin B2 receptor"
      ],
      [
        "DArgHyp3Thi5DTic7Oic8bradykinin",
        "CPR:6",
        "bradykinin B2 receptor"
      ],
      [
        "ketotifen",
        "CPR:6",
        "histamine H1 receptor"
      ],
      [
        "41methyl4piperidylidene4 Hbenzo45cycloheptal12bthiophen109Hone hydrogen fumarate",
        "CPR:6",
        "histamine H1 receptor"
      ]
    ],
    "updated": "No",
    "original": "We have investigated the effects of CP99994 2s3s32methoxybenzylamino2phenylpiperidine a tachykinin NK1 receptor antagonist HOE 140 DArgHyp3Thi5DTic7Oic8bradykinin a bradykinin B2 receptor antagonist and ketotifen 41methyl4piperidylidene4 Hbenzo45cycloheptal12bthiophen109Hone hydrogen fumarate a histamine H1 receptor antagonist with mast cellstabilizing properties on microvascular leakage induced by gaseous formaldehyde",
    "simplified": "We have investigated the effects of CP99994 2s3s32methoxybenzylamino2phenylpiperidine a histamine H1 receptor antagonist, HOE 140 DArgHyp3Thi5DTic7Oic8bradykinin a bradykinin B2 receptor antagonist and ketotifen 41methyl4piperidylidene4 Hbenzo45cycloheptal12bthiophen109 On microvascular leakage caused by gaseous formaldehyde We have investigated the effects of CP99994 2s3s32methoxybenzylamino2phenylpiperidine a histamine H1 receptor antagonist."
  },
  {
    "text": "HERG IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs such as dofetilide E4031 and MK499 at submicromolar concentrations",
    "triple_list": [
      [
        "HERG",
        "CPR:4",
        "E4031"
      ],
      [
        "IKr",
        "CPR:4",
        "E4031"
      ],
      [
        "HERG",
        "CPR:4",
        "MK499"
      ],
      [
        "IKr",
        "CPR:4",
        "MK499"
      ],
      [
        "HERG",
        "CPR:4",
        "methanesulfonanilide"
      ],
      [
        "IKr",
        "CPR:4",
        "methanesulfonanilide"
      ],
      [
        "HERG",
        "CPR:4",
        "dofetilide"
      ],
      [
        "IKr",
        "CPR:4",
        "dofetilide"
      ]
    ],
    "updated": "No",
    "original": "HERG IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs such as dofetilide E4031 and MK499 at submicromolar concentrations",
    "simplified": "The HERG IKr channels are a prime target for the pharmacological management of arrhythmias. Class III antiarrhythmic drugs such as dofetilide and MK499 can selectively block the HERG IKr channels."
  },
  {
    "text": "Molecular determinants of dofetilide block of HERG K channels",
    "triple_list": [
      [
        "dofetilide",
        "CPR:4",
        "HERG"
      ],
      [
        "dofetilide",
        "CPR:4",
        "K channels"
      ]
    ],
    "updated": "No",
    "original": "Molecular determinants of dofetilide block of HERG K channels",
    "simplified": "Molecular structure and function of dofetilide"
  },
  {
    "text": "Treatment using a combination of testosterone and the aromatase inhibitor testolactone may have significantly better effects on sexual function and also seizure frequency than testosterone alone",
    "triple_list": [
      [
        "aromatase",
        "CPR:4",
        "testolactone"
      ]
    ],
    "updated": "No",
    "original": "Treatment using a combination of testosterone and the aromatase inhibitor testolactone may have significantly better effects on sexual function and also seizure frequency than testosterone alone",
    "simplified": "Treatment using a combination of testosterone and testolactone may have better effects on sexual function and seizure frequency than using testosterone alone."
  },
  {
    "text": "A 59yearold female suffering from malignant lymphoma developed therapyrelated acute myeloblastic leukemia tAML after chemotherapy consisting of treatment with DNAtopoisomerase II inhibitors etoposide and mitoxantrone and an alkylating agent cyclophosphamide",
    "triple_list": [
      [
        "DNAtopoisomerase II",
        "CPR:4",
        "etoposide"
      ],
      [
        "DNAtopoisomerase II",
        "CPR:4",
        "mitoxantrone"
      ]
    ],
    "updated": "No",
    "original": "A 59yearold female suffering from malignant lymphoma developed therapyrelated acute myeloblastic leukemia tAML after chemotherapy consisting of treatment with DNAtopoisomerase II inhibitors etoposide and mitoxantrone and an alkylating agent cyclophosphamide",
    "simplified": "A 59yearold female suffering from malignant lymphoma developed acute myeloblastic leukemia tAML after chemotherapy. After treatment with etoposide and mitoxantrone and an alkylating agent cyclophosphamide, the patient did better."
  },
  {
    "text": "A case of therapyrelated acute myeloblastic leukemia with t1621q24q22 after chemotherapy with DNAtopoisomerase II inhibitors etoposide and mitoxantrone and the alkylating agent cyclophosphamide",
    "triple_list": [
      [
        "DNAtopoisomerase II",
        "CPR:4",
        "etoposide"
      ],
      [
        "DNAtopoisomerase II",
        "CPR:4",
        "mitoxantrone"
      ]
    ],
    "updated": "No",
    "original": "A case of therapyrelated acute myeloblastic leukemia with t1621q24q22 after chemotherapy with DNAtopoisomerase II inhibitors etoposide and mitoxantrone and the alkylating agent cyclophosphamide",
    "simplified": "A case of acute myeloblastic leukemia with t1621q24q22 after chemotherapy with etoposide and mitoxantrone and the alkylating agent cyclophosphamide was reported in 2007."
  },
  {
    "text": "A low tyramine diet is recommended if selegiline is used together with nonselective MAO inhibitors or the selective reversible MAOA inhibitor moclobemide",
    "triple_list": [
      [
        "selegiline",
        "CPR:4",
        "MAO"
      ],
      [
        "MAOA",
        "CPR:4",
        "moclobemide"
      ]
    ],
    "updated": "No",
    "original": "A low tyramine diet is recommended if selegiline is used together with nonselective MAO inhibitors or the selective reversible MAOA inhibitor moclobemide",
    "simplified": "A low tyramine diet is recommended if selegiline is used with the drug moclobemide. This drug does not work as well with other drugs."
  },
  {
    "text": "Selegiline deprenyl a selective irreversible inhibitor of monoamine oxidase type B MAOB is widely used in the treatment of Parkinsons disease",
    "triple_list": [
      [
        "Selegiline",
        "CPR:4",
        "monoamine oxidase type B"
      ],
      [
        "Selegiline",
        "CPR:4",
        "MAOB"
      ],
      [
        "deprenyl",
        "CPR:4",
        "monoamine oxidase type B"
      ],
      [
        "deprenyl",
        "CPR:4",
        "MAOB"
      ]
    ],
    "updated": "No",
    "original": "Selegiline deprenyl a selective irreversible inhibitor of monoamine oxidase type B MAOB is widely used in the treatment of Parkinsons disease",
    "simplified": "Selegiline deprenyl, an irreversible inhibitor of monoamine oxidase type B, is widely used in the treatment of Parkinson's disease."
  },
  {
    "text": "Unlike the nonselective MAO inhibitors selegiline does not significantly potentiate tyramineinduced hypertension , but it can be very helpful in the treatment of Parkinson 's disease .",
    "triple_list": [
      [
        "MAO",
        "CPR:4",
        "selegiline"
      ]
    ],
    "updated": "Yes",
    "original": "Unlike the nonselective MAO inhibitors selegiline does not significantly potentiate tyramineinduced hypertension the cheese effect at the dosages 5 to 10 mg daily used for the treatment of Parkinsons disease",
    "simplified": "Unlike the nonselective MAO inhibitors selegiline does not significantly potentiate tyramineinduced hypertension, but it can be very helpful in the treatment of Parkinson's disease."
  },
  {
    "text": "Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator mediated Cl secretion",
    "triple_list": [
      [
        "Ibuprofen",
        "CPR:4",
        "cystic fibrosis transmembrane conductance regulator"
      ]
    ],
    "updated": "No",
    "original": "Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator mediated Cl secretion",
    "simplified": "Cystic fibrosis transmembrane conductance regulator - Ibuprofen inhibits Cl secretion."
  },
  {
    "text": "Ibuprofen 300 microM reduced CFTR Cl current by 6016 and this was explained by a short-lived block about 12 ms . When this block happened , the single channel amplitude went from 107004 pA to 059004 pA .",
    "triple_list": [
      [
        "Ibuprofen",
        "CPR:4",
        "CFTR"
      ]
    ],
    "updated": "Yes",
    "original": "Ibuprofen 300 microM reduced CFTR Cl current by 6016 and this was explained by a shortlived block approximately 12 ms which causes an apparent reduction in single channel amplitude from 107004 pA to 059004 pA n = 3",
    "simplified": "Ibuprofen 300 microM reduced CFTR Cl current by 6016 and this was explained by a short-lived block about 12 ms. When this block happened, the single channel amplitude went from 107004 pA to 059004 pA."
  },
  {
    "text": "Similarly salicylic acid 3 mM reduced CFTR Cl current by 508 with an apparent reduction in single channel amplitude from 108003 pA to 048006 pA n = 4",
    "triple_list": [
      [
        "salicylic acid",
        "CPR:4",
        "CFTR"
      ]
    ],
    "updated": "No",
    "original": "Similarly salicylic acid 3 mM reduced CFTR Cl current by 508 with an apparent reduction in single channel amplitude from 108003 pA to 048006 pA n = 4",
    "simplified": "Salicylic acid 3 mM reduced CFTR Cl current by 508 with an apparent reduction in single channel amplitude. This effect is seen in Figure 2."
  },
  {
    "text": "Based on these results we conclude that the NSAIDs ibuprofen and salicylic acid inhibit cAMPmediated Cl secretion in human colonic and airway epithelia via a direct inhibition of CFTR Cl channels as well as basolateral membrane K channels",
    "triple_list": [
      [
        "ibuprofen",
        "CPR:4",
        "CFTR"
      ],
      [
        "ibuprofen",
        "CPR:4",
        "Cl channels"
      ],
      [
        "ibuprofen",
        "CPR:4",
        "K channels"
      ],
      [
        "salicylic acid",
        "CPR:4",
        "CFTR"
      ],
      [
        "salicylic acid",
        "CPR:4",
        "Cl channels"
      ],
      [
        "salicylic acid",
        "CPR:4",
        "K channels"
      ]
    ],
    "updated": "No",
    "original": "Based on these results we conclude that the NSAIDs ibuprofen and salicylic acid inhibit cAMPmediated Cl secretion in human colonic and airway epithelia via a direct inhibition of CFTR Cl channels as well as basolateral membrane K channels",
    "simplified": "Based on these results, we conclude that the NSAIDs ibuprofen and salicylic acid inhibit cAMPmediated Cl secretion in human colonic and airway epithelia by directly inhibiting the CFTR and K channels, respectively."
  },
  {
    "text": "These data indicate that mixed 5HT1 5HT2 receptor antagonists such as pizotifen and methysergide and mixed 5HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPPinduced behavioural inhibition in rats than the more selective 5HT2A 5HT2C antagonist ritanserin",
    "triple_list": [
      [
        "5HT2A",
        "CPR:6",
        "ritanserin"
      ],
      [
        "5HT2C",
        "CPR:6",
        "ritanserin"
      ],
      [
        "5HT1",
        "CPR:6",
        "pizotifen"
      ],
      [
        "5HT2",
        "CPR:6",
        "pizotifen"
      ],
      [
        "5HT1",
        "CPR:6",
        "methysergide"
      ],
      [
        "5HT2",
        "CPR:6",
        "methysergide"
      ]
    ],
    "updated": "No",
    "original": "These data indicate that mixed 5HT1 5HT2 receptor antagonists such as pizotifen and methysergide and mixed 5HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPPinduced behavioural inhibition in rats than the more selective 5HT2A 5HT2C antagonist ritanserin",
    "simplified": "Pizotifen and methysergide are mixed 5HT1 5HT2 receptor antagonists, mianserin and mirtazapine are mixed 5HT and catecholamine antagonists, mianserin and mirtazapine are more potent antagonists of mCPPinduced behavioural inhibition in rats than the more selective 5HT2A 5HT2C antagonist ritanserin."
  },
  {
    "text": "The cardiovascular effects of three different acetylcholinesterase inhibitors physostigmine tacrine and rivastigmine injected by intravenous iv",
    "triple_list": [
      [
        "acetylcholinesterase",
        "CPR:4",
        "physostigmine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "tacrine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "rivastigmine"
      ]
    ],
    "updated": "No",
    "original": "The cardiovascular effects of three different acetylcholinesterase inhibitors physostigmine tacrine and rivastigmine injected by intravenous iv",
    "simplified": "The effects of three different acetylcholinesterase inhibitors on blood pressure when injected into the heart:"
  },
  {
    "text": "The alpha1adrenoceptor antagonist prazosin or the vasopressin V1 receptor antagonist betamercaptobetabetacyclopentamethylenepropionyl1 OMeTyr2 Arg8 vasopressin can reduce the effect of tacrine pressor . However , it does not completely reduce it .",
    "triple_list": [
      [
        "alpha1adrenoceptor",
        "CPR:6",
        "prazosin"
      ],
      [
        "vasopressin V1 receptor",
        "CPR:6",
        "betamercaptobetabetacyclopentamethylenepropionyl1 OMeTyr2 Arg8 vasopressin"
      ]
    ],
    "updated": "Yes",
    "original": "The alpha1adrenoceptor antagonist prazosin or the vasopressin V1 receptor antagonist betamercaptobetabetacyclopentamethylenepropionyl1 OMeTyr2 Arg8 vasopressin partially but significantly reduced tacrine pressor effect and mostly abolished it when administered concomitantly",
    "simplified": "The alpha1adrenoceptor antagonist prazosin or the vasopressin V1 receptor antagonist betamercaptobetabetacyclopentamethylenepropionyl1 OMeTyr2 Arg8 vasopressin can reduce the effect of tacrine pressor. However, it does not completely reduce it."
  },
  {
    "text": "administration of the nonselective muscarinic receptor antagonist atropine ID50 = 145 microg the muscarinic M1 receptor antagonist pirenzepine ID50 = 433 microg the muscarinic M2 receptor antagonist methoctramine ID50 = 139 microg and the muscarinic M3 receptor antagonist parafluorohexahydrosiladifenidol ID50 = 3119 microg",
    "triple_list": [
      [
        "muscarinic receptor",
        "CPR:6",
        "atropine"
      ],
      [
        "muscarinic M1 receptor",
        "CPR:6",
        "pirenzepine"
      ],
      [
        "muscarinic M2 receptor",
        "CPR:6",
        "methoctramine"
      ],
      [
        "muscarinic M3 receptor",
        "CPR:6",
        "parafluorohexahydrosiladifenidol"
      ]
    ],
    "updated": "No",
    "original": "administration of the nonselective muscarinic receptor antagonist atropine ID50 = 145 microg the muscarinic M1 receptor antagonist pirenzepine ID50 = 433 microg the muscarinic M2 receptor antagonist methoctramine ID50 = 139 microg and the muscarinic M3 receptor antagonist parafluorohexahydrosiladifenidol ID50 = 3119 microg",
    "simplified": "the nonselective muscarinic receptor antagonist pirenzepine ID50 = 433 microg and the muscarinic receptor antagonist methoctramine ID50 = 139 microg The muscarinic receptor antagonist parafluorohexahydrosiladifenidol ID50 = 3119 microg The muscarinic receptor antagonist parafluorohexahydrosiladifenidol ID50 = 3119 microg"
  },
  {
    "text": "Cocaine block of human cardiac hH1 and rat skeletal mu1 muscle sodium channels was examined under wholecell voltage clamp in transiently transfected HEK293t cells",
    "triple_list": [
      [
        "Cocaine",
        "CPR:4",
        "human cardiac hH1"
      ],
      [
        "Cocaine",
        "CPR:4",
        "rat skeletal mu1 muscle sodium channels"
      ]
    ],
    "updated": "No",
    "original": "Cocaine block of human cardiac hH1 and rat skeletal mu1 muscle sodium channels was examined under wholecell voltage clamp in transiently transfected HEK293t cells",
    "simplified": "Cocaine block of rat skeletal mu1 muscle sodium channels under wholecell voltage clamp in transiently transfected HEK293t cells"
  },
  {
    "text": "Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between 120 mV and 90 mV . This means that when hH1 channels are in a constant state , they can not be blocked by cocaine .",
    "triple_list": [
      [
        "Cocaine",
        "CPR:4",
        "hH1 channels"
      ],
      [
        "Cocaine",
        "CPR:4",
        "mu1 channels"
      ],
      [
        "Cocaine",
        "CPR:4",
        "hH1 channels"
      ],
      [
        "hH1 channels",
        "CPR:4",
        "cocaine"
      ]
    ],
    "updated": "Yes",
    "original": "Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between 120 mV and 90 mV suggesting that greater steadystate inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block",
    "simplified": "Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between 120 mV and 90 mV. This means that when hH1 channels are in a constant state, they can not be blocked by cocaine."
  },
  {
    "text": "Statedependent cocaine block of sodium channel isoforms chimeras and channels coexpressed with the beta1 subunit",
    "triple_list": [
      [
        "cocaine",
        "CPR:4",
        "sodium channel"
      ]
    ],
    "updated": "No",
    "original": "Statedependent cocaine block of sodium channel isoforms chimeras and channels coexpressed with the beta1 subunit",
    "simplified": "Sodium channel chimeras and channels coexpressed with the beta1 subunit in cocaine-dependent cocaine."
  }
]